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ABSTRACT

Profiling of sncRNA and mapping transcriptional changes in bovine somatic cell nuclear transfer
embryos during early development through the maternal-to-embryonic transition
by
Jocelyn M. Cuthbert, Doctor of Philosophy
Utah State University, 2020

Major Professor: Dr. Abby Benninghoff and Dr. Kenneth White
Department: Animal, Dairy, and Veterinary Sciences
The efficiency of embryo production by somatic cell nuclear transfer (scNT) is far below
that of in vitro fertilized embryos (IVF), likely due to the accumulation of errors in genome
reprogramming, which may encompass the coding genes for small non-coding RNAs (sncRNAs).
While sncRNAs have been reported to be important in mammalian embryo development, their
potential functions have not been assessed through the critical maternal-to-embryonic transition
(MET) in cattle embryos. The objectives of this study were to examine changes in expression of
sncRNA during the MET in bovine IVF embryos, to assess the dysregulation of sncRNA and
transcriptome profiles in scNT bovine embryos compared to IVF embryos, and to correlate
transcript expression profiles with micro-RNA expression profiles. First, RNA sequencing was
utilized to profile sncRNAs in bovine IVF oocytes and 8-cell- and blastocyst-staged bovine
embryos. The analyses revealed a strong dynamic shift in relative abundance of differentially
expressed sncRNAs, suggesting important roles for sncRNAs during the MET. Next, small and
large RNA fractions were isolated from the same samples of cattle embryos produced via IVF or
scNT at the 2-cell, 8-cell, morula and blastocyst developmental stages, and from MII oocytes,
donor cell fibroblasts and either IVF or scNT blastocyst-derived cells (BDCs). RNA sequencing
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showed that few sncRNAs were differentially expressed between scNT and IVF embryos, with all
significant differences occurring at the morula stage. Differential expression of sncRNAs was
apparent between stages of development within type (scNT or IVF), with changes in sncRNA
populations appearing to be based on the relative differentiation status of developmental stage.
Last, transcriptome data analysis revealed large-scale differences between scNT and IVF embryos
at each developmental stage examined. Interestingly, altered transcripts at the 8-cell stage were
associated with biological functions critical for the MET. The abundance of two miRNAs
differentially expressed in scNT morulae, miR-34a and miR-345, was negatively correlated with
the expression of some predicted mRNA targets. However, broad changes in mRNA expression
were not consistently correlated with aberrations in miRNA expression, suggesting that other
mechanisms leading to altered expression of mRNA in scNT embryos may be at play.

(382 pages)
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PUBLIC ABSTRACT

Profiling of sncRNA and mapping transcriptional changes in bovine somatic cell nuclear transfer
embryos during early development through the maternal-to-embryonic transition
Jocelyn M. Cuthbert

Major Professor: Drs. Abby D. Benninghoff and Kenneth L. White
Department: Animal, Dairy, and Veterinary Sciences
Cloning animals using somatic cell nuclear transfer (scNT) was first successfully
demonstrated with the birth of Dolly the sheep, but the process of cloning remains highly
inefficient. By improving our understanding of the errors that may occur during cloned cattle
embryo development, we could obtain a greater understanding of how specific molecular events
contribute to successful development. The central dogma of biology refers to the process of DNA
being transcribed into messenger RNA (mRNA) and the translation of mRNA into proteins,
which ultimately carry out the functions encoded by genes. The epigenetic code is defined as the
array of chemical modifications, or “marks”, to DNA molecules that do not change the genome
sequence but do allow for control of gene expression. During early development, genome
reprogramming involves the removal of epigenetic marks from the sperm and egg and reestablishment of marks for the embryonic genome that code for proper gene expression to support
embryo development. The point during this process at which the embryo’s genes are turned on is
known as embryonic genome activation (EGA). Small non-coding RNAs (sncRNAs), including
microRNAs (miRNAs), may also contribute to the this process. For example, miRNA molecules
do not code for proteins themselves, but rather bind to mRNAs and effectively block their
translation into protein. We hypothesized that aberrant expression of sncRNAs in cloned
embryos may lead to anomalous abundance of mRNA molecules, thus explaining poor
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development of cloned embryos. First, we used RNA sequencing to examine the total population
of sncRNAs in cattle embryos produced by in vitro fertilization (IVF) and found a dramatic shift
in populations at the EGA. Next, we collected both sncRNA and mRNA from scNT cattle
embryos, and again performed sequencing of both RNA fractions. We found that few sncRNAs
were abnormally expressed in scNT embryos, with all differences appearing after EGA at the
morula developmental stage. However, notable differences in the populations of sncRNAs were
evident when comparing embryos by developmental stage. For populations of mRNA, we
observed dramatic differences when comparing scNT and IVF cattle embryos, with the highest
number of changes occurring at the EGA (8-cell stage) and after (morula stage). While changes
in specific miRNA molecules (miR-34a and miR-345) were negatively correlated with some of
their predicted target mRNAs, this pattern was not widespread as would be expected if these
sncRNAs are functionally binding to all of the predicted mRNA targets. Collectively, our
observations suggest that other mechanisms leading to altered expression of mRNA in cloned
embryos may be responsible for their relatively poor development.
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CHAPTER 1
REVIEW OF THE LITERATURE

Classes of Ribonucleic Acids
The field of molecular biology has long been dominated by the central dogma that
reading the DNA code to generate the protein machinery of the cell is a two-step process, first
requiring the copying of the DNA code into messenger RNA via transcription and then
converting that RNA code into functional protein via translation. However, scientists now
understand that this central dogma is inadequate to fully explain the highly complex process of
copying and translating DNA code to generate the necessary molecular machinery necessary for
cellular function. Indeed, researchers have determined that multiple types of RNA molecules,
including some types that do not code for proteins, are involved in regulating this flow of genetic
information within cells. Small non-coding RNA (sncRNA) includes all RNA under 200 nt in
length that are functional despite not coding for protein. Alternatively, large RNA includes
molecules more than 200 nt in length, both protein coding (messenger or mRNA) and non-protein
coding (long non-coding or lncRNA). RNA interference (RNAi) is the main pathway by which
sncRNAs regulate the flow of genetic information, through the binding of transcripts based on
sequence complementarity. Once bound to the target transcript, sncRNAs cause repression of
translation and degradation. The field of sncRNA is rapidly expanding, as RNAi control of gene
expression was once thought limited to microRNA (miRNA) and small interfering RNA
(siRNA), but new functions in RNAi have been discovered for piwi-interacting RNAs (piRNAs),
transfer RNA fragments (tRFs), and small nucleolar RNA (snoRNAs) fragments. The synthesis,
function, and regulation of these classes of sncRNA, along with the classes of large RNA, share
some biological processes, while differing in some key ways that allow for functional
differentiation between classes.
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Messenger RNA
The fundamentals of messenger RNA (mRNA) synthesis, transcription, and translation
are very well understood and covered in any basic molecular biology textbook. However, there
are nuances in the biosynthesis and modification of transcripts that change the regulation of
mRNA molecules by sncRNA. Localization, RNA-bound proteins, cis-regulatory elements, and
other chemical changes, especially those that impact the 3’ untranslated region (UTR) of the
mRNA, are important in regulating the transcript’s availability for binding by miRNAs and other
sncRNAs that participate in RNAi. The poly-adenylation of transcripts also has specialized
function in early development, as embryos have unique pathways of degradation to protect
maternal transcripts until embryonic genome activation (EGA). Due to the specialized nature of
these pathways, background on traditional polyadenylation and degradation pathways will be
thoroughly covered as well.
The control of protein-coding gene expression is vital to many biological processes and is
highly regulated at the level of transcription. DNA transcription results in in the production of
pre-mRNA molecules, which undergo splicing and process events to produce mRNA. Many of
these mRNA molecules undergo the process of translation to ultimately produce proteins.
Initiation of transcription begins with the sigma subunit of RNA polymerase binding to the TATA
box, which is located at 35 and 25 bases upstream of the initiation site. A group of transcription
factors form the pre-initiation complex, which binds to the promoter region and recruits RNA
polymerase. Once bound, the RNA polymerase is released from the other transcription factors
and elongation begins as pre-mRNA is synthesized from the 5’ to 3’ direction as the polymerase
travels on the template DNA in the 3’ to 5’ direction. The RNA polymerase unwinds the doublestranded template DNA, and template DNA behind rewinds in a transcription bubble of about 25
unwound DNA base pairs. Because eukaryotic DNA is packaged into chromatin and
nucleosomes when the cells are not dividing, a special protein complex facilitates chromatic
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transcription (FACT), pulling away histones from the DNA template and replacing and recreating
the nucleosomes once transcription is complete. Termination signals are different for each
polymerase, with RNA polymerase I requiring a specific termination sequence that causes a
termination protein to bind and block further transcription. RNA polymerase II transcribes the
majority of protein-encoding RNAs, structural RNAs, and regulatory RNA genes. These genes
lack a termination signal, resulting in elongation continuing beyond the gene body; the resulting
tail is removed during mRNA processing, thus releasing the pre-mRNA from the polymerase as it
continues to transcribe, with the continued transcription product degraded by 5’ exonuclease,
which disengages the polymerase from the template DNA. RNA polymerase III requires a
hairpin structure termination signal to terminate transcription that is not completely understood
[1, 2].
The primary transcript originating from the DNA is referred to as “pre-mRNA”, which
includes sequence regions destined to be translated into amino acids, located in exons – and
sections that are excised and not translated – the introns. Removal of introns from pre-mRNA
sequences occurs via the spliceosome, through trans-esterification reactions that recognize the
splicing signals in the intron. Alternative splicing of these sequences can give rise to multiple
mature mRNA sequences for a particular gene, thus greatly amplifying the message
communicated via the genomic code; this process occurs in over 90% of genes in mammals.
Alternative splicing takes place in the nucleus and can occur via intron retention, exon inclusion
or skipping, alternative 3’ splicing, or alternative 5’ splicing [3]. Additional processing includes
modification of the 5’ end of the mRNA molecule to include a specialized structure referred to as
a 7-methylguanylate cap (m7G), a modification that facilitates transport into the cytoplasm,
translation, and protection from degradation. The poly-A tail is created through polyadenylation
of the 3’ end, which also allows for nuclear export of the mRNA molecule, stabilizes the structure
in the cytoplasm, and is involved in the initiation of translation [1].
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In addition to the coding information embedded within its structure, mRNA also contains
information that communicates how frequently the molecule should be translated, how long it
will persist, and where in the cell it will be translated. The lifespan of an mRNA transcript
greatly impacts its cellular function. As a case in point, so-called “housekeeping” genes are those
that are typically ubiquitously and consistently expressed in all cell types as they are required for
basic cell function and maintenance. Thus, housekeeping genes typically have longer half-lives
compared to those encoding regulatory proteins [4]. A transcript’s half-life is encoded in the
form of non-coding genomic sequences called cis-acting sequences that are typically functionally
relevant when located in the mRNA 5’ or 3’ untranslated region [1]. These cis-acting sequences
serve as binding sites for trans-acting factors, RNA binding proteins, and sncRNA and can
impact translation and degradation of the transcript [5]. Messenger RNA has also been found to
be the subject of base modifications via chemical alterations, and it is likely that these changes
impact RNA stability, base pairing, and RNA confirmation [6].
The functional forms of pre-mRNAs and mRNAs in cells are bound by proteins as
ribonucleoprotein complexes (RNPs). Changes in mRNA structure can occur through
modification of the nucleotide sequence through splicing [7]. These changes can dictate whether
proteins dissociate and rebind later in the mRNA’s lifespan or remain stably bound. The early
processing of the mRNA occurs in the nucleus, after which the mRNA is exported to the
cytoplasm. The nuclear pore complex (NPC) is a supramolecular assembly that acts as a
gatekeeper to prevent the movement of proteins and protein RNA complexes between the nucleus
and cytoplasm. Several mRNA binding proteins act as export adaptors, and they bridge the
mRNA to the receptor proteins, which in turn contracts components of the NPC [8]. Once the
mRNAs are in the cytoplasm, many of them are immediately translationally active. These
changes in localization, bound proteins, and structure of mRNAs can significantly change the
regulation of mRNA by sncRNAs, especially those that impact the 3’UTR.
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Gene expression is highly regulated in a multitude of pathways, allowing for the finetuning of expression during both transcription and translation, as well as during RNA processing.
RNA transport and localization, mRNA degradation, translational control, and protein activity all
regulate gene expression. Proteins with DNA binding motifs can recognize DNA sequences and
bind to base pairs in the major or minor groove. These proteins include a DNA binding domain,
which guide the protein to complex with DNA at specific sequences, and a transcriptional effect
domain, which impacts gene transcription [9]. More than 5% of the human genome codes for
transcriptional regulatory machinery, which often function in a combinational, synergistic fashion
[10]. Transcriptional activators recruit basal (general) transcription factors, the transcriptioninitiation complex, or factors that loosen chromatin. Transcriptional repressors can prevent the
binding of activators, mask activation domains, block transcription factors, or recruit factors that
tighten chromatin. Some of these activators or repressors also have an impact on the splicing of
pre-mRNA, due to the close relationship between transcription and RNA processing. Regulation
of transcriptional activity allows a broad range of expression levels, leading to the fine-tuning of
transcription depending on the factors present [9]. Some epigenetic mechanisms that affect the
level of transcription that occur are discussed in more detail below. Highly unstable species of
mRNA (half-lives of 10-15 min) are present at low, steady levels. While low transcription would
conserve resources, using a high rate of turnover to control levels of mRNAs allows for rapid
induction of gene expression when needed and rapid loss when transcripts are no longer
necessary. Transcripts with these types of rapid controls are often critical for regulatory function
during developmental processes, during which period they are needed only briefly [11].
Messenger RNAs are relatively unstable, as the cell contains a multitude of RNA
degrading proteins called ribonucleases. Ribonucleases cleave the phosphodiester linkage
connecting the ribonucleotides, and are either endoribonucleases, which cleave RNA at internal
linkages, or exoribonucleases, which remove nucleotides from a terminus in a directional manner.
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Five-prime (5’) exonucleases hydrolyze RNA from the 5’ end, and 3’ exonucleases hydrolyze
RNA from the 3’ end [12]. The half-life of mRNA is a characteristic of each individual mRNA
molecule [11]. The abundance of a particular mRNA within a cell is often more dependent on the
control of decay processes than on the generation of the mRNA through transcription and RNA
processing [8]. Helicases are an ATP-dependent protein family that participate both in almost all
pathways of RNA processing and degradation. Helicases function with both exonucleases and
endonucleases, unwind secondary structure or remove RNA bound proteins, and may remain in
position while recruiting degradation machinery [13].
The degradation of the majority of mRNAs depends on deadenylation. The poly(A) tail
in mammals is about 200 nt long and is coated by Poly A binding proteins (PABPs). The poly(A)
tail is subject to gradual shortening in the cytoplasm by poly(A) nucleases. The PABPs protect
the poly(A) tail from degradation through interaction with translation factors that bridge to the 5’
cap. Eukaryotic translation initiation factor 4 (eIF4G), functions as a multifunctional adaptor
bringing together translational machinery through interaction with the 5’cap and poly(A) tail to
create a pseudo circular structure. The pseudo circular structure depends on the PABP, which
stimulates translation [2]. The bridging circularizes the mRNA molecule, which increases
translation and prevents degradation [14]. When degraded, the poly(A) tail is initially shortened
by the PAN2/3 complex, which leaves a 60-80 nt long tail. The rest of the poly(A) tail is
degraded rapidly by the CCR4-NOT complex, which contains exonucleases. Another normal
pathway for degradation is for the poly(A) tail to be digested down to 10-12 nt in length, which
then triggers decapping of the 5’ end [14]. During translation, the cap is resistant to decapping
because the cytoplasmic cap binding protein is bound. In addition, non-coding RNA (ncRNA)
will target and degrade mRNA in the cytoplasm, with the specific ncRNA and the method of
function in degradation and translation discussed in depth in the next section. The constellation
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of RNA bound proteins, ncRNA, and sequence signals dictate the mRNAs degradation rates,
acting as a powerful regulator of gene expression [15].
In somatic cells, mRNA decay often occurs in P-bodies, which are discrete cytoplasmic
loci. P-bodies are also the site for miRNA suppression, mRNA storage, and translational
repression. P-bodies lack translational initiation factors or ribosomes, creating an environment of
translational silence, and the number of untranslated mRNAs is correlated with the P-body
number and size [16]. While P-bodies are not essential for mRNA degradation, they form in
response to mRNA degradation. P-bodies contain three classes of mRNA decapping
components: decapping enzymes, activators of decapping, and 5’-3’ exonucleases[17]. The ratio
of messenger ribonuclearproteins and the polysomes influence the rates of translation and decay.
Not all mRNAs that enter the P body are degraded, and silenced mRNAs can exit the P body and
reenter a translational state [16]. Messenger RNA-specific regulators control translation and
degradation by recruiting the decay machinery. Deadenylation of mRNA can take place outside
of P bodies as well, which induces degradation of the transcript [2].
Small Non-Coding RNA
MicroRNA
MicroRNAs (miRNAs) canonically function by binding to the 3’ untranslated region
(UTR) of transcripts, repressing translation; often multiple miRNAs will target a single mRNA
for maximum repression. The majority of miRNAs investigated experimentally inhibit gene
expression through binding interactions that block translation and decrease stability of the target
transcript, but there are miRNAs known to activate translation and gene expression [18].
Facilitation of mRNA degradation is typically based on the recognition of a short sequence at the
3’ region, which corresponds to a matching seed sequence within the first 8 nucleotides on the 5’
end of the miRNA. If there is a high degree of complementarity within this seed sequence, there
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does not need to be strong binding within other areas of the miRNA. Less commonly (<5%),
strong interactions in the 3’ end of miRNA can compensate for weaker interactions in the 5’ end
of the miRNA, which means that weak complementarity in the 3’ end can still result in mRNA
degradation [19]. In cases of perfect complementary binding, miRNAs will cause the degradation
of their target mRNAs, mediated by the Argonaute protein AGO2 [20]. In cases of imperfect
complementary binding, bulges in the double stranded mRNA/miRNA duplex prevent
endonucleolytic cleavage of the RNAs [21], but result in repression of translation by inhibition of
translation initiation [22]. The mechanism of translational repression involves AGO2, which
binds the m7 cap using a domain that is structurally similar to one contained in the translation
initiation factor eIF4E. AGO2 may then hinder recognition of the m7 cap in the initiation of
translation [23]. This mechanism of action is supported by the finding that mRNAs that lack a 5’
cap are refractory to miRNA mediated repression [22]. However, some miRNA binding is
observed in actively translating polysomes, which may mean that miRNA-mediated translational
inhibition results either from rapid protein product degradation or a high drop rate in ribosomes
during elongation, resulting in incomplete protein products [24]. However, it appears that even
non-complementary binding promotes degradation after translationally repressing the mRNA
[25]. It appears that miRNA that do not bind with perfect complementarity to their mRNA targets
cause degradation of mRNA, as they expedite poly(A) tail removal and cause degradation of their
RNA targets to reduce translation [26]. Regardless of the specific miRNA molecule, the cell type
or cell growth condition, or translational state of the mRNA, the destabilization of mRNA
explains 66% to more than 90% of miRNA repression [27].
MicroRNAs promote destabilization of target mRNAs by promoting mRNA decapping
and de-adenylation, leading to the localization of the target mRNA to cytoplasmic degradative
processing bodies [22]. Importantly for embryonic development, non-polyadenylated mRNAs
can also undergo miRNA-mediated repression, although this repression typically is not as strong
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as for mRNA with poly(A) tails [22]. It also appears that the mRNA target’s translational
efficiency impacts miRNA binding, with high translation efficiency linked to a more robust
repression by the miRNA [28]. Beyond their well-established cytoplasmic actions, miRNAs also
have some nuclear functions that have not been as well investigated [29].
MicroRNAs can be transcribed from intergenic regions and from either the intronic or
exonic portions of protein coding genes. The first step in miRNA biogenesis involves a nuclear
protein complex, made up of Drosha and the DiGeorge syndrome chromosomal region 8
(DGCR8) microprocessor complex subunit in mammals. Drosha contains two RNase III domains
for cleavage, and DGCR8 contains two double-strand RNA binding domains for recognition of
the cleavage site [30]. The Drosha/DGCR8 microprocessor cleaves primary-miRNA (primiRNA) to generate precursor miRNA (pre-miRNA) molecules (Figure 1). Drosha is susceptible

Figure 1.1. Biogenesis and actions of miRNA and siRNA. The details of the biogenesis
pathways for miRNA and siRNA are discussed in the text.
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to several modifications, including phosphorylation and acetylation, which leads to nuclear
localization and stabilization of the protein, respectively. Drosha binding to the protein TDP43
also causes stabilization and increased processing power. Phosphorylation of DGCR8 stabilizes
this protein, while its acetylation increases affinity for pri-miRNA. Alternatively, binding to
MECP2 can inhibit DGCR8 binding to primary miRNA (pri-miRNA). After processing,
Exportin 5 transports pre-miRNAs to the cytoplasm, where they are ultimately cleaved into
double-stranded, non-hairpin structures about 22 nt in length by the Dicer complex. Exportin
recognizes and interacts with the stem-loop and 3’ 2 nt overhang on the pre-miRNA that is
created by Drosha. Unlike mRNAs, miRNAs do not have a universal recognition sequence, such
as the poly(A) tail. Dicer associates with TRBP, an RNA binding protein, as well as PKR, a
protein activator that is not required but serves to stabilize the protein-miRNA complex that
targets mRNA, the RNA-induced silencing complex (RISC) [31]. Dicer binds to the 5’
phosphorylated end, and will then cleave the pre-miRNA at specific locations, a fixed distance
from the 3’ end that spans from 21-25 nt in length. The RISC complex is made of associated
proteins, most importantly Dicer and Argonaute (AGO) proteins, although the specific protein
members of RISC differ by species. The specific AGO protein that binds to RISC may be
dependent on the 5’ U or C of the incorporated miRNA. AGO proteins are stabilized by miRNA
binding, and can be ubiquitylated and degraded. The AGO protein unwinds the guide strand,
which is determined by thermodynamic stability, and loads it into the RISC complex [30]. The
processed miRNAs then assemble with RISC, which directs the miRNA to its target messenger
RNA sequence. The unused passenger strand is then degraded. MicroRNA-dependent
degradation or silencing of mRNA can be prevented by mRNA binding proteins such as DND1,
which blocks miRNA binding, or DAZL, which promotes poly(A) tail lengthening. A minority
of miRNAs can also be processed independently of both Drosha and Dicer using alternative
biogenesis pathways [32]. For example, RNases such as RNase Z and Integrator can function as
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Drosha, splicing in mirtrons make Drosha unnecessary, and Ago2 can replace the function of
Dicer [33].
While the canonical biogenesis pathway for miRNAs includes both Drosha and Dicer
processing, non-canonical pathways have also been identified. Generally, these non-canonical
pathways can be grouped into Drosha/DGCR8-independent, and Dicer-independent pathways.
Mirtrons are an example of a Drosha/DGCR8 independent sncRNA, and are produced from
mRNA introns at splicing [34, 35]. 7-methylguanosine (m7G) capped pre-miRNA are also able to
bypass Drosha/DGCR8 processing through direct export to the cytoplasm [36]. Drosha can
process Dicer-independent miRNAs, but Dicer processing requires AGO2 for complete
maturation [37]. Whereas knockout of Drosha expression in mice abolishes canonical miRNA
expression, many miRNAs are still present when Dicer expression is blocked [38]. Interestingly,
knockout of exportin showed that this protein is dispensable for a substantial proportion of
miRNA maturation [39]. While canonical miRNA pathways are generally constitutive, alternate
pathways exist that may allow miRNA expression when core biogenesis proteins are reduced.
P-bodies are cytoplasmic foci that are enriched with mRNA degradation machinery, such
as mRNA decapping proteins and CCR4-NOT complexes [40]. While P-bodies are not necessary
for mRNA degradation, they appear to form in response to activation of these pathways. Because
of their role in mRNA degradation, they were identified early on as potential sites involved with
miRNA-mediation mRNA degradation and silencing pathways. The RISC complex and miRNAs
localize target transcripts to the P-body for degradation. P-body remodeling after miRNA
recruitment modifies the translational complex and facilitates access of the decapping complex to
the cap structure to induce degradation [41]. In addition to facilitating target degradation, P-body
components have also been implicated in the translational repression of targets. The P-body
components GW182 and RCK/p54, when knocked down, relieve miRNA-mediated translational
repression, although the components that contribute to this process appear to differ for individual
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miRNAs and their targets [42]. The target mRNAs can be stored in P-bodies and released and
returned to the translational machinery with the right signals [41]. P-bodies are not required for
miRNA silencing as the mRNA degradation machinery exists diffusely in the cytoplasm. Thus,
RNA interference pathways are still active in the absence of P-bodies, and P-bodies appear to
arise as a consequence of the silencing pathways [43].
Many studies have identified miRNAs located outside of cells, with one population found
in vesicles including exosomes, microvesicles and apoptotic bodies, and the other population
associated with proteins such as AGO2. Like cellular miRNAs that are bound to the RISC
complex, these extracellular miRNAs appear to be highly stable and are able to survive at room
temp for more than four days. These extracellular miRNAs have been found in plasma, serum,
cerebrospinal fluid, saliva, breast milk, seminal fluid, and ovarian follicular fluid [44]. The
extracellular miRNA populations show promise as biomarkers of disease, such as ovarian cancer
[45]. Extracellular miRNAs may be a byproduct of normal cellular activity, as it appears that the
release of miRNAs is a highly regulated process, and exosomal miRNAs are functional in
recipient cells [46]. MiRNAs are not randomly incorporated into exosomes, and a subset of
miRNAs preferentially entered exosomes, with several models for sorting suggested [47]. These
models include an nSMase2-dependent pathway, a miRNA motif/sumoylated hnRNP dependent
pathway, 3’ miRNA sequence dependent pathway, and a miRISC related pathway [48]. Support
for these models includes evidence that preferentially included miRNAs have a GGAG motif in
the 3’ miRNA sequence, or more poly U than poly A at the 3’ end of the miRNAs, and that
miRISC complexes co-localize with the sites of exosomes biogenesis [48]. The exact functions
of these extracellular miRNAs are an expanding area of research. While extracellular miRNAs
may be of keen interest for identifying biomarkers and regulators of disease states such as cancer,
these molecules have also been implicated in cross-species regulation through diet. While one
such study suggested that miRNAs that are ingested could transfer to the blood, accumulate in
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tissues, and exert regulation on host genes [49], follow up work has not been able to repeat these
results [50]. However, recent work from Li et al. found plant miRNAs in human amniotic fluid
and umbilical cord blood and demonstrated that oral gavage of pregnant mice with exogenous
miRNA from the influenza virus was sufficient to elevate levels in serum and fetal liver, and the
miRNA down-regulated mRNA levels of targets in these tissues [51]. The ability of miRNA to
pass from cell to cell and regulate gene expression, including cross-species, opens up new
possibilities for miRNA functional pathways.
When miRNAs are bound in the RISC complex, they are highly stable and can have a
half-life extending out to days, allowing for accumulation at high amounts. However, specific
miRNAs decay rapidly in certain environments [52]. Several sequences have been identified that
regulate miRNA decay rate, including 7 nt at the 3’ end [53], the seed sequence [52], and three
uridines at nt positions 9-11 [54]. Interestingly, it appears that with high complementarity
binding and extensive pairing through the 3’ region of a miRNA with uracil tails, the mRNA
target can evade silencing and cause degradation of the miRNA [55]. Four separate enzymes
have been identified that degrade miRNAs, including the small RNA degrading nuclease 1
(SDN1), which destroys miRNA with high efficiency using a catalytic sequence-independent
reaction proceeding in a 3’-5’ direction. XRN2 is an exoribonuclease that cuts miRNA in a 5’-3’
direction after facilitating miRNAs release from the RISC complex, and also acts in a sequenceindependent manner. XRN2’s close relative XRN1 is involved in the degradation of both the
passenger and guide strand of the duplex miRNA. PNPT1 is a PNPase, acting as a 3’-5’
exoribonuclease and exosome subunit that catalyzes phosphorolysis of miRNAs [52].
Modulation of miRNA levels can be controlled by degradation of the pre-miRNAs as well as
mature miRNAs. The ribonuclease complex Translin/Trax (TN/TX) is a degrading enzyme that
competes with pre-miRNA processing to degrade pre-miRNA in Dicer-deficient contexts [56].
Select pre-miRNAs can also be cleaved by the mammalian endoribonucleases MCP-induced
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protein 1 (MCPIP1), as well as Ser/Thr protein kinase/endoribonucleases IREI-alpha [57].
Recent evidence has suggested that there are different pathways of degradation for specific
populations of miRNA. For example, the RNA binding protein LIN28 initiates degradation of
let-7 precursors through recruitment of terminal uridylyltransferases (TUTases) and causing
oligouridylation [58]. However, LIN18 also binds to miRNA-9 and destabilizes its precursor in a
poly U independent manner, and constitutive expression of LIN18 reduces let-7 but not miRNA9. It appears that the 3’-5’ exoribonuclease Dis312 also seems to contribute highly to control
miRNA-9 production, and there may be multiple degradation pathways working together for one
miRNA population. LIN28 may bind to many miRNAs, but unlike its destabilization action for
Let-7 and miRNA-9, there are several miRNA up-regulated by LIN18 overexpression [59]. It is
unknown whether there is conserved machinery for miRNA decay. Complex systems for
degradation of miRNA that may act differently in different populations of miRNA make
elucidating pathways of degradation a challenge, and more work is needed to understand the
breadth of degradation pathways in different environments.
MiRNAs are subject to RNA tailing, which can result in multiple isoforms with different
3’ ends. The 5’ ends of miRNA are relatively invariable, as they contain the seed sequence and
need to be able to bind to the target mRNA without interruption. The 3’ end of the miRNA does
not always need to bind to the target mRNA, unless the seed sequence has less sequence
complementary. Therefore, the 3’ end of miRNAs tends to be heterogeneous in its modifications
[60]. Changes to an individual miRNA length or sequence can have implications for that miRNA
isoform’s target selection, miRNA stability, and RISC loading [61]. Adenosine deaminases acting
on RNA (ADAR) can convert adenosine to inosine in segments and target many pri- and premiRNAs. The changes in sequence affects Drosha and Dicer processing and can prevent miRNA
export [62]. Because tailing is rare with as few as 5% of miRNAs have these modifications,
tailing may not be a piece of normal miRNA functionality. However, specific miRNA species
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can be highly modified leading to functional consequences under certain conditions. In
mammals, U/A tailing of miRNAs is induced through high complementary binding to targets,
which induces trimming or decay of both the target and miRNA through several enzymes, one of
which may be the 3’-5’ associated exonuclease DIS3L2 [63]. Viruses have been shown to hijack
this degradation pathway in order to degrade host miRNA during infections. Mammalian GLD2
functions in polyadenylation of mRNA as well as adenylating miRNA. In contrast to A tailing
induced by binding, this adenylation appears to stabilize the miRNA [64]. Also, monouridylation of pre-miRNA promotes processing via DICER and increases populations of mature
miRNA, while oligouridylation blocks DICER processing and facilitating decay of pre-miRNA,
thus reducing populations of mature miRNA [65]. Several species of pre-miRNA require 3’ end
mono-uridylation for Dicer processing due to a short 1 nt 3’ overhang from Drosha processing
[66]. In activated Drosophila eggs, over 30% of miRNAs carry a non-template A addition, and
these levels drop in the hours after egg laying. Comparatively, in sea urchin embryos up to the
32-cell stage, adenylation reached levels over 30% in miRNAs [67]. Also, in mouse metaphase II
stage oocytes, adenylation of miRNAs reaches 30% and drops as the embryo develops [67].
These modifications included mono-, di- and tri-adenylation and were carried out by the Wispy
protein. Because adenylation takes place on both the 5’ and 3’ ends of miRNA, the modification
must take place downstream of DICER processing. It also appears that there is no sequence motif
conserved among adenylated miRNAs, and therefore adenylation may not be driven by intrinsic
sequences. It was demonstrated that Wispy associated transiently with AGO1, which makes up
part of the RISC complex that aids in miRNA binding to targets [67]. Therefore, the adenylation
process may be triggered by miRNA activity, as opposed to a particular sequence. When a
miRNA binds to a target with high complementarity, the PAZ domain releases the 3’ end of the
guide miRNA. The release of the 3’ end may make that miRNA susceptible to adenylation via
Wispy, and physical separation from Wispy may protect miRNAs from adenylation. Adenylation
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may act as a molecular basis for the clearance of maternal miRNAs through destabilization and
degradation during early embryogenesis, discussed in more depth below [67]. To complicate this
theory, polyadenylation has a stabilizing effect and we do not have a clear understanding of how
these similar mechanisms have such context-dependent outcomes. When considering miRNA
adenylation, the miRNA molecules that are expressed in early embryogenesis and decline after
the EGA have the highest levels of adenylation as compared to those expressed at or after the
EGA [67]. The conservation between such distinct model species would predict that it might be a
mechanism of clearing maternal miRNA, although timing varies.
Endogenous small interfering RNA
Endogenous small interfering RNAs (endo-siRNAs) have been found in plants and
worms, and generally are produced by RNA-dependent RNA polymerases (RdRPs), which are
lacking in mammalian genomes. However, recently diverse substrates that generate siRNA were
found in Drosophila and mouse oocytes [68]. Small interfering RNAs exert a repressive effect on
mRNA, similar to that of miRNA, through the RISC complex and AGO proteins. Small
interfering RNAs bind with perfectly complementary to target sequences, which then induces
endonucleolytic degradation [68]. SiRNA molecules are exactly 21 nt long, present in both sense
and antisense orientations, with a 3’ modified end. One defining factor that distinguishes siRNA
from miRNA and piRNA is that siRNA molecules are not biased towards uracil in the first
nucleotide position on the 5’ end[69]. In the Drosophila, the genomic sequence coding for
siRNA transcripts are derived from transposons, heterochromatic sequences, intergenic regions,
long RNA transcripts, and mRNAs. In mice, siRNAs have also been found to originate from
psuedogenes. Ghildiya and coworkers showed that pseudogene transcripts can generate siRNA
by annealing to their functional transcripts, and therefore pseudogenes may suppress their
functional counterparts through siRNA degradation [69]. Endo-siRNA has been studied in depth
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in plants and C. Elegans, but the majority of that information does not translate to mammals due
to difference in sncRNA bioprocessing pathways. In mammals, endo-siRNA has only been
found in mouse oocytes, which may be a non-conserved function due to a rodent-specific Dicer
isoform that lacks the N-terminal helicase domain and efficiently generates siRNA [70]. Likely
due in part to the limited known expression of siRNA, little information is currently available
with respect to the persistence or degradation of siRNAs.
The production of endo-siRNA precursors can occur by sense-antisense pairs, which are
derived from transposons [31]. siRNAs are processed from fully complementary, long double
stranded RNA. In both mice and Drosophila, a siRNA precursor can also be a single stranded
RNA that self-hybridizes in a similar fashion to miRNA but with an extended stem length. It
does not appear that these precursor molecules require processing in the nucleus, and the protein
responsible for exportation from the nucleus to the cytoplasm is unknown [31]. The biogenesis
pathway for endogenous siRNA is similar to that for miRNA, but evidence from the studies in
Drosophila indicate that production of siRNA requires Dicer 2 (DCR-2) as opposed to Dicer 1
(DCR-1). In DCR-2 knockout studies, a subpopulation of siRNA persists, which may be due to
the activity of a non-canonical pathway similar to what has been found in miRNA [69]. These
siRNAs produced via a non-canonical pathway require DCR-2 to bind with Loquacious (LOQS).
In a more normal setting, R2D2 will bind to DCR-2, and LOQS will bind to DCR-1. When
siRNA is introduced to the cell from an exogenous source, such as via viral dsRNA, similar
processing occurs save for DCR-2 binding to R2D2 [31]. Also, for processing of exogenous
siRNA, R2D2 is required for loading the siRNA onto AGO2. However, while it is known that
endo-siRNA acts through AGO2, the extent to which R2D2 is needed for loading is still
unknown. Due to the assumption that mammals did not express endo-siRNA due to the lack of
RdRP, and the more recent discovery of these alternative biogenesis pathways mammals, less is
known about the biogenesis of endo-siRNAs than many other sncRNA species reviewed herein.
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Piwi interacting RNA
Piwi-interacting RNAs (piRNA) are single-stranded RNA molecules associated with the
PIWI subfamily of proteins. Most of these proteins are specifically expressed in the germ cell
line, but not in somatic tissues. PiRNAs are highly conserved class of sncRNA about 21-34 bp in
length. In germ cells, piRNAs act as a type of immune system to protect the germ cell genomes
from transposons, but this mechanism is silent in somatic cells [71]. Piwi-interacting RNAs bind
RNA targets based on sequence complementarity and repress targets via slicing or chromatin
mark recruitment. PiRNAs repress transposable elements (TEs) that pose a threat to genomic
stability during genomic remodeling periods in both a transcriptional and post-transcriptional
manner [72]. Piwi-interacting RNAs were originally found to function in gametogenesis and
silence TEs during reprogramming events throughout primordial germline cell development [73].
During pachytene spermatogenesis, piRNAs target not only TEs, but also target mRNA for
degradation, which suggests that piRNAs may function to suppress gene expression in other
cellular functions as well [74]. It has been shown that transcripts derived from TEs are expressed
in bovine embryos at the point at which the embryonic genome is activated, or the maternal-toembryonic transition (MET) [75]. Therefore, piRNAs may be targeting and suppressing TEs
during early development, but not maintain this silencing during the EGA. In mammals, piRNAs
have also been implicated in directing transposon methylation in primordial germ cells (PGCs)
during germ cell development. Knockout studies of piRNA have correlated loss of piRNAs with
elevated transposon activity, compromised histone methylation, diminished de novo DNA
methylation, and impaired control of translation [76, 77]. While piRNAs generally are present
only in early embryos and germline cells, they have been found to be present in cumulus cells,
which are somatic differentiated cells that are highly associated with the oocyte [78]. In
Drosophila, piRNAs also function in genome maintenance, telomere protection [79], maternal
mRNA deadenylation and decay [80] and suppress phenotype variation via transposon silencing.
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PiRNAs could be responsible for the deposition of DNA methylation over a large proportion of
the genome through directing methylation to unmethylated transposons they target, although the
mechanism behind this DNA methylation via piRNA is still unknown [81, 82]. PiRNAs are
expressed during periods of epigenetic reprogramming when methylation and other silencing
marks are removed, such as during the reprogramming of PGCs. With low methylation, active
repeats are transiently reactivated and converted into a primary pool of piRNAs. When the wave
of de novo methylation is engaged, the relative abundance of these transcripts is reduced, but a
fraction of retrotransposon copies are able to evade this silencing and stay transcriptionally active
by mirroring the activity of protein coding genes [83]. These transcripts then engage in
secondary piRNA amplification, which can contribute to the second wave of specificity in the
second wave of de novo methylation in PGC reprogramming [81].
Different piRNAs specifically target different types of TEs, which are mobile genomic
elements that can integrate into the genome at different sites. DNA transposons are full-length
autonomous elements that can encode the protein transposase, which allows an element to be
removed from one position in the genome and inserted at another [84]. Transposons generally
have short inverted repeats at each end and can move if activated. This capacity for mobility
poses a genomic threat; for example, long interspersed nuclear elements (LINEs) encode for a
reverse transcriptase and comprise up to 20% of the human genome [85]. An old lineage of
LINES, LINE2, stopped relocation in the genome before the evolutionary radiation of mammals.
However, a newer LINE family, LINE1, is still active with evidence for genomic insertion in
mammals [86]. Short interspersed nuclear repeat elements (SINEs) comprise up to 15% of the
human genome and rely on the reverse transcriptase from LINEs for movement [87, 88].
Different mammalian lineages have evolved SINE elements independently, with primate
genomes containing Alu elements and mouse genomes containing B1 and B2 type elements. The
insertion process of LINEs and SINEs into the genome causes a short (7-21 nt) sequence to be
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repeated, with one copy at each end of the inserted sequence. Alu elements accumulate
preferentially in GC rich areas, and L1 accumulate preferentially in GC poor regions [89]. Long
terminal repeat (LTR) transposons are characterized by the long terminal repeat on each end of
the transposon that is several hundred base-pairs long [90]. Some such elements are endogenous
retroviruses, which are cousins of retroviruses, such as HIV, and are unable to survive outside of
the cell. In human genomes, none are currently known to still be active. However, active
mobility of non-autonomous repeats are still seen in the mouse genome, referred to as
mammalian LTR elements (MaLR) [91].
While piRNAs may act similarly to miRNAs, they are produced via a distinct biogenesis
pathway (Figure 2). The genomic source of piRNAs and the precise transcript marks required for
piRNA production are unsolved questions in the field. Genomic loci-producing piRNA are
termed piRNA clusters, due to the high density of piRNA sequences mapping to those locations.
In mammals, piRNA precursors are indistinguishable from canonical euchromatic RNA pol 2
transcription units, and they are often produced from primary transcripts derived from active
transposable elements or repetitive loci [71]. PiRNA biogenesis differs from miRNA and siRNA
in that the process employs single-stranded RNA (ssRNA) as a precursor molecule, that piRNA
molecules do not have secondary structures, and DICER is dispensable to piRNA processing.
Precursor piRNAs require endonucleolytic cleavage of their 7-methylguanosine cap to yield a 5’
monophosphate. Precursor piRNA molecules must be long, ssRNA with a 5’ monophosphate cap
in order to enter the piRNA biogenesis pathway [71]. There are two pathways of biogenesis for
piRNAs with the correct 5’ ends. The first pathway is primary piRNA biogenesis, from which
piRNAs originate from the genomic sequence and then bind with complementarity to TE
transcripts, thus acting as guides for PIWI proteins to target and degrade those TE transcripts. In
Drosophila, the nuclear primary piRNAs are processed into mature cytoplasmic primary piRNAs.
The RNA helicase Armitage resolves any secondary structures, and then the piRNA are cleaved
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by Zucchini to generate pre-piRNAs with the 5’ monophosphate. The 3’-5’ exonucleases Nibbler
trims the pre-piRNAs to a final length once they are loaded onto PIWI proteins. Hen1 increases
PIWI binding affinity and piRNA stability, and methylates the 2’ hydroxyl group at the 3’ end.
The piRISC complex migrates to the nucleus, and represses transcription of targets by
establishing a H3K9me3 chromatin state in the DNA producing the transposon targets [92].
These primary piRNAs may be one initiator of the ping-pong cycle, but maternally inherited
piRNA populations also appear to be important [93]. The details and exact proteins involved
differ in somatic and germ cells [94]. The second pathway, the ping-pong cycle, begins with the

Figure 1.2. Biogenesis and actions of piRNA. The details of the biogenesis pathways for
piRNA are discussed in the text.
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PIWI protein Aub guided by an initiator piRNA (antisense), which cleaves a complementary
transposon transcript. The cleavage produces a pre-pre-piRNA, and once the PIWI protein
AGO3 binds that product, it is committed to produce a responder piRNA at the 5’ end (sense).
The pre-piRNA intermediate product of this process is too long and requires cleavage by AGO at
the first 10 nt that are complementary between the responder piRNA and the initiator piRNA.
The resulting piRNA can itself then begin to act as an initiator piRNA that produces new
responder piRNA identical to the original initiator piRNA [71]. The primary pathway processes
many piRNAs from a single precursor transcript, and the secondary pathway utilizes
amplification of a single piRNA, which ensures the piRNA quantity is related to the expression of
their actual target transposons that are active in a cell at any given time [95].
Transfer RNA
Transfer RNA (tRNA) is a key player in the deciphering of the genetic code. In the
process of translating the genetic code, tRNA functions as the carrier of incoming amino acids for
the growing polypeptide chain. Specific transfer RNAs chemically link to the particular
individual amino acids, are then recognized by an amino acyl-tRNA synthetase, and base pairs
with the correct corresponding codon sequence in the mRNA [96, 97]. Transfer RNA molecules
are 70-80 nt in length and form precise three-dimensional structures resembling a clover leaf in
their stem-loop arrangements [97]. These structures dictate the function of tRNAs. Four stems
form by Watson Crick base pairing, creating helices with loops on the end of 7-8 bases. The
anticodon, where the tRNA binds to the mRNA, is made up of three nucleotides on the end on
one of the loops; this anticodon can bind to more than one mRNA codon through nonstandard
base pairing [98]. Transfer RNAs can undergo structural modifications, with methylation of
tRNA acting to stabilize and prevent cleavage [99]. There is growing evidence that tRNA
abundance is actively regulated through transcription and degradation pathways, enabling the cell
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to coordinate translation efficiency and gene expression. The correlation between tRNA
availability, specific codon used, and efficiency of translation have demonstrated that codons
recognized by abundant tRNAs are most efficiently translated. Tumor tissues express aberrant
tRNA profiles, which correlated with the codon usage of genes during proliferation. It is possible
that there is a pathway by which cells are able to up-regulate the tRNAs needed for the mRNAs
that are being transcribed. Interestingly, the population of particular tRNA molecules aberrant in
cancer cells is correlated to the codon usage of genes during proliferation. The profile of
differentially expressed genes in those tissues may be due to the cell up-regulating the tRNAs
necessary for efficient translation of proliferation genes [99]. It is possible that there is a pathway
by which cells are able to up-regulate the particular tRNAs needed for the mRNAs that are
actively transcribed [99]. Because tRNAs are a highly-folded, modified structure, they are one of
the most stable RNAs in the cell with a half-life in the range of several days. Control of tRNA
abundance is achieved through multiple nuclear surveillance mechanisms, such as degradation of
precursor-tRNAs by the TRAMP complex, which polyadenylates the tRNAs 3’ end and triggers
3’ degradation by the 3’ exoribonuclease of the nuclear exosome. The other method of
surveillance is called rapid tRNA decay. Under modified tRNA or tRNA with deleterious
mutations are degraded by this pathway. While the enzymes involved in this pathway are still
being elucidated, CCAase adds the CCA to the 3’ end of tRNA to selectively mark unstable
tRNA, which likely allows access of Rrp44 and Xrn1 exonucleases, initiating degradation [13,
100]. Degradation of tRNA can also occur as a response to stress, and it is endonucleolytically
cleaved by angiogenin in mammalian cells. The cleavage under stress can lead to tRNA
degradation and the production of tRNA fragments [101].
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The biogenesis of tRNA is rather different than pathways for other classes of sncRNAs,
as tRNAs require substantial modifications post transcription (Figure 3). The precursor tRNA
undergoes 5’ cleavage via RNase P and removal of the 3’ extension by tRNase Z, followed by
addition of CCA sequence at the 3’ terminus by CCA nucleotidyltransferase. Before the tRNA is
fully mature, other posttranscriptional editing and modification of many of the nucleotides need
to occur. Up to 20% of the nucleotides in tRNA are modified, and these modifications prevent
degradation of pre- and mature tRNA, modulate efficiency and specificity, and alter translational
speed. These modifications include C to U editing, A to I editing, dihydrouridine, pseudouridine,
thiouridine, isopentenyladenosine, and methylation. Modifications in different positions alter
tRNA identity. Changes to the main body structure impact folding and stability of the tRNA
molecule, while modifications to the anticodon loop regulate correct codon usage and translation
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Figure 1.3. Biogenesis and action of tRFs. The details of the biogenesis pathways for tRNA
fragments are discussed in the text.
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[102]. Mature tRNAs must be exported by the protein Exportin from the nucleus into the
cytoplasm to function in translation. Though some tRNAs are directed to the mitochondria, the
molecular process regulating this targeting is not fully understood [103].
In addition to the basic housekeeping function of tRNAs for facilitating translation, these
molecules also serve other functions as non-coding RNAs, which can be broadly classified into
two main groups, tRNA-derived fragments (tRFs) and tRNA halves (tiRNAs), with characteristic
sizes, biogenesis pathways, nucleotide compositions and cellular functions for each. tRFs are 16
to 28 nt fragments derived from mature or pre-tRNA molecules and are classified by the location
of their origin (e.g., tRT-5 originates from the 5’ end D loop). tiRNAs are typically 30 to 35 nt in
length and originate by splitting the tRNA structure into 3’ and 5’ halves by cleavage within the
anticodon loop. Recently, researchers determined that tRFs can participate in RNAi based on
sequence complementarity. These tRFs were discovered in prostate cancer cells, in which a
significant number of small RNA sequences were found to match processing from the 5’ or 3’
ends of tRNAs [104]. In cancer cells, it was found individual tRFs were up-regulated and
controlled cell proliferation [104]. Similar to piRNAs, tRNAs may prevent transposon
reactivation. Schorn et al. determined that fragments of tRNA, which included the 3’ terminal
CCA of mature tRNA, were abundant in mouse pre-implantation stem cells [105]. The major
targets of these fragments appeared to be the two most active ERV families, which were strongly
inhibited. The 22 nt-long tRNAs targeted coding-competent ERVs through post-transcriptional
silencing, and the 18 nt-long tRNA interfered with transcription and the mobility of retrotransposons [105]. These tRFs and tiRNAs have been found to have major functions in numerous
cancers, as well, including lung cancer, colorectal cancer, prostate cancer, breast cancer, ovarian
cancer, B-cell lymphoma, etc. [106].
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Small nuclear RNA
Small nuclear RNAs (snRNA) are highly conserved sncRNAs involved in splicing
mRNA, performing most of the roles in the splicing reaction including catalysis. SnRNA are
highly abundant, with two different classes that function in the nucleoplasm, both with a 3’ stem
loop. The sm-class of snRNAs are characterized by a 5’ trimethylguanoside cap, binding sites for
sm proteins and include U1, U2, U4, U5, U7, U11, and U12. snRNAs belonging to the lsm-class
contain a monomethylphosphate cap, binding sites for lsm proteins and include U6 [107]. In their
natural state, snRNAs exist as small nuclear ribonucleoprotein particles (snRNPs) with one
snRNA and several proteins [1]. These snRNPs interact with a multitude of proteins to form the
large complex called the spliceosome, which functions to splice introns from primary genomic
transcripts [108]. Five types of snRNAs (U1, U2, U4, U5, and U6) account for about 25% of the
spliceosome and are necessary for the RNA-RNA and RNA-protein interactions that constitutes
its structure [1]. SnRNAs generally have a modified, hypermethylated cap structure thought to
protect against decapping and degradation [13]. snRNAs are also highly 2’-O-methylated and
pseudouridylated. During the assembly of the spliceosome, the snRNPs are recruited to the premRNA substrate, creating the RNA-RNA duplexes. The interactions of these sites help to
position the reacting groups for the first and second steps of splicing. U6 also may participate in
the formation of the spliceosome active site [108]. The U1 snRNP recognizes the 5’ splice site
through base pair interactions and forms the commitment complex. The U2 snRNP binds to the
branch site and forms a pre-splicing complex. The branch site bulges out and made available for
the first chemical reaction, and the paired U4 and U6 join the complex creating complex B1 and
then a series of RNA-RNA interaction rearrangements form the spliceosome. The spliceosome
generates the 5’ exon and the 2/3 lariat intermediate for splicing. The second chemical reaction
releases the lariat intron and ligates the exon to release the mRNA product. All of the snRNAs
are extensively post-transcriptionally modified, especially with pseudouridine. The modifications
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on the 5’ end of the U2 snRNA have been shown to be required for both snRNP biogenesis and
pre-mRNA splicing [108]. The pseudouridines are almost always clustered in functionally
important regions, and so have been of great interest [109]. Assembly-defective snRNAs are
degraded by Rrp6- or Dcp2-dependent decapping and 5’ to 3’ decay [110]. The U1 species is
under specific quality control, as truncated forms of this snRNA form a unique SMN complex
and are diverted from the normal biogenesis pathway to processing bodies for degradation [111].
The half-life of snRNA is dependent on the type, with U1-U5 being highly stable. U6 has a
shorter half-life, of about 15 hours and the two major snRNA precursors in the cytoplasm (U1
and U2) have a half-life of about 20 minutes [112].
SnRNAs also undergo specialized processing through their biogenesis pathway. The smclass of snRNAs are transcribed by a specialized form of RNA polymerase 2, whereas the lsm
class of snRNA are transcribed by polymerase 3 with specialized external promoters. In the smclass biogenesis, RNA polymerase 2 directs the 3’ end formation through a complex with Nrd1.
In the lsm class, RNA polymerase 3 holds the mature 5’ ends at the transcription initiation sight,
and trims the 3’ end of the snRNA [107]. In higher eukaryotes, the lsm class of snRNA never
leaves the nucleus, while the sm-class, biogenesis requires distinct subcellular localization. smclass snRNAs are exported by PHAX and exportin 1 to the cytosol where they undergo specific
maturation steps, and are then imported back into the nucleus by import receptor importin-beta
[107].
Small nucleolar RNA
Small nucleolar RNAs (snoRNAs) are named for their localization in the nucleolus, the
nuclear subdomain that assembles ribosomal subunits in eukaryotic cells. However, as further
functions for snoRNAs are elucidated, a range of localization that fits the function and target of
individual snoRNAs has been found [107]. SnoRNAs are highly conserved and required for the
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processing and modification of ribosomal RNA (rRNA). There are hundreds of types of snoRNA
in vertebrate genomes, and snoRNAs are transcribed from poly-cistrons, individual genes, and
introns of their host genes. Post-transcription, snoRNAs go through complex processing and
maturation steps [1], and the majority of snoRNAs have specific sequences that are
complementary to other RNAs [113]. SnoRNAs generally have a modified, hypermethylated cap
structure thought to protect against decapping and degradation [13]. SnoRNAs guide modifying
enzymes to produce site-specific associated phosphorylation, and 2’O methylation on target
RNAs. Two main classes of snoRNAs have been defined: those with a C/D box structure and
those with the H/ACA box structure. The C/D box class of snoRNAs include molecules 60-200
nt in length that function primarily to methylate ribosomal RNAs (rRNA). The C and D boxes
are positioned at the 5’ and 3’ ends, respectively; these structural motifs come into close
proximity in the folded molecule, which serves as a binding site for core box C/D snoRNA
proteins [107]. SnoRNAs that belong to the H/ACA box class are longer at 120-250 nt and are
required for pseudouridine formation in the rRNA by forming hairpins to act as guides [107].
Both classes of snoRNAs are highly conserved in eukaryotes, and both bind with protein partners
to form small nucleolar ribonucleoprotein complexes, which are highly conserved as well [114].
In higher organisms, non-canonical snoRNAs that lack specific boxes, contain both boxes, are
shortened, or are lengthened are expressed as well, and these snoRNAs may modulate pre-mRNA
splicing or other regulatory roles [115]. Another recently discovered pathway for these noncanonical snoRNAs is processing to shorter ncRNA that act in RNAi pathways [116].
RNA Polymerase 2 is responsible for transcribing snoRNA from DNA, and cotranscriptional assembly of inactive pre-RNPs occurs to create a stable, inactive precursor
snoRNA. The snoRNA undergoes functional maturation at Cajal bodies, where RNA
modifications and formation of functional complexes occur. From the Cajal bodies, snoRNAs are
localized to the necessary location appropriate for their specialized function [107]. SnoRNA can
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also be produced from introns, so once the degradation of introns begins with de-branching
activity, biogenesis in those introns encoding snoRNAs begins. SnoRNAs are not
polyadenylated, and the box C/D snoRNAs form a closed loop, while H/ACA snoRNAs form two
stem loops linked by the H box motif [13]. SnoRNA fragments are processed in a manner
somewhat similar to miRNA processing, requiring processing from an RNase 3, the same enzyme
type as Drosha and Dicer.
In addition to their traditional housekeeping roles as guide RNAs for the posttranscriptional modification of rRNAs, new evidence suggests that snoRNAs may be involved in
cell fate determination and oncogenesis [117, 118]. SnoRNAs undergo extensive processing, and
it appears that some snoRNAs are processed to generate stably accumulating fragments [114].
Multiple groups have reported that these snoRNA fragments associate with AGO proteins and act
in RNAi pathways similar to miRNA [118-121]. It appears that these so-called sno-miRNAs may
then target transcripts, controlling processes involved in cell behavior and carcinogenesis. As a
relatively newly identified pathway, there is still much to be elucidated on the exact function of
snoRNA fragments acting in RNAi, and what conditions regulate the pathway.
Ribosomal RNA
Ribosomes are macromolecular structures comprised of four ribosomal RNAs (rRNA)
and multiple coordinating proteins that are responsible for catalyzing protein synthesis. For every
protein coding gene produced, 10 ribosomes must be produced, on average. Thus, rRNA is
highly abundant in cells. There is growing evidence for additional functions of rRNA in the
regulation of translation efficiency, mRNA recruitment, and facilitation of ribosomal shunting
[122-124]. The investigation of mammalian rRNA functions have not been to the same level as
seen in yeast and bacteria, due to difficulties in expressing modified rRNAs and performing
functional analysis [125]. The mature 80S ribosome has two subunits, the 40S subunit (contains
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the 18S rRNA) and the 60S ribosomal subunit (contains the 28s, 5.8S, and 5S rRNA). Messenger
RNA passes through an mRNA channel in the ribosome, and tRNA reads the codon at the
ribosome interface. The interface side of the 60S subunit contains the peptidyl transferase center
(PTC) is where the peptide bond forms, and the three tRNA binding sites are located in the cavity
between the two ribosomal subunits. Studies have suggested that mRNA rRNA base pairing can
affect initiation of mRNA translation [126].
Ribosome assembly, similar to snoRNA, occurs co-transcriptionally on rRNA genes.
The process is influenced by cell and organism growth, and requires precise coordination of
rRNA and the hundreds of proteins necessary for ribosomal assembly. A dedicated set of
proteins, including RNA polymerase 1, are used to transcribe rRNA, giving rRNA the ability to
be regulated independently from the rest of the genome. The rRNA genes exist in tandem arrays
of several hundred copies, and these genes encode the three largest RNAs of the ribosome. The
formation of the 40S ribosomal subunit requires four rRNA cleavage steps, two each on the 5’
end and 3’ ends. [127]. The ribosomal proteins form these key secondary structures at the same
time as maturation and folding of pre rRNA. The formation of the 60S subunits starts with the
cleavage of nascent pre-rRNA at an A2 site, once transcription has proceeded. Once transcription
is completed, a precursor particle is present, containing 27A2 and many of the r proteins and
assembly factors for the large subunit. The association between r proteins and pre-ribosomes are
strengthened as pre-rRNA is processed as the large subunit assembly proceeds in a hierarchical
fashion [128]. The large subunit and small subunit undergo separate biogenesis pathways in the
nucleolus and nucleus, and then both are exported and undergo final maturation steps in the
cytoplasm. The rRNAs are extensively modified during the transcription and maturation, and
differences in modifications may control translation and impact gene expression [129].
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Epigenetic Control of Gene Expression
The term of epigenetics was first defined in the 1940s by Conrad Waddington as “the
branch of biology which studies the causal interactions between genes and their products which
bring the phenotype into being” [130]. Over time, this definition of has evolved to more
specifically include changes in gene function that are mitotically and/or meiotically heritable and
that do not entail a change in the DNA sequence. More recently, the study of epigenetics has
become more inclusive, by encompassing those mechanisms that regulate gene activity via
modification of DNA structure but that do not alter the genomic sequence, whether or not such
changes are heritable. Epigenetic marks are crucial protectors of genomic stability, through the
silencing of TEs, centromeres, telomeres and other highly repetitive, deleterious regions of the
genome [131]. Some of the enzymes involved in these epigenetic modifications have been well
characterized, such as those responsible for establishing the DNA methylation code or those that
write or erase various histone modifications. Collectively, the full complement of specific
epigenetic modifications cooperates to allow for the timely expression of only a fraction of the
genome, which confers specific structure and function to the various cells of the body.
DNA methylation
The process of DNA methylation is well studied, and mechanisms controlling the
establishment of the methylome are highly conserved among multicellular organisms. DNA
methylation involves the addition of a methyl group (CH3) to the fifth carbon of a cytosine
residue [132]. In mammals, this epigenetic mark is mostly directed at CpG sites, which tend to be
clustered in high CpG density islands. However, CpT and CpA sites are also methylated, though
rarely, in oocytes, early developing embryos, and stem cells. Methylation of the DNA is highly
enriched in most non-coding regions, imprinted genes, regions with high repeats, and transposon
sequences. The transfer of a methyl group to a CpG site is catalyzed by DNA methyltransferases,
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of which three types are well known. DNMT 1 functions in maintenance methylation, meaning
that this enzyme is responsible for copying the methylation code during the process of DNA
replication. DNMT1 preferentially methylates hemi-methylated strands of DNA following
replication, and when bound to an unmethylated CpG at the replication fork, it forms an intrinsic
auto-regulatory loop [133]. DNMT3a and 3b are very similar enzymes that primarily catalyze de
novo DNA methylation by adding methyl groups to CpG sites where there was no methylation
present. Thus, these isoforms are responsible for the proper establishment of the cytosine
methylation profile during development by facilitating epigenetic control of developmentally
critical processes, such as cellular differentiation, transcriptional regulation, X-inactivation,
imprinting and genome stability.
Approximately 50% of the mammalian genome contains CpG islands, and 5methylcytosine (5mC) constitutes approximately 1% of bases [132]. The majority of gene
promoter regions (~70%) reside within a CpG island [134], and housekeeping gene promoters are
often within a CpG island [135]. CpG methylation at these sites can block the start of
transcription, as well as interfere with recognition sites for transcription regulators, such as
CTCF. The presence of CpG islands appears to promote gene expression, as one common feature
of CpG islands is a lack of nucleosomes compared to other areas of DNA [136]. Methylation
within gene bodies also occurs and may stimulate translation as well as impact splicing [137].
However, the mechanisms behind DNA methylation as an activating phenomenon are not
currently well understood. For example, when the methylation within the gene body of repetitive
DNA elements, such as transposons, blocks transcriptional initiation of those elements while still
allowing for transcription of the host gene in which the repetitive element is located. About 45%
of the mammalian genome consists of these transposable and viral elements that must be silenced
via methylation [132]. Specific patterns of DNA methylation also influence silencing of gene
expression through association with chromatin binding proteins; these interactions may occur
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through occur through trans-regulation via specific binding motifs or inhibited binding. Specific
proteins have high affinity for methylated cytosines, such as MeCP2, which when bound recruit
histone modification proteins, such as histone deacetylases (HDACs). Thus, DNA methylation
patterns can influence the application of covalent modifications to histones, further signaling for
repression of gene expression [138]. Alternatively, chromatin modifications can impact DNA
methylation, as the pattern of histone modification can profoundly influence the ability for a
cytosine to become methylated. DNA with the H3K4me2/3 mark is unable to be methylated, and
the histone variant H2AZ has a strong correlation with unmethylated DNA [139, 140]. This
trans-regulation between DNA methylation and chromatin silencing may be necessary, as there
are highly repetitive regions of the genome that can become very mutagenic when unmethylated.
Hypomethylation in these areas can cause global genomic instability, chromosomal
abnormalities, and often leads to cancer and other diseases [141]. Because of the trans-regulation
between these epigenetic marks, DNA methylation is considered a stable epigenetic state. DNA
methylation can be signaled into a genomic area based on repressive H3K9me3 marks, and then
recruit HDACs for very stable silencing [142].
DNA demethylation can occur in either a passive or active manner. Passive
demethylation transpires during cell replication, as loss of DNMT1 during this period will cause
progressive loss of DNA methylation with each cell replication that occurs. Active DNA
demethylation occurs with the enzymatic reaction to process 5mC back to a cytosine. However,
because the covalent bond is so strong, this process requires a series of chemical modifications as
no known enzyme can accomplish this modification in a single step. Briefly, the 5mC undergoes
deamination and/or oxidation reactions to produce a product that the base excision repair (BER)
pathway can recognize and replace. The process occurs via Tet proteins, by converting 5mC to 5hydroxymethylcytosine (5hmC) through oxidation, then generating a 5-dormylcytosine (5fC) and
5-carboxylxytosin (5caC). These oxidative changes prohibit DNA methylation maintenance, and
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the presence of 5fC or 5caC triggers activation of BER and the restoration of an unmodified
cytosine [143, 144]. The exact nature of the stability of DNA methylation marks are still a
debated topic, as X-inactivation and retrotransposon silencing can be relieved through treatment
with demethylating agents. Also, these marks must persist not only for the cell’s lifespan, but also
for the organism’s lifespan [145]. However, others argue that DNA methylation is a memory
signal for long-term maintenance of gene silencing and not a stable epigenetic mark, as the use of
an HDAC inhibitor could reactivate gene expression in genes silenced by a hypermethylated
promoter region. However, the reactivated genes were then slowly re-silenced over time, as
hypermethylation was not removed but could only prevent transcription if chromatin was
inactivated [146]. DNA methylation is often described as a silencing epigenetic mark, but
emerging research suggests a much more complex and nuanced code for gene expression control
then first realized, and that is still being uncovered.
Histone modifications
Aside from the primary structure of DNA dictated by its sequence of nucleotide base
pairs, DNA molecules also have extensive secondary structures. DNA strands are wound around
a core of eight histone proteins, which form a nucleosome, in a bead-on-a-string configuration.
This configuration allows for tighter packing of DNA and blocks transcription of the DNA
through physically impeding access to cellular transcriptional machinery. Modifications to the
histone tails within the nucleosomes affects the compactness of this secondary structure, and thus
influences accessibility of the chromatin[147]. Histone proteins making up the nucleosome
include two dimers of H2A and H2B bound to a tetramer consisting of two H3 and two H4
molecules; a linker H1 protein is bound to the exterior of the nucleosome. The histone tail is a
flexible amino acid domain that protrudes from the surface of these histone proteins, and it serves
as a flexible platform for many different post-translational modifications (PTMs). The core
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histone proteins are a globular domain that are small and highly basic, and are often targets of
post-translational modifications at specific sites and residues. Modifications on these sites can
have both direct impacts on transcription, but also can act indirectly and influence recruitment of
transcription factors, chromatin modifiers, and effector proteins to activate downstream signaling
and block access of remodeling complexes [147]. Cis and trans effects of covalently bonded
histone tails alter the chromatin template. Cis changes cause a shift in the physical property of
the histone tails, modulating changes in charge, structure, contact, and spacing of the DNA and
histones. For example, acetylation can neutralize the charge of very basic tails, causing localized
expansion of the chromatin fiber to impact transcription. Phosphorylation can generate charge by
adding a negative charge to the tail, which alters the nucleosome packaging or exposes histone
amino termini [148]. Linker histones will incorporate into the dyad axis of the nucleosome,
which promotes packaging by shielding the negative linker histone charge. Bulky additions, such
as ADP ribose or ubiquitin, can induce differential arrangements and cause de-condensation of
the nucleosome [149]. Trans effects occur via PTMs recruiting or blocking modifying binding
partners.
Methylation at the H3 and H4 histones were the first PTMs discovered, and such
modifications can occur as mono-, di-, or trimethylation on lysine (K) or arginine (R) residues.
Because both lysine and arginine are positively charged, this covalent modification mediates
hydrogen bonding and amino aromatic interactions. These methylation marks can be either
repressive or activating, depending on the site that is methylated and to what degree. For
example, H3K9me and H3K27me are repressive marks, whereas H3K4me or H3K36me
activating marks [150]. Polycomb proteins act as a complex to mediate mono-, di-, and
trimethylation on H3K17, a hallmark of gene repression that contributes to pathways in cancer
and early development [151, 152]. Histone lysine methyltransferases (KMTs) or G9a catalyzes
lysine methylation, while arginine methyltransferases (PRMTs) methylate arginine residues.
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Lysine demethylases (KDMs) serve to demethylate lysine residues, and are in the family of
amino oxidases. The KDMs include proteins LSD and KDM1A, which use FAD, oxygen, and
cofactors to target mono- and di-methylation. A second type of KDMs is hydroxylases, which
have a JMJC domain as the catalytically active site and use 2-oxygluterate, iron, and cofactors
[153]. Protein arginine deiminases convert unmethylated arginine amino acids to citrulline [154].
Common histone modifications also include acetylation by histone acetyltransferases
(HATs), typically to lysine residues (but also serine and threonine) on histones 3 and 4. These
acetyl marks are removed one of a large class enzymes known as histone deacetylase (HDACs).
Histone acetylation is transcriptionally activating by weakening the charge dependent
interactions, neutralizing the positive charge interactions between histones and nucleosomal
DNA, linker DNA, and adjacent histones, which in turn increases the availability of DNA to
transcriptional machinery [155]. Phosphorylation of serine, threonine, and tyrosine residues of
histones is induced by histone kinases and removed by histone phosphatases. These
phosphorylation modifications modulate DNA repair, transcription, and chromatin compaction in
cell division and apoptosis [156]. ADP-ribosylation is induced by poly-ADP ribose polymerases
(PARPs) and actively creates a negative charge, which may stimulate local chromatin relaxation
to facilitate the DNA repair process [157]. Lysine bases can have a multitude of specific
modifications, including biotinylation, formylation, propionylation, crotonylation, succinylation,
O-GlcNAcylation, glutathionylation, and ubituitylation [158]. Many of these modifications are
still under investigation to understand how, where and at what times they are established and how
they function to modulate gene expression.
The interplay between sncRNA and epigenetic
control of gene expression
Given a relative narrow definition for the study of epigenetics outlined above, the control
of gene expression by sncRNA would be considered beyond that scope as these molecules are
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relatively short acting, not stable and not heritable through cell replication. However, as the
world of ncRNA continues to expand in its breadth of functions, it is difficult to ignore the
immense impact of these molecules on gene expression. While DNA methylation and histone
modifications provide more stable, long-term regulation of gene expression, miRNA and other
ncRNA give cells the ability to react to their environment dynamically in fairly rapid fashion.
The function of miRNAs within the cytoplasm is well-defined, although these molecules can
directly cause transcriptional gene silencing or activation in the nucleus [159]. Moreover, other
ncRNA types, such as lncRNAs, interact directly with epigenetic modifying proteins, including
HDACs and HATs. Given the apparent importance of ncRNA in control of gene expression,
perhaps a broader definition of epigenetics would be useful, one that incorporates mechanisms of
control that alter the abundance of transcripts without changing the original genetic code [29].
Another complication to the more restrictive view of epigenetics that excludes
contributions by sncRNAs is the apparent cross-talk and feedback that exists among these
pathways, including DNA methylation, histone modifications and sncRNA. PiRNAs are an
obvious example of this complex interaction, as these molecules act to recruit DNA methylation
via histone marks to their target transposon genes [82]. One example of this apparent cross-talk
occurs during embryo gastrulation, at which point Oct4 must be turned off in order for the
embryo to differentiate. First, Oct4 transcription is silenced via interaction with repressor
molecules, followed by transcription factor recruitment of a complex containing a
methyltransferase and a deacetylase. The deacetylation of the histone allows the lysine residue to
then be methylated at the H3K9 residue. Heterochromatin protein 1 (HP1) is then able to bind
and facilitate heterochromatin formation, recruiting DNMT 3A and 3B [160]. However, this
heterochromatin process seem to be initiated by a DICER-mediated mechanism, which
recognizes double stranded RNA from the satellite sequences. The RISC complex then targets
those areas, recruiting SUV39H1 [161]. Non-coding RNA has also been shown to recruit histone

38
methylases to imprinted loci during the X-inactivation process [162]. Additionally, studies in
models of cancer have identified miRNAs that indirectly modulate the epigenome through
regulation of the expression of DNMTs, HDACs, HATs, and HMTs [163]. Conversely,
expression of miRNAs is also subject to control via epigenetic mechanisms. For example,
knockdown of DNMT1 or DNMT3b expression in colorectal cancer cells resulted in the
abnormal expression of 10% of miRNAs profiled [163]. In addition, a hallmark of cancer
appears to be DNA methylation of miRNAs [163-165], and more than one-third of human
miRNAs are located downstream from CpG islands [166]. Interestingly, in fetal bovine muscle
tissue, 20% of miRNAs involved in cell proliferation and differentiation were methylated within
the gene body, which would be predicted to have a positive impact on expression. These
observations collectively point to the possible coordination of sncRNA and epigenome modifiers
in the control of gene expression, with potential important roles in early development that warrant
further investigation.
Oocyte Development and Fertilization
The oocyte is a highly specialized, molecularly complex product of gametogenesis that
contains all the components needed to support early embryo metabolism and direct early
developmental events, including successful combination of two haploid genomes into a single
embryonic genome and activation of transcription. Oocytes originate from the primordial germ
cells (PGCs), which migrate to the genital ridge during fetal development, then proliferate via
mitosis and then differentiate into oogonia [167]. Germ cell nests are formed through asymmetric
cytokinesis from these mitotic divisions. The number of mitotic divisions is species-specific,
ranging from four mitotic cycles in mice, to many rounds of mitotic divisions in large mammalian
species. Mitotic division then stops, and germ cells initiate meiosis to form primary oocytes,
passing through the leptotene, zygotene, and pachytene stages of meiotic prophase 1 before
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arresting in the diplotene stage [168]. The germ cell nest breaks down at meiotic arrest to initiate
follicle formation. The primordial follicles form before birth, and the oocyte is then surrounded
by pre-granulosa cells. These primordial follicles constitute the reservoir of germ cells available
for the female reproduction lifespan.
After puberty, once the ovary becomes responsive to gonadotropin hormone, the follicles
are activated and recruited to initiate folliculargenesis [169]. During the transition from
primordial follicles to tertiary follicles, granulosa cells undergo a change from flattened epithelial
cells to cuboidal epithelial cells in the primary follicle. Then, they become multilayer, with an
outer layer of theca cells containing a basal membrane in the tertiary follicle. The maturation of
the follicle is driven by a rise in serum follicle stimulating hormone (FSH) concentration [170].
The oocytes regulate their own maturation as well as the function of the neighboring somatic
cells, which in turn regulate oocyte transcription and promote oocyte competence. Oocytederived factors include growth differentiation factor 9, which promotes the development of
cumulus cells, and bone morphogenic protein 15, which is mitogenic and stimulates granulosa
cell proliferation [171]. Proliferation of granulosa cells occurs at a high rate, as the follicle size
increases and the antral cavity eventually forms, leading to the formation of the antral follicle.
The oocyte modulates the progesterone and estradiol synthesis by the cumulus cells, induced via
FSH, and regulates the differentiation of granulosa cells to cumulus cells [172, 173]. These
cumulus cells closely surround the oocyte and provide nutrient, transcripts, and regulatory
molecules to the oocyte [174, 175]. The antrum serves as an important source of regulatory
substances derived from blood or secretions of the follicular cells. Antral fluid production is
intensified by increased vascularization and permeability of the blood vessels, which causes large
increases in follicle size. At this stage, the oocyte enters an extensive growth phase, reaching up
to 150 mm diameter in cattle and humans. As the oocyte increases in volume, complex
cytoplasmic organization occurs accompanied by large increases in RNA and protein synthesis
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[176]. The number of ribosomes, mitochondria, and organelles increase as well, with an
accumulation of glycogen granules, protein, lipid droplets, and multivesicular bodies, which all
contribute to a high quality mature oocyte [177, 178]. The oocyte also forms the zona pellucida,
a glycoprotein membrane that provides a protective coat around the oocyte.
If an oocyte is fully-grown, meiotically competent and dominant, resumption of meiosis
is initiated by the preovulatory luteinizing hormone (LH) surge. The LH surge initiates both the
final oocyte maturation and follicle maturation, but only for the dominant follicle that is no longer
dependent on FSH levels [179]. All other follicles, which are either subordinate or growth
arrested, enter atresia and degenerate. The high levels of cAMP in the oocyte maintains it in the
arrested state, and a protein called maturation promoting factor (MPF) is responsible for the
oocyte’s resumption of meiosis. The LH surge causes a drastic drop in cAMP levels through the
activation of PDE3A, as well as stimulating expansion of cumulus cells and the closure of gap
junctions, which reduces diffusion of cAMP [176]. After the LH surge, the oocyte undergoes two
consecutive M phase divisions, in the absence of DNA replication and S phase, then arresting at
M2 until fertilization [176]. The LH surge causes ovulation of the oocyte, at which point the
oocyte enters the oviduct and, if sperm is present and the oocyte is of good quality, fertilization
will occur [180]. At fertilization, the sperm penetration triggers activation for the completion of
the meiotic cycle [181].
The breakdown of the germinal vesicle signals an oocyte’s commitment to maturation;
this phase is also one of reduced transcript activity. During this period of transcriptional
quiescence, changes in the transcriptome and proteome occur through interaction and intercellular
transport with surrounding cells, as well as post-transcriptional modifications such as those
triggered by sncRNA or RNA binding proteins. The mature oocyte is transcriptionally inactive
prior to fertilization but contains reserves of transcripts and proteins needed to drive the first
cleavage divisions and reprogramming events. The oocyte provides the maternal inheritance,
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genetic info, as well as epigenetic info for the developing embryo before embryonic gene
expression is turned on at the EGA [182]. Post-fertilization, the oocyte undergoes the second
meiotic division and extrudes a second polar body, at which point both pronuclei de-condense
and substantial epigenetic reprogramming begins [183]. The maternal pronucleus undergoes
passive demethylation via DNA replication. DNMT1, the methyltransferase responsible for
maintaining methylation in a semi-conservative fashion, is excluded from the nucleus during
early embryonic division. In mice an oocyte specific version of DNMT has been found, DNMTo,
which has not been identified in cattle. DNMTo accumulates in oocytes during their growth
phase, and localizes to the cytoplasm in a mature oocyte; this protein is only localized to the
nucleus at the 8-cell stage so as to protect imprinted genes [184]. Therefore, DNA methylation is
reduced progressively over each nuclear division up to the morula stage. DNMT1 re-enters the
nucleus for a single cell division, at the point when the embryonic genome is activated (varies
between species), in order to re-methylate differentially methylated regions (DMRs) and prevent
activation of regions, such as TEs, that need to remain silenced to protect genomic integrity [185].
While the majority of this activity occurs in the maternal pronucleus, DNMT1 also protects
differentially methylated regions in the paternal pronucleus. TET3 is an enzyme that can
demethylate loci and does so in the paternal pronuclei [186]. The STELLA/PGC7/DPPa3
complex binds to DNA and protects maternal imprints from demethylation via binding to
H3K9me2 histone marks and blocking the activity of TET3[187, 188]. Specific histone
modifications mark DNA methylation imprints that must be protected in the maternal pronuclei
and the first embryonic divisions. H3K9me2 is one such mark, however it was found to be
dispensable for imprinting maintenance [189]. TRIM28 is a maternal factor that regulates
embryonic development, maintenance of pluripotency, imprinting, retroviral silencing and DNA
damage response. TRIM28 partners with DNA binding proteins (e.g., KAP1) to induce
heterochromatin activity by acting as a scaffolding protein with the histone deacetylation complex
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NURD, which in turn recruits DNA methyltransferases [190]. The complex will bind to the DNA
and protect these modifications from TET3-mediated demethylation. However, if a gene is
aberrantly demethylated, TRIM28 will not bind and re-methylation will not occur [190].
Histone modifications of the genome undergo major changes during the process of
oogenesis. HAT expression and histone acetylation increases with oocyte growth, and H3K4me3
(active mark) and H3K9me3 (silent mark) both increase with oocyte size [191]. Once the oocyte
is mature, however, few changes occur pre-fertilization. Characteristics that are a component of
heterochromatin, such as lysine methylation, are enriched in areas surrounding precursor
nucleolar bodies, but only in the maternal pronuclei. Histone modifications are asymmetric in
early development, with the maternal pronuclei having many more histone marks then the
paternal pronucleus, especially lysine methylation. Comparatively, the paternal pronuclei is
enriched for H4 acetylation [192]. The exact importance of these changes during oogenesis and
early development is not completely clear.
In the oocyte, maternal mRNAs are stored in messenger ribonucleoprotein particles for
protection until they are recruited for translation at specific time points [193]. The stored mRNAs
are maintained in an untranslated state and generally have short poly (A) tails, which prevents
formation of the translation initiation complex. Extending the poly (A) tail activates translation
by recruiting PABPs and promoting interaction with the 5’ end of the mRNA. In the oocyte,
maternal mRNAs are synthesized in the nucleus and polyadenylated under the nuclear
polyadenylation signal AAUAAA. Once synthesis is complete, they are transported into the
cytoplasm and either become polyadenylated and translated, or deadenylated and stored for later
use [194]. Because there is no active transcription, the oocyte relies heavily on posttranscriptional control of maternal transcripts. The maternal mRNA population that accumulated
during maturation is very diverse, supporting a range of functions during maturation and post
fertilization [195]. There are dynamic shifts in mRNA populations through early development,
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following a carefully orchestrated pattern. Large groups of mRNAs are recruited, translated, or
degraded at specific times. The degradation of these maternal mRNAs must occur before
embryonic genome activation, as embryonic development requires precise orchestration of many
molecular pathways that are controlled by a large number of different genes [196].
Within the smallest cell in the body, the sperm genome is highly specialized, as unique
epigenetic marks are needed to condense the size of the DNA to fit into the compact sperm head.
The majority of histone proteins are replaced with highly basic protamines in order to facilitate
the packaging of the DNA into restricted space. About 1-10% of the sperm genome is still
packaged into histones that can carry modifications [197]. It appears that these histone
modifications are not random and may serve to prime the embryonic chromatin status and
influence states of gene transcription or repression during early embryogenesis [198, 199]. Postfertilization, the protamines are rapidly removed from the spermatic genome and replaced with
histones in a DNA replication-independent fashion [191]. The histones are hypo-methylated and
hyper-acetylated, which may be a function of the incorporation itself. However the paternal
chromatin remains devoid of modifications associated with heterochromatin, until replication of
paternal DNA at the late pronuclear stages [192]. Active demethylation of the paternal pronuclei
occurs within hours of fertilization in mice and is involved with the oxidation of 5mC to 5hmC,
and then to 5caC [200]. The TET hydroxylase enzyme family performs this oxidation, which
explains the high expression of TET3 in the zygote, preferentially expressed in the paternal
pronuclei. It is unknown if the high levels of 5hmC produced by TET3 are diluted out through
cell divisions, or if another enzyme continues the chemical modifications. While TET is the
dominant mechanism of demethylation in the paternal pronucleus, evidence points to the
involvement of base excision repair and nucleotide excision repair, as well [191].
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Maternal-to-Embryonic Transition
Following successful epigenetic reprograming of the maternal and paternal genomes,
embryonic genome activation must occur. The MET of early development is the process of
shifting genomic control from the maternal transcriptome to the activation of embryonic genome.
The shift in transcripts is quite drastic, as maternal transcripts that may have been present in the
oocyte and early embryo for weeks to months are eliminated in a matter of hours. Three major
events occur at the MET that are necessary for continued embryo development (Figure 1.4).
First, transcripts specific to the oocyte must be destroyed. Second, maternally-derived transcripts
that are expressed in both the oocyte and embryo must be replaced mRNAs derived from the
embryo’s genome. And third, de novo production of transcripts specific for the developing
embryos must take place [201]. In this dissertation, MET will be used to refer to the entirety of
this transition, which includes the degradation of maternal transcripts as well as the process of
EGA. The term EGA will be used through this dissertation to refer to the specific step during the
MET at which the embryonic genome is first transcribed and mRNAs and miRNAs from the

Figure 1.4. The maternal-to-embryonic transition in cattle.
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embryo are activated. In cattle, the EGA occurs in two waves, the minor and the major wave,
with the major wave of EGA occurring at the 8-cell stage, whereas the MET occurs over a longer
period of time, approximately from fertilization to the 16-cell stage in cattle [202]. While many
researchers employing the mouse model of embryonic development use the term maternal-tozygotic transition (MZT), as the EGA coincides with the formation of the zygote in mice, this
descriptor is not precise for other mammalian models for which the EGA occurs at later
developmental stages, such as in cattle. (Note that Chapter 2 retains the use of MZT in place of
MET, as that chapter was published prior to the completion of this dissertation.)
During the developmental window prior to EGA, maternally-derived mRNAs are
regulated via stability, location, and translation. These mRNAs are capped on their 5’ end and
polyadenylated at the 3’ end, chemical structure characteristics that control transcripts’ stability
and availability for translation. The 5’ end cap is a 7-methylguanosine that interacts with the
poly(A) tail and is required to form a loop for initiation of translation. In the arrested oocyte,
mRNAs are deadenylated but dormant, and activated through polyadenylation [203]. The timing
for activation of each mRNA depends on a combination of motifs in their 3’ UTR, such as the
nuclear polyadenylation sequence or the cytoplasmic polyadenylation element, that recruit
different RNA binding proteins and determine polyadenylation and translational status. After the
oocyte completes meiosis, the AU-rich element (ARE) binding protein C3H-4 recruits the CCR4NOT complex to mRNAs that are deadenylated and contain ARE motifs. The waves of
deadenylation and polyadenylation drive meiotic transitions by regulating cyclins, CDKs, APC-c,
and CSFs [204]. Many of the maternal mRNAs are present in subcellular structures, such as
cytoplasmic granules, which may facilitate translational repression; because these granules have
no enclosing membrane, these mRNAs can be transported rapidly in response to developmental
cues. [205]. Up to this point in development, all of the molecular processes of oogenesis and
early development rely exclusively on maternal mRNAs. Specific mRNA become dramatically
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adenylated at different stages of oocyte maturation or embryo development, correlating with their
recruitment into polysomes and translational initiation [206]. Large waves of mRNA adenylation
and activation occur at oocyte maturation, and again at fertilization. One protein regulator is
WIPSY (aka GLD2, PAP, TUTase, or HS), which mediates the polyadenylation of the maternal
transcripts and is required for oocyte maturation in mammals [207]. In Drosophila, this activity
is performed by WISPY on maternal transcripts that are critical for early development, to prevent
premature clearance [208]. Other proteins also regulate mRNA storage or action in the oocyte
and early embryo, including CPEB, which is a highly conserved sequence-specific RNA binding
protein that binds to a cytoplasmic polyadenylation element in the 3’ region of the mRNA [209].
CPEB complexes with GLD2 in humans and PAP in Drosophila for polyadenylation. The CPEB
protein is necessary for both nuclear and cytoplasmic polyadenylation, as it modulates mRNA
location and translation [210, 211]. Polyadenylation is necessary to protect those transcripts
necessary for early development from degradation.
Deadenylation in the oocyte and early embryo can cause destabilization and degradation
of transcripts, although a large proportion of mRNAs remain stable even when deadenylated.
Unlike somatic cells, mRNA decapping and decay are not tightly coupled to deadenylation in
embryos. It is possible that embryonic activation of decapping activity is required for
degradation pathways of deadenylated maternal transcripts [212]. The resistance of maternal
mRNA to decay even when deadenylated may protect mRNA molecules with developmentally
important functions in the MET that need to be silenced in the oocyte. In mice, P-bodies
associated with mRNA degradation are only found in early stage oocytes, and these disappear as
the oocyte grows. The components that normally localize to the P-body localize to subcortical
aggregates containing maternal mRNA, but lack the decapping enzyme DCP1 normally
associated. Similar types of specialized localization are seen in Xenupus and zebrafish, into a
similar translationally repressed mitochondrial cloud and Balbiani body, respectively. These
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changes, unique to the mature oocyte and early embryo in mammals, may reflect a function in
mRNA storage and repression, but not degradation [205]. Shortening of the poly(A) tail is still
the rate limiting step for degradation, and the deadenylation is followed by de-capping and
degradation from the 5’ end. The deadenylation complexes include the CCR4-NOT, PAN2PAN3, and PARN complexes. Specificity is through recruitment of elements or motifs of
mRNAs bound by RNA binding proteins, or miRNA binding.
At the MET, 30-40% of transcripts are completely degraded and 60% are significantly
degraded [213]. The pathways for transcript degradation include those driven by the maternal or
by embryonic machinery. The proportion of transcripts degraded by maternal verses embryonic
modes varies across species. Tadros et al. determined that more than 1000 mRNAs were cleared
after egg activation via the maternal degradation pathway in Drosophila and that the protein
Smaug regulated two-thirds of those transcripts [214]. An additional 563 mRNAs were suggested
to be subject to embryonic mode of clearance [215]. In mice, oocyte maturation caused
destabilization of almost 3000 mRNA, all of which were cleared by maternal modes [216].
Immediately following fertilization almost 2300 mRNAs were degraded, consistent with a
maternal mode of regulation, and at the 2-cell stage post MET, almost 500 mRNAs were cleared,
consistent with an embryonic mode of regulation [217].
One major protein contributing to the maternal degradation pathway is Smaug, which is
derived from the oocyte. This protein directs the degradation of a subset of maternal transcripts
through recruiting a deadenylase complex made up of CCR4/POP2/NOT [218] and causes
subsequent down-regulation of maternal proteins that would repress the embryonic genome [219].
In Drosophila, Smaug can also act as a translational repressor through binding to recognition
elements in the 3’UTR and binding to the eIF4E binding protein CUP for destabilization of the
transcript Nos. Stem loop structures termed Smaug response elements in the 3’ UTR repress
mRNA [220]. Smaug may control stability and translation of a large proportion of maternal
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mRNA, as statistical analysis predicted that 3000 transcripts (about 50% of detectable transcripts)
were under translational control, of which 339 were bound to the Smaug protein and a further
two-thirds of those bound transcripts were destabilized [219]. Likely some targets of Smaug
escaped detection, as many of the transcripts destabilized at this point in development contain
Smaug response elements. Importantly, Smaug targets transcriptional repressors for degradation,
which is a critical step to enable activation of the embryonic genome.
The embryonic pathway for clearance of maternal mRNAs is more active at the EGA,
and this pathway is necessary to degrade maternally-derived Smaug. Unstable mRNAs degraded
by the embryonic pathway are enriched in binding sites for Pumillo (Pum), a RNA binding
protein. In support of this link, bicoid mRNA degradation is mediated by Pum [221]. The exact
mechanism has not been identified, but Pumillo associates with the CCR4-NOT complex in other
situations [222], and the CCR4-NOT complex is required both maternally and embryonically for
embryonic development [222]. However, Smaug and Pum do not account for all mRNAs
degraded. Thomsen et al. mined Drosophila deep sequencing data of unstable mRNA, and many
mRNAs that did not have Pum binding sites or Smaug response sites did contain an enrichment
for AREs and miRNA seeds [213]. These researchers were able to experimentally confirm the
activity of miR-14 in maternal transcript degradation [213]. The potential for miRNA as an
embryonic clearance mechanism of maternal transcript has promise but is complicated by species
differences. MicroRNA decay pathways have been identified in both vertebrates and
invertebrates. MiRNA decay-dependent transcripts were shown first in zebrafish, where one
miRNA, miR-430, mediates the decay of hundreds of maternal mRNA [223]. When miRNAs are
loaded into Ago proteins to target mRNA, AGO proteins may interact with the GW182 family,
which in turn recruits CCR4-NOT and PAN2/3 complexes. These interactions have been
demonstrated in Drosophila and mammalian cells, but have not been proven in the context of
early development [224]. Maternal decay by both maternal and embryonic miRNAs has also
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seen in C. Elegans [225], by the miR-430 orthologue miR-427 in Xenopus [226], and in by miR309 in Drosophila, which is highly expressed at the EGA and degrades hundreds of mRNAs
[227]. Interestingly, the miR-430/427/302 family of miRNAs shares a seed sequence with miR290 in mice, which are expressed at high levels in embryos and embryonic stem cells [228, 229].
Genetic inactivation of the cluster miR-290-295 results in problems with fertility, embryonic
lethality, and PGC defects [230]. However, to date, miRNAs have not been shown to be part of
the embryonic mRNA degradation pathway in mammals. The contradiction with other species
may be due to the heavy use of the mouse model to study mammalian early embryonic
development. Discussed in more depth below, mice have an sncRNA pathway in the oocyte and
early embryo that is apparently unique to rodents. PiRNA proteins appear to be divergent from
what is seen in humans and cattle [72], and endo-siRNAs, which are not commonly seen in other
mammalian models of early development, may be up-regulated in mice oocytes due to a rodent
oocyte-specific Dicer isoform that preferentially loads siRNA over miRNA [231]. Findings in
mice support a model by which endo-siRNAs are important for mRNA clearance during oocyte
maturation, and perhaps at the MET, while miRNAs are crucial for mRNA regulation later in
embryonic development as cell differentiation begins [232]. Because of these divergent
pathways, the experimental evidence that miRNAs are not highly active or functional in mouse
oocytes and early embryos [232-234] should not deter further investigation of miRNAs as a
embryonic mRNA clearance mechanism in mammals
Spatial recognition is a highly regulated regulator in maternal mRNA decay and can
protect developmentally important transcripts from decay. In Drosophila, Osk is required for
translocation of mRNA to the posterior pole and prevents Smaug from binding [235]. Similarly,
in zebrafish, Nanos is generally targeted by miR-430, but needs to be protected in the PGCs by
the RNA binding protein Dead End 1 (DND1), which binds to the 3’ UTR and prevents miRNA
association [236]. The zebrafish maternal transcript Tdrd7 similarly requires protection from
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miRNA degradation, and in this case, the RNA binding protein DAZL causes polyadenylation
and stabilization [237]. In this manner, a multitude of proteins with different functions can bind
to protect transcripts from degradation. The complex system that contributes to the abundance of
transcripts involving targeting by degradation proteins, miRNAs, and RNA-binding proteins
makes it difficult to directly connect the abundance of an miRNA molecule to the predicted
down-regulation of its target mRNA [238].
The subcortical maternal complex (SCMC) is essential for successful preimplantation
development. The SCMC is assembled during oogenesis and marks cell populations during
divisions. This structure also includes the proteins MATER, FLOPED, TLE6, PADI6, and Filia
[239], each of which has an effect on early embryogenesis. When cell division occurs nonparallel to the apical basal axis of the polarized blastomeres, SCMC is either present or absent in
the divided cells. Those cells that lack the SCMC preferentially become the inner cell mass
(ICM), while those containing SCMC preferentially form the trophectoderm [240]. These
observations support a model of early development by which maternally-expressed protein
complexes differentially accumulate in topologically distinct blastomeres, despite the embryos’
ability to adjust to the loss of these cells.
There are two phases in activation of the embryonic genome: the minor wave, during
which a minority of transcripts are activated, and the major wave, which coincides with the large
scale onset of transcription [196]. There are several models that may explain the initial triggering
event for the EGA. The first model posits that increasing genomic material relative to the
constant amount of cytoplasm triggers a release from maternal repressive transcriptional factors
present in the cytoplasm [241]. The second model proposes that a maternal clock determines the
timing of gene expression [242]. The maternal clock model requires that a maternal factor is
increased in either quantity or activity, and once it reaches a critical level, transcription is
triggered. Maternal mRNA mobilizes over time and leaves the dormant deadenylated state.
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Therefore, the resulting proteins can function as transcriptional activators, removing the silencing
marks on the embryonic DNA [243]. Support of this model includes the post-fertilization
polyadenylated and translated transcription factors that include Nano, Pou5f1, and Sox19b.
Pou5f1 can bind to specific loci, suggesting it may prime certain genes to be embryonically
expressed. Knockdown of these factors causes developmental arrest, similar to what is seen with
alpha-amanitin treatment, a RNA polymerase 2 inhibitor [244]. In Drosophila, there is evidence
in support of both models, perhaps even working in a coordinated fashion to activate transcription
[245]. There are also a host of maternal genes that have been shown to be required for the major
wave of EGA, and chromatin structure may function early on when early expression of key genes
may be required for the major wave of EGA [246].
To better understand the contributions of maternally-derived transcripts in comparison to
those produced by the embryo, Graf et al. used oocytes from Bos taurus taurus and sperm from
genetically distinct Bos taurus indicus for in vitro fertilization, allowing for the identification of
embryonic transcripts by the presence of paternal single nucleotide polymorphisms [247]. It is
also possible to match mRNA to an oocyte DNA library to identify transcripts that are newly
present post fertilization. Researchers have used this method to identify the major and minor
waves of the EGA in embryos, and to determine when leaky transcription may be occurring prior
to these events. Embryonic contribution can also be measured using modified ribonucleotides,
such as 3H, 32P or bromo uridine triphosphate, but it is difficult using this method to determine the
identity of the transcribed genes [248]. RNA sequencing can identify some features of embryonic
transcripts to distinguish them from maternal transcripts, as embryonic transcripts may have
alternative splicing and poly adenylation patterns [249]. RNA sequencing libraries are often built
using methods that rely on a poly(A) tail for mRNA isolation. However, by sequencing unspliced
pre-mRNA, it may be possible to identify more SNPs and more easily identify embryonic
transcripts.
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The embryonic genome activation occurs following nuclear cycle 13 in Drosophila, at
the 2-cell stage in mice, 4-to-8-cell stage in human, at the 8-cell stage in cattle, and at the midblastula transition (MBT) in zebrafish and Xenopus [212]. In bovine embryos, the major wave of
the EGA occurs at the 8-to-16-cell stage. However, small amounts of transcriptional activation
have been noted as early as the single cell zygotic stage. Graf et al. observed a marked increase
in transcriptional activation of the embryonic genome between the 4-cell and 8-cell stage in
cattle, likely due to the necessary degradation of maternal mRNA for the EGA, as many of those
transcripts were down-regulated [247]. Genes activated prior to the 4-cell stage were associated
with for RNA processing, translation, and transport functions, likely in preparation for genome
activation and active transcription and translation. For example, KLF4 was activated at the 4-cell
stage; this gene may contribute to the major wave of EGA, as it is known to activate transcription
[247]. Genes activated at the 8-cell stage were linked to functions involving transcription,
nucleotide metabolic processes, protein ubiquitination, translational metabolism and RNA
metabolism processes. EIF3 is required for the initiation of protein synthesis and was first
expressed at the 8-cell stage. EIF3 also associates with the 40S subunit to facilitate formation of
the pre-initiation complex, thus stimulating the process of mRNA recruitment and scanning for
AUG recognition [247]. Chromatin remodeling factors, histone deacetylase and DNMT3b are
also activated at this developmental stage in cattle [247].
Small Non-Coding RNAs and the Maternal-to-Embryonic Transition
The transcriptionally silent landscape of the mature oocyte and early embryo make this a
unique window of development during which post-transcriptional machinery may dominate the
regulatory network. As such, this period of embryo development is an interesting point at which
to examine the function of miRNAs in early development. As discussed in detail above, embryos
inherit numerous maternal transcripts that are key for embryo development. In many species, a
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defined role for miRNA in the clearance of maternal transcripts has been well defined. However,
due to differences in the sncRNA biogenesis pathway in mouse oocytes, a popular mammalian
model, discrepancies and controversy has surrounded the putative role of miRNA for clearance of
maternal mRNAs at the MET. During the maternal-to-embryonic transition, depletion of
maternally derived mRNAs is at least partially dependent on the 3’UTR, which points to a
possible of this class of sncRNA during the MET.
The debate on the role of miRNAs centers on the specialized sncRNA biogenesis
pathways in rodents, which are often used as a mammalian model for embryo development.
Because Dgcr8 is necessary for miRNA biosynthesis, but is not part of the siRNA biosynthesis
pathway, it is possible to examine which sncRNA population carries out specific functions using
a Dgcr8 knockdown. Dicer, however, is an essential processor for both siRNA and miRNA
biosynthesis pathways. Therefore, studies using Dicer and Drosha genetic knockout animals
provide valuable clues to the differences in function of these to biogenesis factors. Oocytes
derived from Dicer null mice cannot mature or be correctly fertilized, whereas oocytes from
Dgcr8 null mice can mature, undergo fertilization, and develop to the blastocyst stage [228, 233].
However, the Dgcr8 knockout mouse has a lower fecundity rate, pointing to some function of
miRNAs during development, even in rodents. The reduced fecundity does suggest some
function of miRNA during development, even in rodents. The DGCR8 knockout also does not
affect the embryonic transcription of biogenesis factors, as it is a ZP3-cre mutation [250].
MiRNA could therefore function in the embryonic degradation pathway in the MET, as there
would be no maternal miRNA in the DGCR8 knockouts and embryonic miRNAs would not be
affected. In zebrafish, miRNAs have been shown to function in the degradation of maternal
transcripts [251]. MiR-430 is processed by Dicer at the EGA and targets hundreds of maternal
mRNAs for degradation, linking the onset of EGA and maternal mRNA decay. No such function
has been identified in mice, yet the Dicer knockout phenotype is more severe in mice than in
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zebrafish [251]. As mice have a severe knockout phenotype, but no known function of miRNA,
and zebrafish have known functions of miRNA but a less severe knockout phenotype, we cannot
rule out that the miRNA functionality in mice has simply not yet been identified. Therefore, the
observations from use of Dgcr8 knockout may not rule out a functionality of miRNA, but rather
suggest that the loss of miRNA function does not cause problems until after the EGA, at which
point cellular differentiation begins.
A study in mice assessing Dicer knockout effects showed severe defects in both
chromosomal alignment and spindle organization [233, 252]. While in somatic cells, siRNA
precursors would cause an interferon response, this pathway appears to be lacking in mouse
oocyte [253]. Rather than function via RNAi, it is possible that endo-siRNAs serve a role in
preserving the accuracy of specific developmental arrests and control of the cell cycle required in
the maturing mouse oocyte and early developing embryo. If the Dicer knockdown mouse
phenotype was due to siRNA serving similar roles in spindle organization, this would explain the
immediate devastating consequences of the knockdown. In support of this hypothesis for the
mouse model, the very low levels of siRNA in comparison to miRNA and mRNA may suggest
that siRNAs may not function to degrade in maternal mRNA. The dysregulation of transcripts
via aberrant miRNA expression would not necessarily cause immediate embryo death or damage,
but would lead to the accumulation of increasingly aberrant transcript expression over time
ultimately triggering high stress on the embryo that impairs cells’ capacity to properly
differentiate. These knockout study results suggest that, in mice, endogenous siRNAs are
significant contributors to the development of functional oocytes. The suggested function of
siRNA in oocytes, but lack of need for miRNAs, may be due to a mutant DICER only found in
mouse oocytes that preferentially processes endogenous siRNA, as opposed to miRNAs [231].
However, several miRNAs have been shown to regulate genes vital in early development, even in
mouse species. In fact, miRNAs have been identified that closely regulate the pluripotency
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pathway such that mouse embryonic specific miRNAs can facilitate revision of differentiated
cells into a pluripotent state [254]. The rodent-specific sncRNA pathway likely creates an
species-specific embryonic environment in mice in which siRNAs function to degrade maternal
transcripts, whereas miRNA is necessary later on as differentiation begins to occur in
development [255].
MiRNA may be present concurrently with targets, but unable to degrade those transcripts
until they are released from translational repression and protection [238]. The functionality of
miRNA in the early embryo has been a source of controversy, as in mouse oocytes, luciferase
reporters were not efficiently repressed in mature oocytes [232]. However, the miRNA-mRNA
binding code can be impacted and altered by both modifications and protein binding. For
example, in mammals, adenosine deaminases (ADARs) alter adenosine to either inosines or
guanines in ncRNA as well as their target mRNA. Both of these actions can change binding
ability of miRNA and prevent RNAi targeted degradation of targets [31]. Adenylation can also
occur in miRNAs and it is possible that adenylation seen on miRNAs during early development
of mice, sea urchins, and Drosophila could prevent miRNAs present from binding to their target
mRNA, and may mark maternal miRNAs for degradation [256]. In addition, modifications such
as N6 methyladenosine (M6A) of the mRNA can block A:G base-pairing and interfere the
binding of miRNA to mRNA. The overall cellular M6A abundance and individual transcript
M6A levels can be altered both by Dicer levels, and levels of specific miRNAs [257]. Some
mRNAs express AU rich elements (AREs) in the 3’UTR, which can compete for binding to RNA
binding proteins, interrupt binding of miRNAs, or act cooperatively in miRNA binding [258].
AREs interact with different proteins, such as dead end homologue 1 (DND1). When bound to
AREs, DND1 physically prevents miRNA from binding to the 3’UTR of transcripts. The
function of DND1 has not been characterized in mouse development, but this protein is abundant
in both immature and mature pig oocytes. Direct binding of DND1 to transcripts of key
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pluripotency genes has been shown in the pig model, including OCT4, SOX2, and LIN28 [259].
DND1 may protect maternal transcripts critical for development in the period between germinal
vesicle breakdown and the EGA. Also, DND1 was down-regulated during EGA in pig embryos,
which may allow miRNAs to bind maternal mRNA targets [259]. Moreover, DND1 impacts
fertility, as it is required for embryonic development and both male and female germ line cells
require DND1 expression for viability [259, 260]. Through mediation of miRNA binding to
transcript targets, RNA binding proteins such as DND1 may be a critical mechanism for
restricting the activity of miRNA molecules during early development. The RNA-bound
proteome undergoes extensive changes at the MZT in Drosophila, which likely impacts the
ability of miRNAs to target transcripts [261]. It is possible that other RNA binding elements
function in similar pathways in early development, mediating interactions between sncRNA and
their targets, thus contributing to a dynamic and complex degradation code in the early embryo.
The premise that miRNAs do not have an important function in mammalian early
development has been challenged through studies in other non-rodent species, such as the pig
[262] and cattle [263, 264]. For example, using a PCR approach to profile 98 miRNAs of interest
in cattle oocytes, 8-cell and blastocyst embryos, Berg and Pfeffer determined that most miRNA
concentrations were below the threshold that could reasonably suppress transcript expression
given the apparent abundance of target transcripts [265]. However, they did determine that miR320 was highly expressed in embryos, and that miRNAs were generally more abundant at the 8cell stage compared to oocytes [265]. MiR-130b was found to control granulosa and cumulus cell
proliferation, oocyte maturation, as well as morula and blastocyst formation [266]. In the bovine
blastocyst, miR-218 may regulate NANOG and CDH2, and miR-449b may regulate NOTCH
[267]. In cattle, miR-212 has been demonstrated to negatively regulate the maternal effect gene
FIGLA [264], and miR-196 has been shown to negatively regulate the maternal effect gene
NOBOX [263], supporting a possible function for mammalian miRNA in the degradation of
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transcripts at the MET. In addition to this work in cattle, studies using the porcine model of early
embryo development have shown that Dicer and miRNAs are present in oocytes and embryos,
and that miRNAs were dynamically regulated by developmental stage [268]. MiRNAs in porcine
embryos were also found to regulate abundance of transcripts critical for development [262].
Furthermore, dynamic changes of miRNA populations have been shown in preimplantation embryos in cattle [265, 269], and exogenous supplementation of specific miRNAs
can alter the developmental potential of embryos [270]. Bovine embryos secrete miRNAs into
culture media, and the profiles of miRNAs released were distinct based on cleavage time, with
miR-30c and miR-10b more abundant in conditioned medium of slow-cleaving embryos [271].
Moreover, Lin et al. determined that supplementation with a miR-30c mimic resulted in increased
apoptosis [271]. Furthermore, Kropp et al. showed that the secreted miRNAs that distinguished
embryos that successfully developed to blastocyst stage from those that did not were also detected
in culture medium of both bovine and human pre-implantation embryos [272]. The apparent lack
of concordance for mouse and human models of embryo development with respect to the role of
miRNAs raises concerns when considering the outsized role of rodent models in pre-clinical
studies focused on early development, particularly given that human miRNAs in cumulus cells
have already shown promise as a biomarker for development [273]. The apparent better
concordance of cattle embryo models supports the use of bovine embryos for such studies,
especially those focusing on the function of miRNA during the MET.
In mice and rats, it appears the sncRNA pathways in early development are not the same
as the conserved pathway in other species such as cattle and humans, and this extends from the
miRNA/siRNA dynamics to piRNA [72]. In mouse oocytes, piRNAs are relatively rare and
dispensable, which came as a surprise considering the highly conserved role for piRNAs in
silencing TEs and maintaining genomic stability. In mouse embryonic male germ cells, MIWI2
(PIWIL4) was shown the drive the nuclear piRNA pathway, while the Piwi paralogue MILI
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(PIWIL2) initiated the loading of MIWI2, both of which specifically loaded through the
secondary piRNA ping-pong cycle [274, 275]. In other models, such as cattle and Drosophila,
piRNA is essential in spermatogenesis and oogenesis [276], whereas mouse piRNA proteins
seem to only impact male fertility, not female fertility [262, 277, 278] as minimal transcripts have
been detected in oocytes [279, 280]. Mice lack the PIWI protein PIWIL3, which is found in
human and cattle oocytes [72]. It is possible that the specialized acquisition of the Dicer isoform
has some role in maintaining PIWIL3 function, and extrapolation of mouse sncRNA pathways
during development may be inappropriate across species. PiRNAs may function in early
development beyond silencing of TEs. Based on piRNA populations in bovine oocytes and
zygotes, researchers have hypothesized that piRNAs may also contribute to mRNA degradation
during the MET [281]. Many of the piRNAs expressed in cattle embryos and zygotes are
potentially derived from or targeted at specific mRNA sequences, and many of these sequences
belong to transcripts destined for degradation later in embryogenesis.
In addition to a potential role in the oocyte, sperm can contain paternal RNAs that may
contribute to genome reprogramming. Male gametogenesis requires the expression and function
of small RNAs, and sperm appear to carry a diverse population of paternal miRNA [282].
Knockout of paternal Dicer or Drosha adversely impacted the developmental potential of those
sperm. However, these miRNAs appear to have limited ability to impact maternally-derived
mRNA, so their exact function in embryo development is still unclear. However, six miRNAs
have recently been demonstrated to be present in sperm but absent in the oocyte. One of these,
miR-34c has been shown to impact the first embryonic cleavage through interaction with BCL2
[283]. Also, sperm miRNAs have been shown to be impacted by stress, which can cause
changes in miRNA up to the morula stage [284] and may be a mechanism for intergenerational
inheritance of epigenetic marks [285].
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Other classes of sncRNA are vital in their supporting functions during the MET to
support extreme changes in translation activity, including snRNA, snoRNA and rRNA. However,
beyond these key housekeeping functions, these sncRNAs may also have more nuanced
regulatory roles. For example, while tRNA has the well-known function to support translation,
tRFs have been shown to modulate intergenerational inheritance. In an interesting study,
researchers showed that consumption of a high fat diet altered the profile of tRFs in sperm, and
this phenomenon was connected to an altered gene expression pattern and glucose intolerance in
the resulting offspring [286]. This effect was attributed exclusively to the tRFs, not miRNA or
lncRNA. SnRNA regulate the splicing of mRNA, and specialized isoforms of each snRNA are
expressed during Drosophila development, which is also seen in mouse and human embryos.
The change in isoforms during embryogenesis is unique, and as development progresses, the
single dominant isoform gradually dominates expression. The function of these changes in
snRNA isoforms in early development is unknown, but in other cellular contexts, snRNA variants
can regulate gene expression [287, 288]. Moreover, any depletion of snoRNAs will lead to
problems with translation in early embryos [289]. While no studies have explored the potential
function of newly identified snoRNA fragments in early development, this class of sncRNA
warrants further study to determine their function in differentiation or pluripotency [119]. Other,
very recently discovered RNA molecules, such as circRNAs, may also function in early
development. These non-coding RNAs form through the 3’-5’ ligation of an RNA molecule from
an exon, intron, or exon-intron and regulate gene expression via their “sponge-like” interaction
with miRNAs. The profile of circRNAs differs depending on embryo quality and these
populations also change over the course of embryo maturation [290]. CircRNAs widely exist in
embryos and are aberrantly expressed in bovine scNT embryos, but their function is still unclear
[291, 292].
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Agricultural Significance of scNT
When working with agricultural clients, live offspring is the most important outcome. In
order to get healthy livestock offspring, the practical application of assisted reproductive
technologies (ART) requires integration of laboratory techniques and veterinary management. In
breeding programs, genetic improvements are generated by selecting animals based on the
animal’s breeding value for the relevant valuable traits. Dissemination of the superior genetic
material to the commercial population is then necessary, and genetic improvement is driven by a
small fraction of the total population.
Due to the low efficiency of scNT, commercial applications of this technology in agriculture
are presently limited to the production of animals of high genetic merit or the most elite show
cattle [293]. Conventional breeding for these traits is difficult because they are typically scored
postmortem. Even if such traits are assessed in living animals, breeding is often not an option as
many superior beef cattle are sterile steers. Cloning animals from cells obtained from superior
slaughtered animals has the potential to capture superior carcass trait characteristics. One of the
benefits of ART is to increase the presence of desirable characteristics in production herds (e.g.,
improved carcass quality, increased feed efficiency, reduced waste, improved disease resistance).
A recent large-scale longitudinal study that encompassed nearly 2,000 assisted reproductive
procedures and production of more than 9,200 transferable embryos convincingly showed that the
reproductive performance of clones is comparable to their genetic donors [294]. Therefore,
cloning technology combined with superovulation, artificial insemination and embryo collection
provides a valuable tool for faster dissemination of superior maternal genetics. Improvement in
ART efficiency combined with genomics technologies would make a significant impact on the
rate and dissemination of genetic improvement.
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Medical Significance of scNT
The methods of scNT have created opportunities for significant improvements in human
medicine as well. Livestock cloning can create production of animal organs and tissues that
could be appropriate for human transplantation, including pig organs that can be genetically
modified for the human immune system [295]. ScNT also provides the opportunity for the
addition of genetic material or production of a transgenic animal for the study of human diseases
in appropriate animal models [296]. It is possible some of the knowledge gained from livestock
scNT, including a better understanding of epigenetic reprogramming of somatic cells to
pluripotency, could improve techniques for creating induced pluripotent stem cells (iPSCs).
Induced PSCs could be created from somatic cells taken from a human patient and then used for
stem cell therapy in that same individual. Through this method, many of the ethical concerns of
stem cell therapy could be bypassed, and treatments that match to the individual’s immune
system and genetics could be utilized, if current issues with mutations could be addressed [297].
The process of cloning in livestock also has direct applicability to the basic understanding of the
molecular process of epigenetic reprogramming that must occur in natural development [296,
298]. The research community lacks a complete understanding of gene expression and regulation
in early development and pluripotency involved with reprogramming and development, and cattle
and other agricultural species may serve as a superior model to mice in this realm [299].
Methodological and Molecular Aspects of scNT
Oocytes are required for scNT, and MII stage oocytes are the normal cytoplast recipient.
Oocytes obtained from a abattoir have benefits over in vivo oocytes derived from super-ovulatory
follicles because abattoir-derived oocytes have not been subject to hormone treatment that may
alter the oocyte epigenome and granulosa cell transcriptome [300, 301]. Also, the use of in vitromatured oocytes provides a higher degree of control and consistency in the maturation process.
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The production of animals via scNT is completely reliant on many other technologies such as
oocyte recovery, oocyte maturation, enucleation, cell fusion, embryo culture, embryo vitrification
and storage, and embryo transfer. Oocyte quality can be defined as the competence to yield a
blastocyst within an in vitro production system [302], which dictates that developmental
competence is not only dependent on the intrinsic quality of an oocyte but related to laboratoryspecific features, including the procedures for oocyte collection, in vitro maturation, and IVF.
The developmental potential of embryos is significantly impacted by conditions used for
the collection, manipulation, and culture of oocytes and embryos. Optimizing the temperature
and gas concentration of the incubator, pH of the culture media, media composition, and even air
quality are vital for minimizing stress on the cultured embryo [303-305]. Optimal handling of
oocytes requires processing rapidly to reduce detriment to developmental competence, both in
recovering oocytes pre-maturation, and in polar body assessment and enucleation post
maturation. The post-fertilization embryo culture environment, including medium components,
mineral oil, and co-culture with other cells can also have a dramatic impact on gene expression,
which has implications for how researchers culturing embryos to the blastocyst stage [306-310].
Because of the differences between laboratory procedures for embryo culturing, hormonal
stimulation protocols, and oocyte collection techniques, there may be challenges in repeating
findings in differences between in vitro and in vivo-produced (IVP) embryos.
The first step of oocyte maturation for use in scNT is to culture the cumulus oocyte complex
(COC) in maturation medium that contains species-specific hormones to promote maturation.
Most laboratories utilize TCM-199 medium supplemented with fetal bovine serum, estradiol,
FSH and LH [311, 312]. It is necessary to process oocytes as quickly as possible, to minimize
damage. As oocytes age, they become more prone to spontaneous activation, which can cause
problems with coordinating cell cycle activities [313]. Because of this issue, the protocol
employed for the research described herein calls for incubation of oocytes for exactly 22 hours in
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the maturation media. Oocytes will undergo spontaneous maturation after removal from the
follicular environment [314], but the maturation medium is used to modulate cAMP levels and
stimulate meiosis with FSH and epidermal growth factor (EGF) for slow meiotic progression
[315]. After maturation, the COC is disrupted, and hyaluronidase is used to break down the
hyaluronan-based matrix surrounding the cumulus cells causing their dispersal [316]. Cumulus
cells are necessary to support oocyte competence through maturation, and thus are removed only
immediately prior to enucleation [317]. Oocytes are examined for the extruded polar body, which
indicates that the oocyte has matured to the MII stage. The DNA of the oocyte is then removed,
and the metaphase plate is removed using mechanical aspiration using a microinjection system to
minimize damage to the oocyte. The oocyte must be treated with cytochalasin B or D in order to
destabilize cortical microfilaments and disrupt the plasma membrane [318]. A variable amount of
cytoplasm can be removed with mechanical aspiration, and in larger domestic species with lipid
dense cytoplasm, this approach relies on the polar body location for removal of the metaphase
plate beneath it to minimize harmful irradiation. Successful removal of the metaphase plate is
confirmed by UV inspection of the enucleation needle to confirm DNA presence [319]. Mouse
oocytes are translucent and visualization of the meiotic spindle and pronuclei can be achieved
using plane polarized light.
Different cell types can be used as nuclear donor cells from the individual animal to be
cloned, as live offspring have been generated using nuclear donor cells from cumulus cells,
fibroblasts, neuronal, and Sertoli cells with the best results from cumulus cells [320]. Relatively
few donor cell types have been shown to not work for scNT. Moreover, scNT has been employed
for many species by many research programs, including important agricultural species, such as
sheep [321], goats [322], mules [323] and cattle [324] and to important biological or pre-clinical
model species, including as mice [325], zebrafish [326] and even early humans (not allowed to
develop past blastocyst stage) [327]. While some reports found higher efficiency when using
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pluripotent cells as donor cells [328], others showed higher efficiency with more differentiated
cells [329], and generally mixed results on gene expression abnormalities were found [330].
However, reports of successful cloning using highly differentiated cells, such as lymphocytes,
indicates that successful nuclear reprogramming can occur even in these highly specialized cell
types [331]. The nuclear donor is injected into the space between the oocyte cytoplasm and the
zona pellucida, and electroporation is used to disrupt the lipid bilayer of the closely apposed
membranes, which results in fusion of the donor nuclear cell and the oocyte cytoplasm [296].
Another option is direct injection, which has the advantage of delivering a karoplast devoid of
cytoplasm, but this method requires costly specialized systems and greater micromanipulation
skills and time [332]. The donor nucleus fuses with the oocyte, which is then activated with
ionomycin t mobilize intracellular calcium stores and trigger a single calcium wave, differing
from the natural repetitive calcium wave that occurs with fertilization [333]. 4-Dimethylaminopyridine or cycloheximide is used to induce mitosis promoting factor (MPF) and/or
cytostatic factor, which leads to the resumption of meiosis and entry to the first embryonic cell
cycle [334]. Extrusion of the second polar body would disrupt ploidy necessary for successful
development, and cytochalasin B can be used to prevent this through disruption of microfilaments
[255, 335].
The culture medium used for embryonic culture after activation is of vital importance as
the medium contain materials that aid in development but also alter embryo quality. The medium
composition differs markedly from species to species. For example, goat and sheep embryos are
challenging to culture in vitro and require culture on a ligated oviduct and then prompt transfer
into the oviduct of recipients to increase embryo viability [336, 337]. However, cattle embryos
can be successfully cultured in vitro to the blastocyst developmental stage, followed by nonsurgical transfer into the uterus [338]. Though necessary to successfully culture embryos, fetal
bovine serum is a complex, somewhat undefined mixture containing hormones, growth factors,
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and other factors that may be detrimental to early embryonic development [339]. Though culture
media are designed to promote embryo growth in vitro, it is important to recognize that these
formulations do not perfectly mimic the uterine embryonic environment, which can cause stress
on the embryo [340]. Therefore, careful standardization of protocols, including across research
laboratories, is needed to improve the reproducibility and robustness of experiments utilizing
embryo culture methods.
Another critical element in scNT is the coordination of cell cycles between the donor cell
and the oocyte, so as to maintain appropriate ploidy of the genome. The oocytes used for scNT
should be arrested at metaphase I, and therefore have a high amount of MPF, which causes the
nucleus to break down promotes DNA replication. The donor nuclear cells should then be in the
G0 or G1 phase of the cell cycle, awaiting DNA replication in order to conserve DNA integrity
and ploidy [341]. The chromatin structure in these phases may allow access to those factors
present in the oocyte cytoplasm to reprogram gene expression more efficiently, although some
studies have shown a favorable mitotic window for use in scNT as well [342]. Serum starvation
for 24 hours or confluent cell culture can induce the quiescent G0 state [343].
Epigenetic Errors in Reprogramming Associated with scNT
Somatic cell nuclear transfer is a well-established method for animal cloning in livestock
species, whereby the genetic material from a recipient ovum is removed and then replaced with
nuclear DNA from an adult donor cell. However, compared to in vitro fertilization technology,
with successful term pregnancy rates of approximately 50% in cattle, bovine scNT embryos are
much more likely to abort during pregnancy, with term rates generally below 10% [reviewed in
344]. Regardless of the species or method used for cloning, this method is generally very
inefficient, with only 1-4% of embryos surviving to term as live offspring [345]. It appears that
an accumulation of death occurs at every stage, with less than half of embryos able to develop
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following activation and fusion, and further losses occurring after transfer into a surrogate mother
with total pre-and early post-implantation losses impacting up to 70% of pregnancies [346].
After nuclear transfer, the cellular machinery of the host egg must reprogram epigenome of the
somatic DNA so that the new genome is appropriately coded for a pluripotent state with the
potential for cellular differentiation. Errors associated with epigenome reprogramming of
somatic DNA likely lead to inappropriate gene expression, thus placing an extraordinary demand
on the early developing embryo [297]. The significant cellular stress may be responsible, in part,
for the high loss rate for scNT embryos throughout early development [344], as incorrect global
patterns of DNA methylation and histone modifications have been demonstrated in scNT
embryos. Aberrant epigenetic patterns in cloned embryos appear to be similar to the nuclear
donor cell, indicating poor epigenome reprogramming may contribute to these low efficiencies
[347]. While this technology is not used for human medicine or therapies, cloning does provide a
valuable model to examine the epigenetic reprogramming that occurs in the germline cells and
during early embryogenesis.
Offspring generated by scNT have been documented with a range of abnormalities,
including large offspring syndrome (LOS) in particular, as well as high rates of abortion, high
perinatal death, high birth weight, respiratory failure and oversized organs. Wilson et al.
examined IVP, IVF, and scNT embryos and found that scNT offspring were 20% bigger, with
weight variation 4- to 12- times that of other offspring, even when controlling for dam and sire
effects [348]. LOS is common for offspring generated by IVF, but is most frequent for offspring
generated by scNT [349]. Overall, the magnitude of overgrowth seen in LOS fetuses is correlated
with the number of dysregulated imprinted genes, indicative of issues with aberrant gene
expression causing LOS [350]. Placental perturbations may induce some of these developmental
abnormalities in scNT, and appear to be due to failure to establish appropriate epigenetic marks in
imprinted genes [351]. Placentas from scNT pregnancies harbor wide-scale aberrant gene
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expression patterns that may contribute to some of the problems seen in these pregnancies, as
dysregulation in maternal endometrium occurs as well [352, 353]. For example, dysregulation of
genes in the VEGF pathway may be causative of vascular pathologies in scNT pregnancies [354].
Moreover, scNT pregnancies are typified by abnormal placental vascularization, higher frequency
of abnormal placentomes, and a decrease in the mean number of placentomes [355, 356].
Increased placental mass can occur, with hydroallantois often occurring and contributing to scNT
losses [357]. In addition, placenta growth does not slow at the end of gestation in scNT embryos,
which could cause problems with glucose metabolism [346]. Abnormal estrogen production and
metabolism is also evident in scNT pregnancies, which is problematic as estrone rise is vital for
pregnancy progression at the beginning of the second trimester and at term for parturition onset.
Abnormal estrogen production in scNT may contribute to the loss of pregnancies seen at the
second trimester and the lack of parturition preparation, which can cause longer gestation length,
which is often seen in scNT pregnancies [346].
A dramatic demonstration of the involvement of epigenetics in development is the
dynamic reprogramming of gene expression that occurs during mammalian germ cell
development and early embryonic development [see reviews 358, 359-361]. During germ cell
development, the male and female gamete genomes are globally demethylated then re-methylated
during ensuing development [362]. At fertilization, sperm genome is actively demethylated [363,
364]. The maternal genome is also demethylated during early development, but in a passive,
replication-dependent manner. Global demethylation is subsequently followed by de novo
methylation of the embryo’s genome starting at the 8-cell stage in bovine embryos [365].
Global demethylation and re-methylation events take place following scNT, but differ
from those of normal development in global DNA methylation levels. The difference in
methylation levels suggests faulty reprogramming of epigenetic marks in scNT [347, 366-371].
DNA methylation is the first step of reprogramming and is vital for transcription factors critical
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for establishment and maintenance of pluripotency, such as Oct4 [372]. ScNT embryos typically
show abnormal patterns of DNA methylation and histone modifications, in contrast to IVF or IVP
embryos. Genes that are methylated, and silenced, in differentiated cells may not be correctly
turned back on during the scNT reprogramming, but require expression for embryonic
development and pluripotency pathways [373-375]. Oct4 was seen to be only gradually
demethylated in reprogramming scNT embryos, and ineffective demethylation caused
developmental retardation [376]. Oct4 expression is tightly correlated with DNA methylation,
and this gene is often aberrantly methylated in scNT embryos [377, 378].
Other pluripotency genes show similar aberrant methylation patterns in scNT embryos as
well, including NANOG [379]. A loss of the differential methylated regions (DMRs) has been
found in scNT embryos [380-384], as well as hypermethylation of the entire genome [380].
Specific methylation marks ranged from hyper- to hypomethylated at different locations in scNT
embryos compared to IVF embryos, and there are examples of pluripotency genes and DMRs that
were instead hypomethylated in scNT embryos [380]. Persistent cellular memory from the
nuclear donor cell is likely due to the incomplete DNA methylation seen in scNT embryos. One
likely cause of this incomplete reprogramming is the lack of complete removal of DNA
methylation marks in scNT embryos. In IVF embryos, the DNA methylation levels were close to
0% at the 2-cell stage for the male pronuclei, and at the morula stage for the female pronuclei,
before methylation starts to rise again. However, in scNT embryos, demethylation reached only
about 50% before methylation increased again, and the start of de novo methylation occurred
much earlier in the 4-cell scNT embryo, as opposed to the blastocyst stage seen in IVF embryos
[379, 385].
Aberrant DNA demethylation in cloned embryos appears to be related to repressive
complexes that take too long for the cell to disassemble, creating persistent chromatin states
resistant to demethylation in cloned embryos. In support of this hypothesis, cloned embryos
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exhibited H3K9 hypermethylation, whereas H3K9 methylation is reprogrammed in parallel with
DNA methylation in normal embryos [347, 386]. Other chromatin irregularities have been found
in scNT embryos as well, including abnormally high H3K4me levels [387]. Transcription factors
are required to be present in the cytoplasm of the oocyte and to be able to access the DNA, which
means that chromatin must be open and amenable to change. When histone modifications of the
donor cell are inappropriately maintained, they act as a major barrier for efficient reprogramming
and prevent correct epigenetic reprogramming, which has been shown to occur in scNT embryos
[388]. Interestingly, Kang et al. showed that the transcriptome of scNT blastocyst embryos was a
hybrid of somatic and embryonic transcripts [389]. Higher levels of DNMT1 were present in
scNT embryos, which may stem from active expression in the nuclear donor cell that is partially
maintained, and may also contribute to incomplete demethylation seen [385]. The somatic
isoform of DNMT1 was also higher in scNT embryos compared to the normal expression of
DNMT1o seen in early embryos during reprogramming [390]. Overall, aberrant DNA
methylation was unique to the gene, whereas hypermethylation was noted genome-wide, and
these abnormal levels may be due to abnormal DNMT1 activity or loss of normal demethylation
pathways. The result is a persistence of DNA methylation profile from the donor nuclear cell
[389], which can cause inappropriate gene expression and loss of embryo developmental
competence.
These aberrant epigenome states, unsurprisingly, lead to marked aberrant gene
expression. Overall, transcriptome analyses of scNT embryos have shown a multitude of aberrant
pathways as compared to IVF embryos. In pigs, dozens of dysregulated transcription factors
were expressed in cloned embryos, as well as genes involved with histone lysine methylation
[391]. In buffalo, transcripts related to developmental regulation, epigenetic modifications, and
pluripotency were aberrantly expressed in scNT blastocyst embryos [392]. In cattle,
transcriptome features that distinguished blastocysts or elongated conceptus generated by scNT
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compared from IVF or IVP controls, respectively, included pluripotency genes, TE development
genes, developmental regulators, metabolism and epigenetic modifiers [393, 394]. Histone
modifiers were found to be vitally important for development in scNT as well, and dysregulated
[395]. In mice, after the EGA, 20% of genes with abundant expression in the donor cell
maintained a high expression level inappropriate for embryos, and 15% of genes silenced in the
donor cell and maintained a low expression level inappropriate for embryos, indicative of
incomplete programming [297]. These large-scale changes in transcriptome represent cellular
stresses to the embryo, and when many of these genes are inaccurately expressed in the early
embryo, embryonic death occurs.
Differences in miRNA profiles between scNT embryos and IVF embryos have also been
identified. For example, Hossain et al. revealed that 278 of the 377 miRNAs examined were
down-regulated in bovine scNT embryos as compared to bovine IVF embryos at the blastocyst
stage [396]. It also appears that incomplete reprogramming of the donor cell’s genome occurred
in those scNT bovine embryos, as some miRNAs maintained expression patterns similar to the
donor cells. Moreover, differences in scNT placentas as compared to IVP placentas and placentas
from artificial insemination pregnancies in miRNAs were also identified, as 62% of miRNAs
were differentially expressed in scNT placentas compared to IVP placentas with the majority of
those down-regulated [396]. The aberrations in miRNA profiles for placental tissues for scNT
pregnancies were likely associated with dysregulation of gene expression that may contribute to
pregnancy loss. In another study, researchers examined miRNA profiles in elongated bovine
embryos at day 17 and noted that not all miRNAs measured by microarray appeared appropriately
reprogrammed in the scNT embryos, as their expression was more similar to the somatic donor
cell [397]. Of the 50 miRNAs subject to reprogramming, ten were aberrantly reprogrammed and
another nine were not reprogrammed [397]. To date, these studies are the only reports to assess
expression of miRNA in bovine scNT. Importantly, these studies may not have captured some
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miRNAs of developmental importance, as they did not utilize RNA sequencing or explore the
dynamics of miRNA expression during the activation of the embryonic genome in cloned
embryos.
Improvements in scNT rates have been attempted in a multitude of ways, often by
targeting improvements in epigenetic reprogramming. Caffeine was used to increase MPF and
MAPK activity in sheep oocytes in order to release chromatin-bound factors and allow greater
access for reprogramming the donor chromatin. Researchers have also attempted to change some
of the donor cells’ somatic epigenome through use of chemicals that impact DNA methylation or
histone modification, such as 5-aza-2 deoxycytidine (5-aza-dC) and trichostatin A (TSA).
Overall, many of these treatment options give different results when used in combination, or
when used on donor cells as opposed to use on scNT embryos; also, different results were
obtained by different research groups [398]. The fact that these chemicals have the ability, even
in limited situations, to improve scNT outcomes demonstrates that these epigenetic errors in
reprogramming may be the cause of low efficiency.
Overall, the weakness in these strategies is that they act in a genome-wide, non-specific
manner. Alternatively, targeting specific miRNAs identified as aberrant in scNT embryos may be
a more focused approach to correcting transcriptional abnormalities in an effort to improve
development rates. MiRNA mimics or miRNA sponges are easily synthesized and can be applied
to culture methods by microinjection directly into the embryo or may be absorbed into the
embryo when added to culture media. In fact, a several studies have already shown that
modulation of specific miRNAs can impact rates of development in embryos [270, 399],
including the improvement of scNT embryo development [400-405].
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Bovine Model for Embryo Development
The bovine scNT embryo is an excellent model for the study of epigenetic
reprogramming and gene regulation in early development. The results of experiments designed to
better understand critical aspects of epigenetic remodeling, including a potential role of miRNA,
would prove extremely useful when applied to iPSC technologies. In addition, early
embryogenesis in mouse differs from other mammals in several key aspects. Because of the
rodent-specific pathways for biogenesis of sncRNAs in early development, as outlined above,
moue models are not ideal for study of early embryo development with the intention to learn
about processes that inform human early embryogenesis. Furthermore, studies have cast doubt
on the suitability of the mouse embryo as an optimal model for all mammalian fertilization and
development [reviewed in 406]. Cattle are also one of the most important agricultural species
around the world, and significant resources have been dedicated to improving ART techniques
and breeding efficiency in this species. Therefore, the bovine model is not only the more
appropriate model (over rodents) to examine sncRNA in early embryogenesis and possible
conserved functions in the MET, but also to improve our the understanding of the cause of low
efficiency rates for scNT. Such new knowledge could lead to improvements in scNT an
important agricultural species.
Project Objectives and Overarching Hypothesis
Cloned embryos harbor substantial problems in genome reprogramming, including
extensive aberrant methylation and histone marks for key genes necessary for development.
While investigators have studied DNA methylation and histone modifications as mechanisms for
aberrant epigenome programming, little focus has been given to the role of sncRNA in this
process and no researchers have explored the dynamic expression of sncRNAs during the period
of embryonic genome activation in cattle. Thus, the goal of this project was to determine the
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dynamic expression of sncRNAs and mRNAs in scNT and IVF bovine embryos during early
development through the MET. The overarching hypothesis for this work was that aberrant
genome reprogramming of the donor cell genome would lead to dysregulation of sncRNAs,
particularly for miRNAs, that would in turn drive abnormal gene expression during this critical
window of embryonic development. New knowledge gained from these studies will greatly
increase our understanding of mechanisms controlling epigenetic reprogramming of somatic
DNA and will significantly contribute to our long-term goal of reliably reprogramming the nuclei
of multi-potent and differentiated cells. Chapter 2 describes initial work to profile the array of
miRNAs present in bovine oocytes, 8-cell embryos and blastocyst-staged embryos generated by
IVF using both unbiased (RNAseq) and targeted (PCR) methods. Chapter 3 details comparison
of sncRNA profiles – focusing on miRNA, tRFs and piRNAs – in cattle embryos produced by
scNT and IVF over the course of early embryo development, from the 2-cell to blastocyst stage,
that encompasses the MET in cattle. Chapter 4 presents a parallel set of data describing the
mRNA transcriptome in cloned and IVF embryos, also during the MET, and maps those
transcriptional changes to sncRNA profiles obtained for the same samples. Last, Chapter 5
summarizes our major findings and presents a perspective on opportunities and challenges for the
field of reproductive cloning and the study of molecular aspects of early development.
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CHAPTER 2
THE MATERNAL-TO-ZYGOTIC TRANSITION IN BOVINE IN
VITRO-FERTILIZED EMBRYOS IS ASSOCIATED WITH MARKED
CHANGES IN SMALL NON-CODING RNAS 1

Abstract
In mammals, small non-coding RNAs (sncRNAs) have been reported to be important
during early embryo development. However, a comprehensive assessment of the inventory of
sncRNAs during the maternal-to-zygotic transition (MZT) has not been performed in an animal
model that better represents the sncRNAs biogenesis pathway in human oocytes and embryos.
The objective of this study was to examine dynamic changes in expression of sncRNAs during
the MZT in bovine embryos produced by in vitro fertilization (IVF), which occurs at the 8-cell
stage. An unbiased, discovery-based approach was employed using small RNAseq to profile
sncRNAs in bovine oocytes, 8-cell stage embryos and blastocyst stage embryos followed by
network and ontology analyses to explore the functional relevance of differentially expressed
microRNAs (miRNAs). The relative abundance of miRNAs was markedly higher in 8-cell stage
embryos compared to oocytes or blastocyst stage embryos. This shift in miRNA population was
largely associated with up-regulation of miRNAs predicted to target genes involved in the
biological processes of cell development, cell division, Wnt signaling, and pluripotency, among
others. Distinct populations of piwi-interacting-like RNAs (pilRNAs) were identified in bovine
oocytes and blastocyst stage embryos, though pilRNAs were nearly absent in 8-cell stage
embryos. Also, small nucleolar RNAs (snoRNAs) were highly expressed in 8-cell stage embryos.

1

This chapter has been previously published in: Cuthbert JM, Russell SJ, White KL,
Benninghoff AD. The maternal-to-zygotic transition in bovine in vitro-fertilized embryos is
associated with marked changes in small non-coding RNAs. Biol Reprod 2019; 100:331-350.
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Overall, these data reveal a strong dynamic shift in the relative abundance of sncRNAs associated
with the MZT in bovine oocytes and embryos, suggesting that these molecules may play
important roles in the shift from maternal to zygotic control of gene expression.
Introduction
In vitro embryo production has played an increasingly important role in both medicine
and agriculture by improving methods for treating human infertility and by selecting for superior
genetic traits in key agricultural species, such as cattle. Determinants of embryo developmental
competence are rooted in the oocyte [1]. In addition to the maternal genome, the mature oocyte
provides massive stores of RNA and protein reserves necessary for the first cleavage divisions as
well as embryonic programming events [1]. After fertilization, the epigenetic marks specific to
the differentiated sperm and oocyte must be erased and re-established as embryonic epigenetic
marks for successful development to occur. This process is monumentally complex as it requires
large scale, highly coordinated changes in epigenome programming during a very narrow
developmental window. Coincident with this large-scale reprogramming of the epigenome is the
maternal-to-zygotic transition (MZT), a highly orchestrated process during which control of
embryonic development shifts from the maternally deposited RNA and proteins to those of the
zygotic genome [2]. This process requires degradation of the maternal mRNA transcripts derived
from the oocyte and activation of the zygotic genome via extensive epigenome programming. The
dramatic turnover of the transcriptome is integral in order to prepare the embryo for cell
differentiation and further development. Maternal transcripts are removed by both maternal and
zygotic derived degradation pathways, and although there are many different maternal pathways
for degradation, zygotic degradation activity plays a more prevalent role [3]. Graf and colleagues
pinpointed the 8-cell stage as the major point for the MZT in cattle, with the earliest activation of
genes related to RNA processing occurring at the 4-cell embryonic stage, initiating large-scale
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embryonic genome activation (EGA) [4]. In this period of quiescence, there is high potential for
sncRNA to play a role in the degradation of maternal transcripts, as sncRNA have been found to
act in post-transcriptional regulation of many genes.
Once the MZT has successfully occurred, the newly activated embryonic transcriptome
guides cells through the first of many cell fate decisions at the blastocyst developmental stage.
The first cell lineage specifications are the differentiation of early embryonic cells into the inner
cell mass (ICM), destined to become embryonic tissue, and the trophectoderm (TE) that will
differentiate into extra embryonic tissues. The cells of ICM must maintain a state of pluripotency
for differentiation into many distinct embryonic tissues, whereas TE cells must block
pluripotency signals in order to acquire their specialized functions that support embryo
implantation. In both bovine and human ICM cells, the transcription factors SOX2 and NANOG
direct the change in expression of many other genes to continue the molecular maintenance of
pluripotency [5]. Changes in gene expression patterns must be established correctly through the
epigenetic programming that takes place during the MZT, as any errors in this process could
cause embryonic loss due to failure of pluripotency and cellular lineage specification pathways.
Non-coding RNAs (ncRNAs) were once considered to be non-functional transcription
products of junk DNA. While ncRNAs are not translated into proteins, they are now known to
function in RNA interference (RNAi), acting as powerful post-transcriptional regulators of gene
expression. RNAi involves blocking the translation or reducing the stability of a messenger RNA
(mRNA) through complimentary binding, and this process may control as much as 60% of the
protein coding genes expressed in mammals [6]. In mammals, three classes of sncRNA have
been identified as playing substantial roles in early development in mammals, including
microRNAs (miRNAs), PIWI-interacting RNAs (piRNAs), and endogenous small interfering
RNAs (siRNAs). All three of these sncRNA classes function through RNAi via degradation of
either mRNA or transposable element (TE) targets, although their biogenesis and targeting
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mechanisms differ [7]. Other important sncRNAs include ribosomal (rRNA), transfer (tRNA),
small nucleolar (snoRNA) and small nuclear (snRNA) RNAs. Ribosomal RNA (rRNA) is
necessary for protein synthesis and are of particular importance during cell growth to maintain
ribosomes in subsequent generations [8]. While the amount of rRNA present differs in oocytes
and embryos, the population of rRNA variants is largely similar, suggesting that these rRNA
variants do not have a particular specialized function in embryos [9]. Transfer RNAs play a
critical role in the translation of mRNA sequences to protein, and recently fragments of tRNAs
have been implicated in RNAi through regulation of transcripts and possibly TE [10, 11].
SnoRNAs control ribosome biogenesis by guiding the modification or processing of pre-rRNA.
Specifically, C/D box snoRNAs are associated primarily with methylation modifications and
H/ACA box snoRNAs are associated with pseudouridylation. Similar to tRNA, snoRNAs are
also processed into smaller fragments which may participate in RNAi [12]. Finally, snRNAs
have well defined functions in mRNA splicing and 3’-end formation [13].
MicroRNAs are short, single-stranded RNAs approximately 22 nucleotides (nt) in length
that are a highly conserved subset of ncRNA [7]. RNA polymerase II transcribes the majority of
primary-miRNA transcripts (pri-miRNA) from the genome, which are then cleaved by Drosha
and its mammalian cofactor DGCR8 to generate a 70 nt stem-loop precursor miRNA (premiRNA). Exportin 5 then exports the pre-miRNA from the nucleus to the cytoplasm for
processing, where the Dicer complex cleaves the stem-loop releasing double stranded, nonhairpin miRNA. The miRNA duplex is then loaded onto an AGO protein, which unwinds the
duplex and loads the guide strand of mature miRNA onto the RNA-induced silencing complex
(RISC), which directs the miRNA to its target mRNA [7]. While this is the normal biogenesis
pathway, a minority of miRNAs can also be processed independently of both Drosha and Dicer
using alternative biogenesis pathways [14]. MicroRNAs bind their target RNAs via imperfect
complementary base pairing to target sites in the 3’ untranslated regions (UTR), and often one
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mRNA is targeted by more than one miRNA for maximal repression. In order to destabilize
targets, miRNAs promote the decapping and deadenylation of their target mRNA, localizing the
target to the site of degradation in cytoplasmic processing bodies [15]. The majority of miRNAs
investigated experimentally inhibit gene expression through binding interactions that block
translation and decrease stability of the target transcript.
Several studies have determined that miRNA populations are dynamically regulated
through oocyte maturation and development in multiple species, including zebrafish, mice and
pigs [16]. For example, Giradlez and colleagues reported that miR-430 facilitated the
degradation of hundreds of maternal transcripts in zebrafish embryos, an observation that pointed
to the importance of this miRNA during the MZT [17]. No equivalent function of miR-430 is
known in mammalian development, however several groups have shown that miR-302 (a
mammalian orthologue of miR-430) enhances the reprogramming of fibroblasts to generate
induced pluripotent stem cells (iPSC) in both humans and mice [18]. MicroRNAs have also been
shown to regulate both pluripotency and differentiation of embryonic stem cells by indirectly
targeting the expression of key pluripotency factors [19]. In cattle, miRNAs are differentially
expressed over the course of oocyte maturation [20, 21], in blastocyst stage embryos [22], and in
blastocysts as they mature to the hatching stage [23]. The functions of some miRNA have been
investigated in cattle. For example, Tripurani and colleagues [24] reported that bovine miR-196a
was essential for degrading the maternal effect gene NOBOX in the early MZT. To our
knowledge, the dynamics of miRNA expression throughout the MZT has only been studied using
targeted approaches, such as qPCR [25].
Aside from miRNA, other classes of sncRNA may also be important for the MZT, as
their abundance changes over the course of parental genome silencing and embryonic genome
activation. In mammalian gametes, siRNA and piRNA are also abundant, but due to their
specialized function, different functions of these sncRNA populations have been less thoroughly
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investigated [26]. Endogenous siRNAs are structurally similar to miRNAs and are processed
from long double stranded RNA duplexes by Dicer. However, endogenous siRNAs are less
conserved among species, and their pre-cursors are not processed by Drosha/DGCR8 [27]. The
siRNAs exert a repressive effect on mRNA, similar to that of miRNA, through the RISC complex
and AGO proteins. Small interfering RNAs bind with perfectly complementary to target
sequences, which then induces endonucleolytic degradation [28]
Piwi-interacting RNAs are single stranded RNA molecules associated with the PIWI
subfamily of proteins. Piwi-interacting RNAs bind RNA targets through complementarity and
repress targets via slicing or chromatin mark recruitment. These piRNAs repress transposable
elements (TEs), both transcriptionally and post-transcriptionally during genomic remodeling
periods [29]. Piwi-interacting RNAs were originally discovered to function in gametogenesis and
have been shown to silence TEs during reprogramming events throughout primordial germline
cell development [30], however the role of piRNA silencing of TEs during embryogenesis is
unknown. Bui and colleagues observed transcriptional activation of TEs during the MZT in
bovine somatic cell nuclear transfer embryos, suggesting that TEs may become expressed during
this phase as a consequence of somatic cell nuclear reprogramming [31]. Relatively high
expression of TEs during the MZT has been found in other species as well, including humans [2].
Elevated expression of piRNAs prior to the major wave of the MZT may be necessary to prevent
TE activation and maintain genomic integrity as epigenetic programming takes place. During
pachytene spermatogenesis, piRNAs target not only TEs, but also target mRNA for degradation,
suggesting that piRNAs may have another mechanism to suppress gene expression [32].
Previously, Roovers and colleagues detected piRNAs and high expression of PIWIL3 in bovine
oocytes and 1-2 cell embryos, as well as piRNAs and PIWIL1 in bovine ovaries [29]. As
members of the argonaute family, PIWIL proteins build complexes with piRNAs to regulate gene
expression making them essential for recognition and degradation of piRNA targets. In addition,
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Russell and colleagues examined the expression of piRNAs in cattle oocytes and zygotes and
determined that expression of some piRNAs appeared to correlate with genes destined for
degradation in the embryo [33]. However, mouse oocytes do not express PIWIL3 and contain
relatively low amounts of piRNA. While mouse oocytes do express other PIWI proteins,
including PIWIL1, PIWIL2 and PIWIL4, functional knock out studies suggest that their
expression is not required to maintain female fertility [29].
These observations suggest that the function of the piRNA-PIWI pathway is not
conserved in mammals, and bovine models may better represent these processes for human
development. While it is unclear why the mouse is different from other mammals with respect to
the piRNA-PIWI pathway, it is possible that high production of siRNAs in mouse oocytes may
compensate for the lack of piRNA activity [29]. Although the expression of piRNAs has been
determined in bovine oocytes and presumptive zygotes [33], the dynamics of piRNA expression
during the MZT have not yet been explored. In addition to the similarities in the sncRNA
biogenesis pathways during early development, other similarities exist between bovine and
human embryos. For example, loss of the pluripotency factor Oct4 in mice did not affect
acquisition of pluripotency for cells destined to become the epiblast [34]. Conversely, absence of
OCT4 in both cattle and human embryos inhibited the emergence of these pluripotent epiblast
cells, whereas cells that would become the primitive endoderm continued their development [34].
Additionally, both bovine and human pre-implantation embryos expressed similar miRNAs into
culture media, including miR-25, miR-302c, miR-196a2, and miR-181a, which may serve as
biological markers for selection of high quality embryos [35]. Because of these key similarities
in sncRNA biogenesis and/or activity pathways as well as pluripotency pathways in early
embryogenesis, the use of bovine embryos for the study of sncRNA in early development is
appropriate.
As outlined above, others have investigated the contribution of specific classes of
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sncRNA acting through RNAi to modulate gamete maturation, embryogenesis or acquisition of
pluripotency. Also, recently Yang and colleagues described RNAseq of sncRNAs associated
with the MZT in mouse [36], although the profile of sncRNAs in this mammalian model is likely
influenced by distinct biogenesis pathways for siRNA and miRNA. However, a comprehensive
assessment of the inventory of sncRNAs during the MZT has not been performed in an animal
model that may better represent the sncRNAs biogenesis pathway in human oocytes and embryos.
Thus, the objective of this study was to examine dynamic changes in expression of sncRNAs
during the maternal-to-zygotic transition in bovine embryos produced by in vitro fertilization
(IVF). Based on the evidence discussed above, we hypothesized that miRNAs would be more
abundant in 8-cell embryos at the start of the MZT and that abundant miRNAs would target
maternal mRNAs with important developmental functions associated with epigenetic
programming and development. An unbiased, discovery-based approach was employed by using
small RNAseq to profile all sncRNA classes in bovine oocytes, 8-cell stage embryos and
blastocyst stage embryos followed by network and otology analyses to explore the functional
relevance of differentially expressed miRNAs.
Methods
Oocyte collection and in vitro maturation
Bovine ovaries were collected from a local abattoir (JBS, Hyrum, UT) and transported in
a cooler containing 0.9% saline solution. The cumulus-oocyte complexes (COCs) were aspirated
from 3-8 mm follicles by using an 18-gauge needle and vacuum system. Only compact COCs
with homogenous ooplasm and intact layers of cumulus cells were used. Following aspiration,
COCs were cultured at 39 °C with 5% CO2 for 22 to 24 hr. The oocytes were cultured in TCM199
maturation medium with Earle’s salts, L-glutamine, and sodium bicarbonate (Hyclone, Logan,
Utah) supplemented with 10% fetal bovine serum (FBS), 0.05 mg/ml bovine follicle stimulating

112
hormone (Sioux Biochemicals, Sioux city, IA), 5 mg/ml bovine luteinizing hormone (Sioux
Biochemicals), 100 U/ml penicillin, and 100 mg/ml streptomycin.
In vitro fertilization and embryo culture
Following 22 to 24 hr of culture, MII oocytes were fertilized using the laboratory’s
standard in vitro fertilization (IVF) protocol [37]. Briefly, one straw of cryopreserved bovine
semen obtained from a Holstein bull (Hoffman AI, Logan, UT) was removed from the liquid
nitrogen tank and placed into a 35 °C water bath to thaw. Live sperm were isolated by
centrifugation through a 45%/90% percoll gradient, suspended (final concentration 1x106/ml) in
Tyrode’s albumin lactate pyruvate containing 10 µg/mL heparin and used to fertilize the mature
oocytes. Twenty to 22 hours post-IVF, cumulus cells were removed by vortexing, and fertilized
zygotes were washed in phosphate buffered saline with 0.32 mM sodium pyruvate, 5.55 mM
glucose, and 3 mg/ml bovine serum albumin (PB1+). After washing, zygotes were cultured in
Charles Rosenkrans 2 medium (CR2) at 39 °C with 5% CO2. Half of the CR2 media was
removed and replaced with fresh, equilibrated media every other day starting the day after in vitro
culture. Historically, production of IVF embryos via these methods followed by blastocyst stage
embryo transfer to cattle recipients has generated successful pregnancies at an approximate rate
of 50% by our research group (unpublished observations).
Tissue collection
Three pools of 40 mature oocytes were collected at 22 hr after maturation. To remove
cumulus cells, the mature COCs were treated with 10 mM hyaluronidase for 10 min and then
vortexed for 2 min. After visual inspection for complete removal of cumulous cells and the
presence of a polar body, denuded mature oocytes were washed through four droplets of PB1+.
Oocytes were then snap frozen in cryotubes containing RNA/DNA shield (Zymo, Irvine,
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California), and stored at -80 °C until RNA isolation. Three pools of 40 8-cell staged embryos
and three pools of 40 blastocyst staged embryos were collected at 3 and 8 days post IVF, washed
in PBS, and stored similarly. Example microscopy images of collected tissues are provided in
Supplementary Figure 2.S1.
Small RNA isolation and sequencing
RNA was isolated based on size using the RNA Clean & ConcentratorTM 5 kit (Zymo,
Irvine, CA) from three pools each of oocytes, 8-cell stage embryos or blastocyst stage embryos
according to the manufacturer’s protocol for purification of small RNA (<200nt) and large RNA
(>200 nt) as separate fractions. Small RNA sequencing was performed on the Ion ProtonTM
Sequencer using the Ion Total RNA-seq kit v2 (Thermo Fisher Scientific, Waltham MA)
according to manufacturer’s procedure for small RNA library preparation with no deviations from
the specified protocol. By using an RNA isolation protocol that yielded a specific fraction of
small RNA, an enrichment step was not needed. Sample volumes were reduced to 3 µl by
vacuum centrifugation, and the entire sample was used to prepare the small RNA library for
sequencing. The cDNA sample was then processed on the Agilent Bioanalyzer (Agilent, Santa
Clara CA) to ensure the presence of small RNA bound to a barcode (86 to 106 nt).
MicroRNA data processing and analyses
Sequence data were processed to remove low quality reads and any artificial reads
introduced during library preparation (Perl script Trim Galore, Python script SortMeRNA) [38,
39]. Next, miRDeep2 (v 2.0.0.8) was used to align the small RNA reads to the bovine miRNA
database with all options at program defaults [40]. The output from this program was the number
of reads per bovine miRNA identifier (miR). Following sequence alignment to miRDeep2, read
counts for each mapped miRNA were exported to Excel (Supplementary File 2.1; Appendix C;
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Appendix C) and then filtered to exclude miRNAs with total sequence reads <100 across all
samples. Read counts were then transformed to reads-per-million (RPM) values by dividing the
number of mapped sequence reads to a miRNA ID by the total reads for the sample and
multiplying by 106.
Quantitative RT-PCR
RNA was isolated based on size as described above from pools of 20 oocytes, 8-cell stage
embryos or blastocyst stage embryos for analysis by qRT-PCR (n = 5 to 6 per tissue type).
Reverse transcription was performed on the isolated mRNA using the GoScript Reverse
Transcriptase kit (Promega, Madison WI). The Fluidigm Biomark HD instrument was used for
quantitative, nano-scale PCR using a 48.48 Dynamic Array chip (Fluidigm Corporation, South
San Francisco, CA). Target mRNAs were selected for the mature miRNA sequence (miR) IDs
with most pronounced changes in abundance (two-fold difference), for both over- and underexpressed miRNAs. Selection of target mRNAs was performed using miRmap, which predicts
mRNA targets of miRNAs based on computed repression strength using thermodynamic,
evolutionary, probabilistic and sequence based features [41]. Using the lists of predicted miRNA
targets for each miRNA, 30 genes previously shown to be expressed in early developing cattle
embryos [42] were selected for analysis by qRT-PCR (see Supplementary Table 2.1). Custom
primers were designed to span exons using Integrated DNA Technologies (Coralville, IA)
RealTime qPCR tool and the NCBI reference genome for Bos taurus (Supplementary Table 2.2).
Fluidigm’s recommended protocol (ADP14) was followed for performing quantitative PCR gene
expression analysis using the Biomark HD system. The protocol included a pre-amplification
step (activation at 95°C for 10 min followed by 14 cycles of 95°C for 15 sec and then 58°C for 4
min) followed by standard PCR (polymerase activation/denaturation 95°C for 10 min followed by
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30 cycles of 95°C for 10 sec and 60°C for 1 min). Data were analyzed using the standard ΔΔCt
method with housekeeping genes GAPDH and SDHA for normalization.
Network analyses of predicted gene targets of differentially expressed miRNAs
Gene targets for miRNAs identified as over- or under-expressed in 8-cell stage embryos
as compared to oocytes or blastocyst stage embryos were predicted using TargetScan (release 7.1)
[43] with the Bos taurus miRNA database (miRBase release 21). TargetScan predicts biological
targets of miRNAs by searching for the presence of conserved 8-mer, 7-mer, and 6-mer sites that
match the seed region of each miRNA. TargetScan provides an additional advantage by curating
individual miRNAs by family (identical seed ±m8 sequence). Only transcripts with conserved
sites were included in the predicted gene target list, which was further filtered for total context++
score <-0.35 (efficacy of targeting miRNA site) (Supplementary Table 2.3). The final gene lists
for network analyses included 1079 predicted mRNA targets of over-expressed miRNAs and
1670 predicted targets of under-expressed miRNAs in bovine 8-cell stage embryos
(Supplementary File 2.2; Appendix D). Note that the output of TargetScan is the human
orthologue of the predicted target gene; the representative transcript shown is the transcript with
the UTR profile that is most prevalent (highest number of supporting 3P-seq tags). However,
TargetScan uses the cattle species sequence for prediction, not the human sequence for
prediction. In Supplementary File 2.2; Appendix D, the representative miRNA listed is the
miRNA with the lowest cumulative weighted context++ score within that miRNA family;
although only one miRNA is shown as matched to the target transcript, all other members of the
miRNA family were also predicted to target the same site for that transcript. Supplementary File
2.2; Appendix D also includes a table defining bovine miRNA families by level of conservation
with other species.
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Predicted mRNA targets were subject to gene set enrichment analysis using Metascape
[44]. For these two gene lists (targets of over- or under-expressed miRNAs), pathway and
process enrichment meta-analyses were carried out using the following ontology sources: GO
Biological Processes, KEGG Pathways and Reactome Gene Sets. All genes in the Bos taurus
genome were used as the enrichment background. Terms with p-value <0.05, minimum count of
three associated genes and enrichment factor >1.5 (enrichment factor is the ratio between number
of genes associated with the term observed in the query set and the number expected by chance)
were collected and grouped into clusters based on their membership similarities. More
specifically, p-values were calculated based on accumulative hypergeometric distribution, and
FDR q-values were calculated using the Benjamini-Hochberg procedure to account for multiple
testing. Kappa scores were used as the similarity metric when performing hierarchical clustering
on the enriched terms, and sub-trees with similarity >0.3 were considered a cluster. The most
statistically significant term within a cluster was chosen to label the cluster.
To further capture the relationship among terms, a subset of enriched terms was selected
and rendered as a network plot, where terms with similarity >0.3 were connected by edges.
Terms with the highest q-values for each cluster were used to build the network, with constraints
of no more than 15 terms per cluster and fewer than 250 terms total. Networks were visualized in
Cytoscape [45], and separate network plots were generated for enrichment analyses using GO
biological process terms. The term with the most significant q-value within each cluster was used
to name the cluster, and networks were colored according to cluster identity, q-value or relative
contribution of terms to the node from each gene list.
Results of Metascape ontology analyses were verified by performing enrichment analysis
using the DAVID functional annotation tool (v. 6.8) [46] with the complete predicted mRNA
target list (for both over- and under-expressed miRNAs) and the Bos taurus genome as the
background data set.
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Network analyses of differentially expressed miRNAs and expressed genes in bovine oocytes
A network depicting connections between differentially expressed miRNAs in bovine 8cell stage embryos as compared to oocytes and their predicted mRNA targets was built using
Cytoscape. We expected this network to reveal broad scale patterns in mRNA expression that
corresponded to changes in abundance of the target mRNAs. Many of the mRNA targets were
predicted to be regulated by several (or many) miRNAs. Thus, this network also allowed for
visualization of the interconnectedness, or conversely independence, of all the differentially
expressed miRNAs and their mRNA targets. Central network nodes were defined as miRNAs
over- or under-expressed in 8-cell stage embryos (as compared to oocytes) and were linked by
edges to predicted mRNA targets (TargetScan total context score <-0.4 to reduce network size).
Nodes for predicted mRNA targets were colored using data available from the Gene Expression
Omnibus dataset GSE52415 [42], which includes RNAseq transcriptome data for cattle oocytes
and early developing embryos. These data were expressed either as the variance-stabilizing
transformed read abundance or the calculated log2 ratio of expression in 8-cell stage embryo with
respect to MII oocytes. Because the main effect of miRNA is to target mRNA transcripts for
degradation, nodes representing genes not represented in this dataset were retained in the network
and represented as gray.
Annotation and expression of other sncRNAs
Annotation and expression analysis of other sncRNAs was performed as described
previously [33]. Briefly, data processing and bioinformatics analysis for other sncRNA were
performed primarily with command line tools available at http://www.smallrnagroup.unimainz.de/software.html. First data were filtered for sequence length between 17 and 32 nt, which
includes the canonical size range for mature small RNAs (miRNA, siRNA, piRNA)
(Supplementary File 3). A separate analysis was performed for sequences between 33-93 nt,
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which encompassed longer reads characteristic of snoRNA, tRNA and mitochondrial rRNA. This
split analysis approach avoided possible skewing of the data when comparing between these
diverse sncRNA classes. Sequence annotation was performed with Unitas v1.4.2, which uses the
latest available public small RNA databases to annotate input sequences [47]. Non-annotated
sequences were then mapped to the bovine genome (BosTau8) with sRNAmapper [48] to
determine which non-annotated sequences were likely of biological, not technical, origin. The
mapped sequence reads were redistributed across the genome based on number of mapping
locations using reallocate with the parameters ‘5000 1000 b 0’ (reallocate.pl). Reallocated map
files were then analyzed with ProTRAC v2.3.1 [49], which identifies probable piRNAs through
their genomic clustering based on size, sequence, and cluster characteristics (all options at default
settings, except for increasing allowable piRNA size range to 32 nt). Predicted piRNA clusters
were compared among samples by using the Galaxy “merge” tool (usegalaxy.org) to first
generate lists of predicted clusters by sample type followed by the “join” tool to identify
overlapping genomic intervals among samples. Finally, repeat masker was used to identify
potential piRNAs overlapping with known transposable elements in both the sense and antisense
directions.
Data analysis
For miRNAs and snoRNAs, normalized read count data (RPM values) were log10 (y±1)
transformed and then analyzed by one-way ANOVA followed by post-hoc tests for all pair-wise
comparisons using TM4 MeV [50]. Because the post-hoc tests must be performed independent of
the ANOVA in MeV, the resulting p-values are not corrected for multiple testing across sample
types. Thus, all pairwise p-values were processed using GraphPad Prism (v.7) as a single family
to correct for multiple comparisons across all samples and miRNA or snoRNA species by
controlling the false discovery rate (FDR) (two-stage step-up method of Benjamini, Krieger and
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Yekutieli). For further analysis of miRNA or snoRNA abundance profiles, data were expressed as
the log2 ratio of normalized read counts for each individual sample to the average normalized
read count for oocytes (Supplementary Files 2.1 and 2.3). A significant difference in miRNA or
snoRNA abundance was inferred when FDR q<0.05 and log2 |R|³1 (a two-fold difference).
ClustVis [51] was used to perform unsupervised, bi-directional hierarchical cluster analyses using
both RPM abundance and log2 ratio data, including either all mapped IDs or those determined to
be differentially expressed.
Results
Classification of sncRNA sequences
RNA sequencing of sncRNA obtained from bovine oocytes, 8-cell embryos, and
blastocyst stage embryos generated a total of about 11 million sequence reads, after filtering low
quality reads and artifacts, of which approximately 25% aligned to known bovine sncRNAs
(Supplementary Table 2.4). The number of reads obtained per sample was markedly higher for 8cell stage embryos (approximately 2.8 million reads/sample) than oocytes (about 0.66 million
reads/sample) or blastocyst stage embryos (about 0.45 million reads/sample) (Figure 2.1A). RNA
input was not normalized by sample type when generating the sample libraries for sequencing due
to the exceedingly small amount of small RNA obtained. However, had the number of cells per
embryo been the driving factor in yield of reads per sample type, then a different pattern would
have been observed with blastocyst stage embryos having the greatest number of sequence reads.
As shown in Figure 2.1B, sequence reads of 17-32 nt in length, corresponding to
endogenous siRNA and miRNA classes of sncRNA, were most abundant across sample types.
Also, peaks for read lengths corresponding to snoRNAs (70 to 90 nt) and tRNAs (76-90 nt) were
also evident for all sample types, with other minor peaks at various lengths likely corresponding
to rRNA, snRNA or other miscellaneous RNA fragments. As a fraction of total reads per sample,
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markedly more sequences were annotated for 8-cell stage embryos (36.5% on average) than
oocytes (6.1%) or blastocyst stage embryos (8.5%) (Figure 2.1C). A similar pattern was also
evident for sequences ³33 nt, with 14.1%, 37.8% and 18.0% of reads annotated to non-coding
RNAs in oocytes, 8-cell stage embryos and blastocyst stage embryos, respectively (Figure 2.1D).
When considered as a fraction of total reads for each sample, the sncRNA population was clearly
distinct for each tissue (Figure 2.1C and D, Table 2.1). The relative abundance of miRNAs was
significantly greater in 8-cell stage embryos (14%) compared to just 2.1% or 2.7% for oocytes or
blastocyst stage embryos, respectively (Table 2.1, Supplementary Figure 2.S2A). When
calculated as a fraction of the total annotated reads, the proportion of miRNAs was similar, at
31%, 38% and 33% on average for oocytes, 8-cell stage embryo and blastocyst stage embryo.
However, one should note that the proportion of annotated reads varied markedly by sample type.
Also, the majority of the unannotated reads for oocyte, for example, were classified as putative
piwi-like RNAs (details below). Other classes of sncRNA were also proportionally more
abundant, including genomic tRNA and snoRNA. Distinct sncRNA profiles were also evident
for the ³33 nt sncRNA fraction, with the most notable difference being the marked, significant
increase in relative abundance of snoRNA in 8-cell stage embryos (28.4%) compared to oocytes
(6.2%) or blastocyst stage embryos (7.7%) (Table 2.1, Supplementary Figure 2.S2B).
miRNA expression in oocytes, 8-cell stage
embryos and blastocyst stage embryos
MicroRNA annotated with miRDeep2 were aggregated by bovine miRNA family, which
groups miRNA species by the seed sequence. After filtering out miRNAs with very low
abundance reads across samples (sum of <100 reads across all 9 samples), 151 miRNA species
representing 102 bovine miRNA families were detected across all sample types (Supplementary
File 2.1; Appendix C, Supplementary Figure 2.S3). The Venn diagram in Figure 2.2A depicts
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miRNA species detected by sample type. While a core set of 20 miRNAs were detected by
RNAseq in all sample types, a large set of 45 miRNAs were identified only in 8-cell stage
embryos indicating a unique miRNA expression profile for that tissue. A subset of 35 additional
miRNAs were identified as common to both 8-cell stage embryos and oocytes, whereas all the
miRNAs expressed in blastocyst stage embryos were also present in oocytes or 8-cell stage
embryos.
The sequence data were further examined to identify specific miRNA families
differentially expressed in any one sample type. Of the 102 families detected by RNAseq, 37
were differentially expressed (|log2 R|>1 and FDR q-value <0.01) in 8-cell stage embryos as
compared to oocytes, including 11 miRNA families under-expressed and 26 miRNAs families
over-expressed (Table 2.2, Supplementary Figure 2.S4). No significant differences in miRNA
expression were noted when comparing blastocyst stage embryos to oocytes, and only three
significantly different miRNAs were observed when comparing 8-cell stage embryos to
blastocyst stages, likely due to apparent high variation in expression profiles among the blastocyst
stage samples.
Principal components analysis of miRNA expression data revealed clear grouping of data
sets by sample type, with very tight clusters evident for oocyte and 8-cell stage embryo samples,
indicating high consistency in the overall miRNA abundance profile for those samples (Figure
2.2B). In contrast, the miRNA expression profile for blastocyst stage embryos was more
variable, with one sample notably separated from other samples in the same developmental stage.
These miRNA profiles are illustrated more clearly via unsupervised, bi-directional hierarchical
clustering of miRNA species and samples using miRNA RPM abundance data (Figure 2.2C) or
relative expression with respect to oocytes (Figure 2.2D). For each clustering map, the samples
cluster according to sample type, with the 8-cell stage embryo group clearly distinct from oocytes
and blastocyst stage embryos.
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Ontology and pathway analyses of predicted mRNA targets for
differentially expressed miRNAs in 8-cell stage embryos
Results of biological process gene ontology, KEGG pathway, and Reactome pathway
analyses of TargetScan predicted gene targets of differentially expressed miRNAs in 8-cell stage
embryos are provided in Supplementary File 2.2; Appendix D and summarized in Figure 2.3A.
Note that the heatmaps represent the top 20 terms (clustered by kappa score for similarity) for the
overall data set. Although the input data were separated into subsets corresponding to mRNA
targets of over- or under-expressed miRNAs, the top 20 biological process terms are largely
similar for both subsets including terms related to “developmental processes”, “Wnt signaling”,
“embryonic morphogenesis”, “covalent chromatin modification”, and others. Of note, “cell
division” and “developmental growth” are among the top 20 most significant terms for gene
targets of under-expressed miRNAs, but these terms are not among the 20 most significant for
targets of over-expressed miRNAs (though the terms are indeed significantly enriched.) Results
of this ontology analysis are also represented as a Cytoscape network in Figure 2.3B, with each
cluster corresponding to a term shown in Figure 2.3A colored by the analysis FDR q value.
Clusters related to developmental biological processes (embryo morphogenesis and various
developmental pathways) form a central network further connected to other critical processes
related to embryo development, such as “regulation of cell growth”, “Wnt signaling”, and
“regulation of kinase activity”. Other enriched terms are disconnected from the network, such as
“cell division”, “covalent chromatin modification” and “endomembrane system organization”.
Supplementary Figure 2.S5 depicts this network colored by biological process cluster or by count
of predicted mRNAs associated with each node. Most nodes are represented by terms associated
with mRNA targets of both over- and under expressed mRNAs in 8-cell stage embryos, with a
proportion that approximately represents the number of terms in each query list (1078 or 40% for
over-expressed miRNAs and 1670 or 60% for under-expressed miRNAs). However, some
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biological processes were preferentially associated with mRNA targets of under-expressed
miRNAs, such as terms “negative regulation of cell morphogenesis involved in differentiation”,
“negative regulation of developmental growth”, “cell division”, “positive regulation of Wnt
signaling pathway”, “negative regulation of cell projection organization” and all nodes
represented in the cluster named “endomembrane organization”. In contrast, processes associated
preferentially with mRNA targets of over-expressed miRNAs were fewer, including “positive
regulation of cartilage development”, “positive regulation of chondrocyte development” and
“embryonic skeletal system development”.
Of the enriched KEGG pathways, pathways in cancer was the most significant for targets
of under-expressed miRNAs, whereas MAPK signaling pathway was the most enriched for
mRNA targets of over-expressed miRNAs. Unique pathways for the under-expressed miRmRNA target list included Wnt signaling and p53 signaling pathways. Interestingly, signaling
pathways regulating pluripotency of stem cells (Supplementary Figure 2.S6) and pathways in
cancer (Supplementary Figure 2.S7) were in the top 20 list for mRNA targets of both over- and
under-expressed miRNAs. Finally, less overlap in top 20 terms for mRNA targets of over- or
under-expressed miRNAs was evident for Reactome pathways, with signaling by NOTCH and
signaling by BMP representing top 20 terms unique to mRNA targets of under-expressed
miRNAs in 8-cell stage embryos. Common terms for both subsets include signaling by NGF,
transcriptional regulation by TP53 and post-transcriptional silencing by small RNAs, among
others.
Ontology analysis was also performed using the DAVID functional annotation tool with
the complete predicted mRNA target list (for both over- and under-expressed miRNAs). Very
similar results were obtained for GO biological processes and KEGG pathways, with significant
terms including (clustered by semantic similarity) regulation of nitrogen compound metabolism,
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Wnt signaling pathway, gene expression, regulation of cell communication, regulation of cell
development, among others (Supplementary File 2.2; Appendix D, Supplementary Figure 2.S8).
Network analysis of differentially expressed
miRNAs and predicted mRNA targets
Although sequencing of mRNA was not possible for the samples obtained in the present
study due to the nature of the protocol for isolation of sncRNA, a publicly-available RNAseq
dataset is available for corresponding sample types, including bovine MII oocytes, 8-cell stage
embryos and blastocyst stage embryos (GSE52415) [42]. In order to determine whether predicted
mRNA targets were inversely regulated by their miRNA families, a Cytoscape network was
created, where differentially-expressed miRNAs in 8-cell stage embryos are connected to their
predicted mRNA targets. Figure 2.4 shows the resulting network colored according to relative
expression with respect to oocytes, whereas Supplementary Figure 2.S9 depicts the same network
colored by normalized abundance values. The overall number of predicted mRNA targets was
limited using the TargetScan context score to reduce the complexity of the network diagram. The
overarching observation of this network is that, for each miRNA-mRNA cluster, there is no clear
pattern indicative of a negative correlation as would be expected given the role of miRNA to
down-regulate mRNA abundance. For example, members of the miR-302 family are apparently
very highly expressed and very abundant in 8-cell stage embryos with respect to oocytes, yet an
overall pattern of mRNA suppression does not dominate this cluster. Similarly, miRNAs
belonging to the miR-15/16/195/424-5p/497 are under-expressed relative to oocytes, yet an
overall pattern of high mRNA expression is not evident.
Targeted qPCR analysis of select predicted mRNA
targets of differentially expressed miRNAs
Of the 29 mRNA targets analyzed by qPCR, 24 were differentially expressed in either 8cell or blastocyst stage embryos compared to oocytes (Supplementary Figure 2.S10), yet the
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expression profile for these genes did not entirely distinguish 8-cell stage embryos from oocytes
(Figure 2.5A). Rather, more significant differences were evident for these mRNA targets in
blastocyst stage embryos, which mostly segregated from other samples by unsupervised
hierarchical clustering (Figure 2.5B). Notably, the observed changes in expression of predicted
mRNA targets appeared negatively correlated with miRNA abundance for some of the genes
examined, such as for CDH2 and the miR-10 and miR-15/16/195/424-5p/497 families or KLF4
and the miR-148/152 families (Figure 2.5C-G). However, for other genes examined, the
expression pattern largely did not negatively correlate with their corresponding miRNAs
according to the developmental stage. It was interesting to note that expression of some target
mRNAs in blastocyst stages was strongly negatively correlated with miRNA expression at the 8cell stage embryonic stage, such as observed for MTMR3 and the miR-302 and miR-378/378c
families (Figure 2.5H-I).
Expression of piwi-like RNAs in bovine oocytes,
8-cell stage embryos and blastocyst stages
In addition to miRNA analysis, the RNAseq data were mined to examine expression of
other sncRNA classes, including piwi-interacting RNA (piRNA). Putative “piwi-like”, or
pilRNAs, were identified as sRNAs 24-32 nt in length that mapped to pilRNA-producing loci in
the bovine genome. As a fraction of total reads, pilRNAs accounted for 73%, 14%, or 50% of
sequence reads, on average, for oocytes, 8-cell stage embryos and blastocyst stage embryos,
respectively (Table 2.1, Figure 2.6A-B). Secondary piRNA biogenesis occurs via a “ping-pong”
amplification cycle, which can be detected as a 5’ to 5’ 10 nt overlap; this ping-pong signature
was evident for sequences obtained from all sample types (Figure 2.6C). PiRNAs are also
typified by a strong uracil bias at the 1’ position (1’U) [47], which was also evident for all three
tissues at rates of 81%, 69% and 83% for oocytes, 8-cell stage embryos and blastocyst stage
embryos, respectively (Figure 2.6C).
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Primary piRNAs are transcribed from dense loci located within specific clusters in the
genome. Using weighted proTRAC cluster analysis, a total of 973 clusters were identified across
the study samples. Oocytes were characterized by broad expression of pilRNA across the bovine
genome, with highest expressing clusters located on chromosomes 3, 6, 8, 10, 13, 14,17, 23 and X
(Figure 2.7A, Supplementary Figure 2.S11). In contrast, a major shift in pilRNA expression was
evident in 8-cell stage embryos, with only 66 clusters identified and located randomly across
chromosomes (Figure 2.7B, Supplementary Figure 2.S11). Expression of pilRNA clusters in
blastocyst stages was somewhat like that of oocytes, with 473 clusters identified that were
broadly expressed across the genome, though to less extent than in oocytes focused on
chromosomes 3, 6, 8, 14, 17, 23 (Figure 2.7C, Supplementary Figure 2.S11). To compare cluster
expression across samples, the clusters were joined on their genomic intervals. Only 22 pilRNA
clusters were co-expressed in oocytes, 8-cell stage embryos and blastocyst stage embryos (Figure
2.7D). Far more clusters appeared unique to either oocytes (461 unique clusters) or blastocyst
stage embryos (254 unique), whereas no clusters were uniquely expressed in 8-cell stage
embryos.
Potential target transcripts of candidate pilRNAs were identified by mapping sequences
to bovine TEs annotated by RepeatMasker (Figure 2.7E, Supplementary File 2.3; Appendix E).
The long interspersed nuclear element (LINE) RTE-BovB and L1 and short interspersed nuclear
element (SINE)-tRNA repeats were highly abundant in oocytes and blastocyst stage embryos,
with pilRNAs mapping more frequently to the antisense direction. Long terminal repeat (LTR)
ERVK retrotransposon and the TcMar-Tigger DNA transposon were also abundant in both
oocytes and blastocyst stage embryos, with reads aligning predominantly to the antisense
direction for both TEs. Alternatively, relatively few reads from 8-cell stage embryos mapped to
TEs as compared to oocytes or blastocyst stage embryos, with the exception of more reads
mapped to LSU-rRNA TE in the sense direction.
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Expression of snoRNAs in bovine oocytes,
8-cell stage embryos and blastocyst stages
As mentioned previously, the most abundant sncRNA class for sequence reads ³33 nt in
length was snoRNA, and the relative abundance of snoRNA was markedly greater in 8-cell stage
embryos compared to oocytes or blastocyst stage embryos (Figure 2.1C, Supplementary Figure
2.2SB). Moreover, principal components analysis of snoRNA expression data revealed very clear
segregation of the expression profile for 8-cell stage embryos distinct from expression profiles for
oocytes or blastocyst stage embryos, which overlapped (Figure 2.8A). This separation is also
evident when considering expression on a per gene basis when sorting data by unsupervised, bidirectional hierarchical clustering by abundance (Figure 2.8B) or expression relative to oocytes
(Figure 2.8C). Also of interest was the observation that most of the differentially expressed
snoRNAs belonged to the C/D box subclass.
Discussion
In the developing embryo, the MZT is associated with marked changes in the control of
gene expression that require coordination by multiple control mechanisms, including sncRNAs.
This study is the first to employ a discovery-based, small RNA sequencing approach to determine
the population of sncRNAs in bovine oocytes, 8-cell stage embryos and blastocyst stage embryos.
Importantly, we identified major class changes in the population of sncRNAs associated with the
8-cell stage of embryonic development, coincident with the MZT in cattle. There were three
major findings of this investigation. First, the relative abundance of most miRNAs was markedly
higher in 8-cell stage embryos, the stage at which bovine embryos undergo the MZT, compared
to oocytes before the MZT or blastocysts after the MZT. In contrast, the abundance of pilRNAs
exhibited a mirror-image pattern, with markedly lower expression at the 8-cell stage relative to
the oocyte or blastocyst stages. Finally, snoRNAs, particularly those belonging to the C/D box
class that methylate rRNA, were expressed like miRNAs at much higher levels in 8-cell stage
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embryos during the MZT compared to oocytes or blastocysts. Overall, these data reveal a strong
dynamic shift in relative abundance of sncRNAs associated with the MZT in bovine oocytes and
embryos, suggesting that these molecules may play important roles in the shift from maternal-tozygotic control of gene expression. The patterns of these changes in particular classes of
sncRNAs allow us to infer possible functions of these molecules in controlling the MZT.
Of particular note, the relative abundance of miRNAs was markedly higher in 8-cell
stage embryos compared to oocytes or blastocyst stage embryos. This shift in miRNA population
was largely associated with up-regulation of miRNAs predicted to target genes involved in the
biological processes of cell development, cell division, Wnt signaling, pluripotency and
endomembrane system organization, among others. While previous researchers identified
increased expression of specific targeted miRNAs at the 8-cell stage, our results demonstrate the
breadth of this up-regulation and identify specific miRNAs that are highly dynamic in relative
abundance. The extreme changes in some miRNA families point to miRNAs that are likely
functionally important in this transition, but that have not been previously examined in this role.
Though few miRNA families were under-expressed in 8-cell stage bovine embryos, one such
family was the miR-15/16/195/424-5p/497 family, which is particularly important given its high
abundance with respect to other miRNAs. The miR-15/16/195/424-5p/497 family has a large
number of predicted target mRNAs, which provided the potential for an enormous impact on the
pathway and network analyses presented herein. The scope of these mRNA targets by this
miRNA family suggest that these gene functions must be collectively suppressed in the oocyte
and blastocyst-stage embryo, yet active during the MZT in cattle.
This study was also the first to examine changes in the population of potential pilRNAs
during the MZT in cattle embryos. PilRNAs changed dramatically over the course of early
preimplantation embryo development, as the population of potential pilRNAs was markedly
reduced at the 8-cell stage as compared to oocytes, but appeared to partially rebound at the
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blastocyst stage. The high level of abundance of piRNAs in blastocyst stage embryos was
surprising as it contrasts findings in other species, although piRNA in bovine blastocysts has not
been previously examined. Another surprising major class shift was identified in snoRNAs,
notably in the C/D box subclass involved in methylation of ribosomal RNAs, which were highly
expressed in 8-cell stage embryos. These snoRNAs could be of novel functional interest, as they
have recently been demonstrated to participate in RNAi. However, very little is known about the
role of snoRNAs in early mammalian embryogenesis. Overall, these data reveal a strong
dynamic shift in relative abundance of sncRNAs associated with the developmentally critical
MZT in bovine embryos, indicating that these molecules may play important roles in the shift
from maternal-to-zygotic control of gene expression.
In this study, large scale changes in the relative abundance and expression profile of
miRNAs were evident when comparing oocytes to 8-cell stage embryos, at which point the
zygotic genome is activated in cattle. Most of the available information on expression and
function of sncRNAs in embryo development has been obtained from the mouse model.
However, key differences in the biogenesis and activity pathways for sncRNAs between rodents
and other mammals can impact the population of small RNAs. For example, the mouse embryo
expresses an oocyte-specific isoform of Dicer that preferentially binds endogenous siRNA rather
than miRNA [48]. This oocyte-specific isoform efficiently produces endogenous siRNAs from
long double-stranded (dsRNA) substrates and has higher cleavage activity than the other isoforms
of Dicer. In contrast, in other mammalian cells and mouse somatic cells, Dicer primarily cleaves
hairpin precursors, which includes the miRNA population. Thus, the population of sncRNA in
mouse oocytes may be skewed in favor of production of siRNAs. Also, mouse oocytes lack
PIWI3, a protein necessary for piRNA function in both human and bovine embryos [29].
To date, the data regarding the relative abundance of sncRNAs, or specific classes of
sncRNAs, associated with the MZT in mammals have been inconsistent. In mice the MZT occurs
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between the zygote and 2-cell developmental stages. Previously researchers determined that total
miRNA content was markedly lower in 2-cell mouse embryos, post MZT, as compared to mature
oocytes [52]. Recently, Yang and colleagues employed RNAseq in mouse oocytes and early
embryos to examine the populations of sncRNA in mouse oocytes, zygotes, 2-cell, 4-cell, and 8cell stage embryos [36]. In contrast to our results, they found that the relative increase in total
miRNA population took place later in development at the 4- and 8-cell stages, concurrent with a
marked decrease in endo-siRNA and piRNA. However, they did observe that some select
miRNAs appeared to be more abundant in 2-cell mouse embryos. While these results differ from
our observations, it is reasonable to expect such differences when comparing mouse to cattle preimplantation embryos given the distinct biogenesis pathways for miRNA and endo-siRNA and
activity of piRNAs. On the other hand, the biogenesis pathways for miRNAs in cattle and pig
are similar, yet in porcine embryos, profiling of sncRNA revealed the lowest number of miRNA
sequencing reads associated with the MZT [53]. To date, only one study has investigated
expression of multiple miRNAs in cattle during the MZT in 8-cell stage embryos. Berg and
Pfeffer profiled the expression of 98 mature miRNAs in bovine embryos using a stem-loop PCR
assay [25]. They determined that these miRNAs were more abundant in 8-cell stage embryos
compared to oocytes, and that the miRNA concentration per cell further increased from the 8-cell
to blastocyst stage. However, the authors contended that most of the miRNA species were
detected at amounts below the necessary threshold to functionally repress target mRNAs, with the
notable exception of miR-320. In our RNAseq analysis, which measured the abundance of
miRNAs in pools of bovine embryos rather than per cell, we determined that the marked increase
in miRNA transcripts observed in 8-cell stage embryos was apparently not maintained through
development to the blastocyst stage.
In this study, one of the most marked changes in miRNA expression observed was for the
miR-302 family, which was evidently absent in oocytes and blastocyst stage embryos but very
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abundant in 8-cell stage embryos. In human and mouse embryonic stem cells, miR-302 represses
multiple target genes that modulate the cell cycle, Wnt signaling, vesicular transport and
epigenetic regulation, among others [54, 55]. Deletion of miR-302a-d in mouse embryos resulted
in a fully penetrant late embryonic lethal phenotype due to neural tube defects [56], and knockout
of miR-302 in conjunction with miR-290 in mouse ESCs resulted in silencing naive pluripotency
[57]. Prediction of mRNA targets in cattle for miR-302 revealed a similar assortment of targeted
processes, including regulation of cell signaling cascades, covalent chromatin modification, and
cell fate determination. MiR-302 appears to have a key role in regulating the pluripotency of
embryonic stem cells. For example, Anokye-Danso and colleagues showed that lentiviral
transfection of miR302/367 triggered efficient reprogramming of mouse or human fibroblasts to a
pluripotent state without the need for exogenous transcription factors Oct4/Sox2/Klf4/Myc
commonly used to induce pluripotency [18]. Miyoshi and colleagues showed similar results
employing a direct transfection method with miR-200c and the miR-302 and miR-369 miRNA
families to induce pluripotency in mouse and human somatic cells [58]. In humans, the promoter
controlling expression of the miR-302 cluster is predominately active in embryonic stem cells as
opposed to differentiated cells [59, 60]. Thus, the high expression of miR-302 observed in bovine
8-cell stage embryos may be necessary to promote totipotency in early embryo development.
As with miR-302, we also observed a similar expression pattern for miR-196a, which
was very highly expressed in 8-cell stage embryos but not detected in oocytes or blastocyst stage
embryos. Tripurani and colleagues made similar observations using qPCR to measure miR-196 in
bovine oocytes and embryos, with maximal expression at 4- and 8-cell stage embryos [24]. They
also determined that miR-196a bound to the transcript for NOBOX, a maternal effect gene
preferentially expressed in oocytes that is required for folliculogenesis and early oocyte
development. However, NOBOX mRNA must undergo degradation prior to embryonic genome
activation [24]. Tripurani and colleagues determined that expression of NOBOX was greatest in
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germinal vesicle oocytes and progressively decreased with oocyte maturation; similarly, NOBOX
expression was detectable in the developing zygote and progressively decreased with continued
development to blastocyst stage [61]. A similar pattern was also observed in this study, with PCR
results showing a progressive decline in NOBOX mRNA expression coincident with the observed
transient increase in miR-196a at the 8-cell stage. Of note, in both the Tripurani study and the
present work, expression of miR-196a did not perfectly correlate with the target NOBOX mRNA
expression after the 8-cell stage, as expression of both the miRNA and target declined in
blastocyst staged embryos. It is possible that other epigenetic mechanisms facilitate continued
silencing of NOBOX expression at these latter developmental stages and that RNAi via miR-196a
is no longer necessary.
Ontology and pathway analyses of predicted mRNA targets for miRNAs differentially
expressed in 8-cell stage embryos revealed enrichment of pathways expected to be critical for
early embryo development, including multiple pathways associated with tissue differentiation,
cell growth and embryo morphogenesis. Of interest, pathway analyses predicted miRNA
targeting of biological processes vital in early embryogenesis, including cell development, cell
division, Wnt signaling, and pluripotency. Wnt is involved in cell differentiation via pluripotency
maintenance during cell lineage specification, as well as the axis formation and cell migration
necessary later in pre-implantation embryo development [62]. The canonical Wnt pathway
regulates cell fate, whereas the non-canonical Wnt pathway regulates polarity, cell movements,
and asymmetric cell divisions. Importantly, Wnt pathway may be one of the strongest regulators
in supporting pluripotency in the early embryo, yet the timing of activation of Wnt signaling
appears critically important. Activation of Wnt signaling prior to blastocyst formation decreases
embryonic development to the blastocyst stage [63]. However, Tribulo and colleagues showed in
cattle embryos that only maternally-derived WNT signaling plays a role in pre-implantation
development [64]. Embryo-derived WNT signaling was dispensable for blastocyst formation, yet
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was important for ICM proliferation [64]. Therefore, it is possible that the Wnt pathway must be
inhibited until differentiation begins in the blastocyst embryo and that inhibition by miRNAs are
necessary to prevent premature activation of Wnt pathways from maternally-deposited
transcripts. Exactly which pathways Wnt signaling influences to impact development are still
unknown. It is important to note that this is another early developmental pathway for which the
observations in cattle embryos appear similar to those for the human, yet distinct from those in
mouse [65].
Overall the pathway analysis suggests a general pattern of suppression of cell
differentiation and promotion of pluripotency, particularly when considering those pathways that
exclusively represent predicted mRNAs targets for repressed miRNAs in 8-cell stage embryos, or
vice versa for induced miRNAs. However, interpretation of these pathways is complicated by a
lack of one-to-one regulation of miRNAs and mRNAs. Multiple miRNAs can target a single
mRNA molecule, and individual miRNAs have multiple mRNA targets. The complexity of these
miRNA-mRNA interactions was exemplified by the highly intricate network depicting changes in
expression of miRNAs and their predicted mRNA targets in bovine 8-cell stage embryos.
Similarly, patterns of expression for miRNAs and predicted mRNA targets examined by qPCR
were inconsistent. Expression for some miRNA-mRNA sets fit the expected inverse correlation
(e.g., WEE1 and miR-138 and miR-15/16/195/424-5p/497 families or HDAC1 and miR-31). For
many of the miRNA-mRNA sets, the expression pattern did not meet expectations (e.g., DNMT1
and miR-148/152 family). Moreover, the impact of differential expression of any specific
miRNA is dependent on the suite of miRNAs expressed and the functional context of the targeted
gene. Dissection of the impact of any individual miRNA would require a focused, pathwayspecific approach, which was not the objective of this study. That said, the ontology and network
analyses reveal certain pathways for further investigation using targeted approaches, such as
manipulation of expression of miR-302 or members of the miR-15/16/195/424-5p/497 family.

134
Furthermore, the miRNA-mRNA network does not take into account other regulatory factors that
contribute to post-transcriptional gene silencing. For example, RNA binding proteins mediate
binding of miRNAs to target mRNAs, allowing some mRNA targets to escape repression. One
such RNA binding protein is dead end homologue 1 (DND1), which binds to mRNAs containing
an AU-rich element in the 3’ untranslated region and blocks miRNA binding to this site. Of
interest, DND1 is abundant in pig oocytes and early developing embryos, but is down regulated at
the MZT; DND1 is functionally capable of binding pluripotency genes vital during early
development. [16]. The role of RNA binding proteins during the MZT in modulating miRNAmRNA binding is, as of yet, unknown. It is possible that miRNA targeting of transcripts for
degradation may not be a simple one-to-one matching process, but rather a combination of
degradation signals from miRNA and interactions with RNA binding proteins [66].
In the present study, few piRNA-producing loci and a low abundance of pilRNAs
typified 8-cell bovine embryos, which raises the possibility that TEs targeted by these pilRNAs
could be expressed during the MZT in cattle. Indeed, results of a prior study showed that
transcripts derived from TEs are expressed in 8-cell bovine embryos during the MZT [31]. Also,
of interest, the retrotransposon HERVK-HML-2 was expressed in 8-cell stage embryos through
the blastocyst stage [67]. Alternatively, oocytes were characterized by high abundance of
pilRNAs with dense piRNA clusters located on multiple chromosomes in the bovine genome,
similar to the pattern previously observed [33]. Interestingly, and in contrast to other studies in
mouse and pig [36, 53, 68], we observed high expression of pilRNAs in cattle embryos. Our
piRNA profiling results for oocytes largely corresponds to observations made by Russell and
colleagues [37], suggesting that these results are consistent across research groups and in different
cattle populations. The pattern of pilRNA expression suggests that pilRNAs may be needed to
block TE activation during epigenome programming events during continued development. The
apparent increase in pilRNAs detected in bovine blastocyst stages in this study cannot be
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explained by the higher genomic content in the tissue, as total reads per sample were consistently
lower in all blastocyst stage embryo pools and the analysis was performed on read-normalized
data. Another consideration is the difference in timing of the MZT, which occurs at earlier
developmental stages in mouse (2-cell) and pig (4-cell) and may affect the overall population of
sncRNAs accumulated in blastocyst stage embryos. Moreover, it is possible that the elevation of
pilRNAs associated with the bovine blastocyst stage is unrelated to TE silencing, but rather may
function to modulate mRNA expression as proposed by Russell and colleagues [33].
The discovery-based small RNA sequencing approach used in this study allowed us to
investigate classes of sncRNAs not typically studied in mammalian embryos. Notably, many
snoRNAs belonging to the C/D box class, those that methylate rRNAs, were expressed at much
higher levels in 8-cell stage embryos during the MZT as compared to oocytes or blastocyst stages.
This observed increase may reflect the function of snoRNAs in rRNA biogenesis and translation,
which would be highly active during as the embryonic genome is activated. Aside from their
traditional housekeeping role as guide RNAs for post-transcriptional modification of rRNAs, new
evidence suggests that snoRNAs may be involved in cell fate determination and oncogenesis [69].
SnoRNAs can be processed to produce smaller sequences that appear to act as miRNAs by
associating with the RISC complex to target mRNA [12, 70]. Through this processing, so called
sno-miRNAs my then target transcripts that control processes involved in cell behavior and
carcinogenesis. Given this potential new functional role of snoRNAs, the observed marked
increase in their abundance at the 8-cell stage suggests a possible regulatory role of snoRNAs
during the MZT in mammalian embryogenesis. This working hypothesis warrants further study.
The present study has some limitations with respect to sample collection and data
analysis. To obtain sufficient amounts of small RNA for sequencing, pools of oocytes or
embryos were used. This strategy has the advantage of reducing biological variability among
samples, yet pooling can mask variability for individual oocytes or embryos. Even with pooling
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of embryos, we did note fairly high variability among pooled blastocyst stage samples, which
were collected based on consistency in morphology. That said, blastocyst stage embryos graded
by morphology as high quality have been shown to express different transcriptomes [71], which
may also impact the population of sncRNAs. Furthermore, the breed of the oocyte donor could
also contribute to variability in the embryos, and the breed of oocyte donor and sperm used for
IVF in this study may have been different from other studies examining gene expression. The
protocol for isolating small RNA from these tissues did not allow for concurrent collection of
mRNA for analysis by sequencing or other PCR methods. While that approach would have been
ideal, we did examine expression of selected predicted mRNA target genes by qPCR in tissues
collected by the same methods as for the small RNA sequencing analyses. Also, the miRNAmRNA network was compiled using publicly available RNAseq data for oocyte and 8-cell bovine
embryos. It is possible that the transcriptome of our blastocyst stages differs from that of the data
used due to biological variability in the source material for IVF. With respect to analysis of
sequencing data, the analytical approach involved normalization of sequence reads to the total
reads per sample to account for differences in sample preparation and sequencing efficiency.
While this approach does not allow for precise quantification of the number of sequence reads per
cell or embryo, it does allow for comparison of relative contributions of specific sncRNAs classes
for different sample types, such as comparing the relative amount of miRNA in oocytes versus
blastocyst stage embryos. In addition, the annotation for the Bos taurus genome is not as
thorough as for mouse or human, though it is considered excellent among domestic and
agricultural species. Fewer known miRNA sequences for Bos taurus are available in miRBase
(793 mature sequences in cattle as compared to 1,915 in mice and 2,588 in humans), and the vast
majority of these miRNAs have not yet been functionally validated in the cattle model.
Overall, in every sncRNA population queried, all substantial changes in expression
patterns occurred at the 8-cell stage embryos. While sncRNA plays vital roles in pluripotency
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and differentiation, its function through the MZT in early mammalian development has not been
elucidated. The miRNA population underwent substantial increases in expression at the 8-cell
stage, suggesting a functional role for miRNA in the MZT. To our knowledge, our group is the
first to examine the dynamics of sncRNA populations through the MZT in bovine embryos.
Further research is needed to functionally validate roles for multiple sncRNA species through the
MZT in early mammalian development.
In conclusion, this study defined key class transitions in populations of sncRNAs
associated with the major MZT in bovine embryos, most notably for miRNAs, pilRNAs and
snoRNAs. These regulatory molecules may prove critical for successful zygotic genome
activation and embryo development in mammals. In future studies, the biological relevance and
functions of pilRNAs and snoRNAs should be investigated in depth, as their roles in mammalian
embryogenesis are poorly understood. Furthermore, additional work to define the function of
differentially expressed miRNAs in modulating embryogenesis in mammals is needed, including
a focus on the impact of these miRNAs maternally-derived transcript and activation of the
embryonic genome. Functional validation could be accomplished using knock-in and knock-out
approaches on embryos generated via IVF or somatic cell nuclear transfer to determine the impact
of gain or loss of miRNA expression on preimplantation embryonic development.
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Figure 2.1. Distribution of reads length and sequence annotation. (A) Values are the mean ±
SEM of the total sequence reads per sample after filtering out low quality reads and artifacts. (B)
Read length distribution of sequenced samples after trimming to 17-93 nt and filtering for quality
control. (C) Proportion of sncRNA annotated by class and read length 17-32 nt. (D) Proportion of
sncRNA annotated reads annotated by class and read length ≥33 nt. Abbreviations: oocyte, Oo; 8cell stage embryo, 8c; blastocyst stage embryo, Bl.
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Figure 2.2. Expression of mapped miRNA in bovine oocytes, 8-cell embryos, and blastocyst
stage embryos. (A) Proportional Venn diagram depicting the number miRNAs mapped to the
Bos taurus miR database for each sample, including unique and overlapping IDs, filtered by total
reads (>100 sequence reads per miR across samples) and consistency across biological replicates
(>15 sequence reads for each replicate within a sample type). (B) Principal components analysis
of miRNA family abundance data by sample type (oocyte, 8-cell stage embryo and blastocyst
stage embryo). PC1 and PC2 are shown with 95% confidence intervals (dashed ellipses). (C-D)
Unsupervised, bi-directional hierarchical cluster analyses (Euclidean distance method) of (C)
abundance data (log10 RPM) or (D) ratio data (log2 ratio with respect to average abundance in
oocytes) for miRNA families differentially expressed in any one sample (|log2 R|>1 and FDR qvalue <0.01).
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Figure 2.3. (prior page) Significant ontology and pathway terms and network clustering
associated with predicted mRNA targets of over- or under-expressed miRNAs in bovine 8-cell
stage embryos. (A) Predicted mRNA targets (TargetScan total context++ score <-0.35) of
differentially expressed miRNA families (|log2 R|>1 and FDR q-value <0.01 for 8-cell stage
embryo compared to oocyte) were subject to enrichment analysis using Metascape (minimum
overlap of 3, minimum enrichment 1.5 and FDR q <0.01). Only miR families annotated by
TargetScan as conserved or broadly conserved were included in the Metascape analysis. Each
heatmap depicts the top 20 enriched summary terms identified for Gene Ontology biological
processes (top), KEGG pathways (middle) and Reactome pathways (bottom) with the left column
depicting terms associated with mRNA targets of over-expressed miRs and the right column
under-expressed miRs. Heatmaps are colored by –log10 q-value; empty cells represent terms that
were not among the top 20 enriched terms for the overall dataset (these terms may be
significantly enriched, but not among the top 20). (B) Cytoscape network analysis of Gene
Ontology biological process terms for predicted mRNA targets of differentially expressed
miRNA families, including over- and under-represented miRs in 8-cell stage embryos as
compared to oocytes and/or blastocyst stage embryos. Each term is represented by a circle node,
for which the size is proportional to the enrichment score and the color represents the log10 qvalue. Terms with a similarity score > 0.3 are linked by an edge (the thickness of the edge
represents the similarity score) using force-directed network layout and bundled edges for clarity.
Each cluster is labeled by the term with the highest q-value in the cluster group. A dashed line
was added to represent clusters associated with embryo development and various other
development pathways. Complete results of the Metascape analyses are provided in
Supplementary File 2.2; Appendix D.
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Figure 2.4. Network of differentially expressed miRNAs in 8-cell stage embryos and their
predicted mRNA targets. A network of miRNA families differentially expressed in 8-cell stage
embryos as compared to oocytes and their predicted mRNA targets (TargetScan total context++
score <-0.35) was created using Cytoscape with a force-directed layout. Only miR families
annotated by TargetScan as conserved or broadly conserved were included in the network
analysis. MiR families are represented by squares and colored according to their abundance in 8cell stage embryos (values are log10 RPM), whereas target mRNAs are shown as circles and
colored by their expression in 8-cell bovine IVF embryos using RNAseq data from the Gene
Expression Omnibus dataset GSE52415 (calculated log2 ratio with respect to MII oocytes).
Nodes colored gray were not included in the GSE52415 data set, suggesting that they were not
expressed. Edges between miR and mRNA nodes indicate that the connected mRNA is a
predicted target of the miR in Bos taurus. Supplementary Figure 2.S9 shows the same network
colored by normalized expression (log10 VST-normalized reads for genes and log10 RPM values
for miRs).
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Figure 2.5. (prior page) Expression of selected mRNA targets in bovine oocytes, 8-cell stage
embryos and blastocyst stage embryos. (A) Principal components analysis of mRNA abundance
data by sample type (oocyte, 8-cell stage embryo and blastocyst stage embryo). PC1 and PC2 are
shown with 95% confidence intervals (dashed ellipses colored by sample type). (B)
Unsupervised, bi-directional hierarchical cluster analysis (Euclidean distance method) of select
mRNA targets of differentially regulated miRNAs. Values shown are the log2 fold change in
mRNA expression determined by qRT-PCR for each sample type normalized to expression in
oocytes (i.e., oocyte/oocyte, 8-cell/oocyte and blastocyst stage/oocyte) (n=5 to 6). (C-G)
Expression of selected mRNAs and their predicted targeting miRNAs that exemplify the expected
inverse expression pattern by developmental stage. (H-I) Expression of selected mRNAs and
their predicted targeting miRNAs that depict an expression pattern that does not match by
developmental stage. Values for C-I are the mean log2 fold change vs oocytes + SEM (n=5 to 6)
for mRNA expression data (qRT-PCR) or the mean log2 ratio + SEM (n=3) for miRNA
expression (small RNAseq). Different letters indicate groups are significantly different from each
other (FDR q<0.05). Abbreviations are Oo, oocyte; 8c, 8-cell embryo; Bl, blastocyst stage
embryo.
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Figure 2.6. Annotation and identification of piRNA-like RNAs (pilRNAs) by ping-pong
signature and 1U bias. (A) Fraction of sequence reads mapped as potential piRNAs compared to
reads mapped to other sncRNA classes or not annotated by sample type. (B) Number of
sequencing reads mapped to piRNA clusters (left axis) and number of piRNA clusters identified
(right axis). (C) Identification of pilRNAs by ping pong signature and 1’U bias. Line graphs
represent the number of pairs of reads with a 5’ to 5’ overlap in the datasets. The peak at 10 nt is
characteristic of piRNAs produced by the ping pong cycle. The sequence logos below represent
nucleotide biases at each pilRNA position for reads 32 nt in length (base position number below
each logo). Abbreviations are Oo, oocyte; 8c, 8-cell stage embryo; Bl, blastocyst stage embryo.
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Figure 2.7. Expression of pilRNAs across chromosomes by sample type. (A-C) Chromosome
diagrams for the Bos taurus genome were created using PhenoGram with each pilRNA cluster
location marked by a circle colored according to expression level. (D) Proportional Venn
diagram depicting number of predicted piRNA clusters by sample type. (E) Mapping of piRNAs
to TE sites in the Bos taurus genome. Values shown are the reads per million for the most
common TE sites for putative pilRNAs on the sense (+) or antisense (-) DNA strand.
Abbreviations are: long interspersed nuclear elements, LINE; short interspersed nuclear
elements, SINE; long terminal repeat, LTR; DNA transposon, DNA.
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Figure 2.8. Expression of snoRNAs in bovine oocytes, 8-cell stage embryos and blastocyst stage
embryos. (A) Principal components analysis of snoRNA abundance data by sample type (oocyte,
8-cell stage embryo and blastocyst stage embryo). PC1 and PC2 are shown with 95% confidence
intervals (dashed ellipses colored by sample type). Abbreviations are Oo, oocyte; 8c, 8-cell
embryo; Bl, blastocyst stage embryo. (B-C) Unsupervised, bi-directional hierarchical cluster
analyses (Euclidean distance method) of (B) abundance data (log10 RPM) or (C) ratio data (log2
ratio with respect to average abundance in oocytes) for snoRNAs differentially expressed in any
one sample (|log2 R|>1 and FDR q-value <0.01).

Table 2.1. Classification of sncRNA sequences a

sncRNA class

Oocyte

Sequence reads 17-32 nt
8-cell stage
Blastocyst stage
embryo
embryo

Oocyte

Sequence reads ≥33 nt
8-cell stage
Blastocyst stage
embryo
embryo

miRNA

2.04±0.001

13.95±0.011

2.74±0.003

0.09±0.000

1.00±0.000

0.23±0.001

genomic rRNA

0.62±0.000

3.01±0.003

1.67±0.006

0.00±0.000

0.01±0.000

0.00±0.000

mt rRNA

0.36±0.000

1.01±0.001

0.05±0.000

1.63±0.003

0.83±0.002

0.31±0.001

genomic tRNA
mt tRNA

2.07±0.000
0.58±0.001

11.08±0.003
1.14±0.001

2.87±0.006
0.50±0.001

1.42±0.002
3.93±0.006

4.34±0.013
1.75±0.002

4.67±0.018
4.11±0.009

misc RNA

0.19±0.000

0.92±0.002

0.21±0.000

0.17±0.000

0.37±0.001

0.26±0.001

snoRNA

0.12±0.000

4.46±0.021

0.21±0.001

6.24±0.004

28.41±0.002

7.71±0.023

snRNA
0.15±0.000
0.95±0.002
0.20±0.001
0.62±0.001
potential piRNA
72.68±0.010
14.40±0.029
49.77±0.060
3.10±0.008
a
Values are the mean fraction (%) of total reads ± SEM (n=3 pools of 40 oocytes or embryos).

1.12±0.001
0.52±0.001

0.74±0.001
3.36±0.009
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Table 2.2. Differentially expressed bovine miRNA families.

Cow miR family*
miR-10
miR-1248
miR-1306
miR-138
miR-140
miR-1434-5p

Seed sequence
ACCCUGU
CCUUCUU
CACCUCC
GCUGGUG
ACCACAG
UACAUGA

Conservation †
broadly conserved
other
conserved
broadly conserved
broadly conserved
other

Reads per million (average ± SEM) ‡
8-cell stage
Blastocyst stage
Oocyte
embryo
embryo
a
ab
5.13±0.07
4.21±0.17
4.92±0.11ab
2.85±0.56a
4.44±0.44ab
3.33±0.52ab
2.24±0.11a
2.77±0.14ab
1.35±0.60ab
4.03±0.09a
2.21±0.48b
2.89±1.64ab
2.48±0.29a
3.31±0.16ab
3.00±0.22ab
2.10±0.35a
3.08±0.19ab
1.52±0.90ab

miR-148/152
miR-149-5p
miR-15/16/195/424-5p/497
miR-151-5p
miR-181
miR-191
miR-193-5p
miR-196
miR-197
miR-202
miR-205
miR-28/708
miR-296-3p
miR-302
miR-31
miR-335

CAGUGCA
CUGGCUC
AGCAGCA
CGAGGAG
ACAUUCA
AACGGAA
GGGUCUU
AGGUAGU
UCACCAC
UCCUAUG
CCUUCAU
AGGAGCU
AGGGUUG
AGUGCUU
GGCAAGA
CAAGAGC

broadly conserved
conserved
broadly conserved
conserved
broadly conserved
broadly conserved
broadly conserved
broadly conserved
other
broadly conserved
broadly conserved
conserved
conserved
broadly conserved
broadly conserved
conserved

3.93±0.06a
0.00±0.00a
5.02±0.05a
3.43±0.02a
3.48±0.05a
3.60±0.14a
0.00±0.00a
0.00±0.00a
1.57±0.50a
4.01±0.18a
3.87±0.06a
2.79±0.06a
0.00±0.00a
0.00±0.00a
3.99±0.02a
3.74±0.05a

3.32±0.09ab
2.59±0.26ab
4.54±0.09ab
3.78±0.03ab
3.03±0.19b
3.92±0.05ab
2.60±0.18b
2.97±0.14b
2.57±0.07b
2.89±0.13ab
2.83±0.29ab
3.12±0.16ab
2.74±0.12ab
4.23±0.20b
3.52±0.23ab
2.75±0.15b

3.79±0.11ab
1.32±0.55ab
4.83±0.10ab
2.75±1.52ab
3.84±0.75ab
3.45±0.37ab
0.00±0.00a
0.00±0.00a
2.10±1.03ab
3.68±0.40ab
3.60±0.22ab
2.27±1.10ab
1.35±0.60ab
0.00±0.00a
3.62±0.51ab
3.74±0.23ab
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miR-338
CCAGCAU
broadly conserved
3.20±0.17a
2.07±0.54ab
2.57±1.36ab
miR-3432a
GCGGGAU
other
2.73±0.13a
3.49±0.01ab
2.16±1.02ab
miR-365-3p
AAUGCCC
broadly conserved
2.95±0.16a
3.61±0.20ab
3.21±0.20ab
miR-371
AGUGCCG
other
0.00±0.00a
4.11±0.13ab
2.25±1.09ab
miR-374
UAUAAUA
conserved
2.53±0.17a
3.15±0.12ab
2.21±1.06ab
miR-378/378c
CUGGACU
conserved
1.98±0.85a
4.52±0.14ab
2.59±1.38ab
miR-378b
CUUGACU
other
1.76±0.67a
4.36±0.15ab
2.46±1.26ab
miR-378d
UGGACUU
other
1.32±0.55a
3.25±0.07ab
2.07±0.92ab
miR-425-5p
UGACACG
other
2.61±0.16a
3.07±0.12ab
2.73±0.40ab
miR-455-3p
CAGUCCA
broadly conserved
0.00±0.00a
2.78±0.14ab
1.42±0.73ab
miR-503-5p/6519
AGCAGCG
conserved
3.95±0.01a
3.50±0.08ab
3.52±0.68ab
miR-505
GUCAACA
conserved
2.65±0.08a
3.13±0.19ab
2.02±0.91ab
miR-6526
CCUGUGC
other
1.25±0.43a
3.08±0.19ab
1.45±0.77ab
miR-7
GGAAGAC
broadly conserved
3.64±0.08a
4.11±0.19ab
3.90±0.11ab
miR-7858
CGCAAUU
other
0.00±0.00a
2.81±0.16ab
1.86±0.79ab
* miRNA IDs were grouped by cow miRNA family according to miRBase database (release 21).
†
Conservation annotations are described as follows: broadly conserved, conserved across most vertebrates, usually to zebrafish;
conserved, conserved across most mammals, but usually not beyond placental mammals; other, poorly conserved or other annotations in
miRBase.
‡
Values shown are the average log10 (y±1) transformed RPM ± SEM (n=3 pools of 40 oocytes or embryos). A value of 0 indicates that
no sequences were mapped for the corresponding miR family in any of the replicate samples. Different letters indicate a significant
difference according to pair-wise post-hoc Student’s t-tests. One-way ANOVA was performed using log10 (y±1) transformed RPM data,
followed by post-hoc pairwise tests between each tissue type. False discovery rate (FDR) q values were determined using a single family
for all raw p values from all post-hoc comparisons and the two-stage step-up method of Benjamini, Krieger and Yekutieli (GraphPad
Prism) with a desired Q=5%. Sample read data for all mapped miRNAs and complete statistical results are provided in Supplementary
File 2.1; Appendix C.
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A

B

C

Supplementary Figure 2.S1. Representative microscopic images of bovine MII oocytes, 8-cell
stage embryos, and blastocyst stage embryos from cattle. (A) Typical MII oocyte; (B)
representative 8-cell stage embryo obtained about 3 days post in vitro fertilization; and (C)
representative blastocyst stage embryos obtained approximately 8 days post in vitro fertilization.
Images were acquired via light microscopy with 200× magnification.
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Supplementary Figure 2.S2. Fraction of total reads for sncRNAs classes 1180 for read lengths
17 to 32 nt (A) or ≥33 nt (B). Values shown are average fraction of total reads + SEM (n = 3
pools of oocytes or embryos). For each sncRNAs class, different letters above bars indicate that
the bars are different, defined as p< 0.05 as determined by two-way ANOVA with factors
sncRNAs class and tissue type with Tukey post hoc test for multiple comparisons. Values were
log10 transformed to equalize variance prior to statistical analyses.
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Supplementary Figure 2.S3. Expression of miRNA in bovine oocytes, 8-cell embryos, and
blastocyst embryos. Unsupervised, bidirectional hierarchical cluster analyses (Euclidean distance
method) of (A) abundance data (log10 RPM) or (B) ratio data (log2 ratio with respect to average
abundance in oocytes) for all miRNA families detected by small RNA sequencing.
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Supplementary Figure 2.S4. Volcano plot depicting changes in miRNA abundance. Values
shown are the log2 ratio of expression in 8-cell embryos vs. oocytes (A), blastocysts embryos vs.
oocytes (B), or blastocysts embryos vs. 8-cell embryos (C) plotted against the –log10 FDR qvalue. A significant difference in expression was defined as |log2 R|>1 and FDR q-value <0.01.
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Supplementary Figure 2.S5. (prior page) Significant ontology and pathway terms and network
clustering associated with predicted mRNA targets of over- or underexpressed miRNAs in bovine
8-cell embryos. Predicted mRNA targets (TargetScan total context++ score <−0.35) of
differentially expressed miRNA families (|log2 |R|>1 and FDR q-value <0.01 for 8-cell embryo
compared to oocyte or blastocyst embryo) were subject to enrichment analysis using Metascape
(minimum overlap of 3, minimum enrichment 1.5 and FDR q<0.01). Only miR families
annotated by TargetScan as conserved or broadly conserved were included in the Metascape
analysis. Cytoscape network analysis of Gene Ontology biological process terms for predicted
mRNA targets of differentially expressed miRNA families, including over- and underrepresented
miRs in 8-cell embryos as compared to oocytes and/or blastocyst embryos. Each term is
represented by a circle node, for which the size is proportional to the enrichment score and the
color represents the log10 q-value. Terms with a similarity score >0.3 are linked by an edge (the
thickness of the edge represents the similarity score) using force-directed network layout and
bundled edges for clarity. Each cluster is labeled by the term with the highest q-value in the
cluster group. A dashed line was added to represent clusters associated with embryo development
and various other development pathways. Nodes within the networks are colored by the FDR qvalue (A), by the associated GO biological pathway term for the cluster (B), or by the proportion
of IDs in mRNA target lists for either over- or underexpressed miRs (C).
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Supplementary Figure 2.S6. KEGG reference map04550 signaling pathways regulating
pluripotency of stem cells for Bos taurus. Terms marked by a target symbol represent genes
predicted as targets of over or under-represented miRNAs in 8-cell embryos with respect to
oocytes
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Supplementary Figure 2.S7. KEGG reference map05200 pathways in cancer for Bos taurus.
Terms marked by a target symbol represent genes predicted as targets of over or under
represented miRNAs in 8-cell embryos with respect to oocytes.
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Supplementary Figure 2.S8. Predicted mRNA targets (TargetScan total context++ score
<−0.35) of differentially expressed miRNA families in 8-cell embryos (|log2 R|>1 and FDR qvalue <0.01 compared to oocyte or blastocyst embryo) were subject to enrichment analysis using
DAVID EASE against the Bos taurus genome. Each bar graph depicts the top 20 enriched
summary terms identified for (A) Gene Ontology biological processes or (B) KEGG pathways.
Values are the –log10 enrichment FDR q-value. (B) REVIGO plots for significant biological
process GO terms. (C) REVIGO plot (revigo.irb.hr) depicting enriched GO biological processes
following reduction of the complete GO term list (all terms FDR q<0.05) by semantic similarity
(simrel 0.7) against the Bos taurus database. Terms are plotted by semantic similarity scores and
colored according to the−log10 enrichment FDR q-value. Complete results are provided in
Supplementary Table 2.S2.
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Supplementary Figure 2.S9. Network of differentially expressed miRNAs in 8-cell embryos and
their predicted mRNA targets. A network of miRNA families differentially expressed in 8-cell
embryos as compared to oocytes and/or blastocyst embryos and their predicted mRNA targets
(TargetScan total context++ score <–0.35) was created using Cytoscape with a force-direct
layout. Only miR families annotated by TargetScan as conserved or broadly conserved were
included in the network analysis. MiR families are represented by squares and colored according
to their abundance in 8-cell embryos (values are log10 RPM), whereas target mRNAs are shown
as circles and colored by their expression in 8-cell bovine IVF embryos using RNAseq data from
the Gene Expression Omnibus dataset GSE52415 (log10 VST normalized reads). Nodes colored
gray were not included in the GSE52415 data set, suggesting that they were not expressed. Edges
between miR and mRNA nodes indicate that the connected mRNA is a predicted target of the
miR in cattle.
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Supplementary Figure 2.S10. Expression of selected mRNA targets in bovine oocytes, 8-cell
embryos, and blastocyst embryos. Values are the mean log2 fold change + SEM (n = 5 to 6).
Different letters indicate groups are significantly different from each other (FDR q<0.05). Oo,
oocyte; 8c, 8-cell embryo; Bl, blastocyst embryo.
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Supplementary Figure 2.S11. Potential piRNAs mapped to the Bos taurus genome in oocytes,
8-cell embryos, and blastocyst embryos. Values are the total normalized reads for each sample
type.

CHAPTER 3
PROFILING OF SMALL NON-CODING RNA IN BOVINE SOMATIC CELL
NUCLEAR TRANSFER EMBRYOS DURING EARLY DEVELOPMENT
THROUGH THE MATERNAL-TO-EMBRYONIC TRANSITION
Abstract
Background
Somatic cell nuclear transfer (scNT) is a well-established method for animal cloning that
has a transformative potential impact on production agriculture. However, scNT efficiency
remains low, which represents a significant barrier to use of the technology in production and
limits its potential impact. In cattle and other mammals, small non-coding RNAs (sncRNAs)
have been reported to be important during early embryo development. While errors in epigenetic
modifications such as DNA methylation and histone modification have been investigated
thoroughly in bovine scNT embryos, a comprehensive assessment of the differences in sncRNA
between scNT and in vitro fertilized (IVF) bovine embryos has not been performed. The
objective of this study was to examine dynamic changes in expression of sncRNA during the
maternal-to embryonic transition (MET) in bovine embryos produced by scNT compared to IVF.
Results
An unbiased, discovery-based approach was employed using small RNA sequencing to
profile sncRNA in oocytes, bovine fibroblast cells used as scNT nuclear donors, IVF and scNT 2cell, 8-cell, morula and blastocyst stage embryos, as well as IVF and scNT blastocyst-derived
cells. The relative abundance of miRNAs was similar between IVF and scNT embryos, with the
only statistically significantly different miRNAs detected between IVF and scNT morula stage
embryos. These miRNAs included miR-2340, miR-345, and miR34a. Distinct populations of
piwi-interacting like RNAs (pilRNAs) were identified in bovine embryos before and during the
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maternal-to-embryonic transition (MET), as compared to somatic cell samples and bovine
embryos post MET. Smaller distinct populations of tRNA fragments were also noted in blastocyst
stage embryos, somatic cells, and earlier embryonic stages.
Conclusions
The discovery-based sncRNA sequencing analysis of preimplantation embryos revealed
largely similar profiles of sncRNAs for IVF and scNT embryos at the 2-cell, 8-cell, morula and
blastocyst stages of development. However, clear differences were apparent in sncRNA profiles
of pre- and post-MET embryos and cultured cells with some degree of differentiation.
Introduction
Somatic cell nuclear transfer (scNT) is a well-established method for animal cloning in
livestock species wherein genetic material from a recipient ovum is removed and then replaced
with nuclear DNA from a donor cell. However, bovine scNT embryos are very likely to abort
during pregnancy, and cloning success rates remain quite low regardless of the species or method
used [1, 2]. Improvement in scNT efficiency combined with application of advanced genomics
technologies could make a significant impact on the rate of genetic improvement in agricultural
species.
After nuclear transfer, the cellular machinery of the host egg must reprogram the somatic
DNA so that the new genome is set to a pluripotent state with the potential for cellular
differentiation needed for successful development. The reprogramming of donor DNA takes
place at the level of the epigenome, a layer of cellular information involving specific patterns of
chromatin structure and DNA modifications that facilitate control of gene expression. Errors
associated with epigenetic reprogramming of the nuclear donor genome likely lead to
inappropriate gene expression in scNT embryos [3]. The cellular stress incurred by aberrant
epigenome programming likely contributes to the high loss rate for scNT embryos throughout
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early development and pregnancy [1], as incorrect global patterns of DNA methylation [4-7] and
inappropriate histone modifications [8-10] have been identified in scNT embryos. The epigenetic
patterns in scNT embryos appear to more closely resemble those of the nuclear donor cell,
indicating that poor epigenome reprogramming may contribute to these low efficiencies [11, 12].
One period of embryo development that would be especially detrimentally impacted by
errors in epigenetic reprogramming is the maternal-to-embryonic transition (MET). The MET is
a highly orchestrated process by which maternally deposited transcripts must be degraded in
order to allow successful embryonic genome activation (EGA). The process of degrading
massive amounts of maternal transcripts and replacing those transcripts with mRNA derived from
the embryo is required to prepare the embryo for differentiation and further development [13].
Two pathways drive transcript degradation, one using the maternal molecular machinery, and the
other utilizing the embryonic molecular machinery. One major player in the maternal
degradation pathway is the protein SMAD4, which directs the degradation of a subset of maternal
transcripts, including those that would repress the embryonic genome [14]. Maternally mediated
degradation of mRNA activates a second phase of clearance by enabling the initiation of the
embryonic mode of degradation. After the EGA, the newly activated embryonic transcriptome
guides cells through the first cell fate decisions at the blastocyst stage of development.
Small non-coding RNAs (sncRNA) are RNA molecules that are not translated into
proteins. These sncRNAs have important functions in RNA interference (RNAi), the process by
which sncRNAs block the translation or reduce the stability of protein-coding messenger RNA
(mRNA). In mammals, the microRNA (miRNA), piwi-interacting RNA (piRNA) and small
endogenous interfering RNA (siRNA) classes of sncRNA have been established as functioning in
RNAi in early development [15]. These three sncRNAs all participate in RNAi through binding
and degrading transposable elements (TEs) and/or mRNA, although biogenesis and targeting
mechanisms differ between them [16]. In addition, more recently, additional sncRNAs have been
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identified that function in RNAi. Transfer RNA (tRNA) is a key player in deciphering the
genetic code [17], and recently was found to be processed into fragments that act in RNAi. In
cancer cell lines, individual tRNA fragments (tRFs) are up-regulated and control cell proliferation
[18]. As they are further investigated, it is reasonable to expect that tRFs will be found to be
involved in a myriad of cellular functions. Translation requires snoRNAs to process and modify
ribosomal RNA (rRNA) [19]. Recently, snoRNA was also found to be processed to generate
stably accumulating fragments that act in RNA interference [20, 21]. It appears that these so
called sno-miRNAs may target transcripts controlling cell behavior and carcinogenesis [22, 23].
MiRNAs are sncRNAs that act to silence mRNA expression through binding interactions
with the 3’ untranslated region (UTR), which blocks translation and decreases stability of target
transcripts [24]. These miRNAs are short, single stranded RNAs about 22 nt long that are highly
conserved among species. The canonical pathway for miRNA biogenesis starts with RNA
polymerase II-driven transcription to generate primary-miRNAs (pri-miRNAs), which are then
cleaved by Drosha and its cofactor DGCR8; these miRNA processing proteins recognize cleavage
sites and cleave a stem-loop and 3’ 2 nt overhang on the resulting precursor miRNA (premiRNA). Exportin proteins transport pre-miRNA into the cytoplasm where the Dicer complex
cleaves these molecules into double stranded, non-hairpin, miRNAs. AGO then unwinds and
loads the miRNA duplex into the miRNA-induced silencing complex (miRISC) [25]. The
miRISC directs miRNA to its target transcript and in cases of perfect complementary binding,
AGO will mediate the target degradation [16]. In cases of non-complementary binding, miRNA
represses translation by inhibiting translation at the initiation step [26, 27]. Also, a minority of
miRNAs can be processed independently of either Drosha and/or Dicer using alternative
biogenesis pathways [28]. Micro-RNAs have been shown to be powerful regulators of gene
expression in many organisms and function in the majority of investigated cell functions.
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Piwi-interacting RNAs (piRNAs) are single-stranded RNA molecules that are 21-34 nt
long with a highly conserved function among species, which associate with the PIWI subfamily
of proteins [29, 30]. Because piRNAs act as a type of immune system to protect the germ cell
genomes from transposable elements (TE), they are specifically expressed in the germ cell lines,
and less commonly in somatic tissue, although this is an emerging field of research. Active TEs
may pose a threat to genomic stability and need to be repressed by piRNA during periods of
epigenetic remodeling [31]. Piwi-interacting RNA-mediated repression occurs both
transcriptionally and post-transcriptionally as they bind RNA targets through complementarity
and repress targets via either endonuclease activity or chromatin mark recruitment. Piwiinteracting RNAs were originally discovered to function in gametogenesis and have since been
shown be important in silencing TEs during reprogramming events throughout primordial
germline cell development [32]. It is possible that piRNAs target and suppress TEs during early
development, but this silencing may not be maintained during the MET, as it has been shown that
TE transcripts are expressed in bovine embryos at this time [33]. Activation of a subgroup of TE
transcripts is necessary at this stage, so it is likely that some down-regulation of piRNA occurs to
maintain a balance between licensed and potentially detrimental TE expression [33, 34]. It is also
possible that piRNAs target mRNAs for degradation. Russell and colleagues examined the
expression of piRNA in cattle oocytes and zygotes and determined that piRNA populations
correlated with mRNA destined for degradation in the embryo [35]. Previously, Roovers and
colleagues reported that piRNAs and PIWIL3 were present at high levels in bovine oocytes and
1-2 cell embryos, which points to key functions for piRNA in cattle and is contradictory to what
has been found in mice [31]. During periods of epigenetic reprogramming when methylation and
other silencing marks that repress TEs are removed, piRNAs function to degrade TEs and,
therefore, are key in early development.
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The mature oocyte and early embryo are transcriptionally silent, setting up a unique
window of development during which post-transcriptional machinery, such as sncRNA, may
dominate the regulatory network. A zygotic degradation pathway mediated by miRNA was first
demonstrated in zebrafish, in which a single miRNA (miR-430) mediated the decay of hundreds
of maternal mRNAs [36]. Maternal mRNA decay via miRNA has also been found in C. elegans
by both maternal and zygotic miRNA [37], in Xenopus by a miR-430 orthologue (miR-427)
targeting mRNAs [38], and in Drosophila by miR-309 that is highly expressed at the EGA and
degrades hundreds of mRNAs [39]. To date, mammalian miRNAs have not been shown to
function in a similar manner by targeting maternal mRNA and participating in the degradation
pathway, which may be due to the extensive use of the mouse mammalian model. Mice have a
rodent-specific sncRNA pathway in the oocyte and early embryo dominated by miRNA and
siRNA, while piRNA and associated PIWI proteins may play analogous roles in humans and
cattle [31]. Endo-siRNAs may be up regulated in mouse oocytes due to a rodent oocyte-specific
Dicer isoform that preferentially processes siRNA over miRNA [40]. Evidence from mouse
studies supports a model in which endo-siRNAs are important for TE repression and mRNA
clearance during oocyte maturation, whereas miRNAs are crucial for mRNA regulation later in
embryonic development as differentiation begins [41]. However, due to the divergence in
sncRNA pathways, the experimental evidence that miRNAs are not highly active or functional in
mouse oocytes and early embryos [42-44] should not deter further investigation of miRNA as a
embryonic clearance mechanism in mammals.
While a single miRNA that participates in the same type of maternal mRNA clearance as
seen in Zebrafish and Drosophila has not been found in mammals, mammalian miRNAs have
been identified that may function in early development. Our group previously demonstrated that
in cattle, miRNA and other sncRNA are dynamically regulated with large-scale population
changes through the MET in cattle in vitro fertilized (IVF) embryos [45]. Other groups,
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quantifying only a fraction of total miRNA, also found dynamic changes in miRNA species in
pre-implantation embryos in cattle including increases at the 8-cell stage [46, 47]. Specific
miRNAs have been shown to function in cattle embryogenesis as well, such as miR-130b, which
has been found to impact granulosa and cumulus cell proliferation and oocyte maturation, as well
as morula and blastocyst formation [48]. In addition, miR-218 and miR-449b are specifically
expressed in blastocyst stage cattle embryos. MiR-218 may target and regulate NANOG and
CDH2, and miR-449b may target and regulate NOTCH, and the down-regulation of these genes
would greatly impact development [49]. Additionally, miR-212 has been shown to negatively
regulate the maternal effect gene FIGLA [50], and miR-196 has been shown to negatively
regulate the maternal effect gene NOBOX [51], supporting a possible function for cattle miRNA
in the degradation of transcripts through the MET.
Aberrant expression of miRNA may contribute to the low efficiency for production of
viable scNT embryos. Incomplete reprogramming of the somatic donor cell genome has been
seen in scNT embryos, as patterns of DNA methylation and histone modifications are abnormal
in scNT embryos [11, 52]. Also, DNA demethylation does not appear to occur at the same levels
in scNT embryos [53], and persistent nuclear donor methylation patterns appear to occur [8, 9].
As DNA methylation patterns have been shown to impact miRNA expression, it is possible that
persistent somatic miRNA expression occurs as well, further impacting the aberrant transcriptome
of scNT embryos [54-56]. In addition, others have observed aberrant miRNA expression in
clones at more advanced stages of embryonic or fetal development [57, 58]. Differences in the
expression of miRNA clusters and families in scNT placentas as compared to IVF placentas and
placentas from artificial insemination pregnancies have also been identified that could
significantly contribute to errors in gene expression, causing embryonic death [57]. Interestingly,
one major biogenesis protein for miRNA, AGO, was down regulated in scNT placentas due to
hypermethylation of the promoter region. To date, these studies are the only reports to assess
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expression of miRNAs in bovine scNT. However, these reports are limited by virtue of a targeted
approach that may not have captured miRNAs of developmental importance. The importance of
miRNAs in the development of bovine embryos has been further supported by several studies that
have shown that specific miRNA supplementation can impact rates of development in embryos
[59], including the improvement of scNT embryo development rates [60-64].
A comprehensive assessment of dynamic changes in populations of sncRNAs in scNT
embryos through the MET has not been performed in any mammalian model, except for the
mouse. Because of distinct molecular differences in biogenesis of certain classes of sncRNAs in
rodents and other mammals, the mouse may not be the most useful model for these investigations.
Importantly, these processes appear to function similarly in bovine and human embryos, making
the cattle early developing embryo a useful biological model to understand dynamics of sncRNA
during early development. Importantly, to our knowledge, no one has applied a discovery based,
unbiased approach to characterize populations of sncRNA during the critical MET period in scNT
embryos, as compared to IVF embryos in any mammalian non-rodent species. Thus, the
objective of this study was to examine dynamic changes in expression of sncRNA in scNT
embryos, during early embryo development encompassing the MET period. Based on the
evidence discussed above, we hypothesized that miRNAs found in the nuclear donor cell would
be more abundant in scNT embryos as compared to IVF embryos. Also, we hypothesized that
aberrant expression patterns of miRNAs in scNT embryos would occur as compared to IVF
embryos, and the sncRNA profile of the somatic donor cells would persist in scNT embryos
potentially due to incomplete reprogramming. We predicted that the population of miRNAs
impacted would target maternal mRNAs with important functions associated with epigenetic
reprogramming and development, thus contributing to the aberrant epigenetic landscape found in
scNT embryos. RNAseq was employed to profile all sncRNA classes in bovine oocytes, 2-cell
embryos, 8-cell embryos, morula embryos, blastocyst embryos, and blastocyst-derived cells
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produced using both IVF and scNT methods. Fibroblasts that had been used as donor nuclear
cells for scNT were profiled as well.
Methods
Oocyte collection and in vitro maturation
Bovine ovaries were collected from a local abattoir (JBS, Hyrum, UT) and transported in
a cooler containing 0.9% saline solution to the laboratory. The cumulus-oocyte complexes
(COCs) were then aspirated from 3-8 mm follicles by using an 18-gauge needle and vacuum
system. Only compact COCs with homogenous ooplasm and intact layers of cumulus cells were
used for scNT or IVF. Following aspiration, COCs were cultured at 39 °C with 5% CO2 for 22 to
24 hr. The oocytes were cultured in TCM199 maturation medium with Earle’s salts, L-glutamine,
and sodium bicarbonate (Hyclone, Logan, Utah) supplemented with 10% fetal bovine serum
(FBS), 0.05 mg/ml bovine follicle stimulating hormone (Sioux Biochemicals, Sioux city, IA), 5
mg/ml bovine luteinizing hormone (Sioux Biochemicals), 100 U/ml penicillin, and 100 mg/ml
streptomycin.
In vitro fertilization
Following 22 to 24 hr of maturation, MII oocytes were fertilized using the laboratory’s
standard in vitro fertilization (IVF) protocol [65]. Briefly, one straw of cryopreserved bovine
semen obtained from a Holstein bull (Hoffman AI, Logan UT) was removed from the liquid
nitrogen tank and placed into a 35 °C water bath to thaw. Live sperm were isolated by
centrifugation through a 45%/90% percoll gradient, suspended (final concentration 1x106/ml) in
Tyrode’s albumin lactate pyruvate containing 10 µg/ml heparin and used to fertilize the mature
oocytes. Twenty to 22 hr post-IVF, cumulus cells were removed by vortexing, and fertilized
zygotes were washed in phosphate buffered saline with 0.32 mM sodium pyruvate, 5.55 mM
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glucose, and 3 mg/ml bovine serum albumin (PB1+). After washing, zygotes were cultured on a
monolayer of bovine cumulus cells in 50 µl of synthetic oviductal fluid (SOFaa) with 3% FBS
overlaid with mineral oil. The embryos were cultured at 39 °C in a humidified atmosphere with
5% CO2. Half of the SOFaa medium was removed and replaced with fresh, equilibrated medium
every other day starting the day after in vitro culture. Historically, production of IVF embryos via
these methods followed by blastocyst stage embryo transfer to cattle recipients has generated
successful pregnancies at an approximate rate of 50% by our research group (unpublished
observations). The timing of embryo collection post-fertilization was 24-36 hr for 2-cell stage,
48-60 hr for 8-cell stage, 156-168 hr for morula stage, and 192-204 hr for blastocyst stage.
Somatic cell nuclear transfer
Primary bovine fibroblast cultures were established from ear biopsy tissues from a
Brahma Spanish bull cross using well-established procedures. Frozen/thawed cells were grown to
80-100% confluence then passaged, with cells from passages 4-5 used as nuclear donors. Three
days prior to a cloning session, donor fibroblast cells were thawed and propagated, and incubated
in DMEM media supplemented with 15% (v/v) FBS at 39 °C with 5% CO2. Bovine fibroblasts at
80-90% confluence were serum starved by replacing culture media with DMEM media
containing 0.5% (v/v) FBS 24 hr prior to scNT. Oocytes were matured for 18-20 hr, then
denuded using 100 µl of 1% (v/v) hyaluronidase, incubated for 5 min at 39˚C with 5% CO2,
followed by gentle pipetting. The removed cumulus cells were centrifuged at 500´g for 5 min at
room temperature, and the supernatant was removed. Cumulus cells were then cultured in SOFaa
under oil for use in embryo culture. The denuded oocytes were then rinsed using PB1+, and
oocytes with polar bodies were selected and separated. ScNT was performed according to
established protocols [66-68]. Briefly, oocytes with polar bodies were incubated in 0.6 µg/ml
demecolcine for 30-40 min and a metaphase plate and a polar body were removed using a beveled
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pipette. Fibroblast cells were covered in 0.25% trypsin for 1 min, and then the trypsin was
removed and fibroblasts were incubated for anther 6 min at 39˚C with 5% CO2. Once fibroblast
cells were detached, they were rinsed in warm medium and centrifuged at 150xg for 6 min. The
supernatant was removed, and the cellular pellet was resuspended in 100 µl Hepes SOF medium
[69]. One fibroblast cell was injected into the perivitelline space of the recipient oocyte, and
fused using one direct pulse of 1.2 kV/cm for 22 µs by an Electro Cell Manipulator 2001 (BTX,
San Diego, CA) in 0.28 M sorbitol, 0.05% (w/v) BSA, 0.1 mM CaCl2, 0.5 mM MgCl2, and 0.5
mM Hepes. Following fusion, embryos were washed through Hepes SOF, and incubated in
embryo culture medium for 1 hr. Activation was then performed, with successfully fused
embryos cultured in 5µM ionomycin for 5 min, followed by 4 hr of incubation in activation
medium composed of SOFaa medium with 10µg/ml cyclohexamide and 1 mM 6-dimethylaminopyridine at 39˚C with 5% CO2. Following activation, embryos were cultured on a monolayer of
bovine cumulus cells in 50 µl drops of SOFaa with 3% (v/v) FBS overlaid with mineral oil. The
embryos were cultured at 39 °C in a humidified atmosphere with 5% CO2. Half of the SOFaa
medium was removed and replaced with fresh, equilibrated medium every other day starting the
day after in vitro culture. The timing of embryo collection was the same as for IVF embryos as
described above.
Isolation of blastocyst-derived cells
We followed methods previously described [70] to generate putative embryonic stem
cells (ESCs) from IVF and scNT embryos for comparison. Briefly, bovine expanded blastocysts
produced by IVF and scNT were used for BDC isolation. Zona pellucida-free blastocysts were
placed into 4-well culture dishes onto feeder layers of mitomycin C-treated mouse primary
embryonic fibroblasts. Feeder layer preparation was performed as previously reported [71].
These cells were cultured in DMEM supplemented with 0.2% (w/v) LIF, 1% (w/v) bFGF, and
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30% (v/v) Knock out Serum Replacement (ThermoFisher Scientific, Waltham, MA). When
propagation was needed, cultured cell colonies were mechanically propagated using a small metal
blade. Germ line competent ESCs have only been reported for mouse and rat [72]. However,
bovine putative ESC-like cells expressing pluripotency markers have been reported by several
groups [70, 73-75]. Though the objective here was to generate putative ESC-like cells,
transcriptional profiling revealed that these cells did not consistently express the array of gene
markers typical of pluripotent stem cells (data available with Chapter 4). Thus, we instead refer
to these cells as blastocyst-derived cells (BDCs) herein.
Tissue collection
Four pools of 20 mature oocytes were collected at 22 hr after maturation. To remove
cumulus cells, the mature COCs were treated with 10 mM hyaluronidase for 5 min, followed by
repeatedly pipetting the mixture until cumulus cells were removed. After visual inspection for
complete removal of cumulus cells and the presence of a polar body, denuded mature metaphase
II (MII) oocytes were washed through four droplets of PB1+. Oocytes were then snap frozen in
cryotubes containing RNA/DNA shield (Zymo, Irvine, California), and stored at -80 °C until
RNA isolation. Fibroblasts prepared for scNT were collected after centrifugation and pelleting,
and were snap-frozen in 100ul of RNA/DNA shield (Zymo, Irvine, California). Four pools of 20
2-cell, 8-cell, morula, and blastocyst stage embryos were collected at 2, 3, 6, and 8 days post-IVF
or scNT, washed in PBS, and stored at -80 °C.
Small RNA isolation and sequencing
RNA was isolated based on size using the RNA Clean & ConcentratorTM 5 kit (Zymo)
from four pools each of oocytes, 2-cell stage embryos, 8-cell stage embryos, morula stage
embryos, or blastocyst stage embryos as well as donor fibroblasts and BDCs according to the
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manufacturer’s protocol for purification of small RNA (<200 nt) and large RNA (>200 nt) as
separate fractions. Small RNA sequencing was performed on the Ion ProtonTM Sequencer using
the Ion Total RNA-seq kit v2 (Thermo Fisher Scientific, Waltham MA) according to
manufacturer’s procedure for small RNA library preparation with no deviations from the
specified protocol. By using an RNA isolation protocol that yielded a specific fraction of small
RNA, an enrichment step was not needed. Sample volumes were reduced to 3 µl by vacuum
centrifugation, and the entire sample was used to prepare the small RNA library for sequencing.
The cDNA sample was then processed on the Agilent Bioanalyzer (Agilent, Santa Clara CA) to
ensure the presence of small RNA bound to a barcode (86 to 106 nt).
MicroRNA data processing and analyses
Sequence data were processed to remove low quality reads and any artificial reads
introduced during library preparation (Perl script Trim Galore, Python script SortMeRNA) [76,
77]. Annotation and expression analysis of sncRNAs was performed as described previously
[35]. Briefly, data processing and bioinformatics analysis for other sncRNA were performed
primarily with command line tools available at http://www.smallrnagroup.unimainz.de/software.html. First data were filtered for sequence length between 17 and 32
nucleotides (nt), which includes the canonical size range for mature small RNAs (miRNA,
siRNA, piRNA). A separate analysis was performed for sequences between 33-93 nt, which
encompassed longer reads characteristic of snoRNA, tRNA and mitochondrial rRNA. This split
analysis approach avoided possible skewing of the data when comparing between these diverse
sncRNA classes. Sequence annotation was performed with Unitas v1.6.1, which uses the latest
available public small RNA databases to annotate input sequences [78]. Read length and
annotation summaries for all samples are provided in Supplementary File 3.1; Appendix F. Nonannotated sequences were then mapped to the bovine genome (BosTau8) with sRNAmapper [79]
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to determine which non-annotated sequences were likely of biological, not technical, origin. The
mapped sequence reads were redistributed across the genome based on number of mapping
locations using reallocate with the parameters ‘5000 1000 b 0’ (reallocate.pl). Reallocated map
files were then analyzed with ProTRAC v2.4.2 [80], which identifies probable piRNAs through
their genomic clustering based on size, sequence, and cluster characteristics (all options at default
settings, including repeatmasker and geneset references). Predicted piRNA clusters were
compared among samples by using the Galaxy “merge” tool (usegalaxy.org) to first generate lists
of predicted clusters by sample type followed by the “join” tool to identify overlapping genomic
intervals among samples. Sequence logos representing nucleotide biases were generated with
ggseqlogo [81]. Count tables of sncRNAs were generated from the output of Unitas.
Normalization and differential expression analysis was performed with the DESeq2 R package
[82]. Differentially expressed sncRNAs were called with an adjusted p-value of < 0.05.
Normalized and variance stabilized data for all annotated reads are provided in Supplementary
File 3.2; Appendix G. Complete results of DESeq2 differential expression analyses are provided
in Supplementary File 3.3; Appendix H. BioVenn was used to create proportional Venn

diagrams depicting the number of transcripts mapped to the cattle genome for each
sample [83]. Unsupervised, bidirectional hierarchical cluster analyses (Euclidean
distance method with average linkage) and principal component analyses were performed
using ClustVis [84].
Network analysis of predicted gene targets of differentially expressed miRNAs
Gene targets for miRNAs individual species/families identified as differentially
expressed between scNT and IVF embryos or by developmental stage within the embryo type
were predicted using TargetScan (release 7.2) [85] with the Bos taurus miRNA database
(miRBase release 22). TargetScan predicts biological targets of miRNAs by searching for the
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presence of a conserved 8-mer, 7-mer, and 6-mer sites matching the seed region of each miRNA.
TargetScan provides an additional advantage by curating individual miRNAs by family (identical
seed ± m8 sequence). Lists of predicted target mRNAs were filtered for total context ++ score < 0.35 (efficacy of targeting miRNA site: Supplementary File 3.4; Appendix I), and miRNAs of
interest were defined by family, level of conservation with other species, and by seed sequence.
Note that the output of TargetScan is the human orthologue of a predicted target gene; the
representative transcript that is shown is the transcript with the UTR profile that is the most
prevalent (highest number of supporting 3P-seq tags). Lists of all predicted mRNA targets were
then subject to gene set enrichment analysis using Metascape and the Gene Ontology (GO)
biological process database with the following parameters: minimum overlap of 3 genes in a
category, minimum enrichment of 1.5, and p <0.05 [86]. Ontology analyses were performed
using DEG sets for comparison between IVF and scNT embryos at each developmental stage and
for comparisons by developmental stage within each embryo group. Resulting GO biological
process terms were then clustered by semantic similarity (kappa score >0.3) and represented as
networks in Cytoscape [87]. Clusters of related terms were named according to the term within
the cluster with the lowest p value; thus, clusters with different labels may have some similar
terms within the cluster.
Results
Classification of sncRNA sequences
RNA sequencing of sncRNA obtained from bovine oocytes, fibroblasts, 2-cell embryos,
8-cell embryos, morula stage embryos, blastocyst stage embryos, and blastocyst-derived cells
generated a total of about 115.8 million reads after filtering out low quality reads and artifacts.
Sixty percent of these reads aligned to known bovine sncRNAs, with reasonable read depth
across sample types (Supplementary File 3.1). However, we noted that the sequencing depth per
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sample was somewhat variable and did not achieve the high standard of 2 million reads per
sample as described by ENCODE [88], which was not surprising given the small number of
starting cells that could be obtained early developing embryos. As shown in Figure 3.1A, the
number of reads obtained per sample was markedly higher in the differentiated cell types, BDCs
and fibroblasts. Overall, scNT embryos generally had more reads then their IVF staged
counterparts, although this was not the case at the 8-cell stage, where the scNT embryos had
approximately 390 thousand fewer reads. RNA input was not normalized by sample type when
generating the sample libraries for sequencing due to the exceedingly small amount of small RNA
obtained. However, the RNA input for somatic cells were adjusted to be similar to the low input
obtained for embryos and was normalized.
As shown in Figure 3.1B, sequence reads of 21-24 nt in length, which corresponds with
the miRNA class of sncRNA, were very abundant across all sample types. Also, small peaks for
read lengths corresponding to snoRNAs (70-90 nt) and tRNAs (76-90 nt) were also evident for all
sample types, with these peaks representing a range of sizes down to 60 nt and a larger fraction of
the total reads in the blastocyst staged embryos and the BDCs. Other minor peaks at various
lengths were present, likely corresponding to rRNA, snRNA, or other miscellaneous RNA
fragments. Within the set of sequences 17-32 nt in length, the proportion of reads that were
annotated as sncRNAs in oocyte samples was approximately 5%, whereas 2-cell and 8-cell
embryos had annotation rates ranging from 4-15% and 5-17%, respectively (Figure 3.2A).
Annotation of sncRNAs was greater among morulae (10-39%) and blastocyst stage embryos (1433%) (Figure 3.2B), but the highest annotation rates were noted for more differentiated cells
including fibroblasts (54-85%) and BDCs (10-71%), with notable variation among the BDCs
(Figure 3.2C). For longer reads >33 nt, 5-8% of reads from oocyte samples were annotated,
while annotation rates for 2-cell and 8-cell stage embryos were more variable ranging from 214% and 5-11%, respectively (Figure 3.2D) For mid-stage embryos, annotation rates of reads
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>33 nt in length for morulae were variable ranging from 4-30% compared to rates of 12-41% for
blastocyst stage embryos (Figure 3.2E). In contrast to short sequences 17-32 nt, for sequences
>33 nt, the annotation rate for fibroblasts and BDCs were comparatively low at 4-15% and 1240%, respectively (Figure 3.2F). Note that these annotation percentages do not include those
identified as protein coding (see Supplementary File 3.1). Also, no consistent differences in
sequence annotation rates were noted for IVF or scNT embryos.
Figure 3.2 also shows the distribution of annotated sequence reads by sncRNA class. The
population of sncRNA in 2-cell and 8-cell embryos appears dominated by genomic tRNA, with
smaller populations of miRNA and genomic rRNA (Figure 3.2A). Later embryo stages – notably
blastocyst – had a greater fraction of sncRNA classified as miRNAs. However, this pattern was
highly variable among individual embryo pools. Interestingly, while genomic tRNA was a major
fraction of sncRNA in fibroblasts, miRNA appeared to dominate the population of sncRNA in
BDCs. Fairly strong class differences were evident for sequence reads >33 nt, with 2-cell, 8-cell
having high relative abundance of genomic tRNA and mitochondrial (mt)-RNA, whereas
snoRNA was relatively abundance in blastocysts and BDCs (Figure 3.2E-F).
Expression profiles of miRNAs in IVF and scNT embryos
After filtering out miRNAs with very low abundance reads across samples (<100 total
reads across all 48 samples), 382 miRNA species representing 71 miRNA families were detected.
Figure 3.3 shows overlap in miRNAs detected via sncRNA sequencing by developmental stage
for both IVF and scNT embryos. Over the course of early development, sizable subsets of
miRNAs were commonly expressed at proximal developmental stages (e.g., 230 miRNAs
detected in both 2-cell and 8-cell IVF embryos and 248 miRNAs detected in both morula and
blastocyst stage scNT embryos). However, at each stage, uniquely expressed miRNAs were also
identified (e.g., 390 miRNAs uniquely expressed in 2-cell scNT embryos that were not detected
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in 8-cell scNT embryos). Two exceptions were noted, where all of the miRNAs detected in
oocytes were also detected in 2-cell scNT embryos, and all of the miRNAs identified in 8-cell
scNT embryos were also present in 2-cell scNT embryos. A three-way Venn analysis was used to
compare the IVF and scNT type of each embryo stage with the oocyte and fibroblast sample to
visualize similarities and differences in sample types (Figure 3.3B). Interestingly, at the 2-cell
stage, the scNT embryo expressed all miRNAs that were present in the IVF 2-cell stage embryo,
the oocyte, and the fibroblast. The 2-cell stage pattern did not hold for 8-cell embryos, as this
developmental stage – and all subsequent stages – was typified by a pattern of some miRNAs
specific for scNT or IVF embryos. A fairly large fraction of miRNAs was shared by both embryo
types but not oocytes, and another fairly large pool of miRNAs were detected in oocytes and both
types of embryos. These trends were also evident for comparisons of embryo types to fibroblast
donor cells. Also, BDCs shared a larger fraction of their identified miRNAs with fibroblasts
(288) than oocytes (124) (Figure 3.3B). Last, BDCs originated from scNT embryos had fewer
unique miRNAs as compared to those derived from IVF embryos.
The sequence data were further examined to identify specific miRNAs differentially
expressed in any one-sample type, summarized in Table 3.1. Complete results for all differential
expression analyses by DESeq2 are provided in Supplementary File 3.3; Appendix H. First,
comparisons were made at each developmental stage between IVF and scNT embryos. Of note,
in early developing 2-cell and 8-cell embryos, no differentially expressed miRNAs were
identified, whereas six miRNAs were differentially expressed at the morula stage, including cattle
miRNAs miR-34a, miR-345-5p, and miR-2340-3p (14T®A) (Supplementary Figure 3.S1). In
contrast, substantial differences in miRNA expression were noted for BDCs obtained from either
IVF or scNT embryos, including 24 miRNAs annotated for cattle (Table 3.1).
Comparisons were also made by developmental stage for each embryo type (Table 3.1).
No significant differences in miR expression were noted when comparing oocytes to 2-cell
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embryos or 2-cell embryos to 8-cell embryos for either IVF or scNT embryo types. However, a
major shift was evident when comparing 8-cell to morula embryos, coincident with the EGA,
with 22 differentially expressed miRNAs identified in IVF (e.g., miR-450a and miR-320a) and 19
in scNT embryos (e.g., miR-302a-3p and miR-378), respectively (Table 3.1, Supplementary
Figure 3.S1). An additional 19 and 33 miRNAs were differentially expressed in cattle IVF (e.g.,
miR196a, miR-93-5p and miR-30c) and scNT embryos (e.g., miR-145-5p and miR-451),
respectively, when comparing morula to blastocyst stage embryos (Table 3.1, Supplementary
Figure 3.S1). Finally, extensive changes in expression of miRNAs were evident when comparing
blastocyst stage embryos to cells derived from those embryos, including 160 for IVF blastocysts
vs. BDCs and 201 scNT blastocysts vs. BDCs (Table 3.1, Supplementary File 3.3; Appendix H).
As expected for comparing differentiated and undifferentiated cells, sizable differences were
observed when comparing donor fibroblasts to 2-cell embryos, including 191 differentially
expressed miRNAs for IVF and 202 for scNT embryo types.
Principal components analysis of miRNA expression revealed clear grouping of data sets
by developmental stage, though with no obvious clustering that separated IVF and scNT embryos
(Figure 3.4A). Of note, fibroblasts and IVF morulae were not well clustered, indicating high
overall variability for those sample types. Also, while BDCs were apparently distinct from other
samples, their overall miRNA profiles were more variable as indicated by a greater spread along
the two principal components. An unsupervised, bidirectional hierarchical cluster analysis
(Euclidean distance method) of abundance data (VST normalized) for all miRNA samples
expressed show the same pattern of clustering primarily by embryonic stage without strong
segregation of IVF and scNT embryos (Figure 3.4B). Considering the miRNA expression
profiles, a clear separation was noted for nearly all BDC samples, which includes a set of
miRNAs expressed at markedly greater levels than all other sample types. Also evident in the
hierarchical cluster analysis are the distinct miRNA profiles for some isolated samples that
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clearly did not segregate with their counterparts, such as sample IDs IVF.BDC2, IVF.Mo.3 and
Fb.1.
Principal components and unsupervised, bi-directional hierarchical cluster analyses were
also performed for sequential comparisons of developmental stages for either IVF or scNT
embryos as well as pairwise comparisons for IVF vs. scNT at each stage (Supplementary Figures
3.S2 to S4). Distinct miRNA expression profiles were not evident when comparing oocytes to 2cell IVF embryos, nor when comparing 2-cell to 8-cell IVF embryos, whereas segregation by
developmental stage was evident for all other comparisons (Supplementary Figure 3.S2A). Even
so, high variability was evident across many sample types, particularly for the less abundant
miRNAs. Interestingly, PCA plots revealed some different patterns with broad variability for
miRNA profiles of 2-cell and morula staged IVF embryos, while profiles for oocytes, 8-cell and
blastocysts were highly similar (Supplementary Figure 3.S2B). For scNT embryos, samples
apparently separated earlier in development, as revealed by comparing 2-cell and 8-cell stages
(Supplementary Figure 3.S3A). Again, some variability among the profiles was evident, mostly
for those low-expressed miRNAs. Of interest, PCA revealed highly distinct miRNA profiles for
scNT embryos when comparing 8-cell to morula stages, morula to blastocyst stages, and
blastocysts to BDCs (Supplementary Figure 3.S3B). Last, comparisons at each stage revealed no
clear distinctions for miRNA profiles in IVF and scNT embryos at the 2-cell or 8-cell stages,
whereas clear separation was evident in morula and blastocyst embryos (Supplementary Figure
3.S4). Of note, miRNA expression profiles were highly consistent for BDCs generated from
either IVF or scNT embryos with no separation evident by hierarchical clustering or PCA.
Ontology analysis of predicted mRNA targets for differentially
expressed miRNAs in bovine IVF and scNT embryos
Results of biological process gene ontology analysis of TargetScan predicted gene targets
of differentially expressed miRNAs between separate stages are provided in the Supplementary
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File 3.4; Appendix I (TargetScan predicted mRNA targets) and Supplementary File 3.5;
Appendix J (results of Metascape analysis) and summarized in Figures 3.5 and 3.6. Note that the
heat maps represent the top 20 terms (clustered by kappa score for similarity) for each data set.
For mRNA targets of the three miRNAs differentially expressed in scNT embryos at the morula
stage, the top GO biological process terms included “lateral mesoderm development”, “negative
regulation of cellular component organization” and “establishment of protein localization of
organelles” as well as other terms associated with early development (Figure 3.5A). Results of
this ontology analysis were also represented as a Cytoscape network (Figure 3.5B), with each
cluster corresponding to a term shown in Figure 5A. This network shows that the pathways
associated with differentiation and development as central with other terms branch off into
smaller disconnected networks within their own terms. For mRNA targets of differentially
expressed miRNAs in BDCs obtained from scNT embryos, the top GO terms included
“regulation of protein kinase activity”, “tissue morphogenesis”, “embryonic morphogenesis”,
“regulation of mRNA metabolic process”, “regulation of growth”, “response to growth factor”,
and “Wnt signaling pathway”, as well as other GO terms related to differentiation, growth, and
development (Figure 3.6A). The Cytoscape network for these ontology results depicts
connections between clusters of terms related to morphogenesis, development and growth (Figure
3.6B). A second, unconnected cluster included metabolic processes of mRNA and proteins, and
several other pathways were represented by isolated sub networks, such as Wnt signaling
pathway.
Ontology analyses were also performed for sets of predicted mRNA targets of miRNAs
identified as differentially expressed by developmental stage, including 8-cell vs. morula and
morula vs. blastocyst in IVF embryos (Supplementary Figure 3.S5) or scNT embryos
(Supplementary Figure 3.S6). The enriched terms for differences by type in morula stage
embryos included terms related to basic cell functions that would be important during morula
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development, including “cellular migration and growth”, “tissue development”, “changes in
protein localization and stabilization”, “cellular component organization”, “organelle
organization”, and “cytoskeleton organization”. The differences in scNT and IVF BDC cells
included terms that more directly seemed to relate to early development, including “regulation of
growth”, “Wnt signaling pathway”, and terms related to morphogenesis and differentiation.
These are very similar terms to what was seen in enriched terms within type, between the stages
of morula to blastocyst. The morula to blastocyst stage embryo transition looked similar between
IVF and scNT type embryos, with enriched terms including “response to growth factor”, “Wnt
signaling pathways”, “negative regulation of cell differentiation”, and over half enriched terms
relating to morphogenesis, differentiation, or system development. There were some differences
between the 8-cell to morula transition between IVF and scNT embryos, most notably the scNT
embryos lacked the “Wnt signaling pathway”, although it is possible that since this term shows up
in the scNT morula to blastocyst stage transition, late induction of the miRNAs participating in
this pathway occurred.
Expression of tRNA fragments in bovine IVF and scNT samples
Transfer RNA fragments (tRFs) showed a similar pattern for differential expression as
miRNAs; with no significantly different tRFs expressed between IVF and scNT type embryos at
the 2-cell, 8-cell, blastocyst stage, or BDC samples (Table 3.2; Supplementary File 3.3; Appendix
H). However, at the morula stage, four tRFs were identified as significantly different when
comparing IVF and scNT embryos. Notably more tRFs were differentially expressed when
sequentially comparing developmental stages of IVF embryos, ranging from 3 altered tRFs
comparing oocytes to 2-cell embryos to 26 altered tRFs comparing morulae to blastocysts (Table
3.2). When comparing IVF embryos to more differentiated cells, more substantial differences
were observed as 192 tRFs were noted as significantly different between the blastocyst stage
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embryos and BDCs and 379 tRFs were different between fibroblasts and 2-cell staged embryos.
Alternatively, no differentially expressed tRFs were noted for early developing scNT embryos,
only 21 tRFs were altered for 8-cell vs. morula and a large set of 139 tRFs were differentially
expressed in morula vs. blastocyst scNT embryos. When comparing scNT embryos to more
differentiated cells, similar numbers to those observed in IVF type were apparent, with 129 tRFs
significantly different between the blastocyst staged embryos and BDCs, and 393 tRFs different
between fibroblasts and 2-cell staged embryos. Interestingly, the number of predicted active
tRNA genes in cattle is 439 [89]. Moreover, differential tRNA gene expression leads to changes
in abundance of tRFs rather than mature tRNAs [90]. As each tRNA may generate multiple tRFs
based on the cleavage location, one would expect to detect a sizable population of tRFs by
sequencing [91].
Expression profiles of tRFs in IVF and scNT embryos, oocytes, and donor cell fibroblast
were also examined by PCA and hierarchical clustering. As was noted for miRNAs, the profiles
of tRFs appeared to group more closely by embryonic stage, with oocytes, 2-cell and 8-cell
embryos clustered near each other (Figure 3.7A). Most morula samples were intermediate,
between 8-cell and blastocyst embryos, though two samples appeared to cluster closely with
BDCs. Of note, IVF and scNT embryos were not segregated, even within developmental stage.
These observations were confirmed in the hierarchical clustering of samples, which revealed
distinct tRF profiles for blastocysts, BDCs and fibroblasts separated from earlier developmental
stages including oocytes, 2-cell, 8-cell and most morula embryos (Figure 3.7B).
Expression of piwi-like RNAs in bovine IVF and scNT samples
In addition to miRNA analysis, the RNAseq data were mined to examine expression of
additional sncRNA classes, specifically piwi-interacting RNA (piRNA). Putative “piwi-like”, or
pilRNAs, were identified as sncRNAs 24-32 nt in length with a classic ping-pong signature and
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1U bias (Supplementary Figure 3.S7) and that were mapped to pilRNA-producing loci in the
bovine genome. As shown in Figure 3.8A, pilRNAs accounted for only 0.1%, 0.02% and 0.02%
of sequence reads from fibroblasts, and IVF BDCs, or scNT BDCs – all somatic cell types. A
much greater fraction of sncRNA was identified as pilRNAs in oocytes (47%), 2-cell embryos
(59%), and 8-cell embryos (48%), with no clear distinctions between IVF and scNT embryos; a
substantial portion of these reads were mapped to piRNA clusters (Figure 3.8B). Interestingly,
post-EGA, a substantial decrease in pilRNAs was noted for morula and blastocyst embryos (4%
or 2%, respectively), with a small fraction mapped to piRNA clusters and overall fewer piRNA
clusters identified in these sample types. Secondary piRNA biogenesis occurs via the “pingpong” amplification cycle, which can be detected as a 5’ to 5’ 10 nt overlap. The ping-pong
signature was detected in all embryo sample types as shown in Supplementary Figure 3.S6, with
lower peaks in the blastocyst stage embryos; no signature was detected in the somatic fibroblast
or BDC samples.
The pattern of differential expression between IVF and scNT embryos occurring only at
the morula stage embryo was maintained in pilRNA, with four significantly different pilRNAs
identified at the morula stage embryo, 10 in BDC samples, and 0 at any other stage (Table 3.3,
Supplementary File 3.3; Appendix H). When examining piRNA expression by developmental
stage, many more differentially expressed piRNAs were noted, such as 49 altered piRNAs when
comparing 8-cell to morula or 70 when comparing morula to blastocyst stages. Also, 24 piRNAs
were differentially expressed between 8-cell and morula scNT embryos but were not different
when comparing morula to blastocysts. Similar differences were seen between scNT and IVF 2cell embryos and fibroblasts, at 4,672 and 4,586 differentially expressed piRNA respectively.
These high differences are expected, as early embryos require high piRNA expression and
differentiated fibroblasts should have no piRNA expression. However, there was high disparity
in the differences between blastocyst stage embryos and BDC for IVF and scNT types, at 1,766
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and 717 differentially expressed piRNAs respectively. These differences do suggest some
aberrant piRNA reprogramming in scNT embryos, which may be too variable for statistical
significance when directly comparing IVF and scNT within stage.
PCA of pilRNA expression revealed a similar pattern of sample segregation as was noted
for other sncRNA classes, with clusters evident by developmental stage (Figure 3.9A). The tight
clustering in the PCA plot indicates fairly consistent pilRNA expression for sample types, which
was also evident in the hierarchical cluster analysis (Figure 3.9B). Expression profiles for
pilRNAs were markedly different by developmental stage, with exceedingly low expression in
differentiated cell types (fibroblasts and BDCs), high expression in early developmental stages
(most 2-cell and some 8-cell embryos) and oocytes, and more moderate expression in some 8-cell
embryos, morulae and blastocysts. No clear separation by IVF or scNT sample type was apparent
in the hierarchical cluster heat map. As for other sncRNAs, two IVF morula staged embryos
clustered separately from the other samples in their stage. Interestingly, we noted that morula
embryos exhibited more variable expression and less tight clustering for all the sncRNA classes
examined, including miRNAs, piRNAs, and tRFs.
Primary piRNAs are transcribed from the dense loci that are located in specific clusters in
the genome. Supplementary Figure 3.S8 depicts the total number of pilRNAs mapped to each
cattle chromosome. Using a weighted proTRAC cluster analysis, the somatic cellular samples
(fibroblast cells and BDCs) were typified by very few clusters that were only expressed in a few
loci in the cattle genome (Figures 3.10-11). The oocyte samples were typified by broad
expression of piRNA clusters across the genome, as were both IVF and scNT 2-cell staged
embryos and IVF and scNT 8-cell staged embryos (Figure 3.10). The IVF morula staged
embryos were typified by few piRNA clusters, and the scNT morula staged embryos were
typified with cluster expression falling between the 8-cell staged embryos and the IVF morula
staged embryos with broader cluster expression then the IVF counterpart (Figure 3.11). Both IVF
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and scNT blastocyst staged embryos were typified by a similar low cluster expression as
compared to early embryos, but with the IVF counterpart demonstrating higher cluster expression
(Figure 3.11).
Potential target transcripts of candidate pilRNAs were identified by mapping sequences
to bovine TEs annotated by RepeatMasker (Supplementary File 3.6; Appendix K). Figure 3.12
depicts mapping of sequence reads to the most targeted TEs in the cattle genome. We noted
relatively high numbers of sequence reads mapped to TEs in oocytes, 2- and 8-cell embryos in
both IVF and scNT sample types (Figure 3.12). Also, there appeared to be a notable increase in
reads mapped to 2-cells of scNT embryos as compared to oocytes. Coincident with the EGA,
reads mapped to TEs markedly decreased across all TEs for both IVF and scNT embryos.
Interestingly, no reads mapped to TE in BDCs obtained from IVF embryos (Figure 3.12A), which
contrasted with a modest number of reads that mapped to TEs in scNT embryos, most notably for
RTE-BovB, L1, ERVK and TcMar-Tigger elements (Figure 3.12B).
Discussion
This study is the first to employ a discovery-based, small RNA sequencing approach to
determine the differences in sncRNA profiles for cattle embryos produced by IVF or scNT. In
addition, small quantities of biological sample were successfully utilized for sncRNA sequencing,
demonstrating the possibilities of utilizing these discovery-based approaches with the production
of reasonable numbers of scNT embryos. Previously, we employed RNAseq in IVF embryos and
reported that the MET was associated with major shifts in relative abundance of several classes of
sncRNA, including miRNA, piRNA, tRFs and snoRNA. In the present study, we anticipated that
sncRNA sequencing of scNT embryos would reveal marked differences in profiles of these
sncRNAs as compared to those produced by IVF, particularly at the activation of the embryonic
genome, and that such changes may explain the higher rate of developmental failure for scNT
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embryos. By virtue of their function in RNAi, aberrant expression of miRNA or tRFs could lead
to aberrant control of gene expression – such as failure to degrade maternal transcripts during the
MET – and ultimately lead to poor embryonic development. However, in this study, we
identified few significant differences in expression of miRNA or tRFs when comparing
expression profiles of IVF and scNT embryos. PCA and hierarchical clustering analyses showed
that the overall profiles of sncRNAs were not markedly different for IVF and scNT embryos for
any particular developmental stage, though clear distinctions were apparent when developmental
stages were compared sequentially after the EGA. Moreover, we noted that sncRNA profiles
were markedly variable within sample types, particularly for sncRNAs expressed at low to
moderate levels.
By virtue of their diverse array of transcript targets, miRNAs influence many cellular
functions and are known to be important in the process of tissue differentiation. In this study,
abundance of miRNAs was relatively low in oocytes and embryos prior to the MET (2-cell),
whereas expression of miRNAs increased substantially post-EGA in morula and blastocyst
embryos. Moreover, we also noted that reads of approximately 60 to 80 nt in length were
increased in BDCs (and to a lesser extent in blastocysts), but not fibroblast donor cells. These
read lengths correspond to snoRNAs (70 to 90 nt) and tRNAs (76 to 90 nt), which may be
important for early steps in cell differentiation.
As RNAseq allows for an unbiased assessment of the entire population of miRNA, our
analysis afforded the opportunity to address two questions: What miRNAs are expressed in a
sample? and Are those miRNAs differentially expressed when comparing specific sample types?
Of the several hundred-miRNA molecules identified, we were intrigued to note that all of those
expressed in oocytes were also present in scNT 2-cell embryos. Also, all miRNAs expressed in 8cell embryos were also expressed in early developing scNT 2-cell embryos. However, for IVF
embryos, the pattern was notably different, with oocytes and 8-cell embryos having 76 or 153
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unique miRNAs, respectively, which were not common to 2-cell embryos. One would expect the
2-cell scNT embryo to harbor more miRNAs, as those cells would still contain miRNAs from the
donor fibroblast cell and the oocyte. However, further comparison of scNT 2-cell embryos to
fibroblast cells or oocytes with stage-matched IVF embryos show that the scNT 2-cell embryos
express all of the miRNAs that were identified in fibroblasts, oocytes and IVF embryos. The lack
of a distinct population of miRNA molecules for IVF 2-cell embryos not expressed in fibroblasts,
oocytes or scNT 2-cell embryos was surprising, as sperm sncRNA contributions would have been
expected to be a unique population within the IVF 2-cell embryo [92]. However, at onset of the
EGA and activation of the embryonic genome, unique sets of miRNAs were apparent for IVF 8cell embryos, as well as their scNT counterparts, a trend that continued through the remainder of
development. Also of note, post EGA, the scNT embryos did not share an outsized fraction of
their miRNA pool with fibroblasts as compared to the IVF embryos. Had the donor cell miRNA
population persisted through development of scNT embryos, then one might expect a markedly
greater fraction of miRNAs to be shared with fibroblasts in scNT embryos than IVF embryos.
The greatest difference was noted at the blastocyst stage, with 71 miRNA molecules shared
between scNT blastocysts and fibroblasts as compared to 52 shared between IVF embryos and
fibroblasts.
Expression of miRNAs miR-2340, miR-345-5p, and miR-34a was significantly lower in
scNT morula stage cattle embryos, the only stage for which differences in miRNA expression
between scNT and IVF embryos was observed. However, it is worth noting that while statistical
significance was reached for these three miRNAs at the morula stage, the morula stage was the
most highly variable of the sample types. Future functional validation by over-expression in IVF
embryos and blocking expression in scNT embryos may provide confirmation of their importance
in embryonic development. Ontology analyses for predicted target genes of these three miRNAs
indicate functions to regulate cell proliferation, stabilize proteins, and regulate development of
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several types of tissues. MiR-2340 has no known homologues to its seed sequence in any species
as reported in MirBase, and thus may be unique to cattle. However, miR-2340 has been reported
to be a miRNA present in bovine oocytes, and is differentially expressed through oocyte
maturation [93]. While the function of miR-2340 in bovine embryos is not known, it is a
predicted target of two circular RNA (circRNA) that were observed as abnormally expressed in
bovine scNT placentas, specifically bta_circ_0006612 and bta_circ_0026700 [94]. CircRNAs
sequester miRNAs like a sponge, and thus function as competitive inhibitors that suppress
binding of miRNAs to their mRNA targets. Although this RNAseq analysis did not capture
circRNA sequences, one might speculate that up regulation of these specific circRNAs in scNT
embryos could be linked to lower expression of miR-2340.
The other two differentially expressed miRNAs, miR-34a and miR-345-5p, both have
homologues in mice and humans, which allows for some inference on their possible functions in
cattle based on available evidence from literature on other mammalian embryonic developmental
models. MiR-34a may contribute to folliculogenesis and the ovarian cycle, as this miRNA is
expressed in bovine granulosa cells and its over expression in human granulosa cells inhibits
estradiol release [95]. In pig ovaries, miR-34a was found to target the Inhibin beta B gene,
promoting granulosa cell apoptosis [96]. In bovine corpus luteum, miR-34a modulated luteal
formation and function through regulation of cell proliferation and progesterone production
pathways [97]. In addition to regulating oocyte development via influencing follicular
development, miR-34a may also contribute more directly to early development of the embryo and
acquisition of pluripotency. MiR-34a is present in bovine spermatozoa at low levels, as well as
higher levels in oocytes and 2-cell cleaved embryos [98]. Because miR-34a is stably expressed in
developing oocytes and through preimplantation development embryos, Tscherner and colleagues
speculated that this miRNA may be functionally active during that developmental window, or that
a reservoir of miR-34a may be needed in later embryonic stages. However, this group did not
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measure miR-34a expression beyond embryonic cleavage [98]. In our study, miR-34a expression
was generally low in MII oocytes as well as IVF and scNT 2-cell and 8-cell embryos, though a
notable increase in expression was observed at the morula stage for IVF embryos compared to
their stage matched scNT counterparts. For both embryo types, expression was increased in
blastocysts and BDCs compared to the earlier development stages. Reports in other species point
to miR-34a contributing to pluripotency and cell differentiation. For example, Choi et al. reported
that miR-34a suppressed the transcription factor GATA2 in mouse pluripotent stem cells and
restricted developmental potential. Knockout of miR-34a allows generation of both embryonic
and extra-embryonic lineages from pluripotent stem cells, expanding their developmental
potential [99]. Furthermore, members of the miR-34 miRNA family are direct transcriptional
targets of the tumor suppressor protein p53, and thus are critical mediators of p53-mediated
control of genome reprogramming [100]. Suppression of reprogramming by miR-34a has been
partially attributed to its targeting and suppression of key pluripotency factors Nanog, Sox2 and
Myc. Thus, elevated expression of miR-34a, as was noted in bovine BDCs in this study, may
facilitate early stages of differentiation by turning off these pluripotency signals. Studies of
cancer cell models can provide useful insight on the function of miRNAs, as many pathways
dysregulated in cancer are those also critical for early development. In thyroid cancer, miR-34a
works with the long non-coding RNA (lncRNA) XIST to modulate cell proliferation and tumor
growth, as XIST serves as a competing endogenous RNA (ceRNA) for miR-34a [101]. The
tumor suppressor protein P53 is frequently mutated in human cancers, and regulates miRNAs
including the miR-34 family at high prevalence. MiR-34a is suppressed in many cancers
suggesting that this miRNA may act as a tumor suppressor for many molecular pathways under
normal conditions [102]. Overall, miR-34a function in diverse pathways in both cancer pathways
and pluripotency, and in-depth investigation to possible functions in early development is
warranted.
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While a review of the available literature does not provide evidence for miR-345 having a
critical regulatory role in early development, this miRNA has been detected in some tissues of
importance for development. In human embryos, miR-345 was differentially expressed in
euploid embryos as compared to aneuploid embryos [103] and was also detected in a
mesenchymal stem cell (or a multipotent stromal cell) line derived from human embryonic stem
cells [104]. Interestingly, hsa-miR-345-5p is differentially expressed in the tongues of people
affected by Beck-Wiedemann syndrome (BWS). BWS is a human disease that is notably similar
to large offspring syndrome (LOS) in cattle, and LOS occurs at higher frequency in scNTproduced calves [105]. Although the function of miR-345-5p in early development is not known,
studies in various cancer cell lines point to its importance in regulating cell behavior. For
example, in human non-small cell lung cancer cells, a recent report showed than miR-345
suppressed cell invasion and migration by targeting and down-regulating the oncogenic
transcriptional co-activator Yap1 [106]. Also, expression of miR-345 was also suppressed in
pancreatic cancer, and over-expression of miR-345 leads to increased apoptosis through targeting
of Bcl2 [107]. In colorectal cancer, miR-345 is sensitive to methylation-dependent regulation and
modulates cell proliferation and invasion through targeting the anti-apoptosis protein Bag3 [108].
ScNT embryos have been observed to maintain a higher level of genome wide methylation levels
than their IVF counterparts, and de novo DNA methylation begins earlier in development [8, 53].
If miR-345 is regulated via DNA methylation, aberrant expression in scNT embryos may be due
to aberrant methylation marks in scNT embryos. The function of miR-345-5p in the development
early embryonic cells in unknown, and the difference in expression pattern between scNT and
IVF morula staged embryos warrants further study to explore any potential mechanism of action.
In this study, we also explored sncRNA profiles for BDCs and identified a substantial set
of 24 differentially expressed cattle miRNAs for BDCs generated from scNT embryos as
compared to those obtained from IVF embryos. Interestingly, the mRNA targets of those
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differentially expressed miRNAs were associated with biological processes directly related to
embryo development and growth as well as protein and mRNA metabolic processes. That BDCs
from IVF and scNT embryos harbored distinct differences in miRNA profiles whereas IVF and
scNT blastocysts did not was an important observation. It is also likely that only those embryos
with a normal profile of sncRNAs would progress to the blastocyst developmental stage, and
those embryos harboring abnormal profiles would arrest prematurely. As such, the profiles of
sncRNA for scNT blastocysts likely reflect those embryos that survived the developmental
challenge of the MET and, thus, were more similar to their IVF counterparts.
Thus, it was interesting to note that many sncRNAs were differentially expressed in BDCs from
those scNT embryos that did survive to the blastocyst stage, suggesting that subtle aberrations at
the blastocyst stage may have been amplified through prolonged culture or may have appeared as
differentiation progressed. Also of note, the biological processes associated with predicted
mRNA targets of differentially expressed miRNAs in BDCs were more directly connected to
embryonic development and cell differentiation than were the terms for mRNA targets of the
three differentially expressed miRNAs identified in morula stage embryos.
Other researchers have identified aberrant patterns of miRNA expression associated with
cloning, such as dysregulation of miRNAs in placental tissues from scNT pregnancies [57] or
dysregulation of epigenetic reprogramming controlling miRNA expression in blastocyst scNT
embryos [58]. Both of these studies used a targeted microarray approach that may not have
captured all miRNAs of developmental importance. By employing an RNAseq, discovery-based
approach, we expected to capture the full repertoire of miRNAs expressed in early developing
embryos, and those differentially expressed in clones compared to IVF controls. Although
hundreds of cattle miRNAs were sequenced in this study, very few miRNAs were identified as
differentially expressed in scNT embryos compared to their stage-matched IVF counterparts and
widespread differences were not apparent. Underlying the overarching hypothesis is the
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presumption that errors in genome programming that ultimately control miRNA expression –
particularly through the MET – would follow a pattern that could be discerned through statistical
evaluation of the sequencing data. However, the alternative hypothesis is that such errors are, in
fact, random in nature leading to high variability in genomic reprogramming of scNT embryos.
Moreover, the process of collecting embryo samples could introduce some biologically based
bias, as only competent embryos can progress through each developmental stage. Those scNT
embryos harboring extensive aberrations may undergo developmental arrest or degrade, and thus,
not be included in the later developmental stages. In addition, embryo samples were pooled to
produce sufficient biological material, which could mask individual variability or outliers. To
tackle the issue of biological variability and attempt to address the alternative hypothesis, future
studies could attempt single cell or single embryo RNA sequencing to build libraries from a very
small number of cells.
In addition to the comparisons between IVF and scNT embryos at each stage of
development, we also examined patterns of miRNA expression over the course of embryo
development for IVF and scNT embryos separately to understand the dynamics of miRNA
expression in context of embryonic gene activation. First, no significant differences in miRNA
expression were apparent for either IVF or scNT embryos when comparing oocytes to the 2-cell
stage or the 2-cell to the 8-cell developmental stage, suggesting that the population of miRNAs
was generally stable up to the onset of the EGA. In IVF embryos, the transition from 8-cell to
morula stage embryos was associated with significant differences in the expression of 22 cattle
miRNAs, including the same miRNAs discussed above that were differentially expressed in IVF
and scNT morulae (miR-2340, miR-345-5p, and miR-34a). Other significantly different miRNAs
associated with the EGA included miR-93-5p, miR-320a, miR-378, and miR-450a. Interestingly,
miR-320 has been found to be DGCR8-independent in mouse embryonic stem cells [109], and is
thought to be important for development and embryo quality in mice and humans [110]. MiR-
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320 was also observed as highly expressed in cattle oocytes as well as female bovine embryos
[47, 111]. Evidence from studies in cancer cells indicates that miR-320a functions to downregulate the Wnt signaling pathway [112]. Similar activity in embryos could markedly impact
early embryo development, given the importance of Wnt signaling. MiR-378c may target the
transcript Nodal to promote survival and migration of trophoblast cells [113]. In mice, miR-450a
has been shown to regulate early development through the targeting of BUB1 to repress cell
proliferation [113]. The miR-17 family includes miR-93-5p, which was shown to be expressed
during early development and to regulate STAT3, a known embryonic stem cell regulator [114].
Thus, miR-93-5p expression may influence pluripotency.
In scNT embryos, the transition from 8-cell to the morula stage was associated with
differential expression of 19 cattle miRNAs, excluding three that were regulated in IVF embryos
(miR-2340, miR-345-5p, and miR-34a). Of those differentially expressed miRNAs in scNT
morulae, miR-302 and miR-7 are known to be important in development. MiR-7 is expressed in
the small intestine of bovine fetuses and modulates the development of the gastrointestinal tract
[115]. Bick et al. determined that miR-7 was enriched in porcine blastocysts [116], while others
showed that miR-7 was involved in trophoblast differentiation in mice [117]. MiR-302 is a
bovine and human orthologue to the zebrafish miR-427, which was responsible for degrading
hundreds of maternal transcripts during the MZT [118]. Also, miR-302 has been shown to target
Akt1, which maintains high levels of Oct4 and, therefore, improves self-renewal and pluripotency
in humans [119]. These roles in pluripotency pathways would be vital in early embryo
development, and miR-302 knock-out (in conjunction with miR-290) in mice silences naïve
pluripotency [120].
In IVF embryos, the transition from morula to blastocyst was associated with changes in
19 cattle miRNAs. This set includes miR-2340 and miR-345-5p, which were apparently
decreased at the blastocyst stage, suggesting that these miRNAs may have a specific function
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associated with the morula developmental stage. Other notable miRNAs differentially expressed
over the transition from morula to blastocyst included miR-196a and miR30c/e/f. Tripurani and
colleagues observed maximal expression of miR-196a at the 4-8 cell developmental stage in
cattle embryos [51]. They also noted that miR-196a bound to the Nobox transcript, which must
be degraded prior to the MET. In this study, miR-196a expression was elevated at the blastocyst
stage compared to earlier developmental stages, including 2-cell and 8-cell embryos, an
observation that suggests this miRNA may have a secondary function in embryo development
aside from degrading maternal effect genes. Lin et al. [121] showed that miR-30c was secreted
from bovine embryos, more so from slow cleaving embryos, suggesting this miRNA may serve as
a biomarker of developmental competence. Moreover, a recent review by Mao et al. [122]
highlights the important regulatory functions of miR-30 family members in tissue and organ
development and disease pathogenesis, pointing to the importance of this miRNA family
throughout life.
In scNT embryos, the transition from morula to blastocyst developmental stage was
associated with changes in 33 cattle miRNAs, including miR-34a, which was not different for this
transition in IVF embryos. This set of miRNAs includes miR-106b, miR-15a, miR-145-5p and
miR-451. Interestingly, miR-451 is a miRNA that can mature independent of Dicer, and instead
is cleaved directly by Ago2 [123], and bovine miR-451 can be measured in circulation to identify
early pregnancy [124] as early as day 8 of pregnancy. In mice, miR-451 modulates implantation
[125], and impacts cell fate in mouse embryonic stem cells [126]. MiR-145 influences the
attachment of embryos in mice [127] and also helps regulate initiation, development, and
maintenance of mouse primordial follicles [128]. MiR-145 also targets Lif in bovine granulosa
cells in the follicle, and controls proliferation of primordial follicles through targeting Acvr1b
[128]. Lif plays multiple important roles in implantation, including decidualization, blastocyst
growth, and development. Thus, targeting of Lif by miR-145 in early development may interfere
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with pregnancy [129]. MiR-145 was also found to be most highly expressed in 8-cell staged
bovine embryos, with relatively lower expression in pre and post MET [128]. In contrast, in our
study, miR-145-5p expression was greatest in morula IVF embryos compared to earlier stages or
blastocysts, whereas expression of miR-145-5p was relatively constant from the 2-cell to morula
stages in scNT embryos with a decline in blastocysts. The miR-17 family includes miR-106b,
which regulates Stat3, a known embryonic stem cell regulator, and thus this miRNA molecule
may influence pluripotency in early development [114]. By targeting transcripts of the proapoptotic gene Bcl2, miR-15 regulates apoptosis in cancer cells [130]. In mouse ESCs, miR-15
also has been shown to control the cell cycle through targeting KLF4, which causes downregulation of CYCLIN E.
During early development, the parental epigenome must be reprogrammed for the reestablishment of cellular potency, and the required removal of epigenetic silencing marks can
then make the embryo susceptible to TE activation. If in scNT embryos the process of piRNA
activation is delayed or reduced, scNT embryos may become vulnerable to TE activation, reduced
genomic integrity, and impaired viability [35]. In addition, the expression of more than 50% of
the genome in mammals is controlled by DNA methylation or repressive chromatin marks, and
releasing the TEs from these constraints could allow mobilization of these TEs [131]. However,
because TEs are also required in a developmental context, complete silencing would be
detrimental to the developing embryo. Researchers have shown that there is some functional
requirement for TE expression during early development in mice. For example, suppression of
L1 ORF1 increases the rate of embryo arrest [132], and MuERV-L knockout causes embryo
arrest at the 4-cell stage [133]. Also, LINE1 expression is required for early embryogenesis, but
then must be silenced by the blastocyst stage for successful development [134]. Bui et al. [33]
employed a cDNA array to compare transcripts in normal IVF and scNT embryos during the
MTZ and compared those profiles to donor cells. They found that LTR retrotransposons and
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mitochondrial transcripts up-regulated and ribosomal proteins were down regulated [33],
suggesting that specific categories of transcripts were impacted during somatic reprograming
which likely affected the viability of scNT embryos.
In this study, while four pilRNAs were identified as differentially expressed in scNT
morula embryos compared to their IVF counterparts, large scale differences in embryo types were
not evident for this class of sncRNA. It is interesting to note, however, that this developmental
stage just following the EGA in cattle was associated with the most differentially expressed
sncRNAs, including miRNAs, tRFs, and pilRNAs and tRFs. Also of note, greater fractions of
pilRNAs were mapped to clusters in scNT 8-cell embryos. If piRNAs are aberrantly highly
expressed at the MET, it is possible that they are repressing TEs that are necessary for early
development and successful EGA. We also noted variation in the ping-pong signature for IVF
and scNT embryos, with an apparent increase in the number of sequence reads containing a
strong ping-pong signature for scNT 2-cell embryos as compared to IVF. Indeed, the ping-pong
signature for 2-cell scNT embryos was much more like that of the later 8-cell stage, for which the
signature was consistent for IVF and scNT embryos. Because the ping-pong signature typifies
piRNAs generated via the ping-pong pathway that are destined to target active transposon
sequences, the difference in the relative abundance of sequences with this signature at the 2-cell
stage suggests the possible early activation of TEs in scNT embryos. Another possibility would
be differing sncRNA in scNT embryos from the nuclear donor could create a ping-pong cascade
in the early embryo, but this pattern was not evident in our differential expression analyses.
As with other sncRNA classes, much more pronounced differences were noted when
comparing populations of pilRNAs across developmental stages. Remarkably, pilRNA
expression was more consistent within stage and much more distinct among stages than was
noted for miRNA or tRFs. The observation of extreme changes in piRNA expression as a
function of embryonic development aligns with the putative role for piRNA protection of the
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genome during periods of remodeling. High expression of piRNAs would be required in oocytes
and early embryos up to the 8-cell stage coincident with the EGA, and expression would decline
as cells differentiated and virtually disappear in more differentiated cell types, such as the BDCs
and fibroblasts. In agreement with this model, we observed much higher fraction of reads that
were potential pilRNAs in 2-cell and 8-cell stage embryos, with significant loss of pilRNAs at the
morula stage, even fewer at the blastocyst stage, and none in BDCs or fibroblasts. A very similar
pattern was seen for the number of piRNA clusters, as well as the location of clusters transcribed
from different bovine chromosomes, with high numbers and locations of clusters observed in preMET embryos, a decrease at the morula and blastocyst stages, and ultimately very few noted in
BDCs and fibroblasts. Given the persistent expression of some pilRNAs through the morula
stage, it is possible that these may continue to function beyond the completion of the MET to
constrain activity of TEs that function later in development, such as the differentiation of
trophoblast cells [135], or may be involved in other essential functions, such as renewal of
germline stem cells and support of self-renewal and differentiation [136].
While the PIWI pathway has been clearly identified as a mechanism for controlling
endogenous transposable elements during genomic remodeling periods, some recent research has
implicated the PIWI pathway in the regulation of mRNA transcripts. PiRNAs are known to be
involved in spermatogenesis, but a unique pool of pilRNAs was found to be present in oocytes
and zygotes that appear to have the potential for endogenous gene expression regulation in a
similar manner to miRNA RNAi pathways [35]. Russell et al. found that piRNAs that were
present in the bovine zygote were sequentially complementary to mRNA destined for turnover in
the early bovine embryo. Our results support the hypothesis that pilRNAs are deposited during
oogenesis and remain in the early embryo to regulate TEs that arise during embryonic
reprogramming. Our data suggests that the pilRNA pathway may participate in TE repression
during the MET, as the pilRNA populations in 8-cell stage were associated with a very high ping-
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pong signature, suggesting activation of TEs and associated activation of targeting piRNA.
Interestingly, when the magnitude of change between pilRNA and predicted target mRNA were
analyzed by Russell et al, there was low correlation between the magnitude of change and the
number of targeting pilRNAs, similar to what we observed with miRNA [35].
Our results did not completely match past bovine embryo piRNA data, although there
were patterns of similarity. For example, Russell et al found that the highest pilRNA expression
was noted for clusters on chromosomes 6, 14, 17, and 23 in immature oocytes [35]. While we
only sampled mature oocytes, higher expression for pilRNAs were noted for clusters on
chromosomes 6, 14, 17 and 23, although not to the same extent seen previously. Interestingly, we
noted that scNT morulae tended to have many more pilRNAs mapped to these clusters on
chromosomes 6, 17 and 23 compared to their IVF counterparts. While some differences in
patterns of pilRNA clusters were noted for some chromosomes at other stages, the consistency of
the pattern in scNT morula staged embryos across the bovine genome seems likely to be of
functional importance. It appears that in IVF embryos, piRNA expression before and during the
MET is high, as the genome is reprogrammed. The scNT embryos appear to maintain aberrantly
high levels of piRNA after the EGA at these loci, which could be the result of aberrant
reprogramming during the MET or could be attributed to faulty control of piRNA expression and
may act as a stress response. Based on these data, one may hypothesize that these persistently
expressed piRNAs may interfere with the normal role of TEs in early development, thus
contributing to low efficiency of scNT embryo production.
When examining the dynamic expression of sncRNA for IVF embryos over the course of
early embryo development, we noticed more variability among samples in the present study than
was observed in our prior work on IVF 8-cell and blastocysts embryos and oocytes [45]. These
differences may be explained by some methodological differences in generation and culture of
the embryos. First, although both studies utilized the same semen source for IVF, in the present
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study, oocytes were collected from various cattle breeds at differing ages and originating from
multiple locations at the local abattoir over the course of two years, as opposed to a short threeweek period for the 2019 report. It is possible that the longer time frame required to generate the
much greater number of embryos for this study introduced some variability. However, these
embryos were carefully allocated to sample pools so that each pool included embryos from a
minimum of 3 cloning sessions spread across the entire collection period. Another difference was
the number of embryos allocated to each sample pool, 20 in this study compared to 40 in the 2019
report. Importantly, embryos for this study were cultured in SOFaa medium with oil-covered
medium droplets on top of a cumulus cell feeder layer to improve development, whereas the 2019
study used Charles Rosenkrans 2 medium (CR2) with no oil and no cumulus cells. While group
culture was utilized in both studies, the embryos were cultured in a smaller volume of medium in
the present study. Thus, secreted factors, such as miRNA or growth factors, would have been at a
much higher concentration in the cell culture media, potentially impacting variability of those
embryos in a greater manner than occurred in the previous study. These secreted factors have
been shown to impact development rates [137]. Moreover, cumulus cells in cattle express highly
variable populations of miRNAs, which may impact embryo development, although they do not
appear to affect oocyte quality [138, 139]. It is possible that the use of cumulus cells as feeder
cells to support embryo development introduced an element of variability that was manifest in the
sncRNA profiles of the cultured embryos. Last, we did note variability in sncRNA profiles
among the fibroblast samples that was unexpected, given that all samples were from the same cell
line at similar passage number (5 to 7). The aim of this study was to quantify known sncRNA
rather than to identify novel sncRNAs in the bovine cattle embryo. However, it should be noted
that, there appeared to be a population of reads that did not align to known sncRNAs especially in
embryo samples. It is possible that these reads represent novel sncRNAs, which may be explored
in future work.
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In conclusion, results of this discovery-based sncRNA sequencing analysis of early
developing embryos revealed largely similar profiles of sncRNAs for IVF and scNT embryos at
the 2-cell, 8-cell, morula and blastocyst stage of development. Alternatively, clear distinctions
were apparent when comparing sncRNA profiles by developmental stage that largely
corresponded to a pre-MET phase, post-MET phase and cultured cells with some degree of
differentiation. SncRNAs are known to be important regulators of pluripotency and
differentiation of tissues. However, their specific functions in mediating the MET in mammalian
early development remains unclear. Our team is the first to examine the dynamics of sncRNA
populations through the MET in both scNT and IVF embryos. Further research will be necessary
to assess the function of those miRNAs identified as differentially expressed in scNT embryos as
compared to their IVF counterparts, or those miRNAs identified as differentially regulated over
the course of embryo development. Furthermore, by exploring changes in the transcriptome
coincident with dynamic miRNA expression, we may gain additional insight into the function of
miRNAs in early embryonic development.
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Figure 3.3. Overlap in detection of all mapped miRNAs in bovine oocytes and donor fibroblast
cells as well as early developing embryos and blastocyst-derived cells generated via IVF or scNT.
Proportional Venn diagrams depicting miRNAs mapped to the Bos taurus miR database,
including unique and overlapping IDs. (A) miRNAs identified by sequential comparison of
developmental stages for IVF or scNT embryos. (B) miRNAs identified in IVF, scNT and either
oocytes or donor fibroblast cells at each developmental stage. Colors represent the following
stages and embryo types: grey, oocyte; tan, fibroblast; blue, 2-cell (light, scNT; dark, IVF); green,
8-cell (light, scNT; dark, IVF); yellow, morula (light, scNT; dark, IVF); orange, blastocyst (light,
scNT; dark, IVF); red, BDC (light, scNT; dark, IVF).
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Figure 3.4. Patterns of miRNA expression in bovine oocytes and donor fibroblast cells as well as
early developing embryos and blastocyst-derived cells generated via IVF or scNT. (A) Principal
components analysis of bovine miRNAs using the standard singular value decomposition method
with imputation. (B) Unsupervised, bi-directional hierarchical cluster analysis (Euclidean
distance method) of variance stabilized normalized read counts for all identified miRNAs. Data
were categorized by sample type (Fb, fibroblast; Oo, oocyte; IVF, in vitro-fertilized embryo;
scNT, scNT embryo) and stage (2c, 2-cell; 8c, 8-cell; Mo, morula; Bl, blastocyst; BDC,
blastocyst-derived cells).
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Figure 3.5. (prior page) Significant ontology and pathway terms and network clustering
associated with predicted mRNA targets of over or under expressed miRNAs in bovine scNT
morula stage embryos as compared to IVF morula stage embryos. (A) Predicted mRNA targets
(TargetScan total context ++ score <-0.35) of differentially expressed miRNAs (|log2 R|>1 and pvalue <0.05 for scNT morula stage embryos compared to IVF morula stage embryos) were
subject to enrichment analysis using Metascape (Minimum overlap of 3, minimum enrichment
1.5 and p<0.01). Only miRNAs whose families annotated by TargetScan as conserved or broadly
conserved were included in the Metascape analysis. Each heat-map depicts the top 20 enriched
summary terms identified for Gene Ontology biological processes, with the length of the bar
determined by the –log10 p-value. (B) Cytoscape network analysis of Gene ontology biological
process terms for predicted mRNA targets of differentially expressed miRNAs, including overand under- expressed miRs in the scNT morula staged embryos as compared to IVF morula
staged embryos. Each term is represented by a circle node, for which the size is proportional to
the enrichment score and the color represents the enrichment pathway term. Terms with a
similarity score >0.3 are linked by an edge (the thickness of the edge represents the similarity
score) using force-directed network layout and bundled edges for clarity. Each cluster is labeled
by the term with the highest p-value in the cluster group. Complete results of the Metascape
analysis are provided in Supplementary File 3.5; Appendix J.
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Figure 3.6. (prior page) Significant ontology and pathway terms and network clustering
associated with predicted mRNA targets of over or under expressed miRNAs in bovine scNT
BDCs as compared to IVF BDCs. (A) Predicted mRNA targets (TargetScan total context ++
score <-0.35) of differentially expressed miRNAs (|log2 R|>1 and p-value <0.05 for scNT BDCs
compared to IVF BDCs) were subject to enrichment analysis using Metascape (Minimum overlap
of 3, minimum enrichment 1.5 and p<0.01). Only miRNAs whose families annotated by
TargetScan as conserved or broadly conserved were included in the Metascape analysis. Each
heat map depicts the top 20 enriched summary terms identified for Gene Ontology biological
processes, with the length of the bar determined by the –log10 p-value. (B) Cytoscape network
analysis of Gene ontology biological process terms for predicted mRNA targets of differentially
expressed miRNAs, including over- and under- expressed miRs in the scNT BDCs as compared
to IVF BDCs. Each term is represented by a circle node, for which the size is proportional to the
enrichment score and the color represents the enrichment pathway term. Terms with a similarity
score >0.3 are linked by an edge (the thickness of the edge represents the similarity score) using
force-directed network layout and bundled edges for clarity. Each cluster is labeled by the term
with the highest p-value in the cluster group. Complete results of the Metascape analysis are
provided in Supplementary File 3.5; Appendix J.
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Figure 3.7. Patterns of tRNA expression in bovine oocytes and donor fibroblast cells as well as
early developing embryos and blastocyst-derived cells generated via IVF or scNT. (A) Principal
components analysis of bovine tRNAs using the standard singular value decomposition method
with imputation. (B) Unsupervised, bi-directional hierarchical cluster analysis (Euclidean
distance method) of variance stabilized normalized read counts for all identified tRNAs. Data
were categorized by sample type (Fb, fibroblast; Oo, oocyte; IVF, in vitro-fertilized embryo;
scNT, scNT embryo) and stage (2c, 2-cell; 8c, 8-cell; Mo, morula; Bl, blastocyst; BDC,
blastocyst-derived cells).
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Figure 3.8. Annotation of piRNA-like RNAs (pilRNAs). (A) Fraction of sequence reads mapped
as potential piRNAs compared to reads mapped to other sncRNA classes or not annotated by
sample type. (B) Number of sequencing reads mapped to piRNA clusters (left axis) and number
of piRNA clusters identified (right axis). Oo, oocyte; Fib, fibroblast; 2c, 2-cell; 8c, 8-cell; Mo,
morula; Bl, blastocyst; BDC, blastocyst-derived cells; IVF, in vitro fertilized; NT, somatic cell
nuclear transfer.
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Figure 3.9. Patterns of piRNA expression in bovine oocytes and donor fibroblast cells as well as
early developing embryos and blastocyst-derived cells generated via IVF or scNT. (A) Principal
components analysis of bovine piRNAs using the standard singular value decomposition method
with imputation. (B) Unsupervised, bi-directional hierarchical cluster analysis (Euclidean
distance method) of variance stabilized normalized read counts for all identified piRNAs. Data
were categorized by sample type (Fb, fibroblast; Oo, oocyte; IVF, in vitro-fertilized embryo;
scNT, scNT embryo) and stage (2c, 2-cell; 8c, 8-cell; Mo, morula; Bl, blastocyst; BDC,
blastocyst-derived cells).
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Figure 3.10. Expression of pilRNAs across chromosomes by sample type. (A) Fibroblast donor
cells. (B) MII oocytes. (C) IVF and scNT 2-cell embryos. (D) IVF and scNT 8-cell embryos.
Chromosome diagrams for the Bos taurus genome were created using PhenoGram [140] with
each pilRNA cluster location marked by a circle colored according to expression level.
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Figure 3.11. Expression of pilRNAs across chromosomes by sample type. (A) Morula IVF and
scNT embryos. (B) Blastocyst IVF and scNT embryos. (C) Blastocyst-derived cells (BDCs) from
IVF or scNT embryos. Chromosome diagrams for the Bos taurus genome were created using
PhenoGram [140] with each pilRNA cluster location marked by a circle colored according to
expression level.
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Figure 3.12. Mapping of piRNAs to TE sites in the Bos taurus genome. Values shown are the
reads per million for the most common TE sites for putative pilRNAs on the sense (+) or
antisense (–) DNA strand for IVF embryos (A) or scNT embryos (B). LINE, long interspersed
nuclear elements; SINE, short interspersed nuclear elements; LTR, long terminal repeat; DNA,
DNA transposon.
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Table 3.1. Differentially abundant miRNAs
All
Cattle
Comparison
miRNAs miRNAs Cattle miRNA IDs
IVF vs. scNT
2-cell
1
0
8-cell
0
0
6
3
Morula
miR-34a, miR-345-5p, miR-2340-3p (14T®A)
Blastocyst
1
0
BDCs
26
24
miR-202-5p, miR-376c-3p(6A®G), miR-3432a-2-5p,
miR-204-5p, miR-204, miR-3432b-5p(2T®G), miR376b-3p, miR-221-3p, miR-202, miR-221, miR-3803p, miR-133a-2-3p, miR-369-3p, miR-17-5p(1C®A),
miR-3432a, miR-199b, miR-376c-3p, miR-18a5p(20A®T), miR-376e, miR-22-3p, miR-222-3p,
miR-409a-3p, miR-451, and miR-1260b-5p(9A®G)
Developmental stage
IVF embryos
Oo vs. 2c
2
0
Fb vs. 2c
355
191
See Supplementary File 3.3; Appendix H
2C vs. 8c
1
0
8c vs. Mo
29
22
miR-378, miR-378-3p, miR-378d-3p(1T®A), miR2340-3p(14T®A), miR-378c-5p, miR-378-5p, miR145, miR-2285aj-5p(14T®C), miR-378b-3p(4T®G),
miR-34a-5p, miR-184, miR-199a-3p, miR-34a, miR155-5p, miR-450a, miR-345-5p, miR-378c-5p, miR199a-2-5p, miR-320a, miR-199b-3p, miR-214-3p,
miR-339b,
Mo vs. Bl
25
19
miR-30e-5p, miR-143-3p, miR-28-3p, miR-145, miR2340-3p(14T®A), miR-196a, miR-30f-5p(9C®T),
miR-151-5p, miR-138-1-5p, ,miR-199b-3p, miR-935p,miR-345-5p,miR-30c,miR-146b, miR-339-5p,
miR-199a-2-5p, miR-29b, miR-29e-3p(6T®C), miR26a,
Bl vs.
329
160
See Supplementary File 3.3; Appendix H
BDC
scNT embryos
Oo vs. 2c
3
0
Fb vs. 2c
365
202
See Supplementary File 3.3; Appendix H
2C vs. 8c
0
0
8c vs. Mo
22
19
miR-378, miR-19b-3p, miR-378-5p, miR-6119-5p,
miR-378-3p, miR-7-3-3p, miR-7-3-3p(25C®A), miR138-2-5p(23G®A), miR-7, miR-7858-5p, miR-378c5p, miR-27b-3p(19T®C), miR-138-2-5p(25C®A),
miR-378d-3p(1T®A), miR-107-3p, miR-2155p(19A®C), miR-30e-5p, miR-106b-5p, miR-302a3p
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Table 3.1. Differentially abundant miRNAs
All
Cattle
Comparison
miRNAs miRNAs Cattle miRNA IDs
Mo vs. Bl
56
33
miR-30e-5p, miR-497-5p, miR-125b-1-5p, miR-1381-5p, miR-138-2-5p, miR-376c-3p, miR-152-3p, miR11986c-5p(5C®T), miR-148b-3p(10C®G), miR105a, miR-138-1-5p,miR-138-2-5p, miR-120585p(11T®A), miR-28-3p, miR-507b, miR-99a-5p,
miR-138-1-5p(25C®A), miR-199a-3p, miR-15a,
miR-30f-5p(9C®T), miR-2285cr-1-3p(3T®C), miR10b-5p, miR-11986c-5p(15G®A), miR-146b, miR122-5p, miR-218-1-5p, miR-34a-5p, miR-181a-1-5p,
miR-324, miR-145-5p, miR-195-5p, miR-507-3p,
miR-125b, miR-451
Bl vs.
384
201
See Supplementary File 3.3; Appendix H
BDC
Note: Complete results of DESeq2 differential expression analyses for miRNAs are provided in
Supplementary File 3.3; Appendix H. Abbreviations are: Oo, oocyte; 2c, 2-cell; 8c, 8-cell; Mo,
morula; Bl, blastocyst; BDC, blastocyst-derived cells; Fb, fibroblast; IVF, in vitro-fertilized;
scNT, somatic cell nuclear transfer; miRNA, microRNA; ID, identification number.
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Table 3.2. Differentially abundant tRNA fragments
Comparison
Number
IVF vs. scNT
2-cell
0
8-cell
0
Morula
4
Blastocyst
0
Developmental stage
IVF embryos
Oo vs. 2c
3
Fb vs. 2c
379
2c vs. 8c
10
8c vs. Mo
22
Mo vs. Bl
26
Bl vs. BDC
192
scNT embryos
Oo vs. 2c
0
Fb vs. 2c
393
2C vs. 8c
0
8c vs. Mo
21
Mo vs. Bl
139
Bl vs. BDC
129
Note: Complete results of DESeq2 differential expression analyses for
tRFs are provided in Supplementary File 3.3; Appendix H.
Abbreviations are: Oo, oocyte; 2c, 2-cell; 8c, 8-cell; Mo, morula; Bl,
blastocyst; BDC, blastocyst-derived cells; Fb, fibroblast; IVF, in vitrofertilized; scNT, somatic cell nuclear transfer; miRNA, microRNA; ID,
identification number.
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Table 3.3. Differentially abundant piRNAs
Comparison
Number
IVF vs. scNT
2-cell
0
8-cell
0
Morula
4
Blastocyst
0
Developmental stage
IVF embryos
Oo vs. 2c
1
Fb vs. 2c
4,586
2C vs. 8c
0
8c vs. Mo
49
Mo vs. Bl
70
Bl vs. BDC
1,766
scNT embryos
Oo vs. 2c
0
Fb vs. 2c
4,672
2C vs. 8c
0
8c vs. Mo
24
Mo vs. Bl
0
Bl vs. BDC
717
Note: Complete results of DESeq2 differential expression
analyses for piRNAs are provided in Supplementary File 3.3;
Appendix H. Abbreviations are: Oo, oocyte; 2c, 2-cell; 8c, 8cell; Mo, morula; Bl, blastocyst; BDC, blastocyst-derived
cells; Fb, fibroblast; IVF, in vitro-fertilized; scNT, somatic cell
nuclear transfer; miRNA, microRNA; ID, identification
number.
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Supplementary Figure 3.S1. Dynamic expression of selected miRNAs of interest in early
developing IVF and scNT embryos, oocytes and fibroblasts. Values shown are the normalized
reads per million on a log10 scale. Selected miRNAs are shown to represent (A) miRNAs
differentially expressed at the morula stage between IVF and scNT embryos, (B) miRNAs
differentially expressed in morula vs. 8-cell IVF or scNT embryos, (C) miRNAs differentially
expressed in blastocyst vs. morula IVF or ScNT embryos. * p <0.05 for IVF vs. scNT and # p
<0.05 comparing by developmental stage as indicated and colored according to embryo type
(purple, IVF; pink, scNT) as determined by DESeq2 analysis. Fb, fibroblast; Oo, oocyte; IVF, in
vitro-fertilized embryo; scNT, scNT embryo; 2c, 2-cell; 8c, 8-cell; Mo, morula; Bl, blastocyst;
BDC, blastocyst-derived cells.

240

241
Supplementary Figure 3.S2. (prior page) Patterns of miRNA expression in IVF embryos with
comparisons by developmental stage. (A) Unsupervised, bi-directional hierarchical cluster
analysis (Euclidean distance method) of variance stabilized normalized read counts for all
identified miRNAs present in either sample included in the heat map. Data were categorized by
sample type (Fb, fibroblast; Oo, oocyte; IVF, in vitro-fertilized embryo; scNT, scNT embryo) and
stage (2c, 2-cell; 8c, 8-cell; Mo, morula; Bl, blastocyst; BDC, blastocyst-derived cells). (B)
Principal components analysis of bovine miRNAs present in either sample included, using the
standard singular value decomposition method with imputation.
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Supplementary Figure 3.S3. (prior page) Patterns of miRNA expression in scNT embryos with
comparisons by developmental stage. (A) Unsupervised, bi-directional hierarchical cluster
analysis (Euclidean distance method) of variance stabilized normalized read counts for all
identified miRNAs present in either sample included in the heat map. Data were categorized by
sample type (Fb, fibroblast; Oo, oocyte; IVF, in vitro-fertilized embryo; scNT, scNT embryo) and
stage (2c, 2-cell; 8c, 8-cell; Mo, morula; Bl, blastocyst; BDC, blastocyst-derived cells). (B)
Principal components analysis of bovine miRNAs present in either sample included, using the
standard singular value decomposition method with imputation.
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Supplementary Figure 3.S4. (prior page) Patterns of miRNA expression for comparisons of
IVF and scNT embryos at each developmental stage. (A) Unsupervised, bi-directional
hierarchical cluster analysis (Euclidean distance method) of variance stabilized normalized read
counts for all identified miRNAs present in either sample included in the heat map. Data were
categorized by sample type (Fb, fibroblast; Oo, oocyte; IVF, in vitro-fertilized embryo; scNT,
scNT embryo) and stage (2c, 2-cell; 8c, 8-cell; Mo, morula; Bl, blastocyst; BDC, blastocystderived cells). (B) Principal components analysis of bovine miRNAs present in either sample
included, using the standard singular value decomposition method with imputation.

246

Supplementary Figure 3.S5. Top 20 ontology and pathway terms and network clustering
associated with predicted mRNA targets of over or under expressed miRNAs in IVF embryos.
(A-B) Bovine IVF 8-cell vs. morula stage embryos and (C-D) bovine IVF morula vs. blastocyst
stage embryos. For panels A and C, predicted mRNA targets (TargetScan total context ++ score
<-0.35) of differentially expressed miRNAs (|log2 R|>1 and p-value <0.05) were subject to
enrichment analysis using Metascape (Minimum overlap of 3, minimum enrichment 1.5 and
p<0.01). Each heat map depicts the top 20 enriched summary terms identified for Gene Ontology
biological processes, with the length of the bar determined by the –log10 p-value. For panels B and
D, Cytoscape network analysis of gene ontology biological process terms for predicted mRNA
targets of differentially expressed miRNAs. Each term is represented by a circle node, for which
the size is proportional to the enrichment score and the color represents the enrichment pathway
term. Terms with a similarity score >0.3 are linked by an edge (the thickness of the edge
represents the similarity score) using force-directed network layout and bundled edges for clarity.
Each cluster is labeled by the term with the highest p-value in the cluster group. Complete results
of the Metascape analysis are provided in Supplementary File 3.5; Appendix J.
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Supplementary Figure 3.S6. Top 20 ontology and pathway terms and network clustering
associated with predicted mRNA targets of over or under expressed miRNAs in scNT embryos.
(A-B) Bovine scNT 8-cell vs. morula stage embryos and (C-D) bovine scNT morula vs.
blastocyst stage embryos. For panels A and C, predicted mRNA targets (TargetScan total context
++ score <-0.35) of differentially expressed miRNAs (|log2 R|>1 and p-value <0.05) were subject
to enrichment analysis using Metascape (Minimum overlap of 3, minimum enrichment 1.5 and
p<0.01). Each heat map depicts the top 20 enriched summary terms identified for Gene Ontology
biological processes, with the length of the bar determined by the –log10 p-value. For panels B and
D, Cytoscape network analysis of gene ontology biological process terms for predicted mRNA
targets of differentially expressed miRNAs. Each term is represented by a circle node, for which
the size is proportional to the enrichment score and the color represents the enrichment pathway
term. Terms with a similarity score >0.3 are linked by an edge (the thickness of the edge
represents the similarity score) using force-directed network layout and bundled edges for clarity.
Each cluster is labeled by the term with the highest p-value in the cluster group. Complete results
of the Metascape analysis are provided in Supplementary File 3.5; Appendix J.
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Supplementary Figure 3.S7. Identification of piRNA-like RNAs (pilRNAs) by ping-pong
signature and 1U bias. Identification of pilRNAs by ping-pong signature and 1′U bias. Line
graphs represent the number of pairs of reads with a 5′ to 5′ overlap in the datasets. The peak at
10 nt is characteristic of piRNAs produced by the ping-pong cycle. The sequence logos below
represent nucleotide biases at each pilRNA position for reads 32 nt in length (base position
number below each logo). Oo, oocyte; 8c, 8-cell stage embryo; Bl, blastocyst stage embryo.
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Supplementary Figure 3.S8. Potential piRNAs mapped to the Bos Taurus genome. Samples
include fibroblasts, oocytes, IVF (above the x-axis) and scNT (below x-axis) two cell, eight cell,
morula and blastocyst staged embryos. Values are the log10 normalized counts for each sample
type.

CHAPTER 4
MAPPING TRANSCRIPTIONAL CHANGES ASSOCIATED WITH THE
MATERNAL-TO-EMBRYONIC TRANSITION IN BOVINE EMBRYOS TO SMALL
NON-CODING RNA PROFILES IN BOTH IN VITRO-FERTILIZED AND SOMATIC CELL
NUCLEAR TRANSFER CATTLE EMBRYOS
Abstract
Background
The efficiency rate for the production of high quality embryos by somatic cell nuclear
transfer (scNT) is far below that for in vitro fertilized (IVF) embryos, likely due to an
accumulation of errors in genome reprogramming that impairs proper development. Moreover,
errors associated with genome reprogramming in cloned embryos may also encompass
dysregulation of expression of microRNAs (miRNA), an important class of non-coding RNAs
that suppress translation or reduce stability of coding messenger RNA (mRNA). Thus, the
objectives of this study were to determine the dynamics of mRNA expression in early developing
scNT and IVF embryos in the context of the maternal-to-embryonic transition (MET) and to
correlate apparent transcriptional dysregulation in cloned embryos with miRNA expression
profiles. RNA sequencing was performed using cattle embryos produced via IVF or scNT at the
2-cell, 8-cell, morula and blastocyst developmental stages and using MII oocytes, donor cell
fibroblasts and cells derived from either IVF or scNT blastocysts (BDCs). Sequencing data were
analyzed by DESeq2 to identify transcripts differentially expressed in cloned embryos compared
to their stage-matched IVF controls or to identify transcripts differentially expressed by
developmental stage.
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Results
Analysis of mRNA expression data revealed large-scale differences between scNT and
IVF embryos at each developmental stage examined, with the greatest number of differentially
expressed transcripts detected at the 8-cell and morula stages. Interestingly, those altered
transcripts in 8-cell scNT embryos were associated with biological functions critical for the MET,
such as mRNA processing and metabolism, ncRNA transcription and metabolism, methylation
and chromatin modification. For two miRNAs previously identified as differentially expressed in
scNT morulae, miR-34a and miR-345, negative correlations with some predicted mRNA targets
were apparent, as would be expected if these miRNAs targeted the transcripts for repression or
down-regulation, though these negative correlations were not widespread among all predicted
targets.
Conclusion
Large-scale aberrations in expression of mRNAs were evident during the MET in cattle
scNT embryos. However, this apparent dysregulation of gene expression in scNT embryos was
not consistently correlated with aberrations in miRNA expression, suggesting that other
mechanisms controlling gene expression may be at play.
Introduction
Somatic cell nuclear transfer (scNT) is a well-established method of animal cloning in
livestock species. Using this method, genetic material is removed from a donor oocyte and
replaced with a somatic donor cell’s DNA. However, compared to in vitro fertilization
technology, scNT embryos have low overall success rate, regardless of species [1, 2].
Improvement of scNT would make this assisted reproductive technology more accessible and
allow for more efficient genetic improvement of livestock genetics. A possible cause of the low
efficiency rates for development of scNT embryos is errors in the epigenetic reprogramming of
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the donor somatic genome. Functioning as a second layer of coding information, the epigenome
controls gene expression via changes in DNA structure that do not alter the genetic code, such as
DNA methylation or histone modifications. In scNT embryos, the differentiated donor DNA
must be reprogrammed into the pluripotent state necessary for successful embryo development.
Errors in reprogramming that affect epigenome modifiers may lead to inappropriate gene
expression and place high demands on the developing embryo [1]. Accordingly, inappropriate
DNA methylation patterns [3-6] and histone modifications [7, 8] have been identified in scNT
embryos, including blastocysts and aborted scNT fetuses from two to six months of gestation in
cattle, and at the MZT (zygote) and blastocysts in mice. The significant cellular stress caused by
extensive aberrant gene expression due to inappropriate genome reprogramming could be
responsible, in part, for the low developmental rates of scNT embryos [9]. Of particular
importance, proper genome reprogramming for genes involved in pluripotency is necessary for
successful development to occur [10-12]. Interestingly, researchers have noted that patterns of
epigenome programming in scNT embryos tend to resemble those of the donor cell, indicative of
incomplete genome reprogramming in scNT embryos [13, 14]. It is likely that this incomplete
reprogramming drives inappropriate gene expression and causes lower embryo development.
Incomplete reprogramming would impact non-coding genes as well, such as those coding
sncNRA, which could further impact aberrant gene expresison.
The maternal-to-embryonic transition (MET) is a highly orchestrated shift in genetic
control from the maternal genome to the embryonic genome that may be especially sensitive to
incomplete reprogramming in scNT embryos. In order for embryonic genome activation (EGA)
to be successful, the maternally-deposited transcripts from the oocyte must be completely
degraded to prepare the embryo for further development and tissue differentiation [15]. The shift
in transcripts that occurs at the MET is quite profound, as maternal transcripts that may have been
present in the oocyte and early embryo for weeks or months are eliminated in a matter of hours.
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Three patterns of transcript changes are seen, including the destruction of oocyte-specific
transcripts that are not subsequently expressed in the embryo, the replacement of maternal
transcripts with embryonic transcripts (for ubiquitously expressed genes), and the de novo
transcription of embryonic transcripts that are not present in the oocyte [15]. During this time of
early development, transcripts can be regulated via changes in mRNA stability, translation, and
location. At the MET, mass degradation occurs with 30-40% of transcripts being completely
degraded and 60% being significantly degraded [16], driven by both embryonic and maternal
pathways. The maternal pathway involves several different degradation mechanisms, with the
primary of these being mediated by protein SMAD4, which acts to degrade the maternal
transcripts that would repress the embryonic genome [17]. Alternatively, embryonic degradation
machinery functions to rapidly degrade maternal transcripts still present [18]. Once the massive
turnover of transcripts is complete, embryonic gene expression actively drives embryonic
development allowing for differentiation to occur.
In bovine embryos, the major wave of the EGA occurs at the 8-16 cell stage, although
small amounts of transcriptional activation have been seen as early as the embryonic stage [19].
Graf and colleagues [19] determined that genes activated before the 4-cell stage in IVF embryos
were associated with RNA processing, translation, and transport biological functions; an uptick in
expression of these genes is likely necessary to prepare the embryo for genome activation and
active transcription and translation. For example, KLF4 encodes a protein belonging to the
Kruppel family of transcription factors, and this gene was activated at the 4-cell stage. Similarly,
genes activated at the 8-cell developmental stage had functions associated with transcription and
translation, such as EIF3, which is required for the initiation of protein synthesis [19].
Researchers have shown that embryos generated via cloning harbored aberrations in their
populations of mRNA molecules, notably at the blastocyst developmental stage or later, with
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expression patterns suggesting incomplete or faulty reprogramming of the donor genome [20, 21].
Moreover, the use of trichostatin A (TSA), a potent inhibitor of histone deacetylase, improved
development of scNT embryos. However, TSA did not appear to correct all reprograming errors,
suggesting that other mechanisms contribute to reprogramming errors in scNT embryos [22].
Prior to the EGA, transcript abundance is controlled via precise degradation pathways in early
developing embryos. Small non-coding RNAs (sncRNAs) function through RNA interference
(RNAi), the process by which ncRNAs block the translation or reduce the stability of the coding
mRNA. In mammals, microRNAs (miRNAs), piwi-interacting RNAs (piRNAs) and small
endogenous interfering RNAs (siRNAs) have been established as functioning in RNAi during
early development [23]. While the biogenesis and targeting mechanisms between these three
sncRNAs differ significantly, all can participate in RNAi through binding and degrading either
transposable elements (TEs) or mRNA [24]. MiRNAs act to silence mRNA expression through
binding interaction with the 3’ UTR blocking translation and decreasing stability of target
transcripts [25]. MiRNAs are short, 22 nt single stranded RNAs that are transcribed from the
DNA by RNA polymerase II into primary-miRNAs (pri-miRNAs), which are then cleaved by
Drosha and its cofactor DGCR8. The cleavage results in precursor miRNAs (pre-miRNAs) that
are transported by Exportin proteins into the cytoplasm where the Dicer complex cleaves them
into double stranded, non-hairpin, miRNA molecules. AGO then unwinds and loads the miRNA
duplex into the miRNA-induced silencing complex (miRISC) [26]. The miRISC functions to
direct the miRNA to its target transcript. In cases of perfect complementary binding AGO will
mediate the target degradation [24], while in cases of non-complementary binding, miRNA
represses translation by inhibiting translation at the initiation step [25, 27]. MiRNAs have been
shown to be highly conserved, powerful regulators of gene expression, functioning in the
majority of investigated cell functions.
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As the oocyte matures, it becomes transcriptionally silent, a developmental state that
persists through early development until the EGA. The transcriptional silence makes the early
embryo a unique window of development during which post-transcriptional machinery, such as
miRNAs, may dominate the regulatory network. MiRNAs have been shown to contribute to the
zygotic degradation pathway of maternal transcripts in Zebrafish, for which a single miRNA
(miR-430) mediated the decay of hundreds of maternal mRNAs [28]. A similar mechanism of
miRNA-mediated decay has also been found in C. Elegans by both maternal and zygotic
miRNAs [29], in Xenopus by a miR-430 orthologue (miR-427) targeting mRNAs [30], and in
Drosophila in which miR-309 degrades hundreds of mRNAs at the EGA [31]. Of note, miRNAs
have not yet been shown to contribute to the embryonic degradation pathway in mammals, which
may be due to heavy use of mouse models, as mice have a rodent unique sncRNA pathway in the
oocyte and early embryo. In mice, piRNA proteins appear to be divergent from those in humans
and cattle [32], and in mice and rats, a rodent oocyte-specific Dicer isoform preferentially loads
siRNAs over miRNAs [33]. These species divergent pathways mean that further investigation in
other mammalian species of miRNAs function in the MET is needed.
While most investigators have focused on aberrations in DNA methylation or histone
marks to explain abnormalities in the transcriptome of scNT embryos, it is possible that
deviations in populations of sncRNAs may also contribute to their poor development. Prior
studies found that the donor cell miRNA expression pattern was persistent in the scNT bovine
embryo or embryonic tissues [34, 35]. In addition to the limited studies that have examined
miRNA populations in bovine embryos, researchers demonstrated that manipulation of specific
miRNAs impacted rates of development in embryos [36, 37], including the improvement of scNT
embryo rates [38-43]. Dysregulation of miRNA populations – and their transcript targets –
necessary for a successful MET could contribute to high embryonic stress and death rates typical
for production of scNT embryos.
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While others have shown that scNT embryos harbor distinct transcriptomes compared to
high quality embryos (IVF or in vivo produced), many of these studies were limited in that none
have explored the dynamics of gene expression over the course of early embryo development
through the MET [21, 44]. No prior studies have employed a discovery-based RNAseq approach
to examine the entire population of miRNAs, and only a single recent study examined the entirety
of the mRNA transcriptome through the MZT in scNT embryos [45]. Moreover, it is not known
how aberrations in the transcriptome of scNT embryos correlate with populations of miRNAs
during early embryo development. Thus, in this study, we sought to examine the dynamic
changes in the transcriptome in scNT embryos through the MET and to examine those variations
in context of the population of miRNAs in the same embryo samples. We hypothesized that
transcripts derived from the maternal genome that need to be degraded for successful MET would
be aberrantly expressed in the scNT embryos at the 8-cell stage. In addition, we hypothesized
that samples found to have unique changes in miRNA populations would also show a distinct
transcriptome profile in transcripts predicted to be targets of those unique miRNAs. An unbiased,
discovery-based approach was employed using RNAseq of both small (<200 nt in length) and
large (>200 nt in length) RNA populations in bovine oocytes, fibroblast donor cells, 2-cell
embryos, 8-cell embryos, morula embryos, blastocyst embryos, and blastocyst-derived cells
(BDCs) produced using both IVF and scNT methods.

Methods
Oocyte collection and in vitro maturation
Bovine ovaries were collected from a local abattoir (JBS, Hyrum, UT) and transported in
a cooler containing 0.9% saline solution to the laboratory. The cumulus-oocyte complexes
(COCs) were then aspirated from 3-8 mm follicles by using an 18-gauge needle and vacuum
system. Only compact COCs with homogenous ooplasm and intact layers of cumulus cells were
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used for scNT or IVF. Following aspiration, COCs were cultured at 39 °C with 5% CO2 for 22 to
24 hr. The oocytes were cultured in TCM199 maturation medium with Earle’s salts, L-glutamine,
and sodium bicarbonate (Hyclone, Logan, Utah) supplemented with 10% fetal bovine serum
(FBS), 0.05 mg/ml bovine follicle stimulating hormone (Sioux Biochemicals, Sioux city, IA), 5
mg/ml bovine luteinizing hormone (Sioux Biochemicals), 100 U/ml penicillin, and 100 mg/ml
streptomycin.
In vitro fertilization
Following 22 to 24 hr of maturation, MII oocytes were fertilized using the laboratory’s
standard in vitro fertilization (IVF) protocol [46]. Briefly, one straw of cryopreserved bovine
semen obtained from a Holstein bull (Hoffman AI, Logan UT) was removed from the liquid
nitrogen tank and placed into a 35 °C water bath to thaw. Live sperm were isolated by
centrifugation through a 45%/90% percoll gradient, suspended (final concentration 1x106/ml) in
Tyrode’s albumin lactate pyruvate containing 10 µg/ml heparin and used to fertilize the mature
oocytes. Twenty to 22 hr post-IVF, cumulus cells were removed by vortexing, and fertilized
zygotes were washed in phosphate buffered saline with 0.32 mM sodium pyruvate, 5.55 mM
glucose, and 3 mg/ml bovine serum albumin (PB1+). After washing, zygotes were cultured on a
monolayer of bovine cumulus cells in 50 µl of synthetic oviductal fluid (SOFaa) with 3% FBS
overlaid with mineral oil. The embryos were cultured at 39 °C in a humidified atmosphere with
5% CO2. Half of the SOFaa medium was removed and replaced with fresh, equilibrated medium
every other day starting the day after in vitro culture. Historically, production of IVF embryos via
these methods followed by blastocyst stage embryo transfer to cattle recipients has generated
successful pregnancies at an approximate rate of 50% by our research group (unpublished
observations). The timing of embryo collection post-fertilization was 24-36 hr for 2-cell stage,
48-60 hr for 8-cell stage, 156-168 hr for morula stage, and 192-204 hr for blastocyst stage.
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Somatic cell nuclear transfer
Primary bovine fibroblast cultures were established from ear biopsy tissues from a
Brahma Spanish bull cross using well-established procedures. Frozen/thawed cells were grown to
80-100% confluence then passaged, with cells from passages 4-5 used as nuclear donors. Three
days prior to a cloning session, donor fibroblast cells were thawed and propagated, and incubated
in DMEM media supplemented with 15% (v/v) FBS at 39 °C with 5% CO2. Bovine fibroblasts at
80-90% confluence were serum starved by replacing culture media with DMEM media
containing 0.5% (v/v) FBS 24 hr prior to scNT. Oocytes were matured for 18-20 hr, then
denuded using 100 µl of 1% (v/v) hyaluronidase, incubated for 5 min at 39˚C with 5% CO2,
followed by gentle pipetting. The removed cumulus cells were centrifuged at 500´g for 5 min at
room temperature, and the supernatant was removed. Cumulus cells were then cultured in SOFaa
under oil for use in embryo culture. The denuded oocytes were then rinsed using PB1+, and
oocytes with polar bodies were selected and separated. ScNT was performed according to
established protocols [47-49]. Briefly, oocytes with polar bodies were incubated in 0.6 µg/ml
demecolcine for 30-40 min and a metaphase plate and a polar body were removed using a beveled
pipette. Fibroblast cells were covered in 0.25% trypsin for 1 min, and then the trypsin was
removed and fibroblasts were incubated for anther 6 min at 39˚C with 5% CO2. Once fibroblast
cells were detached, they were rinsed in warm medium and centrifuged at 150xg for 6 min. The
supernatant was removed, and the cellular pellet was resuspended in 100 µl Hepes SOF medium
[50]. One fibroblast cell was injected into the perivitelline space of the recipient oocyte, and
fused using one direct pulse of 1.2 kV/cm for 22 µs by an Electro Cell Manipulator 2001 (BTX,
San Diego, CA) in 0.28 M sorbitol, 0.05% (w/v) BSA, 0.1 mM CaCl2, 0.5 mM MgCl2, and 0.5
mM Hepes. Following fusion, embryos were washed through Hepes SOF, and incubated in
embryo culture medium for 1 hr. Activation was then performed, with successfully fused
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embryos cultured in 5µM ionomycin for 5 min, followed by 4 hr of incubation in activation
medium composed of SOFaa medium with 10µg/ml cyclohexamide and 1 mM 6-dimethylaminopyridine at 39˚C with 5% CO2. Following activation, embryos were cultured on a monolayer of
bovine cumulus cells in 50 µl drops of SOFaa with 3% (v/v) FBS overlaid with mineral oil. The
embryos were cultured at 39 °C in a humidified atmosphere with 5% CO2. Half of the SOFaa
medium was removed and replaced with fresh, equilibrated medium every other day starting the
day after in vitro culture. The timing of embryo collection was the same as for IVF embryos as
described above.
Isolation of blastocyst-derived cells
We followed methods previously described [51] to generate putative embryonic stem
cells (ESCs) from IVF and scNT embryos for comparison. Briefly, bovine expanded blastocysts
produced by IVF and scNT were used for BDC isolation. Zona pellucida-free blastocysts were
placed into 4-well culture dishes onto feeder layers of mitomycin C-treated mouse primary
embryonic fibroblasts. Feeder layer preparation was performed as previously reported [52].
These cells were cultured in DMEM supplemented with 0.2% (w/v) LIF, 1% (w/v) bFGF, and
30% (v/v) Knock out Serum Replacement (ThermoFisher Scientific, Waltham, MA). When
propagation was needed, cultured cell colonies were mechanically propagated using a small metal
blade. Germ line competent ESCs have only been reported for mouse and rat [53]. However,
bovine putative ESC-like cells expressing pluripotency markers have been reported by several
groups [51, 54-56]. Though the objective here was to generate putative ESC-like cells,
transcriptional profiling revealed that these cells did not consistently express the array of gene
markers typical of pluripotent stem cells (data available with Chapter 4). Thus, we instead refer
to these cells as blastocyst-derived cells (BDCs) herein.
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Tissue collection
The same samples were used to isolate the small RNA fraction for profiling sncRNAs
and the large RNA fraction for profiling mRNAs so that direct comparisons of the two RNA
profiles could be made. Four pools of 20 mature oocytes were collected at 22 hr after maturation.
To remove cumulus cells, the mature COCs were treated with 10 mM hyaluronidase for 5 min,
followed by repeatedly pipetting the mixture until cumulus cells were removed. After visual
inspection for complete removal of cumulus cells and the presence of a polar body, denuded
mature metaphase II (MII) oocytes were washed through four droplets of PB1+. Oocytes were
then snap frozen in cryotubes containing RNA/DNA shield (Zymo, Irvine, California), and stored
at -80 °C until RNA isolation. Fibroblasts prepared for scNT were collected after centrifugation
and pelleting, and were snap-frozen in 100ul of RNA/DNA shield (Zymo, Irvine, California).
Four pools of 20 2-cell, 8-cell, morula, and blastocyst stage embryos were collected at 2, 3, 6, and
8 days post-IVF or scNT, washed in PBS, and stored at -80 °C.
Large RNA isolation and sequencing
RNA was isolated based on size using the RNA Clean & ConcentratorTM 5 kit (Zymo)
from three pools each of oocytes, 2-cell stage embryos, 8-cell stage embryos, morula stage
embryos, or blastocyst stage embryos according to the manufacturer’s protocol for purification of
small RNA (<200 nt) and large RNA (>200 nt) as separate fractions. Small RNA sequencing was
performed as outlined in Chapter 3. The large RNA fraction was used to generate sequencing
libraries using the Ovation SoLo RNA-Seq System (NuGen Technologies; San Carlos, CA) as
directed by the manufacturer’s protocol for total RNA input. Briefly, first strand cDNA
synthesis, cDNA processing, second strand synthesis, and end repair were conducted according to
manufacturer’s protocols, and samples were then stored at -20°C overnight. Then, adaptor
ligation and purification were performed, followed by PCR amplification of the sequence
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libraries (optimized to 16 cycles per instructions) and bead purification (twice) of the resulting
samples. Library DNA concentrations were quantified using the Qubit dsDNA HS Assay
(ThermoFisher Scientific). Because DNA concentrations were low, the PCR amplification step
was repeated once more with an additional 19 cycles to improve yield. Next, InDA-C treatment
was conducted, a third round of PCR was performed, and the resulting libraries were beadpurified according to the manufacturer’s protocol. Libraries were sequenced on the Illumina
NextSeq using single-end 75 bp reads by the USU Genomics Core Facility.
Data processing and analyses
Methods for processing and analysis of sncRNA sequencing data are provided in Chapter
3. For the large RNAseq data, high quality sequencing data were confirmed with FastQC [57],
and visualized across samples with MultiQC [58]. A STAR index was generated for read
alignment using Bos taurus UMD3.1 using the parameter --sjdbOverhang 74 [59]. Reads were
aligned with default parameters including --quantMode GeneCounts to generate feature count
tables (Supplementary File 4.1; Appendix L). Count tables were imported to R where the DESeq2
R package [60] was used to identify differentially expressed genes with a Benjamini–Hochberg
false discovery rate (FDR) adjusted p-value < 0.05. Comparisons were made for IVF vs. scNT
embryos at each developmental stage (2-cell, 8-cell, morula, blastocyst, and BDC) as well as
between developmental stages for each embryo type (oocyte vs. 2-cell, 2-cell vs. 8-cell, 8-cell vs.
morula, morula vs. blastocyst, and blastocyst vs. BDC). BioVenn was used to create proportional
Venn diagrams depicting the number of transcripts mapped to the cattle genome for each sample
[61]. Unsupervised, bidirectional hierarchical cluster analyses (Euclidean distance method with
average linkage) and principal component analyses were performed using ClustVis (large data
version) [62], but due to the large number of transcripts detected (over 20,000), only 2,400 genes
were randomly selected to include for hierarchical clustering and principal components analyses.
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Lists of all differentially expressed genes (DEGs) (Supplementary File 4.2; Appendix M) were
then subject to gene set enrichment analysis using Metascape and the Gene Ontology (GO)
biological process database with the following parameters: minimum overlap of 3 genes in a
category, minimum enrichment of 1.5, and p <0.05 [63]. Ontology analyses were performed
using DEG sets for comparison between IVF and scNT embryos at each developmental stage and
for comparisons by developmental stage within each embryo group. Resulting GO biological
process terms were then clustered by semantic similarity (kappa score >0.3) and represented as
networks in Cytoscape [64] (Supplementary File 4.3; Appendix N). Clusters of related terms
were named according to the term within the cluster with the lowest p value; thus, clusters with
different labels may have some similar terms within the cluster.
In Chapter 3, we identified a few differentially expressed miRNAs in scNT versus IVF
embryos, or by sequentially comparing developmental stages. Here, one objective was to
compare patterns of expression for those differentially expressed miRNAs to the relative
abundance of putative target transcripts in IVF or scNT embryos. Thus, the list of mRNAs was
filtered to include only predicted targets of those select miRNAs using TargetScan (release 7.2)
[65] with the Bos taurus miRNA database (miRBase release 22). TargetScan predicts biological
targets of miRNAs by searching for the presence of a conserved 8-mer, 7-mer, and 6-mer sites
matching to the seed region of each miRNA. Then, correlation analyses were performed using
cor and corrplot functions in R (www.R-project.org). A correlation was considered significant
when the Spearman r > 0.5 or <-0.5 and p < 0.05. Last, networks were constructed linking those
differentially expressed miRNAs and predicted mRNA targets using Cytoscape.
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Results
Expression profiles of mRNAs in IVF and scNT embryos
Figure 4.1 illustrates the overlap in the number of sequences mapped to the cattle genome
for each developmental stage (panel A) or comparing IVF and scNT embryos to either oocytes or
donor fibroblast cells (panel B). The vast majority of transcripts sequenced were shared by each
developmental stage, with an evident increase in the number of unique transcripts detected after
the EGA in morula and blastocyst stage IVF and scNT embryos. Also, approximately 4000 fewer
mRNAs were identified in scNT morula and blastocyst embryos (approximately 14,800 detected)
than their IVF counterparts (more than 19,000 detected). More transcripts were in common with
oocytes for each of the developmental stages than for fibroblasts, for both IVF and scNT embryos
(Figure 4.1B). However, we also noted that the set of mRNAs identified in BDCs generated from
both IVF and scNT embryos had greater overlap with fibroblasts than did the developing
embryos.
Complete results for all DESeq2 differential expression analyses are provided in
Supplementary File 4.2, and plots for individual genes of interest are provided in Supplementary
Figure 4.S1. When comparing scNT embryos to their IVF controls, substantially more DEGs
were identified in 8-cell and morula stage embryos, 1539 and 2140, respectively, than in earlier or
later developmental stages with fewer than 300 DEGs (Table 4.1, Figure 4.2A). Also, for each
type of embryo (IVF or scNT), we identified DEGs by progressively comparing developmental
stages (Table 4.1, Figure 4.2B). Relatively few DEGs were identified when comparing 2-cell
embryos to oocytes, whereas an increase in transcriptional activity was clearly evident by the 8cell stage with nearly 3000 DEGs identified in 8-cell vs. 2-cell IVF embryos. Interestingly,
transcriptional activity was reduced in scNT embryos at this transition point, with only 1092
DEGs identified when comparing 8-cell to 2-cell scNT embryos. The greatest boost in gene
expression in developing embryos was noted when comparing morula to 8-cell staged embryos,
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with 7106 and 10,942 DEGs for IVF and scNT embryos, respectively. The markedly greater
number of DEGs identified in scNT embryos at this later developmental transition (8-cell to
morula), coupled with the relatively low number in the prior transition (2-cell to 8-cell) suggests
that transcriptional activation may have been delayed in the scNT embryos. Indicative of
continuing transcriptional activity with further development, the morula to blastocyst transition
included 6,678 and 5,859 DEGs for IVF and scNT embryos, respectively. Last, when comparing
blastocyst stage embryos to the transcriptional profiles of the BDCs, substantial transcriptional
differences were noted with 8814 and 8623 DEGs identified for BDCs obtained from IVF or
scNT embryos, respectively.
Principal component analysis of the transcriptome data showed that samples clustered
clearly by developmental stage, although there was a clear segregation of samples by embryo
type at the morula stage (Figure 4.3A). Furthermore, unsupervised, bidirectional hierarchical
cluster analysis showed that samples were clearly grouped primarily by developmental stage,
with 2-cell and 8-cell embryos clustered in the same tree as oocytes, and morula and blastocyst
embryos clustered as separate sub-trees very distant from earlier developing embryos (Figure
4.3B). Fibroblasts and BDCs were also clustered, but the fibroblast’s sub-trees clustered
distinctly from other later-development stages. Interestingly, within the developmental stages,
the transcriptional profiles of IVF and scNT embryos were sufficiently distinct that the samples
clustered by type, with IVF and scNT embryos clustered separately for the morula and blastocyst
stages and for BDCs (Figure 4.3B; Supplementary Figure 4.S2). However, IVF and scNT
transcriptional profiles for 2-cell and 8-cell embryos were not sufficiently different to cause
complete segregation by embryo type for those stages.
Principal components and hierarchical clustering were also performed for each embryo
type to compare transcriptional profiles progressively by developmental stage (Supplementary
Figures 4.S3 to S4). For IVF embryos, distinct transcriptional profiles were evident by the 8-cell
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stage, at which point the pattern of gene expression was clearly distinct from that for morula stage
embryos. This pattern persisted through the blastocyst stage and was also evident when
comparing blastocysts to BDCs and fibroblast cells (Supplementary Figure 4.S3). Interestingly,
for scNT embryos, embryos segregated by developmental stage for all stages examined, from 2cell through blastocyst and for comparisons of blastocyst to BDCs and fibroblast donor cells
(Supplementary Figure 4.S4).
Ontology analysis of mRNA populations in IVF and scNT embryos
Results of biological process gene ontology analysis of mRNAs differentially expressed
in scNT versus IVF embryos at each developmental stage are summarized in Figures 4.4-4.8 and
in Supplementary File 4.3. Note that bar charts represent the top 20 terms (clustered by kappa
score for similarity) for each data set. At the 2-cell stage, the most significant terms and highly
enriched terms included “extracellular structure organization”, “plasma lipoprotein particle
clearance”, and “smooth muscle cell proliferation” (Figure 4.4). Notably, at the 8-cell stage, clear
trends in biological processes dysregulated in scNT embryos compared to IVF were evident, with
terms related to epigenetic control of gene expression highly enriched, including “covalent
chromatin modification” and “methylation” (Figure 4.5). Terms related to small or non-coding
RNA were also enriched at this developmental stage only, including “ncRNA metabolic process”,
“ncRNA transcription”, and “tRNA processing”. Also, terms related to RNA metabolism and
functions were also highly enriched, including “regulation of mRNA processing” (and variations
thereof), “RNA localization”, and “translation”. Last, two terms related to development were
associated with transcriptional dysregulation in scNT embryos, “chordate embryonic
development” and “stem cell population maintenance.” Of note, the enrichment scores and
significance p values were the highest and lowest for comparison of scNT to IVF embryos at the
8-cell developmental stage.
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After the EGA, the collection of biological processes associated with DEGs for scNT and
IVF morulae was distinct from the prior developmental stages, with enriched terms including
those associated with early nervous system development enriched (e.g., “dendrite development”,
“cell surface receptor signaling pathway involved in cell-cell signaling”, “positive regulation of
synaptic transmission”, and “signal release”) and cellular organization (“actin cytoskeleton
organization” and “mitochondrion organization”) (Figure 4.6). At the blastocyst stage, top
biological process terms for DEGs in scNT embryos included “synapsis”, “regulation of receptor
localization to synapse”, and “chloride transport” (Figure 4.7). Last, the array of terms associated
with differential expression in BDCs derived from scNT embryos compared to IVF included
many associated with metabolic processes, such as “aspartate family amino acid process”, “small
molecule catabolic process”, and “phosphatidylinositol metabolic process” (Figure 4.8) as well as
a few terms connected to development (“regulation of cell morphogenesis”, “head development”,
and “regulation of collateral sprouting”).
Ontology analyses were also performed for sets of DEGs for progressive comparison by
developmental stage (Supplemental Figures 4.S5 to S8). The most interesting feature of these
analyses in both IVF and scNT embryos was the identification of terms with functions relevant to
embryonic genome activation at the 8-cell developmental stage (Supplementary Figures 4.S6 and
4.S8), including “mRNA processing”, “RNA localization”, and “ncRNA metabolic process” as
examples. Also enriched at this stage were terms associated with “cellular response to stress”,
“DNA repair” and regulation of the cell cycle checkpoint (i.e., terms clustered with “signal
transduction by p53 class mediator” in scNT embryos or “response to cellular stress” in IVF
embryos). For comparisons beyond the 8-cell developmental stage, no significant enrichment in
ontology terms was noted for differentially expressed genes in either IVF or scNT embryos.
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Correlation of mRNA and miRNA expression in IVF and scNT embryos
As outlined in Chapter 3, several miRNAs were identified as differentially expressed in
scNT versus IVF cattle embryos. Here, we selected miR-34a and miR-345 for further
exploration, as these miRNAs have putative roles in early embryogenesis and they were
significantly over-expressed in scNT morula stage embryos compared to IVF. Relative
expression of these miRNAs was compared to a subset of mRNAs identified as predicted targets
as described above. Correlation plots were generated for the full set of predicted targets for each
miRNA and for a subset of transcripts that were identified as differentially expressed in scNT
versus IVF embryos at the morula stage. MiR-34a was significantly negatively correlated with
24 of the 57 predicted target mRNAs that were detected by this RNAseq experiment and
positively correlated with 17 other mRNAs (Supplementary Figure 4.S9). The strongest negative
relationship in expression was evident for genes ELMOD1, TMED8, PTPN4, TMCC3, MLLT1,
SIDT2, PNOC, RSPO4, SIX3, UHRF2, and EVI5L. When further refining this list to include only
those transcripts differentially expressed in scNT morulae, clear inverse relationship in expression
evident for RALGDS, AMER1, SIPA1, EVI5L, and HCFC2 (Figure 4.9; Supplementary Figure
4.S10). WNT2B was the only predicted target of miR-34a that was differentially expressed in
scNT morula embryos but not negatively correlated with miR-34a expression. A similar analysis
was performed for miR-345, however a clear trend toward negative correlations for this set of 104
target transcripts was not apparent (Supplementary Figures 4.S11). When the target transcript list
was filtered to include only those mRNAs differentially expressed in scNT morula stage embryos,
significant negative correlations were noted for SENP8, TINF2, CREBL2, NOSTRIN, VSX2,
GNB5, FHAD1, and PDK2 (Figure 4.9; Supplementary Figure 4.S12). Alternatively, no
correlation was evident for miR-345 and expression of HIGD1A or F3, and a positive correlation
was noted for EIF3L, suggesting that these mRNAs were not degraded by miR-345.
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Network analysis of differentially expressed miRNAs and
predicted mRNA targets
To determine whether predicted mRNA targets were inversely regulated by their miRNA
families, a Cytoscape network was created, where differentially expressed miRNAs in IVF and
scNT morula stage embryos are connected to their predicted mRNA targets. Of note, very few
mRNA transcripts were targeted by both miR-34a and miR-345 (Figure 4.10). As was noted for
the correlation analyses, these network visualizations show that the pattern of expression of
predicted mRNA targets is fairly mixed with no clear trend for decreased mRNA expression in
the context of elevated miRNA expression. Some exceptions are noted (medium- to dark-purple
mRNA nodes connected to yellow miRNA nodes), as was evident in the correlation analyses
(Supplementary File 4.4; Appendix O) contains resulting networks for changes in miRNA and
mRNA within type for stage transitions 8-cell to morula stage embryos and morula to blastocyst
stage embryos, as these were the only stage transitions with significantly different miRNA
expression profiles. These networks were all markedly more complex with many more
overlapping miRNA targets among the differentially expressed miRNAs, as more differences in
miRNA expression were noted when comparing by developmental stage than when comparing
scNT versus IVF embryo types. (No differentially expressed miRNAs were identified for oocyte
vs. 2-cell or for 2-cell vs. 8-cell stage comparisons for either IVF or scNT embryo types, and thus
networks were not generated.) When comparing 8-cell to morula stage IVF embryos, most
differentially expressed miRNAs were over-expressed in morulae (Supplementary File 4.4;
Appendix O); of those, a higher fraction of down-regulated transcripts was connected to miR214. However, each subnetwork was composed of a mix of up- and down-regulated transcripts
with no overwhelming trend toward suppression of mRNAs by an over-expressed miRNA or vice
versa. This pattern was also evident when examining the miRNA-to-mRNA network for IVF
blastocyst embryos (Supplementary File 4.4; Appendix O). Networks for scNT embryos
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transitioning from 8-cell to morula were also mixed in their expression profiles, though a greater
proportion of predicted targets for some miRNAs were inversely expressed, such as for miR-378d
or miR-138 (Supplementary File 4.4; Appendix O). Last, in the comparison of scNT morula- to
blastocyst stage embryos, many more miRNAs were under-expressed in the blastocyst embryos
(Supplementary File 4.4; Appendix O). However, the networks do not show a clear pattern of
corresponding over-expression for most mRNA targets. Rather, expression values for each of the
subnetworks of miRNA-to-mRNA targets appear fairly heterogeneous. In summary, for each of
these networks, only a fraction of the predicted mRNA targets depicts the anticipated inverse
expression pattern for the differentially expressed miRNA.
Discussion
The present study is the first to employ a discovery-based, RNA sequencing approach to
compare both sncRNAs and mRNAs transcriptional profiles of IVF and scNT embryos during the
MET in cattle. In addition, sncRNA sequencing was employed on the same samples,
demonstrating that small quantities of biological sample can be successfully utilized for both
sncRNA and mRNA sequencing approaches with the production of reasonable numbers of scNT
embryos. Our analysis of mRNA expression data revealed large-scale differences between IVF
and scNT embryos at each developmental stage examined. Aberrant expression of genes that
participate in developmentally important pathways could restrict the developmental competency
of scNT embryos. However, the overall transcriptional profiles primarily reflected the
developmental stage with pre-MET embryos, post-MET embryos, and more differentiated cells
harboring distinct patterns of mRNA expression. Though a core set of transcripts was shared
between differentiated fibroblasts and all embryo types, the clustering and principal components
analyses did not suggest that mRNA profiles of scNT embryos were broadly similar to their
donor cell fibroblasts. Previously, we determined that three miRNAs were differentially
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expressed in morula staged IVF and scNT embryos. Interestingly, results of this study revealed
the largest number of differentially expressed transcripts in IVF and clones also at the morula
stage. Taken together, these observations suggest that the greatest deviations in RNA expression
were manifest shortly after the EGA in cattle. By sequencing both large and small fractions of the
population of RNA molecules, this study provided us the ability to correlate expression patterns
of miRNAs and their putative mRNA targets in the same embryo samples. For two miRNAs
identified as differentially expressed in morulae, miR-34a and miR-345, negative correlations
with some predicted mRNA targets were apparent, as would be expected if these miRNAs
targeted the transcripts for repression or down-regulation. However, when considering the whole
population of potential targets, these negative correlations were not widespread, suggesting other
mechanisms controlling gene expression were likely at play .
Differences in transcript abundance detected at the 2-cell stage reflect populations present
in the oocyte and transcripts originating from either the sperm for IVF embryos or donor cell for
scNT embryos. At the 2-cell stage, differentially expressed transcripts were associated with key
functions in early development, as exemplified by FGF7, which was expressed at higher levels in
scNT embryos and contributes to embryonic development, cell growth, and morphogenesis [66].
PRRX1 was also more highly expressed in scNT embryos and is a member of the homeobox
family, acting as a transcription co-activator for growth and differentiation factor response.
Interestingly, there is evidence for post-transcriptional regulation of PRRX1 gene in embryos
[67]. Genes that were under-expressed in scNT 2-cell stage embryos included CATSBER, a gene
required for sperm motility transcripts of which were likely provided by sperm in the IVF
embryos [68]. Collectively, differentially expressed transcripts in 2-cell embryos were associated
with biological functions related to cell proliferation, division, and growth. However, as some
cyclins and cyclin dependent kinases appear to be dispensable at this stage, it is possible that
changes in these pathways in scNT embryos do not negatively impact development until later in
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development [69]. Differentially expressed transcripts in scNT embryos were also associated
with ontology terms “smooth muscle proliferation” and “epithelial cell proliferation”, which may
be derived from the differentiated fibroblast nuclear donor causing aberrant expression in scNT
embryos. In addition, enriched terms included positive regulation of PI3K signaling, which is a
key pathway to control cellular differentiation in the embryo; loss of this pathway is embryonic
lethal [70].
In cattle, the EGA occurs at the 8-cell stage, and abnormalities in gene expression during
this critical transition at could impair the developmental competence of scNT embryos. Several
developmentally important genes were up-regulated in scNT 8-cell stage embryos, including
YAP1, which restricts proliferation and promotes apoptosis [71], as well as continued overexpression of FGF7. Of particular interest was the apparent over-expression of DICER1 and
DROSHA in scNT 8-cell embryos, as these genes code for key biogenesis proteins involved in
processing miRNA. Thus, one may expect excess miRNA biogenesis in 8-cell scNT embryos,
although we did not detect a significant over-abundance of any specific miRNA at this stage
(Chapter 3). However, it is possible that the lack of differential miRNA expression was due to the
apparent down regulation of XPO1 in the scNT embryos, as this transcript codes for EXPORTIN
1. Although EXPORTIN 5 is the primary Exportin protein responsible for pre-miRNA export
into the cytoplasm, EXPORTIN 1 promotes the processing of pri-miRNA to pre-miRNA in C.
Elegans and Drosophila [72]. NOBOX was also expressed at higher levels in scNT embryos
compared to their IVF counterparts at the 8-cell stage; this gene is oocyte-specific and degraded
by the miRNA miR-196a [73]. That NOBOX was higher in 8-cell embryos but miR-196a was not
correspondingly decreased, suggests that the abundance of this miRNA may have been
insufficient to effectively target NOBOX transcripts, or possibly other miRNAs may cooperate in
its down regulation. (Incidentally, the TargetScan database does not map any known cattle
miRNAs as targeting NOBOX transcripts.) DPPA2 (developmental pluripotency associated 2)
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expression was decreased in 8-cell scNT embryos; this developmentally-important gene was
shown to be necessary for the activation of the first group of genes activated in EGA in mice [74].
It is possible that down-regulation of DPPA2 in scNT embryos would delay the onset of EGA and
may interfere with proper genome reprogramming. Interestingly, down-regulated genes in scNT
embryos at the 8-cell stage also included NANOG, a key pluripotency factor [75]. NANOG is
critical for maintenance of pluripotency in stem cells and represses differentiation of early
embryonic cells in a multifaceted manner, as NANOG is both an activator and repressor of
multiple gene targets of pluripotency and differentiation [76]. Though OCT4 has been shown to
be required for NANOG expression in bovine embryos [77], expression of this gene was not
significantly different in IVF and scNT embryos at the 8-cell stage, suggesting other mechanisms
may be responsible for altering NANOG expression. Aberrant expression of this key
transcriptional factor could greatly compromise the developmental competence of scNT embryos,
especially occurring at the MET when embryonic transcripts must be regulated carefully. Also of
interest was the apparent over-expression of NOTCH2 in 8-cell scNT embryos, as this gene is
involved in cell fate determination in early embryogenesis.
In a previous study using RNAseq to explore transcriptional changes associated with
EGA in bovine embryos, Graf et al. determined that embryonic genes activated at the 8-cell stage
were involved in “DNA dependent transcription”, “purine nucleotide metabolic processes”,
“translational initiation”, and “RNA metabolic process” by ontology analysis [19]. These
annotated biological processes correlate with the major events of the MET, such as transcriptional
initiation and translation, and the degradation of maternally stored transcripts and proteins.
Results from this RNAseq comparison of IVF and scNT embryos suggest major dysregulation for
genes critical for embryonic genome activation, including “mRNA processing”, “ncRNA
metabolic process”, “RNA localization and regulation of mRNA metabolic process.” Of note,
differentially expressed genes in scNT 8-cell embryos were associated with “ncRNA metabolic
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process”, “tRNA processing”, and “ncRNA transcription,” which would suggest potential
aberrant control of the production of non-coding RNA molecules, including sncRNAs. However,
RNAseq of the population of sncRNAs in scNT embryos did not reveal large scale, consistent
differences in relative abundance of miRNA, tRNA fragments or piRNAs at this developmental
stage. If such aberrations in the population of sncRNAs did occur, they may have been random in
nature. Also, aberrant gene expression in scNT 8-cell embryos was associated with
dysregulation of mRNA processing, mRNA metabolism, and RNA localization, an observation
that aligns well with the very large shift in transcript abundance observed subsequently in morula
stage scNT embryos.
Several transcripts that were noted as under-expressed in 8-cell scNT embryos compared
to stage-matched IVF controls were noted as over-expressed in scNT embryos at the morula
developmental stage, pointing to dynamic dysregulation of their expression. These transcripts
included EIF3D, which functions to initiate translation, and EI24, which is involved in P53mediated apoptosis. Another example includes XPO1 (exportin), which was down-regulated in 8cell scNT embryos, but over-expressed in clones at the morula stage. Conversely, the inverse
expression pattern was noted for the miRNA biogenesis genes DICER and DROSHA, which were
higher in 8-cell scNT embryos, but lower in scNT morulae compared to their stage-matched IVF
controls. This pattern of expression may explain the apparent differential expression of some
miRNAs in scNT morula embryos. Moreover, although expression of NOBOX was higher in 8cell scNT embryos, this transcript was significantly lower in morula scNT embryos, perhaps as a
consequence of elevated (though not significantly so) expression of miR-196a.
Some genes down regulated in morula stage scNT embryos are involved in epigenetic
control of gene expression, including histone modifiers, chromatin-binding proteins, and control
of DNA methylation (e.g., KDM6A, SUV39H1, SUV39H2, KDM1B, HDAC7, MBD1, MBD5,
METTL3, and TRIM28). TRIM28 is required for genomic imprinting through the establishment
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and maintenance of DNA methylation marks, even after genome reprogramming [78], and loss of
TRIM28 in bovine scNT embryos causes loss of methylation in imprinted genes [79]. Errors in
epigenetic coding of imprinted genes are a known problem in scNT embryos and could cause
lower developmental rates as well as often observed placental abnormalities [77]. TDRD1 and
TDRD5 encode transcripts that repress transposable elements and form complexes with piRNA
and PIWI proteins in spermatogenesis [80]; interestingly, expression of these genes was down
regulated in scNT morula staged embryos. Importantly, higher retrotransposon expression has
been observed in scNT embryos, and loss of these transcripts may contribute to that issue [81].
As the largest differences in expression of piRNAs were noted when comparing IVF and scNT
embryos at the morula stage, the changes in expression of TDRD1 and TDRD5 transcripts are of
key functional interest and warrant further investigation. Lastly, Graf et al. observed that genes
with functions connected to basic metabolic processes were activated shortly after the EGA in 16cell cattle embryos [19]. Of note, our analyses revealed that differential expression of transcripts
in scNT embryos at the morula stage included many genes connected to cellular processes such as
“small GTPase mediated signal transduction”, “actin cytoskeleton organization”, and
“mitochondrial organization.” Aberrant regulation of key metabolic and cellular function
pathways in scNT embryos after the MET could contribute to the high loss of scNT embryos
during early development and further impact successful implantation and placentation of these
embryos following transfer to recipient animals.
While a remarkable number of transcripts were differentially expressed in morula stage
scNT embryos, many fewer were noted by the blastocyst stage of development. This difference
could be attributed to an element of natural selection, such that embryos harboring large scale
aberrations in gene expression were not sufficiently competent to develop to the blastocyst stage
and instead arrested their development. Functions of those genes that were significantly different
in scNT blastocysts appeared connected to general functions, such as “cyclic nucleotide
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metabolic process”, “synapsis” and “chloride transport.” Overall, the relatively low enrichment
values for differentially expressed genes in blastocyst stage scNT embryos suggest that those that
progress to this developmental stage harbor fewer overall differences compared to their stagematched IVF counterparts than did earlier stages evaluated. However, these persistent
dysregulated pathways may yet contribute to embryo loss post embryo transfer. Interestingly,
HAND1 was down regulated in scNT blastocyst stage embryos; this transcriptional factor is
required for placental development through promotion of differentiation in trophoblast giant cells
[82]. HAND1 has been shown previously to be reduced in scNT bovine embryos at day 17 [83],
and may be connected to some of the placental aberrations commonly found in scNT pregnancies.
Our main objective in collecting sncRNA and mRNA sequencing data from the same
embryo samples was to correlate differences in expression of specific miRNAs in scNT embryos
with abundance of their predicted mRNA transcripts over the course of early development. Our
approach here was similar to that as we employed previously for sncRNA sequencing data and
published transcriptome data for mRNA expression in 8-cell and blastocyst embryos [84].
However, as discussed above, relatively few significantly different miRNAs were identified in
scNT embryos, with only three differentially expressed miRNAs noted at the morula stage.
Interaction networks were constructed for these miRNAs and their TargetScan predicted targets.
Within the morula stage embryo network, we noted that miR-34a had the most mRNA targets.
MiR-34a has been demonstrated to control cell fate and differentiation, as knock down of its
expression in pluripotent stem cells expanded cell fate potential [85]. Even though miR-34a was
under-expressed in scNT morulae, a broad pattern of over-expressed mRNA targets was not
dominant at this developmental stage. However, the expression of a subset of these predicted
targets was indeed strongly negatively correlated with miR-34a over the entire window of embryo
development studied (2-cell to blastocyst stage). Of these gene targets, many had regulatory
functions in cancer (e.g., AMER1, RALGDS, and SIPA1) suggesting possible function in
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controlling pluripotency and cell fate [86-88]. A smaller network of predicted targets was
identified for miR-345, and a similar trend was noted with the expression of only a fraction of the
targets inversely correlated with this miRNA. To date, no evidence specifically points to a role
for miR-345 in early development, although this miRNA is known to suppress proliferation,
migration and invasion in cancer cells [89]. We also considered the pattern of expression for
miR-345 over the full window of early development and correlated expression with predicted
gene targets. Of those genes with the expected inverse expression pattern from 2-cell to
blastocyst stage, PDK1 is particularly interesting as this gene codes for a master kinase that is
required for normal development, [90] and promotes somatic reprogramming efficiency through
functions in self-renewal and differentiation in embryonic stem cells [91]. A similar pattern was
evident for NOSTRIN, which modulates the differentiation of trophoblast giant cells as they begin
to differentiate from trophoblast stem cells [92]. While miR-2340 was identified as significantly
differentially expressed in morula scNT embryos, predicted targets of this miRNA overlapped
entirely with miR-34a and miR-345; also, this miRNA does not have a known homologue in
humans or mice. Moreover, although its expression was statistically significant, we noted that
response was largely driven by a single sample.
Overall, the miRNA-mRNA networks did not suggest broad inverse patterns of
expression as would be predicted given the role of miRNAs to degrade mRNA transcripts. This
pattern was evident when considering interaction networks for differentially expressed transcripts
in scNT embryos compared to their IVF counterparts at specific developmental stages as
described above, or when comparing differentially expressed transcripts at progressive
developmental stages (e.g., morula vs. 8-cell IVF embryos). However, interpretation of RNAi
mediated regulation is complicated by a lack of one-to-one regulation of miRNAs and mRNAs.
As seen in the networks, multiple miRNAs can target a single mRNA transcript, and individual
miRNAs may have hundreds of mRNA targets. The complexity of how miRNAs interact with
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targets was exemplified by the network generated for transcripts at the morula-to-blastocyst
transition, as the highly intricate map shows overlap in many targeted transcripts between three or
four miRNAs. The lack of a dominant pattern of negative correlation between miRNAs and
predicted target mRNAs may be explained by the influence of other regulatory factors, such as
RNA-binding proteins, which can allow some mRNA targets to escape repression through
mediation of binding between miRNAs and the 3’ untranslated region (UTR). As an example,
Dead end homologue 1 (DND1) binds to mRNAs containing an AU-rich element in the 3′
untranslated region, blocking miRNA binding to this site. DND1 is abundant in pig oocytes and
early developing embryos, and is down-regulated at the MET [93]. DND1 may function in early
development to protect developmentally important genes from degradation before the activation
of the embryonic genome, as DND1 is functionally capable of binding pluripotency genes vital
during early development [93]. It likely that miRNA targeting of transcripts for degradation is a
combination of degradation signals from miRNA and interactions with RNA-binding proteins, as
opposed to a simple one-to-one matching process [94]. Also, it is possible that the TargetScan
prediction algorithm is not accurately predicting mRNA targets for these mRNAs, or that multiple
miRNA species are necessary to degrade these transcripts. Lastly, the lack of broad-scale
negative correlations may be attributed to the timing for comparisons. Herein, the network for
miRNA-mRNA interactions was visualized using time-matched data from the same
developmental stage. However, this approach would not fully capture delayed degradation of
mRNA targets, which has been detected up to 32 hours after miRNA induction [95].
Of particular interest was the vast scale of transcriptional changes associated with the
later developmental transitions from 8-cell to morula and morula to blastocyst stages, with
thousands of DEGs identified, even while controlling for type I errors. We explored these lists of
DEGs in context of the report by Graf et al. [19], who applied RNAseq methods to determine the
timing of EGA in cattle IVF embryos. Comparing the lists of genes that were induced during
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embryo development, our numbers are not out of line with those reported by Graf et al., although
their stage comparisons were slightly different. For example, 1,937 genes were induced over the
transition from 2-cell to 8-cell stage in this study compared to 1,296 genes for the transition from
4-cell to 8-cell stage in Graf et al. Similarly, 2,980 genes were induced when transitioning from
8-cell to morula stage in IVF embryos in this study as compared to 2,943 genes for the transition
from 8-cell to 16 cell in Graf et al. Interestingly, we did identify many more up-regulated
transcripts when comparing oocytes to 2-cell embryos in this study than did Graf and coworkers
[19], though our study design did not facilitate distinction of maternal transcripts from those
newly produced by the embryo. Thus, our data from the 2-cell stage also captures maternal genes
that had undergone polyadenylation and been protected from active degradation pathways in very
early development, likely inflating the number of over-expressed genes.
There were several limitations in this study that should be considered. Due to the small
amount of genetic material in the developing embryos, pools of embryos were necessary for RNA
sequencing. The use of pooled samples can mask the biological variability of individual embryos,
and, conversely, an extreme outlier can shift the RNA population of the pool. In our studies,
marked variability was noted for sncRNA profiles, though less so for the mRNA profiles of the
same samples. Embryos were staged based on their morphology, though others have shown that
blastocyst stage embryos with similar morphology can harbor distinct transcriptomes [96].
Populations of sncRNAs could also differ for embryos with similar morphologies. Another
possibility to consider is that the sex of the IVF embryos contributed to some variation in gene
expression after the EGA. Others have reported sex-based differences in expression of both
miRNA and mRNA, with up to one third of expressed transcripts demonstrating sex-specific
transcriptional regulation in bovine preimplantation embryos [97]. Also, bovine blastocysts
showed sexual dimorphism in secreted miRNAs [98]. While IVF embryos were created using a
single bull’s semen, the semen was not sex sorted. Thus, the sample pools for IVF embryos
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contained both males and females, whereas the pools of scNT were exclusively male. Moreover,
IVF embryo samples would also be impacted by sperm-specific transcripts and sncRNAs. Last,
culture conditions could have increased variability within embryos as well, as cumulus cell
transcriptomes and secreted factors can vary from oocyte to oocyte [99, 100].
In conclusion, major differences were observed in the transcriptomes of scNT and IVF
embryos at every stage through the MET. Importantly, we identified a cohort of genes
differentially expressed in scNT embryos during the EGA that function in epigenetic control of
gene expression, processing of sncRNA and processing of mRNAs. To our knowledge, our
group is the first to assess the dynamics of sncRNA and mRNA populations derived from the
same scNT embryos through the MET. When comparing the dynamics of specific miRNAs and
populations of predicted targets, negative correlations were not widespread, suggesting other
mechanisms controlling gene expression were likely responsible for the large-scale aberrant
transcript expression in scNT embryos. Such mechanisms may involve abnormal patterns of
DNA methylation or chromatin modification, as others have noted in scNT embryos. Moreover,
expression of sncRNA loci in scNT embryos may also be impacted by poor reprogramming of
these epigenetic marks, although results from this work suggest that such changes in miRNA
expression may be more random than for transcripts, as we identified many fewer significantly
differentially expressed miRNAs than mRNAs within the same RNA population. Additionally,
further study is needed to better explore the complex network of miRNA-mRNA interactions,
given that an individual miRNA may have many hundreds of gene targets and a transcript may be
targeted by multiple miRNAs. Also, future studies should consider the added complexity of RNA
binding proteins that restrict access to transcripts and block miRNA-mediated repression or
degradation.
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Figure 4.1. Overlap in detection of all mapped mRNAs in bovine oocytes and donor fibroblast
cells as well as early developing embryos and blastocyst-derived cells generated via IVF or scNT.
Proportional Venn diagrams depicting mapped to the Bos Taurus transcriptome, including unique
and overlapping transcript IDs. (A) mRNAs identified by sequential comparison of
developmental stages for IVF or scNT embryos. (B) mRNAs identified in IVF, scNT and either
oocytes or donor fibroblast cells at each developmental stage.
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Figure 4.2. Distribution of the number of significantly different genes by embryo type or
developmental stage. (A) Number of significantly different genes down-regulated (left) or upregulated (right) in scNT embryos as compared to their stage-matched IVF counterparts. (B)
Number of genes down-regulated (left) or up-regulated (right) in IVF or scNT embryos by
sequential comparison of developmental stage. A significant difference in gene expression was
inferred when the FDR adjusted p-value <0.05.
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Figure 4.3. Patterns of mRNA expression in bovine oocytes and donor fibroblast cells as well as
early developing embryos and blastocyst-derived cells generated via IVF or scNT. (A) Principal
components analysis of bovine miRNAs using the standard singular value decomposition method
with imputation. (B) Unsupervised, bi-directional hierarchical cluster analysis (Euclidean
distance method) of variance stabilized normalized read counts for a subset of 2,400 randomly
chosen mRNAs. Data were categorized by sample type (Fb, fibroblast; Oo, oocyte; IVF, in vitrofertilized embryo; scNT, scNT embryo) and stage (2c, 2-cell; 8c, 8-cell; Mo, morula; Bl,
blastocyst; BDC, blastocyst-derived cells).
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Figure 4.4. Significant biological process ontology terms and network clustering associated with
significantly different genes in bovine scNT versus IVF 2-cell stage embryos. (A) Bar chart
depicts the top 20 enriched summary terms identified for ontology biological processes. (B)
Cytoscape network depicting biological process ontology terms represented as nodes connected
with terms with shared differentially expressed genes. The size of the node is proportional to the
term’s enrichment score. Terms with a similarity score >0.3 are similarly colored and linked by
an edge (the thickness of the edge represents the similarity score) using force-directed network
layout and bundled edges for clarity. Each cluster is labeled by the term with the lowest p-value
within the cluster group. Complete results of the Metascape analysis are provided in
Supplementary File 4.3.
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Figure 4.5. Significant biological process ontology terms and network clustering associated with
significantly different genes in bovine scNT versus IVF 8-cell stage embryos. (A) Bar chart
depicts the top 20 enriched summary terms identified for ontology biological processes. (B)
Cytoscape network depicting biological process ontology terms represented as nodes connected
with terms with shared differentially expressed genes. The size of the node is proportional to the
term’s enrichment score. Terms with a similarity score >0.3 are similarly colored and linked by
an edge (the thickness of the edge represents the similarity score) using force-directed network
layout and bundled edges for clarity. Each cluster is labeled by the term with the lowest p-value
within the cluster group. Complete results of the Metascape analysis are provided in
Supplementary File 4.3.
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Figure 4.6. (prior page) Significant biological process ontology terms and network clustering
associated with significantly different genes in bovine scNT versus IVF morula stage embryos.
(A) Bar chart depicts the top 20 enriched summary terms identified for ontology biological
processes. (B) Cytoscape network depicting biological process ontology terms represented as
nodes connected with terms with shared differentially expressed genes. The size of the node is
proportional to the term’s enrichment score. Terms with a similarity score >0.3 are similarly
colored and linked by an edge (the thickness of the edge represents the similarity score) using
force-directed network layout and bundled edges for clarity. Each cluster is labeled by the term
with the lowest p-value within the cluster group. Complete results of the Metascape analysis are
provided in Supplementary File 4.3.
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Figure 4.7. Significant biological process ontology terms and network clustering associated with
significantly different genes in bovine scNT versus IVF blastocyst stage embryos. (A) Bar chart
depicts all enriched summary terms identified for ontology biological processes. (B) Cytoscape
network depicting biological process ontology terms represented as nodes connected with terms
with shared differentially expressed genes. The size of the node is proportional to the term’s
enrichment score. Terms with a similarity score >0.3 are similarly colored and linked by an edge
(the thickness of the edge represents the similarity score) using force-directed network layout and
bundled edges for clarity. Each cluster is labeled by the term with the lowest p-value within the
cluster group. Complete results of the Metascape analysis are provided in Supplementary File
4.3.
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Figure 4.8. Significant biological process ontology terms and network clustering associated with
significantly different genes in bovine BDCs derived from scNT versus IVF embryos. (A) Bar
chart depicts the top 20 enriched summary terms identified for ontology biological processes. (B)
Cytoscape network depicting biological process ontology terms represented as nodes connected
with terms with shared differentially expressed genes. The size of the node is proportional to the
term’s enrichment score. Terms with a similarity score >0.3 are similarly colored and linked by
an edge (the thickness of the edge represents the similarity score) using force-directed network
layout and bundled edges for clarity. Each cluster is labeled by the term with the lowest p-value
within the cluster group. Complete results of the Metascape analysis are provided in
Supplementary File 4.3.
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Figure 4.9. Spearman correlation plots for miRNAs and select predicted mRNA target genes.
Significant correlation values (p <0.05) are represented by colored dots according to the scale,
with positive correlations in blue and negative correlations in red. Only mRNA predicted targets
that were differentially expressed in scNT and IVF morula staged embryos are shown, although
the correlation analyses used all expression data for all developmental time points.
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Figure 4.10. (prior page) Network of differentially expressed miRNAs in morula stage embryos
and the expression of predicted mRNA targets. A network of miRNA differentially expressed in
scNT morula stage embryos as compared of IVF morula stage embryos, and their expressed
predicted mRNA targets (TargetScan total context ++ score <−0.35) was created using Cytoscape
with a force-directed layout. Only miRNAs within families annotated by TargetScan as conserved
or broadly conserved were included in the network analysis. MiRNAs are represented by squares
and colored according to their relative abundance in scNT morula stage embryos as compared to
IVF morula stage embryos, and target mRNAs are shown as circles and colored by their
expression in scNT morula stage embryos as compared to IVF morula stage embryos using
RNAseq data collected from the same samples (values are log2 fold change of normalized reads).
Edges between miR and mRNA nodes indicate that the connected mRNA is a predicted target of
the miRNA in Bos taurus.
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Table 4.1. Differentially abundant mRNA transcripts
Cattle
Comparison
mRNAs
Top 20 mRNA IDs
IVF vs. NT
2-cell

113

ASPN, ECM2, MEDAG, PRRX1, FGF7, COL6A3,
BGN, S100A4, LOC534578, BEX2, CLCA3,
LOC616308, LOC511494, ZSCAN4, SLC6A6, TMC6,
LOC520023, CYP11A1, SLC35D2, KCNE4

8-cell

1,539

CALML5, GALR1, CACNA2D4, ATP6V0D2, CD48,
SDS, SLC28A2, STC2, CXCL2, IGSF5, TACR3,
GPR171, TENT5D, KRT15, LOC781486, GRO1,
LOC789301, C15H11orf34, LOC786811, INSL3

Morula

2,140

ENPP6, LOC507550, BEST3, MZB1, FADS6, SRRM4,
KRT73, DNER, GRIA3, RBFOX1, RBP7, GPR34,
KLHL31, CSN3, ADAMDEC1, PRRX1, KRT1, NAPRT,
DPT, C16H1orf158

Blastocyst

289

GIMAP4, GSTA3, GABRB3, AGMO, WNT11, ACTL8,
LOC524236, CXCL14, LOC614881, ST6GALNAC1,
NPSR1, LOC619094, GABRB1, FAM216B, CSN3,
C16H1orf158, BCL11B, BHMT, CD8B, TPH1

BDC

283

GRIN2B, LOC781494, DCDC1, LOC617219,
LOC785803, CRHBP, OXT, FAM216B, NETO1,
FGF12, WSCD1, TMEM176B, TMEM176A, MRO,
IGSF11, ZBTB16, DMRTA1, LIN7A, ASIP, CYP19A1

Oo vs. 2c

1,400

PTGES, LOC511494, LOC616308, APOA1, BCHE,
LOC281376, COL11A1, LOC789138, VILL, XCL1,
TAGLN, LOC100299783, MSC, ATP1A2, ADPRHL1,
COL5A2, LOC520034, CLCA3, KLF17, TMEM26

2C vs. 8c

2,977

TFAP2C, RET, MIR371, ZFP42, MYOD1, CT55,
LOC782781, TENT5D, GALR1, ESRRB, SLC34A2,
CNR2, KCNK5, FOLR1, MEDAG, LOC617141, SCTR,
ETNPPL, NANOG, INSL3

8c vs. Mo

7,106

INSL3, MMP3, BRB, MPZ, CHI3L2, GDPD2, CRCT1,
IL27, SPIC, PLAC8, NUPR1, FCGR2B, LOC520336,
SUSD2, PECAM1, S100A5, WNT6, SMPDL3A,
LOC528262, MAG

Developmental Stage
IVF embryos

301
Mo vs. Bl

6,678

NLRP9, LBX1, RGS2, WEE2, SOX5, PRKG2, LRMP,
UBASH3A, OXT, KRT73, IL18RAP, FAM216B,
POPDC3, LOC783399, CLDN8, PAG2, CCL24,
PRSS8, RBBP8NL, LOC508879

Bl vs.
BDC

8,814

PAG11, GJB6, TKDP4, S100G, NUDT11, FGF12,
RBM24, NETO1, CRHBP, WSCD1, INSL3, OXT,
LOC516378, POU5F1, SPIC, BRB, ZAP70, DPPA2,
OTX2, LOC528262

2C. vs Fib

12,471

CCN3, ESM1, S100A4, CCN5, BGN, PRRX2, COL6A3,
BTG4, NEFL, SALL4, KCNN3, KPNA7, EIF4E1B,
NLRP8, MOS, LOC100301263, WEE2, ACCSL,
BMP15, NLRP14

scNT embryos
Oo vs. 2c

696

TFCP2L1, TLL2, A4GALT, BEX2, MBD3L3, PRRX1,
S100A4, BGN, NOV, AEBP1, FGF7, COL3A1,
COL6A3, LOC281376, COL11A1, EMP1, THBD,
ECM2, TFPI2, OMD

2C vs. 8c

1,092

BEX2, KLHL31, LOC534578, LOC616308, CLCA3,
FOLR1, LOC789138, LOC617709, KLF17,
LOC525100, LOC100139585, LOC520023,
LOC782781, LOC616911, BECN2, LOC525101,
LOC530538, MBD3L3, LOC520034, ZSCAN4

8c vs. Mo

10,942

CYP4A22, B3GNT6, FGFR4, CHI3L2, CLDN6, CSN3,
EIF1AY, LOC615989, SLC39A2, RNASE1, SPIC,
LOC785540, BRB, S100A5, LOC100847738, KRT1,
LOC528262, CD48, ATP6V0D2, KLHL31

Mo vs. Bl

5,859

C26H10orf90, LOC100139585, POPDC3, GABRB1,
CHRM3, KLHL31, CCL17, PAG2, CLDN8,
C9H6orf58, CCL22, PRSS8, MYL7, PRSS22, CLDN23,
HNF4A, ZBTB42, SULT1E1, GPR34, SLC9A3

Bl vs.
BDC

8,623

MMP9, TKDP4, GABRB1, S100G, IGSF11, NUDT11,
TMEM176B, LIN7A, TMEM176A, ZBTB16, MRO,
RBM24, DMRTA1, INSL3, LOC516378, SPIC, DPPA2,
CFAP54

2C vs. Fib

13,049

BTG4, NEFL, LOC100848540, KCNN3, MBD3L3,
SALL4, KPNA7, LOC101904481, EIF4E1B, MOS,
WEE2, NLRP8, ACCSL, NLRP14, LOC100301263,
DPPA3, BMP15, LHX8, NPM2, HHIP
Complete results of DESeq2 differential expression analyses for miRNAs are provided in
Supplementary File 4.2. Abbreviations are: Oo, oocyte; 2c, 2-cell; 8c, 8-cell; Mo, morula; Bl,
blastocyst; BDC, blastocyst-derived cells; Fb, fibroblast; IVF, in vitro-fertilized; scNT, somatic
cell nuclear transfer; miRNA, microRNA; ID, identification number.
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Supplementary Figure 4.S1. Dynamic expression of selected mRNAs of interest in early
developing IVF and scNT embryos, oocytes and fibroblasts. Values shown are the normalized
reads per million. * p <0.05 for IVF vs. scNT as determined by DESeq2 analysis. Differential
expression by embryo stage is summarized in Supplementary File 4.2. Fb, fibroblast; Oo, oocyte;
IVF, in vitro-fertilized embryo; scNT, scNT embryo; 2c, 2-cell; 8c, 8-cell; Mo, morula; Bl,
blastocyst; BDC, blastocyst-derived cells.
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Supplementary Figure 4.S2. (prior page) Patterns of mRNA expression in IVF and scNT
embryos at each developmental stage. (A) Unsupervised, bi-directional hierarchical cluster
analysis (Euclidean distance method) of variance stabilized normalized read counts for mRNAs
identified as significantly different between embryos of the same stage and different types. Data
were categorized by sample type (IVF, in vitro-fertilized embryo; scNT, scNT embryo) and stage
(2c, 2-cell; 8c, 8-cell; Mo, morula; Bl, blastocyst; BDC, blastocyst-derived cells). (B) Principal
components analysis of bovine mRNAs significantly different for the stage transition, using the
standard singular value decomposition method with imputation.
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Supplementary Figure 4.S3. Patterns of mRNA expression in IVF embryos with comparisons
by developmental stage. (A) Unsupervised, bi-directional hierarchical cluster analysis (Euclidean
distance method) of variance stabilized normalized read counts for mRNAs identified as
significantly different between embryos of the same stage and different types. Data were
categorized by sample type (IVF, in vitro-fertilized embryo; scNT, scNT embryo) and stage (2c,
2-cell; 8c, 8-cell; Mo, morula; Bl, blastocyst; BDC, blastocyst-derived cells). (B) Principal
components analysis of bovine mRNAs significantly different for the stage transition, using the
standard singular value decomposition method with imputation.
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Supplementary Figure 4.S4. (prior page) Patterns of mRNA expression in scNT embryos with
comparisons by developmental stage. (A) Unsupervised, bi-directional hierarchical cluster
analysis (Euclidean distance method) of variance stabilized normalized read counts for mRNAs
identified as significantly different between embryos of the same type and subsequence stages.
Data were categorized by sample type (Fb, fibroblast; Oo, oocyte; IVF, in vitro-fertilized embryo;
scNT, scNT embryo) and stage (2c, 2-cell; 8c, 8-cell; Mo, morula; Bl, blastocyst; BDC,
blastocyst-derived cells). (B) Principal components analysis of bovine mRNAs significantly
different for the stage transition, using the standard singular value decomposition method with
imputation.
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Supplementary Figure 4.S5. Significant biological process ontology terms and network
clustering associated with significantly different genes in bovine 2-cell IVF embryos compared to
oocytes. (A) Bar chart depicts the top 20 enriched summary terms identified for ontology
biological processes. (B) Cytoscape network depicting biological process ontology terms
represented as nodes connected with terms with shared differentially expressed genes. The size
of the node is proportional to the term’s enrichment score. Terms with a similarity score >0.3 are
similarly colored and linked by an edge (the thickness of the edge represents the similarity score)
using force-directed network layout and bundled edges for clarity. Each cluster is labeled by the
term with the lowest p-value within the cluster group. Complete results of the Metascape analysis
are provided in Supplementary File 4.3.
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Supplementary Figure 4.S6. Significant biological process ontology terms and network
clustering associated with significantly different genes in bovine 8-cell versus 2-cell IVF
embryos. (A) Bar chart depicts the top 20 enriched summary terms identified for ontology
biological processes. (B) Cytoscape network depicting biological process ontology terms
represented as nodes connected with terms with shared differentially expressed genes. The size
of the node is proportional to the term’s enrichment score. Terms with a similarity score >0.3 are
similarly colored and linked by an edge (the thickness of the edge represents the similarity score)
using force-directed network layout and bundled edges for clarity. Each cluster is labeled by the
term with the lowest p-value within the cluster group. Complete results of the Metascape analysis
are provided in Supplementary File 4.3.
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Supplementary Figure 4.S7. Significant biological process ontology terms and network
clustering associated with significantly different genes in bovine 2-cell scNT embryos compared
to oocytes. (A) Bar chart depicts the top 20 enriched summary terms identified for ontology
biological processes. (B) Cytoscape network depicting biological process ontology terms
represented as nodes connected with terms with shared differentially expressed genes. The size
of the node is proportional to the term’s enrichment score. Terms with a similarity score >0.3 are
similarly colored and linked by an edge (the thickness of the edge represents the similarity score)
using force-directed network layout and bundled edges for clarity. Each cluster is labeled by the
term with the lowest p-value within the cluster group. Complete results of the Metascape analysis
are provided in Supplementary File 4.3.
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Supplementary Figure 4.S8. Significant biological process ontology terms and network
clustering associated with significantly different genes in bovine 2-cell versus 8-cell scNT
embryos. (A) Bar chart depicts the top 20 enriched summary terms identified for ontology
biological processes. (B) Cytoscape network depicting biological process ontology terms
represented as nodes connected with terms with shared differentially expressed genes. The size
of the node is proportional to the term’s enrichment score. Terms with a similarity score >0.3 are
similarly colored and linked by an edge (the thickness of the edge represents the similarity score)
using force-directed network layout and bundled edges for clarity. Each cluster is labeled by the
term with the lowest p-value within the cluster group. Complete results of the Metascape analysis
are provided in Supplementary File 4.3.
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Supplementary Figure 4.S9. Spearman correlation plots for miR-34a and select predicted
mRNA target genes. Significant correlation values (p <0.05) are represented by colored dots
according to the scale, with positive correlations in blue and negative correlations in red.
Correlation analyses used all expression data for all developmental time points.
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Supplementary Figure 4.S10. Comparison of expression for miR-34a and selected mRNA
targets. Values shown are the normalized reads per sample for mRNAs, showing mean and +/SEM for transcripts predicted to be targeted by miR-34a and demonstrating a negative correlation
of expression in correlation plots. See Supplementary File 4.3 for statistical results for all
comparisons of interest.
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Supplementary Figure 4.S11. Spearman correlation plots for miR-345 and select predicted
mRNA target genes. Significant correlation values (p <0.05) are represented by colored dots
according to the scale, with positive correlations in blue and negative correlations in red.
Correlation analyses used all expression data for all developmental time points.
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Supplementary Figure 4.S12. Comparison of expression for miR-345 and selected mRNA
targets. Values are the normalized reads per sample for mRNAs, showing mean and +/- SEM for
transcripts predicted to be targeted by miR-345 and demonstrating a negative correlation of
expression in correlation plots. See Supplementary File 4.3 for statistical results for all
comparisons of interest.

CHAPTER 5
CONCLUSIONS

Deficiencies in cloned embryo development are likely the result of incomplete or
abnormal epigenetic reprogramming. Following somatic cell nuclear transfer (scNT), persistent
DNA methylation [1, 2] and histone profiles [3, 4] of the somatic donor cell are seen in the
resulting embryo. These aberrant epigenetic profiles are expected to lead to inappropriate gene
expression, likely causing the low developmental rates observed in scNT embryos [5]. Small
non-coding RNAs (sncRNAs) target and degrade messenger RNA (mRNA) through RNA
interference (RNAi). These sncRNAs are dynamically expressed through early development, and
it is possible that these regulatory molecules are also incompletely reprogrammed in scNT
embryos. In Chapter 2, our first hypothesis was that miRNAs would be more abundant in 8-cell
embryos at the start of the MZT and that abundant miRNAs would target maternal mRNAs with
important developmental functions associated with epigenetic programming and development. In
Chapter 3, we next we hypothesized that miRNAs found in the nuclear donor cell would be more
abundant in scNT embryos as compared to embryos produced via in vitro fertilization (IVF).
Also, we hypothesized that aberrant expression patterns of miRNAs in scNT embryos would
occur as compared to IVF embryos, and the sncRNA profile of the somatic donor cells would
persist in scNT embryos potentially due to incomplete reprogramming. Finally, in Chapter 4, we
hypothesized that transcripts derived from the maternal genome that need to be degraded for
successful MET would be aberrantly expressed in the scNT embryos at the 8-cell stage. In
addition, we hypothesized that samples found to have unique changes in miRNA populations
would also show a distinct transcriptome profile in transcripts predicted to be targets of those
unique miRNAs. The experimental approach involved the use of sncRNA sequencing on a pool
of IVF embryos from embryo developmental stages before, during, and after the MET. In a
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second experiment, we also performed RNA sequencing of both small and large RNA fractions
isolated from the same pool of samples, comprised of developmental stages before, during, and
after the MET in addition to somatic nuclear donor cells (fibroblasts) and blastocyst-derived cells
(BDCs). To examine the impact of specific miRNA errors on the transcriptome of the embryo
through the MZT, we aimed to identify sncRNA molecules aberrantly expressed bovine scNT
embryos, and to link those differences to abnormally expressed target transcripts.
We determined that pools of 20 embryos could be successfully used to isolate both large
and small RNA, and to generate good quality sequencing data. We found that sncRNA
populations were distinct at different stages of embryo development. Moreover, over the course
of development, the profile of scRNAs changed accordingly to the level of differentiation, within
the embryo type (IVF or scNT). However, no striking differences in the profile of sncRNAs were
evident when comparing scNT to IVF embryos for microRNAs (miRNAs), piwi-interacting
RNAs (piRNAs), and transfer RNA fragments (tRFs). However, a few statistically significant
differences were noted for several sncRNAs at the morula stage of development when comparing
scNT versus IVF embryos. Alternatively, large-scale differences in the transcriptome were
evident at multiple developmental stages when comparing scNT embryos to their IVF
counterparts, with the greatest number of differentially expressed genes noted at the morula stage,
coinciding with the developmental stage with significant alternations in sncRNAs. Ontology
analysis of these differentially expressed genes pointed to enriched biological process pathways
related to RNA processing and ncRNA pathways, suggesting that aberrant gene expression in
scNT embryos could negatively impact the EGA. Finally, through network mapping, potential
associations were examined between differentially expressed miRNAs and their predicted target
mRNAs. Overall, the expression patterns were not broadly inversely correlated as would be
anticipated for widespread miRNA target binding and degradation of the predicted targets. This
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observation suggests that the observed marked changes in mRNA abundance were not closely
tied to changes miRNA abundance in these embryos.
As in any study, this work had limitations. The first limitation concerns the accuracy of
prediction tools to tie miRNA changes to predicted target expression. Identifying miRNA targets
can be difficult as a single miRNA molecule may target hundreds of mRNAs, and one mRNA
may be targeted by multiple miRNAs [6]. Further complicating the miRNA-mRNA relationship,
the miRNA-mRNA network is influenced by regulatory factors that contribute to posttranscriptional gene silencing. RNA-binding proteins mediate binding between miRNAs and the
3’ untranslated region (UTR) in target transcripts, allowing those targets to escape repression.
One such protein is dead end homologue 1 (DND1), which binds to mRNAs containing an AUrich element in the 3′ UTR and blocks miRNA binding to this site. DND1 is abundant in early
developing embryos, although its expression is down-regulated at the EGA, the stage at which
maternal transcripts would require degradation. DND1 is also functionally capable of binding
pluripotency genes, which are vital during early development, and may protect developmentally
important transcripts from degradation before the embryonic stage at which they are functional
[7]. It is likely that the effectiveness of miRNAs targeting transcripts for degradation is a
combination of degradation signals from miRNA and interactions with RNA-binding proteins as
opposed to a simple one-to-one matching process [6]. However, the complexity of the miRNAmRNA binding code limits our ability to predict when a miRNA will repress expression of a
target mRNA.
The difference noted for expression of sncRNA in Chapter 2 and Chapter 3 may be due to
methodological differences in embryo sample collection and culture. Pools of oocytes or
embryos were required to obtain sufficient amounts of small RNA and mRNA for sequencing. In
our first study, pools of 40 embryos and oocytes were used. However, based on the robust results
of the first study, the subsequent experiment used pools of only 20 embryos. However, this two-
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fold variation in the number of embryos between pools in the two studies could mean that the
variability among individual embryos was more effectively masked in the first study. Pooling
can mask biological variability between individual embryos, making it difficult to identify
embryos that may represent outliers. Staged embryos were collected based on consistency in
morphology, however high quality morphology blastocyst stage embryos are known to express
variable transcriptomes [8], and one may also expect similar differences in sncRNA expression.
In this project, the same donor semen was used for all experiments, with the first study only
requiring two weeks to generate the total population of IVF embryos sequenced. Because the
second experiment required the generation of both IVF and scNT embryos, and additional
embryo stages were needed, the production of embryos occurred over the span of two years.
Given the short duration of collection for the first experiment, it is possible that the abattoir had
received cattle from a restricted geographical area or from the same breed, which could lead to
bias in the population of cattle from which oocytes were collected. Alternatively, over a two year
span, a range of cattle breeds from many regions of the U.S. and Canada would be expected to be
processed through the abattoir. Differences in breed, season of collection, and nutritional status
could influence variability in the transcriptome and sncRNA populations of the oocyte, and thus
the embryo, which would have been distributed broadly across samples in the project that
collected samples over two years. Heat stress has been shown to cause low quality of oocytes,
and therefore negatively impact embryo development [9], as well as to impact gene expression in
heat-stressed oocytes [10]. Oocyte quality, and therefore the transcriptome and sncRNA
populations of the resulting embryos, could be impacted by age, as pre-pubertal heifers and older
cattle oocytes contain differences in quality and gene expression [11, 12]. Follicular and oocyte
physiology, specifically oocyte gene expression and quality, are also likely impacted by
nutritional status, as differences based on under-nutrition, high protein diets more typical of dairy
cattle, and supplementation have been shown [13, 14]. Again, it is likely that over a 24-month
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period, changes in transcriptome or sncRNA populations due to these environmental factors
would not have an outsized impact on one pool over another, as samples were constructed by
pooled together several different IVF and scNT sessions from a range of seasons and time frames.
In addition to environmental differences, the sex of the embryo can contribute to both changes in
the mRNA population [15], as well as differences in miRNA profiles [16]. While the changes in
transcription and the sncRNA profile originating from genetic sex would not occur until the
embryonic genome activation (EGA), they also would not be present in scNT embryos, which
were all genetically the same male. The sexual dimorphism of miRNAs and mRNA may explain
some of the variability seen in IVF embryos in comparison to scNT embryos, although sexual
dimorphism would not be expected in embryos collected prior to EGA.
Culture conditions are another possible source of differences between the studies detailed
in Chapters 2 and 3. The investigations described in Chapter 2 utilized Charles Rosenkrans 2
medium (CR2) in larger volumes (500 µl) to negate the need for oil incubation, while the studies
of Chapter 3 utilized smaller volumes (50 µl) of synthetic oviductal fluid (SOFaa) medium under
mineral oil. Embryos secrete factors to communicate with the maternal environment, and those
factors may influence other embryos when co-cultured as groups in vitro. The resulting embryodriven modification of the in vitro culture environment can be either beneficial or negative.
Overall, group culture of embryos is beneficial for development, although poor-quality embryos
may secrete molecules that negatively impact the development of the other co-cultured embryos
[17-20]. Both human and bovine embryos secrete miRNAs into culture media, and specific
miRNAs may be used as biomarkers of embryo quality and developmental competence [21, 22].
Thus, populations of sncRNA may also be impacted by group culture of embryos. While
embryos were group cultured in both experiments for this dissertation, the embryo-to-media ratio
was different, which has been shown to impact development rates [23]. A higher ratio of embryo
volume to media volume (as in Chapters 3-4) would lead to greater concentrations of these

326
secreted factors in the medium, potentially leading to greater impact on embryo development and
variability in sncRNA profiles. Additionally, in Chapters 3-4, the embryos were also co-cultured
with cumulus cells that had been stripped from the donor oocytes. Cattle cumulus cells exhibit
highly variable expression of miRNAs, although these varying patterns of miRNAs do not
correlate with quality of the associated oocyte [24]. In addition, cumulus-oocyte-complexes have
been shown to express specific populations of miRNA [25]. It is possible that when cumulus
cells are co-cultured with embryos, high variability in cumulus cell miRNA expression could
cause higher variability in miRNA expression of co-cultured embryos. In addition to sncRNA
populations, cumulus cell mRNA transcriptomes vary from oocyte to oocyte, and specific mRNA
expression can be correlated with improved oocyte quality [26, 27]. It is possible that with
embryo and cumulus cell cross talk, co-culture of early embryos with cumulus cells originating
from a large group of oocytes could impact the transcriptome or sncRNA populations of these
embryos. The use of cumulus cells collected from each batch of matured oocytes introduces a
culture variable that was not defined, and there may have been significant differences between
each culture batch that contributed to some of the observed variation in sncRNA. Though the
nuclear donor bibroblast cells were derived from the same primary cell culture line, cultured in
the same cell medium under the same culture conditions, and consistently collected at passages 57, these cells showed higher variability than expected with respect to their sncRNA profiles.
However, this pattern was not apparent for the fibroblast transcriptomes. The source of this
sncRNA variability in the fibroblast samples needs to be established. Another open question is
whether cell-to-cell variability of the nuclear donor cell impacts cloning rates, and what
functional role such variability may play in the fibroblasts [28]. The lack of variability in the
majority of other sample types suggests that the variability noted in the fibroblast samples was
not technical noise, and the very tight clustering and similarities between the transcriptome data
in sample types suggests that these samples were not abnormal. However, sncRNA may be more
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variable then mRNA, and perhaps mechanisms mediating expression of these molecules are more
sensitive in some cells types to differing culture conditions.
A follow-up project is in progress that utilizes the supplementation of scNT embryos with
miRNA mimics to determine whether artificial induction of specific miRNAs that were
determined to be deficient in scNT morula stage embryos will improve developmental
competence and repress predicted target transcripts. MiRNA mimics are synthetic miRNAs that
contain the same sequences as our miRNAs of interest, and these mimics should functionally act
to degrade the same mRNA molecules as endogenously-produced miRNAs. We will quantify
mRNA and protein levels of predicted targets of miR-34a (SATB2) and miR-345 (KLF5) to
assess the function of these miRNA in early development. Observations from this follow-up
study will provide important information as to whether these selected miRNAs have a functional
role in early development and confirm whether they indeed bind to and degrade the predicted
target transcripts.
While functional examination of differentially expressed miRNAs is of great interest for
future study, the work presented in this dissertation provided novel techniques and findings that
enhanced the field of somatic cell nuclear transfer. These findings provided a better
understanding of the dynamics of sncRNA populations in IVF and scNT bovine embryos through
the MET and highlighted some miRNAs that may be used to increase developmental competence
of these embryos. The first publication from our group demonstrated that cattle miRNAs and
other sncRNAs are dynamically regulated with large-scale population changes occurring through
the MET [29]. Other researchers, who quantified only a fraction of the total miRNA population,
also found dynamic changes in miRNA molecules in pre-implantation cattle embryos, including
miRNA increases at the 8-call stage [30, 31]. While numerous studies have compared differences
in specific miRNAs in scNT and IVF cattle embryos at more advanced stages of embryonic or
fetal development [32, 33], those studies did not employ a global approach and, therefore, likely
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missed many miRNAs of potential biological importance. Those earlier studies also failed to
assess other populations of sncRNA and did not address dynamic changes in sncRNA through the
MET. Most importantly, no other study has isolated sncRNA and mRNA from the same samples
in order to link alterations in sncRNAs, specifically miRNAs, to differential transcript abundance.
The identification of sncRNA populations, including tRNA fragments, piRNAs, and miRNAs,
that were differentially expressed through development or that were aberrant in scNT bovine
embryos provides valuable information for understanding early development. The results of this
study produced good quality data, showing that in-depth global analysis of sncRNA populations
and mRNA populations are possible from a much smaller pool of samples then has been used
previously in cattle. The large amount of data produced herein should provide ample opportunity
to pursue further assessment of sncRNA dynamics in early embryos as more tools become
available to assess tRNA fragments and piRNA function in early embryos.
While the main focus of the project was to identify differences in sncRNA expression
between scNT and IVF embryos, few miRNAs were found to differ significantly between IVF
and scNT bovine embryos, and a high amount of sncRNA expression variability was seen within
biological replicates. My dissertation research assessed average expression levels of sncRNA,
and high variability prevented a clear understanding of sncRNA changes between IVF and scNT
embryos and function. Gene expression is both signal and noise, and the idea that investigating
variability can shed light on regulatory control has been gaining traction [34]. Examining
biological variability itself can have high value in identifying genes that may demonstrate
distinctive patterns of variable expression, which could clarify potential functions and regulation
[35]. In support of this strategy, specific differences in protein variability have been found to be
strongly correlated to the mode of regulation and function of that protein [28]. New technologies
that allow quantification of single cell gene expression have been invaluable to identify specific
genes that may direct cell fate transitions [36, 37]. Researchers can now identify genes that have
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low expression variability, which may provide a marker for cell fate determination, as well as
genes with high variability, which may provide valuable information about the environmental
regulation of that gene [38-40]. A knowledge gap in developmental biology is the understanding
of patterns in gene expression variability and how variable expression might contribute to
function. Utilizing single cell technologies to examine variability in both transcripts and sncRNA
could improve understanding of how sncRNAs may be acting as regulators within the parameters
of an individual transcriptome in future studies. Studying variability can help identify key
regulators and offer valuable insights into the regulations of the transcriptional programs that
drive early development. Results could guide possible follow up studies that connect regulatory
pathways in early development. The transcriptional silence of the early embryo provides a
unique opportunity to examine how non-coding RNA mechanisms work together to achieve
developmental competence. While the data presented in this dissertation do not point to
widespread differences in sncRNA, they does provide an opportunity to better understand
regulation and variable expression patterns of sncRNA that may be critical in early development.
In addition to the further assessment of biological variability in sncRNA and mRNA
populations and how they may help us understand function in early development, further work is
needed to understand the role of technological noise and variability in our results as well. The
tools and protocols for sncRNA sequencing are much newer than for traditional mRNA
sequencing, and thus, these approaches have be subject to less technological development,
including optimization for applications using low inputs. In addition, library preparation of
sncRNA cannot include an amplification step prior to barcoding because these RNA molecules
are short and nucleotide differences would induce amplification bias. The inability to include an
amplification step necessarily limits the number of reads that can be sequenced when using a
small amount of starting material [41], as for early developing embryos. While the sncRNA
library was sequenced on the Ion Torrent using newer library preparation technologies, the
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mRNA library was prepared using a kit specifically designed for low biological input and
sequenced using the newer technology of the Illumina Miseq. Differences in data quality
produced via these two technologies have been shown [42], which may have impacted our ability
to directly compare miRNA to predicted target mRNA in the most accurate way possible.
In addition, studies that aim to elucidate the complex miRNA-mRNA regulatory
relationship in early embryonic development would be incredibly valuable. Further work is also
needed to understand the timing of miRNA-mediated degradation of target mRNAs. Each of our
stages assessed represents a snapshot in development, and whether or not the timing of this
snapshot was accurate to capture miRNA-mediated mRNA degradation is unknown.
Destabilization of mRNA explains 66% to more than 90% of miRNA-mediated repression
regardless of the specific miRNA, the cell type, the cell growth conditions, or the translational
state of the mRNA [43]. Due to the possibility of delayed degradation of target mRNAs,
additional studies that utilize additional stages of development, such as the 4-cell stage, 16-cell
stage, compact morula, and expanded blastocyst stage embryos, could be very useful for more
closely examining the dynamic relationship between miRNA and mRNA. Because of these
unknowns, the lack of negative correlation between miRNA and mRNA targets may be a
reflection of the early embryo’s specialized mRNA degradation pathways, and it is possible that
functional binding, repression, and degradation are in fact occurring. Further functional follow
up is needed to better understand the dynamics of miRNA binding and mRNA degradation in the
context of the early embryo.
Luciferase binding assays could be used to identify the mRNA binding targets of specific
miRNAs in the context of the developing embryo. However, luciferase binding assays would
only demonstrate that the miRNA has the potential to bind the mRNA 3’ UTR and would not
reveal whether RNA binding proteins are blocking binding and degradation of targets [44, 45].
Once mRNA targets are identified via luciferase binding assay, the use of a miRNA mimic to
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assess actual binding in an early embryo context would be appropriate. If the target transcript and
associated protein of the miRNA mimic are reduced with mimic supplementation, it would be
important to identify whether or not the same results are found in both IVF and scNT embryos.
In any cases where the miRNA mimic does not successfully reduce transcripts or protein
abundance, follow up work that utilizes an RNA-protein crosslink, RNA pull-down, or shotgun
proteomics approach to isolate and assess any proteins that may be bound to the mRNA may help
identify why miRNAs and their targets can both be present at high levels in the embryo and
whether this is the result of RNA binding proteins [46]. In addition, continued work to identify
biologically relevant targets outside of the bioinformatically predicted targets would be
beneficial, as individual miRNAs can regulate hundreds of genes using a complex degradation
code [47, 48].
In conclusion, this research provided valuable new information on changes in the
sncRNA population and mRNA transcriptome in scNT embryos that may be contributing to the
low rates of reproductive success. Although few individual miRNAs were found to be statistically
different between scNT and IVF embryos and there was limited negative correlation in the
relative abundance of these miRNAs and their putative mRNA targets, some interesting
differences in the pattern of miRNA expression between stages of early developmental were
found. To our knowledge, this research project is the first to utilize a global, unbiased approach
to quantify sncRNAs and mRNAs from the same samples and to compare sncRNA expression
between scNT and IVF embryos through the MET. Limitations in our studies included different
culture conditions used in the two sncRNA sequencing investigations and the lack of functional
testing of miRNAs. Future studies should focus on identifying patterns of variability within
populations of sncRNAs to identify functionally significant sncRNAs of possible function, to
identify which target mRNAs are bound by miRNAs in early development, and to explore the
roles of RNA binding proteins in miRNA function in this opening period of development.
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changes in small non-coding RNAs
Dear Dr. Benninghoff,
Congratulations! We are pleased to accept your manuscript for publication. The PDF version of the article will be published
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to publish. (N.B. If you are a UK-based author and are looking to comply with the HEFCE policy on open access in the
Research Excellence Framework, you should use the official acceptance date when depositing in your repository.)
Also, beginning 12 months after the date of final publication, all articles published in Biology of Reproduction will be covered
by a Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC). Authors whose funding agency
requires access earlier than the 12-month embargo must choose an open-access option. Upon final publication, Open Access
articles will be publicly available on the journal site and, if required, deposited to PMC/I with a 6 month embargo and
published with CC BY-NC license in accordance with funding agency policy. Articles may be shared or adapted--provided that
the original source is credited and changes are indicated. Under the CC BY-NC license, articles and material therein cannot be
used for commercial purposes.
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Appendix C
Supplementary File 2.1 Original and Processed miRNA Expression Data
Microsoft Office Excel document with original and processed data for miRNA
expression in oocytes, 8-cell stage embryos, and blastocyst stage embryos. Spreadsheets include
unmodified output data from miRDeep2, processed expression data (log (y ± 1) transformation,
calculation of ratio with respect to average oocyte RPM, and log2 transformation), and results of
ANOVA and pairwise statistical tests with FDR-adjusted P values. File accessible online at
https://doi.org/10.1093/biolre/ioy190.
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Appendix D
Supplementary File 2.2 Predicted mRNA Targets
for Differentially Expressed miRNAs.
Microsoft Office Excel document with lists of target mRNAs for over- or under
expressed miRNAs in 8-cell stage embryos compared to mature oocytes predicted using
TargetScan. This document also includes results of Metascape gene ontology, KEGG pathway
and Reactome pathway enrichment analyses, as well as ontology analysis using the DAVID
EASE platform. File accessible online at https://doi.org/10.1093/biolre/ioy190.
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Appendix E
Supplementary File 2.3 Differentially Expressed
sncRNAs and mapping of pilRNAs to transposable elements
Microsoft Office Excel document data for sncRNA expression in oocytes, 8-cell stage
embryos, and blastocyst stage embryos. Summary tables for sequence reads for snoRNA, snRNA,
pilRNA, mitochondrial rRNA, genomic rRNA, mitochondrial tRNA, genomic tRNA, and
miscellaneous sncRNA. Mapping of pilRNAs to TEs and analysis of sequence reads for
snoRNAs. File accessible online at https://doi.org/10.1093/biolre/ioy190.
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Appendix F
Supplementary File 3.1. Read Lengths and
Annotation Summaries of sncRNA
Microsoft Excel document detailing the read lengths and annotation results for small
RNA sequencing. This file includes multiple spreadsheets, as follows: “Read lengths” provides
the number of reads for each sample at 17 to 92 nt in length; “Annotation summary 17-32 nt”
provides the number of reads per sample for each classification category for those reads 17-32 nt
in length; and “Annotation summary 32+ nt” provides the number of reads per sample for each
classification category for those reads >32 nt in length.
For each spreadsheet, samples are named by the following convention: for embryo type,
in vitro fertilized (IVF) or somatic cell nuclear transfer (NT); and for developmental stage,
fibroblasts (Fb), oocytes (Oo), 2-cell stage embryo (2c), 8-cell stage embryo (8c), morula stage
embryo (Mo), blastocyst stage embryo (Bl), blastocyst derived cells (BSCs). Numbers indicate
the sample replicate.
This file is accessible online at https://doi.org/10.26078/8jjx-1v90.
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Appendix G
Supplementary File 3.2. Normalized and VarianceStabilized Values for Annotated sncRNAs
Microsoft Excel document detailing normalized and variance-stabilized reads generated
by RNA sequencing of small non-coding RNA from cattle embryos. This file includes two
spreadsheets, the first providing the normalized reads per sequence per sample and the second
providing the variance-stabilized reads per sequence per sample. The first column (starting row
4) for each spreadsheet provides the identifier(s) of the mapped sequence, and the remaining
columns provide values for each sample ID.
Supplementary file 2 row definitions.
ID
Assigned sample ID
Sample type
Indicates whether the sample was IVF or scNT embryo, or
fibroblast or oocyte samples
Developmental stage
Indicates the developmental stage at which the sample was
acquired, as applicable
Abbreviations are: for embryo type, in vitro fertilized (IVF) or somatic cell nuclear
transfer (NT); and for developmental stage, fibroblasts (Fb), oocytes (Oo), 2-cell stage embryo
(2c), 8-cell stage embryo (8c), morula stage embryo (Mo), blastocyst stage embryo (Bl),
blastocyst derived cells (BSCs).
This file is accessible online at https://doi.org/10.26078/8jjx-1v90.
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Appendix H
Supplementary File 3.3. Results of DESeq2 Analyses
for miRNAs, tRNA Fragments and piRNAs
Microsoft Excel document with results of DESeq2 differential expression analysis
comparing scNT vs IVF embryos at each developmental stage and sequential comparisons of
developmental stage for both IVF and scNT embryos. This file includes three spreadsheets
providing results of DESeq2 analyses for miRNAs, tRNA fragments and piRNAs. For each
spreadsheet, the pairwise comparisons are noted with the two naming conventions. First, for
sequential comparisons by stage: “embryo type: sample A vs. sample B” (e.g., IVF: Oo vs 2c).
Second, for comparisons of scNT vs IVF embryos at a specific stage: “scNT vs IVF: stage” (e.g.,
scNT vs IVF: Mo). Abbreviations are: for embryo type, in vitro fertilized (IVF) or somatic cell
nuclear transfer (NT); and for developmental stage, fibroblasts (Fb), oocytes (Oo), 2-cell stage
embryo (2c), 8-cell stage embryo (8c), morula stage embryo (Mo), blastocyst stage embryo (Bl),
blastocyst derived cells (BSCs).
For each comparison, results of the DESeq2 analyses are provided as outlined below:
Supplementary file 3 column definitions.
ID
Official sncRNA name, for sncRNA type (miRNA, tRNA,
piRNA) indicated by spreadsheet tab
baseMean
The mean of normalized counts of all samples, normalizing
for sequencing depth
Log2FoldChange
Average log2 fold change calculated for comparison
indicated in the top row name
lfcSE
Log2 standard error of the calculated average log2 fold
change
stat
Wald statistic
P-value
Wald test unadjusted P-value
Padj
False discovery rate adjusted P-value using the BenjaminiHochberg method
For comparisons that did not yield any significant differences, no results are shown.
This file is accessible online at https://doi.org/10.26078/8jjx-1v90.

356
Appendix I
Supplementary File 3.4. TargetScan Prediction of mRNA
Targets for Differentially Expressed miRNAs
Microsoft Excel document providing results of TargetScan prediction of mRNA targets
for differentially expressed miRNAs. This file includes multiple spreadsheets, each providing the
results of the TargetScan prediction of mRNA targets for differentially expressed miRNAs. The
spreadsheets are labeled according to the specific comparison made. For comparisons of scNT vs
IVF embryos at a specific stage: “scNT vs IVF at stage” (e.g., scNT vs IVF at Mo). For
sequential comparisons by stage: “stage A vs stage B for embryo type” (e.g., Oo vs 2c for IVF).
Abbreviations are: for embryo type, in vitro fertilized (IVF) or somatic cell nuclear
transfer (NT); and for developmental stage, fibroblasts (Fb), oocytes (Oo), 2-cell stage embryo
(2c), 8-cell stage embryo (8c), morula stage embryo (Mo), blastocyst stage embryo (Bl),
blastocyst derived cells (BSCs).
Supplementary file 4 column definitions.
Ortholog of target gene
Gene symbol of predicted target gene
Representative transcript
Ensembl ID for representative transcript of predicted target
gene
Gene name
Name of predicted target gene
Representative miRNA
ID of the miRNA molecule querried
Cumulative weighted context++
Score that quantifies the predicted efficacy of the miRNA
score
binding sites
Total context++ score
Score that is predictive for all types of interactions,
including those of miRNAs that are not highly conserved
miRNA family
The ID for the family of miRNA molecules to which this
specific miRNA belongs
This file is accessible online at https://doi.org/10.26078/8jjx-1v90.
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Appendix J
Supplementary File 3.5. Results of Metascape Ontology Analyses
for Predicted mRNA targets of differentially Expressed miRNAs
Microsoft Excel document providing results of Metascape ontology analysis for
biological processes associated with differentially expressed miRNAs. This file includes multiple
spreadsheets, each providing the results of the Metascape ontology enrichment analysis. The
spreadsheets are labeled according to the specific comparison made. For comparisons of scNT vs
IVF embryos at a specific stage: “scNT vs IVF at stage” (e.g., scNT vs IVF at Mo). For
sequential comparisons by stage: “stage A vs stage B for embryo type” (e.g., Oo vs 2c for IVF).
Abbreviations are: for embryo type, in vitro fertilized (IVF) or somatic cell nuclear
transfer (NT); and for developmental stage, fibroblasts (Fb), oocytes (Oo), 2-cell stage embryo
(2c), 8-cell stage embryo (8c), morula stage embryo (Mo), blastocyst stage embryo (Bl),
blastocyst derived cells (BSCs).
Supplementary file 5 column definitions.
GroupID
Indicates whether the term is a member of the cluster of
terms, or the term that serves as the overall label (summary)
Category
Specifies the type of ontology term (biological process,
cellular compartment, or molecular function)
Term
Accession number for the ontology term
Description
Descriptive name of the ontology term
LogP
Log10 p value
Log(q-value)
Log10 of the false discovery rate-corrected p-value (the qvalue)
InTerm_InList
Number of genes within the query set that are annotated by
that term/number of genes in the complete list for that term
Genes
Gene ID accession numbers for all genes that were
annotated with that term
Symbols
Gene symbols for all genes that were annotated with that
term
This file is accessible online at https://doi.org/10.26078/8jjx-1v90.
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Appendix K
Supplementary File 3.6. Mapping of piRNAs to Transposable Elements
Microsoft Excel document providing results of ProTrac mapping of putative piRNAs to
transposable elements in the bovine genome. This file includes two spreadsheets providing
results of mapping of piRNAs to transposable elements in the bovine genome in either the
forward, “TE mapping (+)”, or reverse, “TE mapping (-)” directions.
Abbreviations are: for embryo type, in vitro fertilized (IVF) or somatic cell nuclear
transfer (NT); and for developmental stage, fibroblasts (Fb), oocytes (Oo), 2-cell stage embryo
(2c), 8-cell stage embryo (8c), morula stage embryo (Mo), blastocyst stage embryo (Bl),
blastocyst derived cells (BSCs). Numbers indicate the sample replicate.
This file is accessible online at https://doi.org/10.26078/8jjx-1v90.
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Appendix L
Supplementary File 4.1. Normalized Reads for Annotated mRNA Transcripts
Microsoft Excel document providing normalized sequencing reads per sample. This file
provides the normalized reads per sample for transcripts >200 nt in length that mapped to the
bovine genome. The first column provides the Ensemble transcript accession.
Abbreviations are: for embryo type, in vitro fertilized (IVF) or somatic cell nuclear
transfer (NT); and for developmental stage, fibroblasts (Fb), oocytes (Oo), 2-cell stage embryo
(2c), 8-cell stage embryo (8c), morula stage embryo (Mo), blastocyst stage embryo (Bl),
blastocyst derived cells (BSCs). Numbers indicate the sample replicate.
This file is accessible online at https://doi.org/10.26078/svr1-5r53.
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Appendix M
Supplementary File 4.2. Results of DESeq2 Analyses for Annotated mRNAs
Microsoft Excel document with results of DESeq2 differential expression analysis
comparing scNT vs IVF embryos at each developmental stage and sequential comparisons of
developmental stage for both IVF and scNT embryos. This file includes three spreadsheets
providing results of DESeq2 analyses for mRNAs. For each spreadsheet, the pairwise
comparisons are noted with the two naming conventions. First, for sequential comparisons by
stage: “embryo type: sample A vs. sample B” (e.g., IVF: Oo vs 2c). Second, for comparisons of
scNT vs IVF embryos at a specific stage: “scNT vs IVF: stage” (e.g., scNT vs IVF: Mo).
Abbreviations are: for embryo type, in vitro fertilized (IVF) or somatic cell nuclear
transfer (NT); and for developmental stage, fibroblasts (Fb), oocytes (Oo), 2-cell stage embryo
(2c), 8-cell stage embryo (8c), morula stage embryo (Mo), blastocyst stage embryo (Bl),
blastocyst derived cells (BSCs).
For each comparison, results of the DESeq2 analyses are provided as outlined below:
Supplementary file 2 column definitions.
ID
Ensemble transcript accession ID
baseMean
The mean of normalized counts of all samples, normalizing
for sequencing depth
Log2FoldChange
Average log2 fold change calculated for comparison
indicated in the top row name
lfcSE
Log2 standard error of the calculated average log2 fold
change
stat
Wald statistic
P-value
Wald test unadjusted P-value
Padj
False discovery rate adjusted P-value using the BenjaminiHochberg method
This file is accessible online at https://doi.org/10.26078/svr1-5r53.
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Appendix N
Supplementary File 4.3. Results of Metascape Ontology
Analyses for Differentially Expressed mRNAs
Microsoft Excel document with results of Metascape ontology analyses for biological
processes associated with predicted mRNA targets of differentially expressed miRNAs. This file
includes multiple spreadsheets, each providing the results of the Metascape ontology enrichment
analysis. The spreadsheets are labeled according to the specific comparison made. For
comparisons of scNT vs IVF embryos at a specific stage: “scNT vs IVF at stage” (e.g., scNT vs
IVF at Mo). For sequential comparisons by stage: “stage A vs stage B for embryo type” (e.g., Oo
vs 2c for IVF).
Abbreviations are: for embryo type, in vitro fertilized (IVF) or somatic cell nuclear
transfer (NT); and for developmental stage, fibroblasts (Fb), oocytes (Oo), 2-cell stage embryo
(2c), 8-cell stage embryo (8c), morula stage embryo (Mo), blastocyst stage embryo (Bl),
blastocyst derived cells (BSCs).
Supplementary file 5 column definitions.
GroupID
Indicates whether the term is a member of the cluster of
terms, or the term that serves as the overall label (summary)
Category
Specifies the type of ontology term (biological process,
cellular compartment, or molecular function)
Term
Accession number for the ontology term
Description
Descriptive name of the ontology term
LogP
Log10 p value
Log(q-value)
Log10 of the false discovery rate-corrected p-value (the qvalue)
InTerm_InList
Number of genes within the query set that are annotated by
that term/number of genes in the complete list for that term
Genes
Gene ID accession numbers for all genes that were
annotated with that term
Symbols
Gene symbols for all genes that were annotated with that
term
This file is accessible online at https://doi.org/10.26078/svr1-5r53.
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Appendix O
Supplementary File 4.4. Cytoscape Networks for Differentially
Expressed miRNAs and Their Predicted mRNA Targets
PDF document depicting Cytoscape networks for differentially expressed miRNAs and
their predicted targets. Networks depicted within this PDF document were created using data for
differentially miRNAs and their predicted mRNA targets (TargetScan total context ++ score
<−0.35) using Cytoscape with a force-directed layout. Only miRNAs within families annotated
by TargetScan as conserved or broadly conserved were included in the network analysis.
MiRNAs are represented by squares and target mRNAs as circles and both are shaded according
to their log2 fold change for the comparison indicated. Edges between miR and mRNA nodes
indicate that the connected mRNA is a predicted target of the miRNA in Bos taurus.
Abbreviations are: for embryo type, in vitro fertilized (IVF) or somatic cell nuclear
transfer (NT); and for developmental stage, fibroblasts (Fb), oocytes (Oo), 2-cell stage embryo
(2c), 8-cell stage embryo (8c), morula stage embryo (Mo), blastocyst stage embryo (Bl),
blastocyst derived cells (BSCs).
This file is accessible online at https://doi.org/10.26078/svr1-5r53.
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